data_2lai_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lai _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.422 ' O ' ' HD2' ' A' ' 82' ' ' TYR . 1.2 tp . . . . . 0 CA--C 1.552 1.031 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -116.7 -65.98 1.13 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.901 -0.136 . . . . 0.0 110.93 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 51.6 p -41.66 -50.21 4.17 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.748 1.219 . . . . 0.0 112.848 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.555 ' O ' HD13 ' A' ' 87' ' ' ILE . 8.5 t -62.86 -49.37 75.14 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 113.367 -1.742 . . . . 0.0 110.371 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.422 ' HD2' ' O ' ' A' ' 78' ' ' ILE . 64.3 m-85 -86.79 17.22 4.14 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.639 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.534 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 13.1 t -119.15 -17.47 8.92 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.405 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.54 164.91 22.59 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.768 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -88.68 117.84 27.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.026 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.23 68.13 1.21 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.284 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 81' ' ' SER . 2.4 tp -96.95 -29.05 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.635 ' HB3' ' O ' ' A' ' 139' ' ' GLY . 39.1 t60 . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.53 ' HA ' ' CD1' ' A' ' 120' ' ' TYR . 10.2 mt . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -130.28 -6.1 4.31 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -96.11 -43.42 7.76 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.81 -5.59 18.29 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.294 0.371 . . . . 0.0 111.892 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.53 ' CD1' ' HA ' ' A' ' 116' ' ' LEU . 36.0 m-85 -97.16 139.29 21.4 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.786 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.13 -58.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.523 2.149 . . . . 0.0 114.074 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.33 -60.73 0.08 OUTLIER Glycine 0 C--N 1.343 0.972 0 CA-C-O 118.919 -0.934 . . . . 0.0 113.596 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.27 -31.98 69.18 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.078 2.519 . . . . 0.0 114.017 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.94 -41.81 97.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.38 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.422 ' O ' HG22 ' A' ' 129' ' ' VAL . 7.1 mt -70.54 -40.11 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.574 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.98 -24.12 66.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.793 0.437 . . . . 0.0 111.941 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -77.76 -45.09 25.64 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.407 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.7 mt -63.06 -47.24 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 122.844 0.457 . . . . 0.0 111.197 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 144' ' ' GLY . 5.3 m -58.64 -51.56 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.791 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.1 m -58.35 -39.03 78.4 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 m -71.38 -26.17 62.67 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.9 mt -85.65 -37.6 19.29 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -83.81 6.38 21.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.598 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.472 HH11 ' CE1' ' A' ' 135' ' ' HIS . 4.5 tmt_? -86.9 -42.82 12.9 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.28 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.534 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 88.5 m-70 -91.64 -25.38 19.18 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.982 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.2 t70 70.54 76.12 0.2 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.115 0.966 . . . . 0.0 110.535 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -101.02 130.02 46.95 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.503 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.69 -14.91 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 123.437 0.461 . . . . 0.0 111.695 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.635 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -96.76 -7.57 57.64 Favored Glycine 0 C--N 1.336 0.575 0 O-C-N 123.344 0.403 . . . . 0.0 112.293 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -130.02 1.59 4.77 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.363 0.665 . . . . 0.0 111.607 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -62.59 -27.39 69.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.003 0.521 . . . . 0.0 111.398 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.507 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 1.5 p30 -76.21 -39.06 55.59 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.441 0.463 . . . . 0.0 110.887 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.0 tp -64.07 -59.97 3.81 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.885 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.521 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -58.41 -56.3 25.99 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.799 -0.637 . . . . 0.0 114.66 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.4 -41.84 76.98 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.507 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -65.98 -40.25 91.05 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.929 0.143 . . . . 0.0 111.357 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 22.0 mt -69.85 -27.9 65.23 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.336 0.398 . . . . 0.0 110.781 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -95.6 5.56 51.16 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 123.142 0.276 . . . . 0.0 110.937 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -85.38 -2.71 58.39 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.329 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.627 179.575 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.5 tp . . . . . 0 CA--C 1.551 1.012 0 CA-C-O 121.15 0.5 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 83' ' ' SER . 7.1 tp10 -119.8 -53.89 2.17 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.137 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.1 m -56.46 -56.78 16.89 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.419 0.688 . . . . 0.0 112.235 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.8 m -59.51 -55.81 29.86 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.289 0.368 . . . . 0.0 111.043 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.43 ' CE1' HG21 ' A' ' 128' ' ' ILE . 2.1 m-85 -61.43 -11.88 12.29 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 8.3 t -87.94 -40.09 14.21 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.624 0.193 . . . . 0.0 111.324 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.71 152.62 30.56 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -82.88 131.56 35.19 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.081 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.78 28.05 5.79 Favored Glycine 0 C--N 1.336 0.536 0 O-C-N 123.731 0.644 . . . . 0.0 112.783 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.584 ' O ' HD11 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -91.51 -19.54 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 122.735 0.414 . . . . 0.0 111.049 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.8 p80 . . . . . 0 CA--C 1.547 0.832 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.641 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.503 HD21 ' CE2' ' A' ' 120' ' ' TYR . 3.0 mp . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -98.87 146.6 25.8 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.142 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt 70.77 -34.59 0.3 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.455 1.102 . . . . 0.0 112.889 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.5 -31.78 19.78 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.503 ' CE2' HD21 ' A' ' 116' ' ' LEU . 13.6 m-85 -88.82 158.14 48.01 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 119.241 -0.409 . . . . 0.0 111.095 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.67 -44.43 0.14 Allowed 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.412 2.074 . . . . 0.0 113.832 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.35 -59.58 0.42 Allowed Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.9 -0.944 . . . . 0.0 113.508 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.09 -18.03 41.48 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.905 2.403 . . . . 0.0 114.049 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -78.13 -40.03 39.38 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.299 0.374 . . . . 0.0 111.254 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 129' ' ' VAL . 6.1 mt -68.71 -33.14 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.626 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -69.43 -50.53 44.82 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.466 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -51.77 -44.52 63.39 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.617 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.514 ' O ' HD13 ' A' ' 132' ' ' LEU . 23.7 mt -63.61 -57.02 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 122.356 0.262 . . . . 0.0 111.546 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 125' ' ' ILE . 5.0 m -55.49 -45.07 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.8 t -64.38 -30.1 71.15 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 22.8 m -72.78 -34.91 67.25 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.994 0.184 . . . . 0.0 111.349 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.67 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 0.9 OUTLIER -75.02 -28.86 60.66 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.154 0.284 . . . . 0.0 111.336 178.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -90.01 18.93 5.28 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.373 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -109.97 -41.31 4.51 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.38 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.67 ' NE2' ' HA ' ' A' ' 132' ' ' LEU . 5.7 p80 -87.21 -41.98 13.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.94 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 70.95 81.06 0.16 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.254 1.022 . . . . 0.0 112.015 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.515 ' HG2' ' CE1' ' A' ' 135' ' ' HIS . 10.3 pt-20 -128.23 139.79 52.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.645 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.98 -13.5 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.709 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -79.76 -28.77 50.04 Favored Glycine 0 C--N 1.34 0.792 0 O-C-N 123.341 0.4 . . . . 0.0 113.849 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -123.11 1.95 9.22 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -58.79 -25.18 62.87 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.953 0.501 . . . . 0.0 112.22 179.427 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.566 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 7.6 m-20 -81.43 -32.99 32.42 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.784 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.8 tp -68.61 -56.84 6.9 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.532 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.82 -48.28 87.04 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.851 -0.613 . . . . 0.0 114.153 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.7 -41.49 86.4 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.566 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 14.4 mptt -65.45 -34.57 78.61 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 30.8 mt -72.83 -30.89 64.4 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.205 0.316 . . . . 0.0 111.616 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.492 ' O ' ' HD2' ' A' ' 148' ' ' ARG . 1.8 tmm_? -87.67 -19.64 27.4 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 123.173 0.296 . . . . 0.0 111.189 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.49 22.65 3.33 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 123.382 0.426 . . . . 0.0 111.153 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.513 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.932 179.867 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.474 ' O ' HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.8 0 CA-C-O 120.642 0.258 . . . . 0.0 110.379 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -75.13 -53.35 9.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.099 0.56 . . . . 0.0 111.974 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.495 ' O ' ' HB2' ' A' ' 83' ' ' SER . 37.3 m -49.57 -47.9 48.99 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.097 0.959 . . . . 0.0 112.815 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.9 p -54.65 -58.64 6.72 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.523 0.514 . . . . 0.0 111.943 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -74.45 -4.79 38.74 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.561 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 4.4 m -78.65 -37.01 43.01 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.85 0.46 . . . . 0.0 110.987 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.98 161.93 12.21 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.91 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -96.36 98.25 10.12 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.602 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.76 60.04 0.16 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.876 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.483 HG23 ' OE2' ' A' ' 137' ' ' GLU . 3.9 tp -86.44 -31.3 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 122.43 0.292 . . . . 0.0 111.181 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.8 t60 . . . . . 0 N--CA 1.466 0.369 0 O-C-N 123.387 0.43 . . . . 0.0 109.997 179.408 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.513 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 4.6 mt . . . . . 0 C--O 1.238 0.47 0 CA-C-O 120.748 0.309 . . . . 0.0 111.766 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 116' ' ' LEU . 36.0 mmtt -157.86 -48.64 0.06 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.89 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -94.22 -43.72 8.31 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -83.71 0.37 47.38 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 123.177 0.298 . . . . 0.0 111.688 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -127.68 123.34 22.94 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.795 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -73.41 -49.61 0.21 Allowed 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.658 2.239 . . . . 0.0 113.871 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 172.81 -61.21 0.14 Allowed Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.94 -0.922 . . . . 0.0 113.556 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.96 -31.41 73.93 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.928 2.419 . . . . 0.0 113.926 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -70.5 -20.47 62.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.644 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 8.8 mt -95.1 -28.29 4.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.13 -36.49 84.19 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.745 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -77.73 -10.64 59.64 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.877 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.599 ' O ' ' HB2' ' A' ' 132' ' ' LEU . 96.6 mt -84.14 -41.9 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.633 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 144' ' ' GLY . 3.8 m -72.31 -38.29 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.132 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 21.2 t -71.77 -60.91 1.99 Allowed 'General case' 0 C--N 1.348 0.502 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.701 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.6 m -56.86 -25.11 55.81 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.599 ' HB2' ' O ' ' A' ' 128' ' ' ILE . 4.3 tt -74.77 -48.27 26.44 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.586 0.176 . . . . 0.0 111.191 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -96.29 13.18 28.43 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 120.873 0.368 . . . . 0.0 111.645 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 130' ' ' SER . 4.5 tmt_? -76.03 -42.17 48.65 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.561 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 21.2 m-70 -88.85 -111.6 0.07 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 176.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -123.17 -89.54 0.59 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 141' ' ' LYS . 3.7 mm-40 55.48 89.87 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.487 1.115 . . . . 0.0 111.262 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.25 -15.64 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.021 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -94.02 -31.26 8.21 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.42 ' O ' HD21 ' A' ' 132' ' ' LEU . . . -89.62 -16.92 29.47 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.106 0.562 . . . . 0.0 111.204 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 19.2 tptt -51.59 -28.83 15.24 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.424 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 1.3 p30 -78.34 -44.14 25.89 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.714 0.293 . . . . 0.0 110.495 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.4 tp -60.62 -66.55 0.51 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.964 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.419 ' O ' HG13 ' A' ' 129' ' ' VAL . . . -49.54 -34.71 20.62 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.332 177.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.72 77.71 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 117.218 0.509 . . . . 0.0 112.104 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.424 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -66.78 -50.55 62.3 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.1 0.25 . . . . 0.0 110.685 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 26.9 mt -61.79 -28.43 69.45 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.225 0.328 . . . . 0.0 111.423 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -80.77 -38.15 29.07 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 123.369 0.418 . . . . 0.0 110.773 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.83 0.27 27.76 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.239 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.499 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.474 ' O ' HG22 ' A' ' 131' ' ' THR . 0.2 OUTLIER . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 121.443 0.64 . . . . 0.0 111.209 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 83' ' ' SER . 7.0 tp10 -120.87 -55.68 1.98 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.428 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 m -64.49 -58.94 5.0 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.6 m -53.21 -62.06 1.9 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.443 ' CD2' HG12 ' A' ' 87' ' ' ILE . 44.9 m-85 -51.64 -33.51 33.79 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 178.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 6.3 t -65.78 -33.73 76.54 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.22 174.58 0.13 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.261 0.624 . . . . 0.0 112.643 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -98.22 119.04 36.18 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.198 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.04 51.14 1.66 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.058 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.443 HG12 ' CD2' ' A' ' 82' ' ' TYR . 3.8 tp -85.54 -42.29 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 122.47 0.308 . . . . 0.0 111.189 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 59.1 t60 . . . . . 0 CA--C 1.55 0.95 0 CA-C-O 121.235 0.54 . . . . 0.0 111.939 179.644 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.501 HD23 ' CZ ' ' A' ' 120' ' ' TYR . 9.2 mt . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 120.985 0.422 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -134.07 3.4 3.43 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.973 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.9 -48.96 13.63 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.44 10.48 6.74 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 123.394 0.434 . . . . 0.0 111.03 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.501 ' CZ ' HD23 ' A' ' 116' ' ' LEU . 63.5 m-85 -97.51 105.26 24.76 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.693 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.3 -35.38 14.11 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.653 2.236 . . . . 0.0 113.621 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 157.64 -56.85 0.37 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.868 -0.962 . . . . 0.0 113.122 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.16 -22.72 41.29 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.887 2.391 . . . . 0.0 114.028 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -74.31 -39.69 62.73 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.296 0.372 . . . . 0.0 111.293 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.0 mt -78.16 -30.91 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.371 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -62.38 -52.51 63.3 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.339 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.443 ' O ' ' OG1' ' A' ' 131' ' ' THR . 76.9 mtt180 -55.94 -27.72 53.65 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 177.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 69.2 mt -70.9 -50.48 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 121.999 0.12 . . . . 0.0 111.022 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.4 m -60.37 -39.72 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 43.2 p -78.73 -18.19 54.67 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 78' ' ' ILE . 89.1 m -86.62 -28.67 23.1 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 122.883 0.114 . . . . 0.0 111.224 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 144' ' ' GLY . 1.7 mp -80.43 -46.27 16.25 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.087 0.242 . . . . 0.0 110.444 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.413 ' OE1' ' HG2' ' A' ' 148' ' ' ARG . 44.4 mt-10 -80.18 12.87 2.59 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.881 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 130' ' ' SER . 4.6 tmt_? -79.71 -46.18 17.57 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.218 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.582 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 3.9 p80 -110.22 -12.45 14.47 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 70.31 78.83 0.19 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.337 1.055 . . . . 0.0 111.935 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.582 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 0.2 OUTLIER -99.77 130.44 45.98 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.923 179.08 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.89 -7.62 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.025 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -93.08 -22.11 28.5 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.512 -0.375 . . . . 0.0 112.705 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -126.93 5.25 6.56 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.18 -33.83 59.05 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.039 0.536 . . . . 0.0 111.753 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.561 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 3.1 t70 -74.95 -34.95 62.12 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.47 0.481 . . . . 0.0 111.232 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.9 tp -69.05 -59.61 2.92 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.825 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.439 ' N ' HD22 ' A' ' 132' ' ' LEU . . . -55.43 -56.25 24.44 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.852 -0.613 . . . . 0.0 113.934 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . -54.94 -43.63 73.57 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.561 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 14.3 mptt -62.24 -41.13 98.15 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.922 0.139 . . . . 0.0 111.246 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.4 mt -59.47 -34.42 72.54 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.44 0.463 . . . . 0.0 111.622 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 145' ' ' ALA . 0.1 OUTLIER -94.17 7.3 45.77 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 120.656 0.265 . . . . 0.0 111.029 178.544 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -108.18 17.65 22.02 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.245 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.447 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.976 179.963 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.56 1.335 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -120.38 -77.99 0.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 35.2 m -41.63 -47.55 3.92 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.313 1.045 . . . . 0.0 112.715 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.4 t -61.54 -51.61 67.87 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.806 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -88.37 17.98 4.83 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.392 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m -119.73 -15.88 8.85 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.997 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.34 154.74 17.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.169 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.6 133.67 37.27 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.504 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 94.44 34.12 6.5 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.669 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.7 tp -89.31 -24.06 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 29.2 p-80 . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.269 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.5 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 6.2 mt . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -91.64 141.23 28.93 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.213 0.321 . . . . 0.0 111.062 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.2 mptt 70.64 -35.68 0.33 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.348 1.059 . . . . 0.0 113.018 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.99 -18.09 20.51 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 122.252 0.221 . . . . 0.0 111.324 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.507 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 19.3 t80 -133.57 50.55 5.48 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 123.335 0.397 . . . . 0.0 111.315 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.507 ' HD3' ' N ' ' A' ' 120' ' ' TYR . 3.5 Cg_exo -76.19 111.18 3.22 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.26 1.973 . . . . 0.0 112.287 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -172.91 -160.55 21.69 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.713 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.665 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 12.5 Cg_exo -70.29 -34.83 12.12 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 123.295 2.663 . . . . 0.0 112.803 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -56.09 -30.69 62.41 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.492 0.495 . . . . 0.0 111.62 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.451 HD13 ' O ' ' A' ' 116' ' ' LEU . 46.4 mm -67.12 -44.53 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.642 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -68.9 -18.71 64.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.237 0.615 . . . . 0.0 111.243 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 123' ' ' PRO . 24.2 mmm180 -79.99 -46.63 16.32 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.604 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.4 mt -61.23 -49.33 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.916 0.487 . . . . 0.0 110.744 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 125' ' ' ILE . 7.0 m -58.68 -52.11 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.699 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 57.9 m -59.48 -38.41 80.77 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.2 m -72.69 -24.12 60.97 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 19.3 mt -85.66 -30.91 22.85 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.075 0.235 . . . . 0.0 111.406 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -84.97 5.1 30.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.15 0.5 . . . . 0.0 111.167 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -98.04 -36.22 10.18 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.442 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -85.36 -33.41 22.03 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.436 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 67.18 69.84 0.38 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.225 1.01 . . . . 0.0 111.492 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -95.82 136.68 35.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.49 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.2 m -75.23 -48.71 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -77.43 -2.12 78.53 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.176 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -122.53 -4.79 8.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.737 0.415 . . . . 0.0 111.386 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -62.28 -37.61 86.19 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 122.798 0.439 . . . . 0.0 111.013 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.492 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 8.1 m-20 -73.42 -38.16 65.65 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.482 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.3 tp -66.74 -55.91 12.91 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.75 0.42 . . . . 0.0 110.781 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.05 -41.65 85.65 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.483 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -61.51 -41.21 96.96 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.492 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -62.13 -38.05 87.49 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.141 0.275 . . . . 0.0 111.464 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.2 mt -66.41 -32.15 73.35 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.257 0.348 . . . . 0.0 110.328 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.41 12.47 31.19 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.423 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 5.4 t70 -106.47 43.32 1.16 Allowed 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.288 0.566 . . . . 0.0 110.375 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.503 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.661 179.826 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 tt . . . . . 0 CA--C 1.554 1.103 0 CA-C-O 120.732 0.301 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -120.18 -57.57 1.92 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.272 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.9 m -47.35 -46.84 25.98 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.191 0.996 . . . . 0.0 112.7 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.2 t -61.19 -53.04 61.91 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.887 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -79.62 5.28 13.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.926 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.508 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 23.3 t -91.32 -47.45 7.47 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.943 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.98 160.21 4.97 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -92.07 92.13 8.13 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.219 0.533 . . . . 0.0 110.921 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.5 48.31 0.05 OUTLIER Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.98 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.494 HG21 ' OE1' ' A' ' 137' ' ' GLU . 2.7 tp -91.84 -29.62 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 122.623 0.369 . . . . 0.0 111.929 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.434 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 32.4 t60 . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.4 mp . . . . . 0 C--O 1.236 0.367 0 CA-C-O 120.528 0.204 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 71.02 -3.48 2.02 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.376 1.07 . . . . 0.0 112.759 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -97.43 -45.1 6.57 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.396 0.278 . . . . 0.0 110.69 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.46 7.34 1.93 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.834 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -92.93 114.13 61.76 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.618 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.55 177.85 1.12 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.709 2.273 . . . . 0.0 112.863 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.68 -55.58 14.15 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.878 -0.957 . . . . 0.0 113.87 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.5 -15.17 39.51 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.732 2.288 . . . . 0.0 113.762 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.416 ' O ' HG13 ' A' ' 128' ' ' ILE . 3.2 t70 -80.05 -41.35 25.86 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.553 0.341 . . . . 0.0 111.021 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.0 mt -67.7 -39.11 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.472 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.8 -50.65 65.89 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.183 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -49.34 -40.67 36.27 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.828 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 124' ' ' ASP . 29.0 mt -66.64 -54.59 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.142 0.177 . . . . 0.0 111.436 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 144' ' ' GLY . 4.2 m -60.23 -51.78 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.571 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 75.2 m -62.91 -25.49 68.35 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.2 m -83.28 -26.0 31.06 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 117.54 0.154 . . . . 0.0 111.297 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.5 mt -81.15 -38.55 26.99 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.592 0.234 . . . . 0.0 111.031 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -88.45 8.81 26.1 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.822 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.571 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.1 tmt_? -82.17 -40.63 21.51 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.987 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.508 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 87.6 m-70 -100.4 -9.4 22.25 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.457 0.473 . . . . 0.0 111.298 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 67.67 70.21 0.35 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.178 0.991 . . . . 0.0 111.326 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' A' ' 141' ' ' LYS . 43.5 mt-10 -90.7 129.13 36.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.437 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.16 -45.15 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -76.16 -18.53 79.29 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.579 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.62 -11.58 17.61 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 124.041 0.495 . . . . 0.0 111.033 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -51.78 -34.76 41.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.643 0.777 . . . . 0.0 112.461 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.518 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 8.0 m-20 -74.57 -36.62 63.06 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.434 0.459 . . . . 0.0 111.495 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.434 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 14.3 tp -67.39 -60.24 2.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.74 0.416 . . . . 0.0 110.884 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.428 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -55.49 -43.6 85.42 Favored Glycine 0 C--N 1.343 0.947 0 O-C-N 123.618 0.574 . . . . 0.0 113.928 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -60.64 -43.6 97.35 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.518 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -61.97 -40.19 94.73 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.3 mt -67.11 -30.75 70.85 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 123.264 0.352 . . . . 0.0 110.302 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -94.25 9.84 36.44 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.367 0.417 . . . . 0.0 110.703 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 3.7 t70 -114.27 16.49 17.93 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.694 0.283 . . . . 0.0 111.082 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.611 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.826 179.736 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 tp . . . . . 0 CA--C 1.554 1.096 0 CA-C-O 121.114 0.483 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 83' ' ' SER . 37.5 tt0 -120.03 -60.82 1.66 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.835 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.5 m -52.17 -56.42 14.7 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.589 0.755 . . . . 0.0 112.196 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.0 p -60.59 -53.72 54.02 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.958 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.455 ' CE1' HG23 ' A' ' 128' ' ' ILE . 3.9 m-85 -69.21 -0.31 5.88 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.586 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 10.9 t -95.55 -43.48 7.93 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.51 161.96 26.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.271 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.628 ' HA ' ' OE1' ' A' ' 137' ' ' GLU . 19.3 mtpp -86.19 145.99 26.75 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.083 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.65 18.68 27.15 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.255 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.563 HD12 ' O ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -79.23 -19.36 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 122.528 0.331 . . . . 0.0 111.717 179.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.53 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 75.2 t60 . . . . . 0 CA--C 1.546 0.79 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.169 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.408 HD22 ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 120.943 0.401 . . . . 0.0 111.637 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -147.33 -39.3 0.19 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.527 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.06 -8.09 46.89 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.632 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.2 -46.61 10.91 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.236 0.335 . . . . 0.0 111.08 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -98.28 161.36 25.61 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 123.495 0.497 . . . . 0.0 110.902 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.17 -31.01 24.06 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.467 2.112 . . . . 0.0 113.419 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 152.1 -52.66 0.48 Allowed Glycine 0 CA--C 1.531 1.077 0 CA-C-O 118.781 -1.01 . . . . 0.0 113.751 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.87 -17.52 18.92 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.986 2.457 . . . . 0.0 114.847 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -74.93 -42.1 58.36 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.313 0.245 . . . . 0.0 111.453 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 129' ' ' VAL . 4.6 mp -62.7 -32.69 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.794 0.438 . . . . 0.0 110.667 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -70.19 -50.53 39.2 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.68 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.62 -46.26 70.38 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.455 HG23 ' CE1' ' A' ' 82' ' ' TYR . 23.3 mt -61.17 -59.36 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 122.532 0.333 . . . . 0.0 111.488 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 125' ' ' ILE . 16.5 m -53.42 -41.94 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 123.49 0.494 . . . . 0.0 112.078 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 12.9 t -68.25 -26.48 65.7 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.5 m -72.06 -40.8 68.06 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.238 0.215 . . . . 0.0 110.933 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.51 HD21 ' N ' ' A' ' 144' ' ' GLY . 4.1 mp -77.1 -24.54 51.76 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.283 0.365 . . . . 0.0 111.508 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -91.13 12.1 21.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.272 0.558 . . . . 0.0 110.324 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.9 tmt_? -118.95 -36.64 3.38 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.128 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.586 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 52.2 m-70 -90.18 -32.17 16.73 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.912 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.9 t70 60.62 61.16 1.77 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.064 0.945 . . . . 0.0 111.674 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.628 ' OE1' ' HA ' ' A' ' 85' ' ' LYS . 37.1 mt-10 -84.99 130.22 34.66 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.641 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.452 ' O ' ' HD2' ' A' ' 141' ' ' LYS . 3.4 t -79.8 -22.42 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.404 0.44 . . . . 0.0 111.645 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -87.09 -19.05 56.66 Favored Glycine 0 C--N 1.342 0.884 0 C-N-CA 121.424 -0.417 . . . . 0.0 112.742 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.89 3.25 11.05 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.893 0.477 . . . . 0.0 111.374 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER -48.05 -42.33 28.25 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.783 0.833 . . . . 0.0 112.617 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 2.4 p-10 -68.21 -40.96 81.98 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.532 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.53 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 32.6 tp -56.18 -51.92 66.26 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.56 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.51 ' N ' HD21 ' A' ' 132' ' ' LEU . . . -60.92 -60.78 7.84 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.923 -0.581 . . . . 0.0 113.654 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -54.97 -42.11 72.01 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -63.54 -32.81 74.39 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.112 0.258 . . . . 0.0 111.518 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.0 mt -70.82 -30.93 67.5 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.295 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' A' ' 148' ' ' ARG . 1.0 OUTLIER -98.93 4.47 47.37 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 123.153 0.283 . . . . 0.0 111.041 178.806 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 1.8 t70 -99.24 24.77 7.55 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.84 0.352 . . . . 0.0 111.2 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.453 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.022 179.885 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 tt . . . . . 0 CA--C 1.549 0.923 0 CA-C-O 120.644 0.259 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -103.96 -43.52 5.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.842 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 m -63.53 -63.06 1.28 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.4 t -45.24 -25.39 0.37 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -104.29 -10.9 17.5 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.8 t -91.91 -25.01 19.12 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.91 118.07 2.92 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.98 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.504 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 12.4 ptmt -60.64 105.61 0.46 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.86 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.23 75.58 1.3 Allowed Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.295 -0.866 . . . . 0.0 114.256 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.1 tt -106.65 -103.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.545 ' O ' ' HA3' ' A' ' 139' ' ' GLY . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 120' ' ' TYR . 5.2 mt . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 120.745 0.307 . . . . 0.0 111.501 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -92.47 -11.69 34.01 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.815 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -96.54 -38.4 10.0 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.108 0.255 . . . . 0.0 111.674 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.8 t -94.4 -42.45 8.87 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 123.316 0.385 . . . . 0.0 111.638 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.482 ' HB2' ' O ' ' A' ' 116' ' ' LEU . 6.3 m-30 -97.86 119.39 62.43 Favored Pre-proline 0 CA--C 1.543 0.707 0 O-C-N 123.429 0.455 . . . . 0.0 110.67 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.87 -48.81 0.35 Allowed 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.638 2.225 . . . . 0.0 114.041 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -171.03 -63.92 0.04 OUTLIER Glycine 0 C--N 1.342 0.891 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.448 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.08 -30.45 78.87 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.061 2.507 . . . . 0.0 113.85 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.8 -21.58 66.04 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.347 0.404 . . . . 0.0 111.977 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 6.9 mt -89.41 -50.13 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -45.53 -41.18 9.46 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.649 0.78 . . . . 0.0 112.082 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -62.17 -42.76 99.57 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.967 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.51 -61.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.962 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 144' ' ' GLY . 3.4 m -49.16 -31.27 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 18.3 t -76.76 -50.36 13.75 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.04 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.5 m -56.55 -33.89 66.55 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.5 mp -79.24 -48.99 13.2 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.645 0.202 . . . . 0.0 111.243 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -56.29 -20.41 18.58 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -79.58 -45.27 19.49 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.28 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.504 ' NE2' ' HA ' ' A' ' 85' ' ' LYS . 50.0 t-80 -64.97 -41.51 95.39 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 72.9 80.4 0.14 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.032 0.933 . . . . 0.0 111.162 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.844 ' O ' ' HB2' ' A' ' 141' ' ' LYS . 20.5 mt-10 -125.09 153.59 42.71 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.157 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.3 t -83.9 -40.23 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 88' ' ' HIS . . . -86.9 -15.49 62.96 Favored Glycine 0 N--CA 1.47 0.931 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.402 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -95.98 -17.47 20.98 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 113.832 -1.184 . . . . 0.0 109.771 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.844 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 3.2 tptm -70.04 -22.38 63.09 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 9.8 m-20 -81.17 -28.42 35.0 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.767 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.2 tp -76.51 -63.38 1.35 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.867 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.511 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -61.87 -26.59 67.32 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.529 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . -85.27 -39.81 17.31 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.581 0.691 . . . . 0.0 112.409 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -70.47 -31.85 69.15 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 121.331 -0.148 . . . . 0.0 111.009 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.7 mt -71.27 -45.12 63.88 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 123.126 0.266 . . . . 0.0 110.406 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -66.07 -21.67 66.38 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 178.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -95.56 -13.19 24.64 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 123.322 0.389 . . . . 0.0 111.378 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.193 179.307 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 78' ' ' ILE . 4.5 mp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 121.474 0.654 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -120.81 -89.41 0.6 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.695 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.9 m -54.04 -43.36 70.13 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.89 0.876 . . . . 0.0 112.602 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.493 ' O ' HG13 ' A' ' 87' ' ' ILE . 24.1 p -68.46 -41.14 80.63 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.71 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -94.33 13.05 24.83 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.247 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.3 t -110.02 -25.51 10.21 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.03 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.19 164.34 26.18 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.728 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -95.06 135.56 36.45 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.511 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.36 55.82 4.17 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.898 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.543 ' O ' HD11 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -113.61 -13.25 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.606 ' HB3' ' O ' ' A' ' 139' ' ' GLY . 61.5 t60 . . . . . 0 CA--C 1.54 0.562 0 CA-C-N 117.859 0.299 . . . . 0.0 111.732 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? 73.52 -0.27 3.42 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.203 1.001 . . . . 0.0 111.722 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.9 mmpt? -103.9 -33.47 8.84 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.018 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.28 -42.84 8.33 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.545 0.528 . . . . 0.0 111.27 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -85.55 159.27 55.94 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 119.336 -0.364 . . . . 0.0 111.425 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.83 -37.61 1.58 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.536 2.157 . . . . 0.0 113.389 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 160.94 -55.46 0.32 Allowed Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.776 -1.013 . . . . 0.0 113.646 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.58 -24.97 38.96 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.973 2.448 . . . . 0.0 114.364 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -65.63 -40.47 92.59 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.254 0.346 . . . . 0.0 111.327 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.561 ' O ' HG22 ' A' ' 129' ' ' VAL . 4.8 mp -69.25 -46.57 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.456 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -53.0 -39.03 62.81 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.145 0.578 . . . . 0.0 112.223 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -70.79 -48.44 54.25 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.378 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.2 mt -55.87 -48.86 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.088 0.555 . . . . 0.0 111.657 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 125' ' ' ILE . 4.9 m -61.66 -52.98 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.0 t -55.77 -51.59 66.88 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.3 m -60.13 -29.71 68.81 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.626 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 27.6 mt -79.25 -32.23 43.71 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -79.6 -4.95 53.87 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.307 0.243 . . . . 0.0 111.57 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -82.91 -47.14 12.12 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.887 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.626 ' NE2' ' HA ' ' A' ' 132' ' ' LEU . 9.2 p80 -85.03 -35.6 21.81 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.562 0.345 . . . . 0.0 111.584 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 t70 64.5 11.81 6.89 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.255 1.022 . . . . 0.0 113.622 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.53 ' HG2' ' CE1' ' A' ' 135' ' ' HIS . 12.7 pt-20 -47.09 153.29 0.46 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.98 -30.68 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.606 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -79.94 3.37 70.73 Favored Glycine 0 N--CA 1.466 0.645 0 O-C-N 123.374 0.421 . . . . 0.0 113.67 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -144.95 -3.49 0.77 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.388 0.675 . . . . 0.0 112.105 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.47 -42.24 70.43 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 123.822 0.849 . . . . 0.0 112.768 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 3.9 p-10 -65.98 -38.48 88.63 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.572 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.475 ' O ' HD13 ' A' ' 147' ' ' LEU . 44.6 tp -61.65 -50.63 71.73 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.44 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -62.69 -62.65 5.33 Favored Glycine 0 C--N 1.343 0.958 0 N-CA-C 115.171 0.828 . . . . 0.0 115.171 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -58.85 -36.91 75.36 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 14.1 mptt -71.97 -33.23 68.01 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.494 0.134 . . . . 0.0 111.326 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.475 HD13 ' O ' ' A' ' 143' ' ' LEU . 0.5 OUTLIER -72.92 -31.81 64.88 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 123.292 0.37 . . . . 0.0 110.845 177.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -79.75 -40.91 27.73 Favored 'General case' 0 C--N 1.348 0.523 0 O-C-N 123.415 0.447 . . . . 0.0 110.139 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -85.56 45.04 1.15 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.241 0.543 . . . . 0.0 111.446 179.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.528 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.941 179.922 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.527 ' HB ' ' CD1' ' A' ' 82' ' ' TYR . 1.6 pp . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -120.36 -59.11 1.8 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.338 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.9 m -62.33 -56.04 22.25 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.444 0.697 . . . . 0.0 112.86 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.8 m -56.51 -55.49 33.07 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.632 0.373 . . . . 0.0 111.937 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.527 ' CD1' ' HB ' ' A' ' 78' ' ' ILE . 36.2 m-85 -58.98 -27.99 65.91 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.9 t -70.82 -28.41 64.59 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.31 0.381 . . . . 0.0 110.608 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.77 171.45 11.59 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.561 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -100.02 78.59 2.11 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.224 0.535 . . . . 0.0 110.408 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 143.87 70.21 0.02 OUTLIER Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.411 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.5 tp -100.6 -29.66 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 122.44 0.296 . . . . 0.0 111.73 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.46 ' ND1' HD22 ' A' ' 143' ' ' LEU . 18.1 t60 . . . . . 0 C--O 1.235 0.335 0 O-C-N 123.154 0.284 . . . . 0.0 110.55 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.469 HD21 ' CE1' ' A' ' 120' ' ' TYR . 5.2 mt . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.112 0.482 . . . . 0.0 111.608 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -140.3 -40.24 0.43 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.644 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -94.93 -39.27 10.29 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.85 -6.39 59.1 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.254 0.346 . . . . 0.0 111.901 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.469 ' CE1' HD21 ' A' ' 116' ' ' LEU . 39.8 m-85 -123.75 134.32 25.23 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.683 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.15 -45.45 0.27 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.586 2.191 . . . . 0.0 113.646 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 163.1 -61.85 0.26 Allowed Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.887 -0.951 . . . . 0.0 112.957 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.28 -30.01 78.69 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.898 2.399 . . . . 0.0 113.516 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.36 -25.66 67.68 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.508 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.4 mt -86.88 -36.52 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.725 178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.25 -36.54 68.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.61 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -77.02 -11.04 59.75 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.189 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.9 mt -83.73 -47.66 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 144' ' ' GLY . 4.4 m -69.28 -34.68 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.628 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.5 t -66.58 -52.4 45.79 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.651 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.3 m -64.71 -27.51 68.96 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.54 ' HA ' ' CE1' ' A' ' 135' ' ' HIS . 30.1 mt -79.14 -39.79 32.62 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 129' ' ' VAL . 12.1 pt-20 -71.52 -6.82 43.44 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -79.17 -69.41 0.58 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.141 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.566 ' ND1' ' HG2' ' A' ' 137' ' ' GLU . 5.7 p80 -65.01 -35.5 81.38 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.4 t70 57.49 61.65 2.41 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.871 0.868 . . . . 0.0 111.641 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.566 ' HG2' ' ND1' ' A' ' 135' ' ' HIS . 11.1 pt-20 -107.14 139.02 42.23 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.409 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.3 153.09 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.848 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . 96.73 -17.94 58.38 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -138.78 -16.67 1.12 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.113 0.965 . . . . 0.0 111.055 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -68.92 -29.57 67.86 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 123.906 0.883 . . . . 0.0 111.235 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.565 ' O ' ' HG2' ' A' ' 146' ' ' LYS . 2.4 p-10 -72.13 -43.7 64.29 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.604 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.46 HD22 ' ND1' ' A' ' 88' ' ' HIS . 12.3 tp -58.11 -63.97 1.07 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.578 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.489 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -48.96 -43.67 31.36 Favored Glycine 0 C--N 1.345 1.043 0 O-C-N 123.959 0.787 . . . . 0.0 114.38 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.42 -45.32 84.73 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 142' ' ' ASP . 5.7 mmmt -63.18 -45.39 92.01 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.0 mt -58.17 -36.96 73.79 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.676 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -77.99 -39.29 42.77 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 120.647 0.261 . . . . 0.0 110.554 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.91 3.99 18.17 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.406 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.524 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.969 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.513 ' HB ' ' CD1' ' A' ' 82' ' ' TYR . 1.2 pp . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 121.44 0.638 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -120.42 -53.42 2.12 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.434 -178.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.5 m -56.71 -60.82 2.99 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.245 0.618 . . . . 0.0 112.506 -177.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.7 t -59.14 -53.99 52.11 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.082 0.239 . . . . 0.0 110.436 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.513 ' CD1' ' HB ' ' A' ' 78' ' ' ILE . 18.8 m-85 -57.16 -15.13 4.97 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.621 ' HA ' ' CD2' ' A' ' 135' ' ' HIS . 23.0 t -86.06 -34.96 20.56 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 122.459 0.304 . . . . 0.0 110.394 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.01 159.75 33.68 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.72 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.53 150.07 22.6 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.286 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 98.65 14.49 37.37 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.41 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.1 tt -77.14 -27.14 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.556 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 70.8 t60 . . . . . 0 CA--C 1.544 0.736 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.417 ' O ' HD11 ' A' ' 125' ' ' ILE . 12.8 mt . . . . . 0 N--CA 1.468 0.461 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -112.35 97.16 6.43 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.371 0.605 . . . . 0.0 110.499 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.8 tptt -179.89 -55.85 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.899 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.6 -4.53 2.28 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.273 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.497 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -88.41 -29.94 0.37 Allowed Pre-proline 0 CA--C 1.549 0.936 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.759 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 120' ' ' TYR . 88.1 Cg_exo -49.65 112.18 0.64 Allowed 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 122.734 2.289 . . . . 0.0 113.516 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 126' ' ' GLU . . . 149.95 -135.82 5.44 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.768 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.64 -32.37 83.19 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.164 2.576 . . . . 0.0 114.322 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.561 ' O ' HG13 ' A' ' 128' ' ' ILE . 8.4 m-20 -70.5 -49.64 46.25 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.417 HD11 ' O ' ' A' ' 116' ' ' LEU . 5.3 mt -71.27 -39.11 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 122' ' ' GLY . 10.8 pt-20 -59.68 -47.63 84.87 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.037 0.211 . . . . 0.0 110.871 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -57.0 -35.34 69.09 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.561 HG13 ' O ' ' A' ' 124' ' ' ASP . 53.3 mt -61.49 -57.2 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 123.095 0.247 . . . . 0.0 110.81 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 8.0 m -57.44 -38.68 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 123.475 0.484 . . . . 0.0 111.746 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.1 t -70.48 -20.22 62.88 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.3 m -77.6 -44.84 27.05 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.45 HD11 ' O ' ' A' ' 128' ' ' ILE . 3.2 mp -72.14 -27.19 62.45 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.782 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -89.03 10.78 20.36 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.205 0.526 . . . . 0.0 110.551 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -115.93 -31.16 5.84 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.345 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.621 ' CD2' ' HA ' ' A' ' 83' ' ' SER . 42.9 m-70 -92.68 -32.71 14.64 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.812 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 63.67 64.43 0.79 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.028 0.931 . . . . 0.0 111.927 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -91.11 120.17 31.85 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.341 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.494 ' O ' ' HD3' ' A' ' 141' ' ' LYS . 3.5 t -78.49 -16.5 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.644 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -91.07 -22.19 33.47 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.022 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.88 4.25 14.8 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.327 0.651 . . . . 0.0 110.731 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.494 ' HD3' ' O ' ' A' ' 138' ' ' VAL . 42.6 pttt -50.92 -37.68 45.5 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.11 0.964 . . . . 0.0 112.948 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.516 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 3.4 t70 -73.91 -30.17 62.44 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.174 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.556 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 15.9 tp -67.7 -57.23 6.73 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.475 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.18 -49.67 62.48 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.87 -0.604 . . . . 0.0 114.035 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.73 87.9 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.516 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.2 mptm? -61.44 -40.2 93.61 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 30.1 mt -63.33 -32.86 74.39 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.417 0.448 . . . . 0.0 111.509 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -75.21 -39.32 60.17 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.14 0.275 . . . . 0.0 110.529 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -78.7 5.59 10.82 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.945 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.44 0 C-N-CA 122.628 0.371 . . . . 0.0 111.608 179.396 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.577 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 1.3 mp . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 83' ' ' SER . 5.0 pt-20 -85.78 -67.5 0.8 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.3 m -64.5 -56.99 10.47 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -48.52 -57.24 6.44 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.636 0.374 . . . . 0.0 111.231 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.577 ' HB2' ' O ' ' A' ' 78' ' ' ILE . 27.6 m-85 -69.15 -11.47 60.83 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.532 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 7.4 t -100.23 -1.91 35.23 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.62 147.12 24.21 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.796 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.51 126.3 29.91 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.329 -0.396 . . . . 0.0 112.014 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.88 57.24 2.73 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.408 -0.814 . . . . 0.0 113.501 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.537 HG22 ' OE1' ' A' ' 137' ' ' GLU . 2.9 tp -79.27 -38.39 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 122.749 0.42 . . . . 0.0 111.348 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.595 ' CE1' ' HA3' ' A' ' 139' ' ' GLY . 21.6 p-80 . . . . . 0 CA--C 1.547 0.853 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mt . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 120.981 0.419 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -147.69 -45.84 0.17 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.209 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -112.45 -36.22 5.32 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.97 -33.48 39.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.555 0.342 . . . . 0.0 111.451 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -127.0 64.39 60.16 Favored Pre-proline 0 CA--C 1.549 0.904 0 O-C-N 123.523 0.514 . . . . 0.0 110.556 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -95.06 133.94 0.62 Allowed 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.778 2.319 . . . . 0.0 114.648 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.01 -110.99 3.28 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 119.087 -0.84 . . . . 0.0 114.923 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -46.72 -30.09 8.68 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.66 2.907 . . . . 0.0 114.911 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -72.23 -39.91 68.13 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.309 0.381 . . . . 0.0 111.355 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.543 ' O ' HG21 ' A' ' 129' ' ' VAL . 16.3 mt -76.59 -29.73 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.307 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.42 -56.41 16.44 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.629 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -55.86 -29.82 60.5 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.472 HG23 ' CZ ' ' A' ' 82' ' ' TYR . 50.6 mt -73.64 -45.03 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 120.563 0.221 . . . . 0.0 110.53 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.543 HG21 ' O ' ' A' ' 125' ' ' ILE . 12.6 m -77.79 -25.6 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.238 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.1 t -83.74 -19.05 35.83 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.781 0.676 . . . . 0.0 112.306 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.7 m -98.11 -27.3 14.26 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.072 0.232 . . . . 0.0 110.496 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.4 tt -80.41 -35.21 35.51 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.176 0.297 . . . . 0.0 110.884 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -72.65 -1.37 15.98 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -97.03 -76.19 0.52 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -46.34 -37.9 8.07 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.604 0.762 . . . . 0.0 112.676 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.8 t70 69.7 76.81 0.21 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.128 0.971 . . . . 0.0 111.203 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.537 ' OE1' HG22 ' A' ' 87' ' ' ILE . 10.4 mm-40 -83.94 123.44 29.97 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.063 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -78.7 -25.6 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.595 ' HA3' ' CE1' ' A' ' 88' ' ' HIS . . . -88.33 -27.83 24.2 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 178.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.421 ' CB ' ' HB3' ' A' ' 88' ' ' HIS . . . -100.49 -1.66 35.13 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.212 -0.494 . . . . 0.0 111.324 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -32.13 36.64 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.14 0.576 . . . . 0.0 112.533 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.553 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 19.8 m-20 -77.49 -40.21 43.77 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.258 0.349 . . . . 0.0 110.679 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.3 tp -65.59 -61.79 1.89 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.58 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.31 -47.35 62.16 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.724 -0.671 . . . . 0.0 114.511 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.13 -41.9 89.32 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.553 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -61.26 -41.09 96.32 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.021 0.2 . . . . 0.0 111.278 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.0 mt -62.36 -37.9 87.45 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.269 0.355 . . . . 0.0 111.345 177.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -88.44 3.16 51.03 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -120.12 -11.0 9.31 Favored 'General case' 0 C--N 1.345 0.373 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.365 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.163 179.387 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 tt . . . . . 0 CA--C 1.548 0.901 0 CA-C-O 120.466 0.174 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.19 -76.51 0.51 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.018 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.1 m -65.26 -60.75 2.65 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.683 0.393 . . . . 0.0 110.49 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.584 ' O ' HD12 ' A' ' 87' ' ' ILE . 25.6 p -44.45 -39.61 4.9 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.405 0.682 . . . . 0.0 112.687 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.527 ' CZ ' HG21 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -89.46 -10.09 47.69 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.2 t -95.04 -6.99 40.93 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.555 0.217 . . . . 0.0 110.685 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.47 149.63 27.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.464 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -74.68 87.03 2.17 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.377 0.608 . . . . 0.0 111.072 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 133.57 63.19 0.07 OUTLIER Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.929 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 81' ' ' SER . 4.4 tp -105.79 -15.53 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.589 ' HB3' ' O ' ' A' ' 139' ' ' GLY . 49.2 t60 . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.473 ' HA ' ' CD1' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -172.72 -24.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.048 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -52.96 -34.55 56.28 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.06 0.457 . . . . 0.0 110.998 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.6 t -129.6 46.5 2.63 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.664 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.56 ' CD1' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -57.34 -45.34 99.9 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.389 -178.349 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -78.79 37.86 0.68 Allowed 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.086 1.857 . . . . 0.0 112.116 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.5 -171.47 18.45 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 115.946 -0.57 . . . . 0.0 114.234 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.536 ' HA ' ' OE1' ' A' ' 126' ' ' GLU . 3.6 Cg_exo -75.24 -37.4 1.93 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.56 2.84 . . . . 0.0 113.33 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.423 ' OD2' HD12 ' A' ' 125' ' ' ILE . 6.9 p-10 -61.95 -19.74 63.07 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.56 HG12 ' CD1' ' A' ' 120' ' ' TYR . 1.1 mp -89.97 -51.81 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 123.372 0.42 . . . . 0.0 111.181 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.536 ' OE1' ' HA ' ' A' ' 123' ' ' PRO . 8.5 pt-20 -50.45 -27.78 7.12 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 177.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -72.04 -35.32 69.31 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.87 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.527 HG21 ' CZ ' ' A' ' 82' ' ' TYR . 75.1 mt -58.86 -52.31 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.713 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.7 m -59.91 -54.55 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 123.114 0.259 . . . . 0.0 111.639 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.7 t -56.06 -52.55 63.87 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.2 m -67.88 -17.66 64.55 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 140' ' ' ALA . 3.5 tt -88.33 -44.47 10.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 117.782 0.265 . . . . 0.0 111.09 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -79.01 -1.49 35.78 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -79.55 -50.0 11.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.191 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.483 ' HE1' ' OE2' ' A' ' 137' ' ' GLU . 5.8 p80 -89.13 -35.86 16.04 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.174 0.297 . . . . 0.0 111.772 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 74.84 87.72 0.09 Allowed 'General case' 0 C--N 1.357 0.91 0 C-N-CA 124.205 1.002 . . . . 0.0 112.159 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.546 ' OE2' HG23 ' A' ' 87' ' ' ILE . 6.6 pt-20 -114.96 151.7 33.66 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.709 178.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.2 m -76.44 -44.89 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.589 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -68.7 0.65 12.64 Favored Glycine 0 N--CA 1.471 1.012 0 N-CA-C 115.2 0.84 . . . . 0.0 115.2 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . 0.416 ' O ' HD13 ' A' ' 132' ' ' LEU . . . -136.74 -11.4 1.79 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.91 0.484 . . . . 0.0 112.036 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 6.4 tptm -53.65 -41.33 66.69 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.292 0.637 . . . . 0.0 112.084 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.455 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 2.1 p-10 -70.16 -42.46 72.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.585 ' O ' HD13 ' A' ' 147' ' ' LEU . 14.2 tp -63.81 -52.25 61.08 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.953 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.04 -38.6 89.89 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 123.697 0.623 . . . . 0.0 113.851 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.91 83.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.873 0.337 . . . . 0.0 111.867 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.455 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.3 mptm? -66.96 -33.82 76.41 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.211 0.319 . . . . 0.0 110.662 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.585 HD13 ' O ' ' A' ' 143' ' ' LEU . 0.6 OUTLIER -66.04 -41.11 91.3 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.548 0.53 . . . . 0.0 110.315 177.507 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -64.73 -38.41 90.88 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.85 1.03 48.85 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.091 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.513 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.129 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 tt . . . . . 0 CA--C 1.544 0.726 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -91.86 -28.84 17.06 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.059 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.8 m -69.08 -61.48 1.78 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.842 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.456 ' O ' HD12 ' A' ' 87' ' ' ILE . 40.6 m -86.9 58.41 5.06 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-O 123.389 1.566 . . . . 0.0 109.727 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.547 ' CD2' HG12 ' A' ' 87' ' ' ILE . 0.9 OUTLIER -158.66 -41.62 0.06 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 111.651 -2.522 . . . . 0.0 105.327 -179.426 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.3 t -70.55 -23.76 62.67 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.097 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.86 1.03 4.82 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt 59.34 152.79 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.959 0.903 . . . . 0.0 112.949 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.65 2.6 78.78 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.66 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.547 HG12 ' CD2' ' A' ' 82' ' ' TYR . 7.6 tp -64.05 -9.12 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.508 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 70.1 t60 . . . . . 0 CA--C 1.546 0.825 0 CA-C-O 121.599 0.714 . . . . 0.0 110.903 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.451 ' O ' HD12 ' A' ' 125' ' ' ILE . 12.2 mt . . . . . 0 CA--C 1.542 0.635 0 CA-C-O 120.838 0.351 . . . . 0.0 111.553 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -147.23 0.54 0.71 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.13 -54.01 4.01 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.09 8.44 2.49 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.873 0.368 . . . . 0.0 110.907 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -89.57 -30.68 0.36 Allowed Pre-proline 0 CA--C 1.55 0.953 0 CA-C-O 118.285 -0.864 . . . . 0.0 112.886 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' TYR . 78.0 Cg_exo -44.93 120.65 3.02 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.065 2.51 . . . . 0.0 114.046 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 165.27 -147.63 12.76 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.726 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -62.71 -22.78 74.25 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.971 2.448 . . . . 0.0 113.754 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.514 ' O ' HG13 ' A' ' 128' ' ' ILE . 9.4 m-20 -71.43 -49.49 41.17 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.594 0.358 . . . . 0.0 111.595 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.537 ' O ' HG21 ' A' ' 129' ' ' VAL . 10.2 mt -73.26 -34.97 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 123.271 0.357 . . . . 0.0 110.875 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -55.92 -48.22 76.08 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.72 0.637 . . . . 0.0 111.004 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -66.09 -35.65 81.08 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 124' ' ' ASP . 32.9 mt -61.27 -55.34 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 125' ' ' ILE . 5.5 m -65.12 -27.32 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.223 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.2 t -83.26 -13.89 54.31 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 26.9 m -92.09 -42.42 9.95 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 123.037 0.211 . . . . 0.0 110.913 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 144' ' ' GLY . 4.7 mp -77.74 -37.25 49.61 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 129' ' ' VAL . 10.3 mm-40 -76.97 7.53 4.76 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.295 0.372 . . . . 0.0 111.673 178.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -108.06 -80.25 0.57 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -47.81 -37.45 13.71 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.816 0.847 . . . . 0.0 112.789 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 65.69 68.24 0.48 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.995 0.918 . . . . 0.0 111.769 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -88.72 129.77 35.47 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.437 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.514 ' O ' ' HD3' ' A' ' 141' ' ' LYS . 3.1 t -73.41 -16.4 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -86.51 -32.02 17.23 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.43 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -110.0 5.74 22.51 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.84 0.456 . . . . 0.0 111.149 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.514 ' HD3' ' O ' ' A' ' 138' ' ' VAL . 21.3 pttm -47.32 -37.65 11.35 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.965 0.906 . . . . 0.0 113.087 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 2.5 p-10 -75.29 -41.6 56.75 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.303 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.508 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 17.6 tp -56.83 -55.04 39.53 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.218 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.453 ' N ' HD23 ' A' ' 132' ' ' LEU . . . -59.87 -59.5 10.37 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 115.793 -0.639 . . . . 0.0 114.049 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.71 78.17 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 14.1 mptt -62.51 -36.01 81.19 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 123.027 0.204 . . . . 0.0 111.418 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.6 mt -66.68 -35.71 80.8 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.417 0.448 . . . . 0.0 111.954 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.0 ttp180 -93.14 -2.66 55.15 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -105.94 28.94 7.1 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.938 0.399 . . . . 0.0 110.848 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.47 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.266 -179.917 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.544 0.714 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 83' ' ' SER . 4.5 pt-20 -93.2 -57.77 2.52 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.6 m -67.29 -50.07 61.71 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.4 p -53.96 -54.64 36.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.782 0.433 . . . . 0.0 111.595 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.574 ' CZ ' HG23 ' A' ' 128' ' ' ILE . 46.9 m-85 -58.94 -65.02 0.73 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.542 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -38.71 -32.79 0.09 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.19 144.93 44.55 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.274 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.485 ' HA ' ' OE2' ' A' ' 137' ' ' GLU . 58.9 mttp -77.95 105.31 9.07 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 123.439 0.462 . . . . 0.0 111.845 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.15 50.18 0.35 Allowed Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.817 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.0 tp -70.02 -23.41 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 79.2 t60 . . . . . 0 CA--C 1.553 1.08 0 CA-C-O 120.978 0.418 . . . . 0.0 111.035 179.37 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.457 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 13.5 mt . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -114.84 2.54 14.38 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.38 -47.28 6.35 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.9 t -134.34 -1.98 2.83 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 116' ' ' LEU . 2.9 t80 -94.38 144.27 27.71 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 119.288 -0.387 . . . . 0.0 110.725 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -57.1 162.76 8.81 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.621 2.214 . . . . 0.0 113.54 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -86.44 -51.39 3.5 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.605 -1.108 . . . . 0.0 113.511 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.594 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 52.2 Cg_exo -55.15 -24.42 41.0 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.833 2.356 . . . . 0.0 114.134 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.48 -43.93 65.66 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.514 0.326 . . . . 0.0 111.423 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.412 ' O ' HG22 ' A' ' 129' ' ' VAL . 9.8 mt -61.99 -26.75 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 122.823 0.449 . . . . 0.0 110.764 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -73.2 -47.96 39.19 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.185 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 123' ' ' PRO . 25.5 mmm180 -56.04 -48.01 76.8 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.492 178.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.574 HG23 ' CZ ' ' A' ' 82' ' ' TYR . 17.4 mt -56.62 -64.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.114 0.566 . . . . 0.0 111.498 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.421 ' CG1' ' HB3' ' A' ' 148' ' ' ARG . 31.5 m -51.26 -38.22 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.203 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.0 t -73.03 -42.41 63.19 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.8 m -60.79 -29.8 69.66 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.217 0.207 . . . . 0.0 111.483 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 128' ' ' ILE . 1.9 mt -83.9 -33.79 24.68 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.314 0.384 . . . . 0.0 110.281 178.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -83.2 7.54 15.88 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.933 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -113.75 -41.02 3.66 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.149 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -88.1 -44.11 11.18 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 63.5 67.7 0.63 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.985 0.914 . . . . 0.0 111.185 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.485 ' OE2' ' HA ' ' A' ' 85' ' ' LYS . 22.5 mt-10 -87.37 139.21 30.78 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.887 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -77.7 -41.15 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.63 -1.61 62.04 Favored Glycine 0 CA--C 1.526 0.726 0 O-C-N 123.412 0.445 . . . . 0.0 113.93 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -137.06 -2.54 2.06 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.065 0.546 . . . . 0.0 111.53 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -50.85 -40.5 56.29 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.817 0.847 . . . . 0.0 113.002 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 7.9 m-20 -72.51 -36.41 68.35 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.22 0.325 . . . . 0.0 110.922 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.8 tp -65.64 -52.48 51.44 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.993 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.99 -62.75 5.58 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.58 -0.736 . . . . 0.0 114.007 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.58 ' HA ' ' NE ' ' A' ' 148' ' ' ARG . . . -53.37 -37.1 62.1 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 5.7 mptp? -72.79 -24.46 60.93 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 147' ' ' LEU . 0.6 OUTLIER -78.71 -30.88 46.25 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.422 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.58 ' NE ' ' HA ' ' A' ' 145' ' ' ALA . 8.6 ptt85 -84.31 -3.77 58.45 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 117.807 0.276 . . . . 0.0 110.848 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -81.44 -1.4 45.65 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.778 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.377 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.579 179.552 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 121.397 0.618 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 83' ' ' SER . 2.9 mt-10 -120.43 -41.79 2.59 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.155 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.9 m -65.82 -60.5 2.82 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.169 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.7 t -56.81 -55.25 36.74 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 123.218 0.324 . . . . 0.0 110.705 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -50.9 -31.36 17.3 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 5.7 t -73.57 -34.52 65.16 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 122.604 0.362 . . . . 0.0 111.713 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.5 146.34 20.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.854 0.462 . . . . 0.0 111.979 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -79.96 99.99 7.88 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.189 0.518 . . . . 0.0 111.876 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 126.52 47.9 0.19 Allowed Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.371 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.4 tp -88.8 -43.65 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 122.842 0.457 . . . . 0.0 111.187 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.47 ' CE1' HD11 ' A' ' 143' ' ' LEU . 47.4 t60 . . . . . 0 CA--C 1.552 1.021 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.031 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 mt . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 110.638 -0.134 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.6 tptp 73.4 -2.1 2.85 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.205 1.002 . . . . 0.0 111.952 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -99.84 -37.09 9.2 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.948 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.5 t -93.83 -41.72 9.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.45 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -96.66 159.3 32.02 Favored Pre-proline 0 CA--C 1.541 0.596 0 O-C-N 123.423 0.452 . . . . 0.0 111.115 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.58 -34.84 2.35 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.505 2.137 . . . . 0.0 113.289 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 157.6 -55.7 0.38 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-O 118.939 -0.923 . . . . 0.0 113.433 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.16 -19.72 28.31 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.971 2.447 . . . . 0.0 114.431 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 2.4 t70 -73.65 -35.07 65.22 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.181 0.301 . . . . 0.0 111.133 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.9 mp -72.71 -27.33 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.382 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.95 -53.33 18.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.728 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.447 ' HG2' ' O ' ' A' ' 124' ' ' ASP . 13.6 ptm180 -53.83 -36.54 62.64 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 178.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.559 ' O ' HD12 ' A' ' 132' ' ' LEU . 44.7 mt -65.38 -56.51 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 122.199 0.2 . . . . 0.0 111.211 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.63 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 2.8 m -54.09 -43.96 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.562 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 12.4 t -64.67 -31.99 73.46 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.3 m -69.94 -38.57 76.23 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 128' ' ' ILE . 1.3 mp -73.83 -35.79 64.87 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.63 ' HG2' ' O ' ' A' ' 129' ' ' VAL . 10.6 pt-20 -89.08 14.02 11.7 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 120.954 0.407 . . . . 0.0 111.62 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.562 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.6 tmm_? -105.95 -41.29 5.44 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.851 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 49.5 t60 -94.64 -32.14 13.53 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.976 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 67.73 73.33 0.31 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.049 0.94 . . . . 0.0 111.633 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.33 132.12 43.36 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.99 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.55 -39.05 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 O-C-N 123.417 0.448 . . . . 0.0 111.684 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -74.26 -9.52 81.04 Favored Glycine 0 C--N 1.341 0.819 0 O-C-N 123.316 0.385 . . . . 0.0 113.914 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.6 2.34 5.54 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.726 0.411 . . . . 0.0 111.995 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -34.62 74.12 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.949 0.499 . . . . 0.0 111.732 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.618 ' O ' ' HG2' ' A' ' 146' ' ' LYS . 8.2 m-20 -75.08 -38.78 61.16 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.984 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.47 HD11 ' CE1' ' A' ' 88' ' ' HIS . 14.2 tp -60.49 -56.83 16.71 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.994 0.518 . . . . 0.0 110.609 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -54.77 -45.3 79.66 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.683 0.614 . . . . 0.0 113.756 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -54.89 -48.68 72.71 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -59.19 -42.57 91.18 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.716 0.234 . . . . 0.0 110.394 178.53 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.8 -41.42 82.12 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.41 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 144' ' ' GLY . 14.2 ptm180 -88.1 -14.19 39.45 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -87.47 27.06 1.14 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 122.784 0.433 . . . . 0.0 112.063 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.507 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.53 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.403 HG21 ' C ' ' A' ' 127' ' ' ARG . 3.9 mp . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 121.216 0.532 . . . . 0.0 110.158 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 83' ' ' SER . 4.1 mm-40 -121.56 -86.63 0.65 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.09 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.2 m -55.1 -55.65 28.72 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.199 1.0 . . . . 0.0 113.601 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.41 ' O ' HD11 ' A' ' 87' ' ' ILE . 16.9 t -46.66 -55.58 7.49 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.728 0.643 . . . . 0.0 111.772 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -84.06 0.11 49.59 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.508 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 8.0 t -103.71 -2.64 26.17 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.696 0.284 . . . . 0.0 110.388 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.44 156.31 16.82 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.848 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.21 142.53 32.08 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.244 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.77 34.79 14.62 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.304 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.41 HD11 ' O ' ' A' ' 81' ' ' SER . 2.5 tp -84.38 -28.4 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 36.6 t60 . . . . . 0 CA--C 1.547 0.83 0 CA-C-O 120.629 0.252 . . . . 0.0 111.356 178.991 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.7 mt . . . . . 0 CA--C 1.537 0.475 0 CA-C-O 121.182 0.515 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -150.63 -30.13 0.2 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.096 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -83.76 -44.43 14.42 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.74 19.51 7.23 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.55 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -134.9 50.08 4.42 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 120' ' ' TYR . 9.4 Cg_endo -91.6 127.96 1.08 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.805 2.337 . . . . 0.0 113.369 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 135.96 -148.82 19.84 Favored Glycine 0 C--N 1.343 0.97 0 C-N-CA 120.485 -0.864 . . . . 0.0 114.575 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.618 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 49.1 Cg_exo -56.45 -32.55 89.56 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.634 2.889 . . . . 0.0 113.871 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.481 ' O ' HD12 ' A' ' 128' ' ' ILE . 6.3 m-20 -52.27 -37.86 56.67 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 123.457 0.473 . . . . 0.0 111.02 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.467 ' O ' HG22 ' A' ' 129' ' ' VAL . 15.8 mt -67.85 -43.61 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.412 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -61.9 -21.34 64.65 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.977 0.511 . . . . 0.0 112.134 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.618 ' HG2' ' O ' ' A' ' 123' ' ' PRO . 17.4 mmm180 -79.97 -46.67 16.26 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.825 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.481 HD12 ' O ' ' A' ' 124' ' ' ASP . 5.7 mt -62.95 -44.52 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.046 0.538 . . . . 0.0 111.278 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 144' ' ' GLY . 7.1 m -63.29 -55.1 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.523 0.514 . . . . 0.0 112.094 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 56.4 m -54.94 -34.79 63.55 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.7 m -82.41 -22.36 35.4 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 123.263 0.352 . . . . 0.0 111.831 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.429 ' HG ' ' OE2' ' A' ' 137' ' ' GLU . 3.0 tt -82.6 -40.31 21.01 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.474 0.31 . . . . 0.0 110.919 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -89.28 12.38 16.23 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.014 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -79.69 -49.15 12.52 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -96.08 -9.06 31.77 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 70.71 80.92 0.16 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.133 0.973 . . . . 0.0 112.46 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 141' ' ' LYS . 2.9 pt-20 -107.02 130.7 54.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.331 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -81.77 -26.43 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -84.98 -2.47 88.37 Favored Glycine 0 C--N 1.343 0.944 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.391 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.11 -9.76 3.39 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.903 0.481 . . . . 0.0 111.75 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 7.8 tptp -50.89 -33.29 23.46 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.866 0.867 . . . . 0.0 112.975 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.532 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 10.0 m-20 -74.82 -36.13 62.43 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.369 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.4 tp -66.13 -59.63 3.58 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.113 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.542 ' O ' HG13 ' A' ' 129' ' ' VAL . . . -58.94 -41.97 96.56 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-N 116.089 -0.505 . . . . 0.0 114.089 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.08 92.16 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.6 mptp? -68.66 -36.07 78.08 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.032 0.207 . . . . 0.0 111.511 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.1 mt -71.16 -34.21 70.75 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.236 0.335 . . . . 0.0 110.449 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -75.29 -39.47 59.63 Favored 'General case' 0 C--N 1.349 0.562 0 O-C-N 123.478 0.486 . . . . 0.0 110.882 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.55 42.27 0.35 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.134 0.492 . . . . 0.0 112.038 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.46 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.854 179.598 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.537 HG22 ' CG ' ' A' ' 82' ' ' TYR . 4.6 mp . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 121.297 0.57 . . . . 0.0 110.865 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.622 ' O ' ' HB2' ' A' ' 83' ' ' SER . 3.6 tp10 -120.96 -81.27 0.64 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.47 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.5 m -70.59 -59.32 2.9 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.1 m -88.66 69.38 8.77 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 123.551 1.643 . . . . 0.0 109.62 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.537 ' CG ' HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -179.45 -34.29 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 111.304 -2.68 . . . . 0.0 108.038 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.622 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.7 t -75.67 -32.58 60.21 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.279 177.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -45.89 157.14 0.12 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.439 ' HA ' ' OE2' ' A' ' 137' ' ' GLU . 6.6 mptt -84.37 100.97 11.62 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.667 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.53 74.27 0.9 Allowed Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.533 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 tp -103.71 -35.0 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 122.462 0.305 . . . . 0.0 111.558 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . 0.572 ' ND1' HD22 ' A' ' 143' ' ' LEU . 39.9 t60 . . . . . 0 N--CA 1.468 0.469 0 O-C-N 122.979 0.174 . . . . 0.0 111.172 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.2 mt . . . . . 0 C--O 1.239 0.517 0 CA-C-O 121.048 0.451 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -149.99 -46.4 0.13 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.897 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.3 tttm -116.88 -6.51 11.48 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.6 m -79.83 -41.15 26.97 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.459 0.304 . . . . 0.0 111.624 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -97.71 158.82 32.34 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 123.29 0.368 . . . . 0.0 111.345 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -78.22 -38.08 0.66 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.646 2.231 . . . . 0.0 113.352 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.72 -55.48 0.27 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.835 -0.981 . . . . 0.0 113.731 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.4 -34.52 71.57 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.163 2.576 . . . . 0.0 114.48 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 128' ' ' ILE . 6.1 m-20 -70.58 -42.96 70.35 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.521 ' O ' HG23 ' A' ' 129' ' ' VAL . 3.6 mt -73.08 -16.14 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 123.301 0.376 . . . . 0.0 110.276 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.78 -53.83 10.49 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.468 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -56.27 -33.57 65.61 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.436 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 29.3 mt -67.61 -57.95 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 122.358 0.263 . . . . 0.0 111.236 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.525 HG11 ' O ' ' A' ' 144' ' ' GLY . 4.1 m -56.55 -39.03 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 18.2 t -71.5 -54.83 9.26 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.166 0.291 . . . . 0.0 111.772 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.8 m -54.92 -25.03 26.46 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 128' ' ' ILE . 33.4 mt -85.66 -48.22 9.07 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.672 0.273 . . . . 0.0 110.386 178.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -83.28 18.04 1.89 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.244 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' A' ' 130' ' ' SER . 1.1 tmt_? -87.54 -38.83 15.67 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.351 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -105.22 -16.24 14.83 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.607 0.567 . . . . 0.0 110.971 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 68.93 72.5 0.27 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.178 0.991 . . . . 0.0 110.536 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.439 ' OE2' ' HA ' ' A' ' 85' ' ' LYS . 28.9 mt-10 -96.43 133.59 40.67 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.767 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 t -76.61 -12.58 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 123.557 0.536 . . . . 0.0 111.274 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -87.31 -27.52 27.6 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.023 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.77 1.65 12.17 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.69 0.396 . . . . 0.0 111.762 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 8.7 tptp -53.27 -41.73 65.83 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.54 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 8.2 m-20 -77.88 -32.99 52.23 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.042 0.214 . . . . 0.0 111.546 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.572 HD22 ' ND1' ' A' ' 88' ' ' HIS . 14.8 tp -69.7 -59.38 2.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.414 0.286 . . . . 0.0 110.391 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.525 ' O ' HG11 ' A' ' 129' ' ' VAL . . . -56.53 -55.39 30.03 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-N 115.775 -0.648 . . . . 0.0 114.163 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -58.59 -44.96 90.0 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.54 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -61.34 -42.66 99.05 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.718 0.235 . . . . 0.0 111.035 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.0 mt -60.15 -34.97 74.28 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.445 0.465 . . . . 0.0 111.36 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -88.18 -7.36 56.99 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.716 0.293 . . . . 0.0 110.522 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 1.4 m-20 -114.45 13.45 17.66 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.973 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.376 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.799 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.57 ' HB ' ' CD1' ' A' ' 82' ' ' TYR . 1.9 pp . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 121.382 0.611 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -103.99 -52.33 2.97 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.846 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.7 m -58.9 -59.35 5.6 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.207 0.603 . . . . 0.0 111.945 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.8 p -57.32 -55.21 37.73 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.761 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.57 ' CD1' ' HB ' ' A' ' 78' ' ' ILE . 17.2 m-85 -54.49 -24.47 20.58 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 177.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.546 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 11.8 t -75.66 -32.65 60.26 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 122.176 0.191 . . . . 0.0 110.752 178.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.05 162.03 1.09 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.334 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -94.16 103.55 15.59 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.864 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.89 65.04 0.56 Allowed Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.95 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.6 tt -93.12 -44.97 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 51.2 t60 . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.044 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.78 -38.85 0.12 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.011 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -93.72 -26.08 17.16 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.421 0.45 . . . . 0.0 111.972 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.44 -41.85 10.07 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.276 0.36 . . . . 0.0 111.681 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -88.86 155.96 49.89 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 123.288 0.368 . . . . 0.0 111.624 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -80.84 -54.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.732 2.288 . . . . 0.0 113.942 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.65 -59.48 0.19 Allowed Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.876 -0.958 . . . . 0.0 113.591 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.485 ' HA ' ' OE2' ' A' ' 126' ' ' GLU . 52.2 Cg_exo -54.65 -30.84 68.0 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.079 2.519 . . . . 0.0 114.04 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 8.1 m-20 -71.25 -29.72 65.44 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.538 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 6.4 mt -86.64 -19.06 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.485 ' OE2' ' HA ' ' A' ' 123' ' ' PRO . 37.5 mt-10 -65.24 -51.88 58.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.782 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 124' ' ' ASP . 1.9 ptp180 -57.9 -21.03 41.39 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.274 176.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 83.2 mt -77.72 -50.11 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 122.577 0.351 . . . . 0.0 111.027 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 144' ' ' GLY . 4.6 m -61.98 -36.28 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 4.3 m -70.71 -58.18 3.91 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.502 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.9 m -52.7 -29.03 24.51 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.8 mt -76.19 -46.81 26.62 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.026 0.13 . . . . 0.0 111.15 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -87.43 16.49 5.36 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 123.517 0.511 . . . . 0.0 110.96 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 130' ' ' SER . 3.3 tmt_? -99.58 -34.97 10.01 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.694 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.546 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 75.1 m-70 -96.72 -32.9 11.93 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.561 0.538 . . . . 0.0 111.914 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.7 t70 74.72 81.08 0.11 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.227 1.011 . . . . 0.0 110.096 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -137.11 128.18 27.7 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.088 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.68 159.47 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.396 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 96.25 -53.52 1.57 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -104.48 -12.87 16.27 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.916 0.421 . . . . 0.0 111.7 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.46 -36.27 75.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.346 0.658 . . . . 0.0 112.436 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.492 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 9.9 m-20 -74.82 -34.99 62.43 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.5 tp -61.41 -58.81 6.7 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.319 0.387 . . . . 0.0 110.148 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.531 ' O ' HG13 ' A' ' 129' ' ' VAL . . . -51.9 -46.7 54.99 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.934 178.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.77 -39.28 91.08 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.492 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -65.29 -49.45 69.47 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.992 0.183 . . . . 0.0 110.707 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 25.9 mt -59.3 -30.82 68.61 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.41 0.444 . . . . 0.0 111.64 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -83.25 -10.81 58.34 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 123.001 0.188 . . . . 0.0 111.381 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -97.15 0.13 47.89 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 123.162 0.288 . . . . 0.0 111.43 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.319 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.987 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.488 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 2.9 tp . . . . . 0 CA--C 1.55 0.98 0 CA-C-O 120.716 0.294 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 83' ' ' SER . 37.9 tt0 -96.57 -49.73 5.01 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.817 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.7 p -54.26 -58.05 8.88 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.326 1.051 . . . . 0.0 112.595 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 t -60.16 -54.94 39.97 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.67 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 78' ' ' ILE . 3.4 m-85 -58.07 -16.73 14.02 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 8.4 t -86.36 -31.85 21.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.701 0.4 . . . . 0.0 111.255 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -46.08 165.18 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -90.37 113.88 25.87 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.212 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.5 67.2 1.32 Allowed Glycine 0 C--N 1.34 0.787 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.635 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.494 HG22 ' OE1' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -91.96 -25.05 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 15.6 t60 . . . . . 0 N--CA 1.467 0.412 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.283 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.8 mt . . . . . 0 N--CA 1.466 0.369 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -89.07 100.72 13.44 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.42 0.628 . . . . 0.0 111.279 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -179.77 -44.04 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.197 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.91 -17.91 12.8 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.357 0.41 . . . . 0.0 111.665 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -94.15 135.22 24.75 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 119.323 -0.37 . . . . 0.0 111.184 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.21 -36.32 1.04 Allowed 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.467 2.111 . . . . 0.0 113.1 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.64 -59.21 0.26 Allowed Glycine 0 CA--C 1.53 0.976 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.227 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.539 ' HA ' ' OE2' ' A' ' 126' ' ' GLU . 52.0 Cg_exo -56.49 -30.38 82.01 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.931 2.421 . . . . 0.0 114.096 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -65.89 -30.04 70.57 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.269 0.355 . . . . 0.0 111.844 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 10.9 mt -81.68 -31.19 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.539 ' OE2' ' HA ' ' A' ' 123' ' ' PRO . 42.7 mt-10 -56.26 -47.65 78.14 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.55 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -16.8 61.65 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 177.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.0 mt -78.16 -51.06 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 144' ' ' GLY . 3.7 m -63.03 -35.32 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 4.9 m -73.2 -56.51 4.99 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.387 0.429 . . . . 0.0 111.37 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.8 m -56.13 -24.61 41.93 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 25.9 mt -79.97 -51.63 8.84 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.929 0.143 . . . . 0.0 111.017 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -85.06 16.16 3.65 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.453 0.47 . . . . 0.0 111.312 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.0 tmt_? -79.6 -42.78 24.21 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.27 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.424 ' CE1' HH11 ' A' ' 134' ' ' ARG . 91.2 m-70 -96.96 -11.88 24.07 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.135 0.272 . . . . 0.0 111.242 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.1 t70 67.83 55.85 0.58 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.129 0.972 . . . . 0.0 110.969 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.494 ' OE1' HG22 ' A' ' 87' ' ' ILE . 11.1 pt-20 -88.99 124.46 34.29 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.936 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.07 -8.17 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.825 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.99 -26.89 20.69 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.417 -0.42 . . . . 0.0 112.857 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -121.81 6.05 9.93 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 122.807 0.443 . . . . 0.0 111.613 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -34.63 78.61 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.527 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 2.8 t70 -78.81 -34.62 45.19 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.596 0.236 . . . . 0.0 110.899 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.7 tp -64.45 -68.97 0.31 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.846 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.55 ' O ' HG13 ' A' ' 129' ' ' VAL . . . -48.81 -43.72 30.4 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 114.843 0.697 . . . . 0.0 114.843 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.5 96.69 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.527 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 14.4 mptt -60.86 -49.74 76.24 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.995 0.184 . . . . 0.0 110.896 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 35.8 mt -57.56 -30.45 65.25 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.405 0.441 . . . . 0.0 112.05 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -80.18 -35.98 35.62 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 120.565 0.221 . . . . 0.0 110.67 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -78.84 8.93 4.71 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.988 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.47 0 C-N-CA 122.61 0.364 . . . . 0.0 111.749 179.56 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.0 t . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.516 0.198 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -100.4 136.27 40.54 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.895 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.91 151.02 23.23 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.612 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 tt -101.35 140.71 35.26 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.646 0.263 . . . . 0.0 110.521 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.38 30.69 6.82 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.999 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -120.21 -18.8 7.93 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.343 0.257 . . . . 0.0 111.225 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.71 151.78 20.49 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.375 0.422 . . . . 0.0 111.523 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -95.71 159.76 14.83 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.159 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -86.82 159.43 51.99 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.149 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.27 140.79 45.41 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.5 2.134 . . . . 0.0 112.961 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.84 151.93 20.72 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.065 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -94.91 11.97 29.89 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.499 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? 63.99 125.75 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.013 0.925 . . . . 0.0 111.947 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -105.19 -2.96 23.51 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.791 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -90.09 137.23 32.51 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.305 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.8 p -102.88 0.4 32.43 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.67 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -89.09 42.49 1.09 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.222 0.534 . . . . 0.0 111.245 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.0 mm -92.99 -21.85 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.809 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 tp -62.88 -24.82 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 123.169 0.587 . . . . 0.0 111.747 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -109.55 29.04 7.94 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.753 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.6 t -87.44 -55.86 3.61 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.239 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.31 -72.68 0.46 Allowed Glycine 0 C--N 1.343 0.95 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.631 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -83.5 -48.02 0.76 Allowed Pre-proline 0 CA--C 1.547 0.857 0 CA-C-O 118.421 -0.799 . . . . 0.0 113.151 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.48 112.75 3.54 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.089 1.86 . . . . 0.0 112.467 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.422 ' O ' ' HD2' ' A' ' 82' ' ' TYR . 1.2 tp -143.71 5.15 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.536 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -116.7 -65.98 1.13 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.901 -0.136 . . . . 0.0 110.93 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 51.6 p -41.66 -50.21 4.17 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.748 1.219 . . . . 0.0 112.848 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.555 ' O ' HD13 ' A' ' 87' ' ' ILE . 8.5 t -62.86 -49.37 75.14 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 113.367 -1.742 . . . . 0.0 110.371 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.422 ' HD2' ' O ' ' A' ' 78' ' ' ILE . 64.3 m-85 -86.79 17.22 4.14 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.639 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.534 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 13.1 t -119.15 -17.47 8.92 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.405 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.54 164.91 22.59 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.768 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -88.68 117.84 27.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.026 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.23 68.13 1.21 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.284 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 81' ' ' SER . 2.4 tp -96.95 -29.05 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.635 ' HB3' ' O ' ' A' ' 139' ' ' GLY . 39.1 t60 -112.98 -31.92 6.53 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.563 ' OE2' ' HA2' ' A' ' 139' ' ' GLY . 26.3 mt-10 -117.16 46.44 1.68 Allowed 'General case' 0 C--O 1.24 0.583 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 50.0 tttt -121.01 -20.35 6.88 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.513 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.2 mp -79.57 -6.02 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 123.424 0.452 . . . . 0.0 111.454 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.433 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 3.4 mp -94.3 -22.36 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 123.071 0.232 . . . . 0.0 110.848 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -93.78 -33.14 13.7 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.239 0.337 . . . . 0.0 111.285 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.28 -29.86 66.16 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.241 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -117.56 -56.82 2.18 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 123.624 0.577 . . . . 0.0 109.82 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 14.3 t70 42.47 91.14 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.58 1.152 . . . . 0.0 112.472 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.3 tp -144.8 135.67 24.79 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.184 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 68.7 m80 63.65 158.73 0.08 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.876 0.87 . . . . 0.0 112.218 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 m -90.2 122.42 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.561 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.0 m 62.7 124.68 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.037 0.935 . . . . 0.0 112.026 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -102.69 116.28 32.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.262 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.1 t -134.77 129.51 34.73 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.461 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.437 ' HE2' ' O ' ' A' ' 103' ' ' LYS . 0.3 OUTLIER -131.02 -48.96 1.02 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.588 0.555 . . . . 0.0 111.037 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.475 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 3.3 t-20 -128.68 -9.94 5.02 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 123.26 0.35 . . . . 0.0 111.789 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.0 104.45 9.5 Favored Pre-proline 0 CA--C 1.542 0.658 0 O-C-N 123.06 0.225 . . . . 0.0 111.483 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 104' ' ' ASN . 66.1 Cg_endo -82.52 162.07 16.93 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.406 2.071 . . . . 0.0 113.088 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.2 mt -124.15 99.35 6.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.773 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -136.35 -51.51 0.7 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.88 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -138.95 -60.35 0.58 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.399 0.437 . . . . 0.0 110.747 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -148.53 142.26 25.6 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.282 0.364 . . . . 0.0 111.028 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.8 p -133.32 113.84 13.05 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.661 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.7 p -145.38 134.79 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.886 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 23.1 mmt -134.72 120.02 18.95 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.448 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -133.22 130.81 39.57 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.847 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -133.75 -0.93 3.11 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.348 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.53 ' HA ' ' CD1' ' A' ' 120' ' ' TYR . 10.2 mt -88.85 11.97 16.48 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.044 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -130.28 -6.1 4.31 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -96.11 -43.42 7.76 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.81 -5.59 18.29 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.294 0.371 . . . . 0.0 111.892 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.53 ' CD1' ' HA ' ' A' ' 116' ' ' LEU . 36.0 m-85 -97.16 139.29 21.4 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.786 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.13 -58.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.523 2.149 . . . . 0.0 114.074 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.33 -60.73 0.08 OUTLIER Glycine 0 C--N 1.343 0.972 0 CA-C-O 118.919 -0.934 . . . . 0.0 113.596 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.27 -31.98 69.18 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.078 2.519 . . . . 0.0 114.017 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.94 -41.81 97.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.38 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.422 ' O ' HG22 ' A' ' 129' ' ' VAL . 7.1 mt -70.54 -40.11 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.574 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.98 -24.12 66.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.793 0.437 . . . . 0.0 111.941 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -77.76 -45.09 25.64 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.407 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.7 mt -63.06 -47.24 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 122.844 0.457 . . . . 0.0 111.197 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 144' ' ' GLY . 5.3 m -58.64 -51.56 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.791 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.1 m -58.35 -39.03 78.4 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 m -71.38 -26.17 62.67 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.9 mt -85.65 -37.6 19.29 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -83.81 6.38 21.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.598 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.472 HH11 ' CE1' ' A' ' 135' ' ' HIS . 4.5 tmt_? -86.9 -42.82 12.9 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.28 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.534 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 88.5 m-70 -91.64 -25.38 19.18 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.982 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.2 t70 70.54 76.12 0.2 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.115 0.966 . . . . 0.0 110.535 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -101.02 130.02 46.95 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.503 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.69 -14.91 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 123.437 0.461 . . . . 0.0 111.695 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.635 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -96.76 -7.57 57.64 Favored Glycine 0 C--N 1.336 0.575 0 O-C-N 123.344 0.403 . . . . 0.0 112.293 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -130.02 1.59 4.77 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.363 0.665 . . . . 0.0 111.607 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -62.59 -27.39 69.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.003 0.521 . . . . 0.0 111.398 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.507 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 1.5 p30 -76.21 -39.06 55.59 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.441 0.463 . . . . 0.0 110.887 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.0 tp -64.07 -59.97 3.81 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.885 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.521 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -58.41 -56.3 25.99 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.799 -0.637 . . . . 0.0 114.66 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.4 -41.84 76.98 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.507 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -65.98 -40.25 91.05 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.929 0.143 . . . . 0.0 111.357 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 22.0 mt -69.85 -27.9 65.23 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.336 0.398 . . . . 0.0 110.781 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -95.6 5.56 51.16 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 123.142 0.276 . . . . 0.0 110.937 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -85.38 -2.71 58.39 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.17 -8.14 49.49 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.627 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.9 mp -103.83 -37.88 7.26 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.711 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -86.91 -43.41 12.43 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.318 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -106.47 130.21 54.3 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.3 0.375 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.505 -179.978 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.0 p . . . . . 0 N--CA 1.487 1.419 0 N-CA-C 111.252 0.093 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -127.81 125.7 40.31 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 123.366 0.417 . . . . 0.0 110.838 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.63 -60.07 1.24 Allowed Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.598 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 63.11 122.87 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.956 0.903 . . . . 0.0 111.824 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.2 73.71 0.22 Allowed Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.559 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 61.97 136.34 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.051 0.941 . . . . 0.0 112.477 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.88 -11.44 26.73 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.954 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -132.08 129.44 39.97 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -117.11 -44.76 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 118.549 -0.738 . . . . 0.0 112.224 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.8 -35.59 1.88 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.224 1.949 . . . . 0.0 113.029 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.6 mt -99.13 132.49 44.4 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.387 0.43 . . . . 0.0 110.974 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -126.48 23.16 6.92 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.085 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 63.81 122.59 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.995 0.918 . . . . 0.0 111.935 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -118.37 21.78 12.47 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.163 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.532 ' O ' ' HB2' ' A' ' 102' ' ' SER . 91.9 m-85 -82.67 -32.68 28.02 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.165 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 94' ' ' ALA . 18.0 t -92.16 105.53 17.74 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 120.993 0.425 . . . . 0.0 111.085 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.649 ' HZ2' ' HH ' ' A' ' 115' ' ' TYR . 12.9 ttmt -137.64 174.84 10.15 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.359 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.556 HD11 ' O ' ' A' ' 90' ' ' LYS . 0.5 OUTLIER -82.26 -30.96 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.158 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 tt -67.16 122.77 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 O-C-N 123.257 0.348 . . . . 0.0 110.3 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.7 t80 62.75 31.29 16.63 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.44 0.696 . . . . 0.0 111.006 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.1 t -79.58 -40.67 28.86 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.011 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.03 -37.04 0.46 Allowed Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.157 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -90.07 159.93 41.49 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.456 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.11 148.44 69.23 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.453 2.102 . . . . 0.0 113.394 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.5 tp -88.75 28.43 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.99 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 83' ' ' SER . 7.1 tp10 -119.8 -53.89 2.17 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.137 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.1 m -56.46 -56.78 16.89 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.419 0.688 . . . . 0.0 112.235 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.8 m -59.51 -55.81 29.86 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.289 0.368 . . . . 0.0 111.043 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.43 ' CE1' HG21 ' A' ' 128' ' ' ILE . 2.1 m-85 -61.43 -11.88 12.29 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 8.3 t -87.94 -40.09 14.21 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.624 0.193 . . . . 0.0 111.324 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.71 152.62 30.56 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -82.88 131.56 35.19 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.081 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.78 28.05 5.79 Favored Glycine 0 C--N 1.336 0.536 0 O-C-N 123.731 0.644 . . . . 0.0 112.783 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.584 HD11 ' O ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -91.51 -19.54 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 122.735 0.414 . . . . 0.0 111.049 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.467 ' CE1' ' HG3' ' A' ' 89' ' ' GLU . 2.8 p80 -56.49 -29.84 62.27 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.467 ' HG3' ' CE1' ' A' ' 88' ' ' HIS . 40.5 mt-10 -93.11 -24.82 18.14 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.301 0.375 . . . . 0.0 111.07 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.556 ' O ' HD11 ' A' ' 71' ' ' ILE . 91.8 mttt -62.0 -4.97 1.85 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.92 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.6 mm -83.12 -16.84 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 mt -90.06 0.33 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.297 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -67.14 -18.56 65.34 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.219 0.608 . . . . 0.0 111.891 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 69' ' ' SER . . . -67.58 -18.18 64.9 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.303 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -94.02 -28.64 15.64 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.801 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.4 ' OD1' HD13 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -96.24 129.99 43.42 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.755 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.4 HD13 ' OD1' ' A' ' 96' ' ' ASP . 4.7 mp 64.1 147.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.981 0.912 . . . . 0.0 112.067 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -128.01 111.21 13.28 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.796 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.1 p -148.24 133.65 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.493 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.0 m 63.06 149.22 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.954 0.902 . . . . 0.0 112.444 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -109.44 126.72 53.78 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.56 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.532 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 55.4 m -130.12 157.88 41.21 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.912 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -90.14 124.67 35.01 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.203 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -131.31 165.06 24.24 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.926 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.87 122.52 72.86 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.713 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.484 ' HG2' ' OE1' ' A' ' 108' ' ' GLN . 60.6 Cg_endo -77.12 169.62 21.15 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.438 2.092 . . . . 0.0 113.033 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.4 tp -91.43 134.3 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.484 ' OE1' ' HG2' ' A' ' 106' ' ' PRO . 2.4 mp0 -126.29 -35.4 2.41 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.306 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -88.51 166.19 14.35 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.199 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.25 -37.52 57.53 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.753 0.421 . . . . 0.0 112.089 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.8 p -96.83 122.92 40.32 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.709 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.9 p -100.62 116.29 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.014 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.402 ' HB3' ' OE2' ' A' ' 114' ' ' GLU . 23.2 mmt -141.85 -46.38 0.36 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.831 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.402 ' OE2' ' HB3' ' A' ' 113' ' ' MET . 4.6 mp0 -128.97 134.91 48.36 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.474 0.484 . . . . 0.0 110.644 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.649 ' HH ' ' HZ2' ' A' ' 70' ' ' LYS . 38.3 p90 -128.75 -4.25 5.23 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 123.619 0.574 . . . . 0.0 111.889 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.503 HD21 ' CE2' ' A' ' 120' ' ' TYR . 3.0 mp -89.77 7.27 37.8 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -98.87 146.6 25.8 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.142 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt 70.77 -34.59 0.3 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.455 1.102 . . . . 0.0 112.889 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.5 -31.78 19.78 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.503 ' CE2' HD21 ' A' ' 116' ' ' LEU . 13.6 m-85 -88.82 158.14 48.01 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 119.241 -0.409 . . . . 0.0 111.095 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.67 -44.43 0.14 Allowed 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.412 2.074 . . . . 0.0 113.832 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.35 -59.58 0.42 Allowed Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.9 -0.944 . . . . 0.0 113.508 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.09 -18.03 41.48 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.905 2.403 . . . . 0.0 114.049 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -78.13 -40.03 39.38 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.299 0.374 . . . . 0.0 111.254 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 129' ' ' VAL . 6.1 mt -68.71 -33.14 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.626 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -69.43 -50.53 44.82 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.466 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -51.77 -44.52 63.39 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.617 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.514 ' O ' HD13 ' A' ' 132' ' ' LEU . 23.7 mt -63.61 -57.02 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 122.356 0.262 . . . . 0.0 111.546 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 125' ' ' ILE . 5.0 m -55.49 -45.07 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.8 t -64.38 -30.1 71.15 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 22.8 m -72.78 -34.91 67.25 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.994 0.184 . . . . 0.0 111.349 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.67 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 0.9 OUTLIER -75.02 -28.86 60.66 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.154 0.284 . . . . 0.0 111.336 178.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -90.01 18.93 5.28 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.373 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -109.97 -41.31 4.51 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.38 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.67 ' NE2' ' HA ' ' A' ' 132' ' ' LEU . 5.7 p80 -87.21 -41.98 13.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.94 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 70.95 81.06 0.16 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.254 1.022 . . . . 0.0 112.015 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.515 ' HG2' ' CE1' ' A' ' 135' ' ' HIS . 10.3 pt-20 -128.23 139.79 52.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.645 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.98 -13.5 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.709 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -79.76 -28.77 50.04 Favored Glycine 0 C--N 1.34 0.792 0 O-C-N 123.341 0.4 . . . . 0.0 113.849 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -123.11 1.95 9.22 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -58.79 -25.18 62.87 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.953 0.501 . . . . 0.0 112.22 179.427 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.566 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 7.6 m-20 -81.43 -32.99 32.42 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.784 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.8 tp -68.61 -56.84 6.9 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.532 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.82 -48.28 87.04 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.851 -0.613 . . . . 0.0 114.153 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.7 -41.49 86.4 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.566 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 14.4 mptt -65.45 -34.57 78.61 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 30.8 mt -72.83 -30.89 64.4 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.205 0.316 . . . . 0.0 111.616 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.492 ' HD2' ' O ' ' A' ' 148' ' ' ARG . 1.8 tmm_? -87.67 -19.64 27.4 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 123.173 0.296 . . . . 0.0 111.189 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.49 22.65 3.33 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 123.382 0.426 . . . . 0.0 111.153 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -81.51 -7.18 59.55 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.932 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.3 tt -97.55 -49.44 4.88 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.3 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -120.01 108.19 14.0 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 123.442 0.464 . . . . 0.0 110.482 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -137.63 -44.34 0.54 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.853 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.561 -179.863 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.5 p . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 111.376 0.139 . . . . 0.0 111.376 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -99.98 -44.16 6.12 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.962 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.21 -159.16 12.32 Favored Glycine 0 C--N 1.339 0.743 0 O-C-N 123.44 0.462 . . . . 0.0 112.64 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.8 mt 70.77 -51.62 0.67 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.382 1.073 . . . . 0.0 112.319 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.71 -136.59 13.17 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 121.45 -0.405 . . . . 0.0 112.499 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.46 153.06 26.67 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.711 0.301 . . . . 0.0 111.042 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.62 21.31 7.45 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.656 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -89.02 156.65 18.73 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.264 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -90.56 143.53 29.29 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.807 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.36 -38.4 6.53 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.464 2.109 . . . . 0.0 113.224 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 tt -130.16 123.66 30.81 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 123.301 0.376 . . . . 0.0 110.643 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -137.41 160.2 39.77 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.029 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.4 tttt 64.56 175.3 0.19 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.876 0.871 . . . . 0.0 111.891 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 68.05 94.05 0.07 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.166 0.987 . . . . 0.0 111.378 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -123.86 -168.6 1.81 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.451 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.1 p -106.9 156.52 18.61 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.341 0.256 . . . . 0.0 110.985 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -87.48 116.01 25.29 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.022 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.9 tt -149.58 162.7 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.624 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.452 ' HB ' ' OE2' ' A' ' 114' ' ' GLU . 2.9 tp -112.47 -37.62 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.573 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.438 ' CD2' HG21 ' A' ' 72' ' ' ILE . 66.5 m-85 -90.95 -42.18 10.72 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 30.7 t 54.66 26.79 7.84 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.866 0.866 . . . . 0.0 112.249 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.7 -72.93 0.48 Allowed Glycine 0 C--N 1.34 0.768 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.362 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -139.29 -45.86 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.852 0 CA-C-O 118.801 -0.618 . . . . 0.0 112.058 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -75.07 157.05 42.69 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.406 2.071 . . . . 0.0 113.61 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.474 ' O ' HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -122.56 -18.5 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.379 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -75.13 -53.35 9.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.099 0.56 . . . . 0.0 111.974 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.495 ' O ' ' HB2' ' A' ' 83' ' ' SER . 37.3 m -49.57 -47.9 48.99 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.097 0.959 . . . . 0.0 112.815 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.9 p -54.65 -58.64 6.72 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.523 0.514 . . . . 0.0 111.943 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -74.45 -4.79 38.74 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.561 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 4.4 m -78.65 -37.01 43.01 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.85 0.46 . . . . 0.0 110.987 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.98 161.93 12.21 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.91 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -96.36 98.25 10.12 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.602 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 90' ' ' LYS . . . 125.76 60.04 0.16 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.876 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.483 HG23 ' OE2' ' A' ' 137' ' ' GLU . 3.9 tp -86.44 -31.3 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 122.43 0.292 . . . . 0.0 111.181 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -122.41 -38.46 2.67 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.387 0.43 . . . . 0.0 109.997 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.548 ' O ' ' HB2' ' A' ' 93' ' ' GLU . 7.3 tt0 -87.07 26.57 1.15 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.095 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 13.4 ttpp -76.45 -28.8 56.7 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.345 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.6 tp -78.62 0.35 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 O-C-N 123.354 0.409 . . . . 0.0 111.712 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 1.0 OUTLIER -132.88 -4.35 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.722 179.12 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 2.7 tp10 -89.23 -37.61 14.85 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.82 -0.78 36.03 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -119.69 -11.36 9.42 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.341 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 2.1 t70 -94.76 -26.14 16.38 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.33 0.394 . . . . 0.0 111.606 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.8 mt -90.21 137.39 32.39 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.35 0.406 . . . . 0.0 111.454 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -109.4 125.78 52.76 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.077 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.3 154.08 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.622 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.4 t -92.24 144.01 25.83 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.918 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.3 tttm 62.18 114.84 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.844 0.858 . . . . 0.0 111.43 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.7 m -131.17 150.91 51.94 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.094 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -115.87 157.99 23.64 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.802 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.5 2.38 50.82 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.001 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.404 ' N ' ' HD2' ' A' ' 106' ' ' PRO . . . -90.95 -49.57 0.34 Allowed Pre-proline 0 CA--C 1.547 0.831 0 CA-C-O 118.673 -0.68 . . . . 0.0 112.406 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 105' ' ' ALA . 33.6 Cg_endo -64.8 165.13 21.93 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.1 1.866 . . . . 0.0 113.32 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.0 mt 65.77 126.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.791 0.836 . . . . 0.0 110.988 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -129.45 147.15 51.24 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.77 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -100.35 113.84 26.88 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.563 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -139.92 130.05 25.07 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.024 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.0 p -131.79 113.08 13.08 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.909 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.8 t -131.18 148.79 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.093 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.02 133.28 45.75 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.139 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.452 ' OE2' ' HB ' ' A' ' 72' ' ' ILE . 9.1 pt-20 -130.75 150.45 51.92 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.563 0.539 . . . . 0.0 111.619 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -129.51 125.39 36.23 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.939 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.513 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 4.6 mt -109.75 77.32 1.05 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.766 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 116' ' ' LEU . 36.0 mmtt -157.86 -48.64 0.06 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.89 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -94.22 -43.72 8.31 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -83.71 0.37 47.38 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 123.177 0.298 . . . . 0.0 111.688 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -127.68 123.34 22.94 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.795 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -73.41 -49.61 0.21 Allowed 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.658 2.239 . . . . 0.0 113.871 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 172.81 -61.21 0.14 Allowed Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.94 -0.922 . . . . 0.0 113.556 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.96 -31.41 73.93 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.928 2.419 . . . . 0.0 113.926 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -70.5 -20.47 62.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.644 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 8.8 mt -95.1 -28.29 4.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.13 -36.49 84.19 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.745 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -77.73 -10.64 59.64 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.877 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.599 ' O ' ' HB2' ' A' ' 132' ' ' LEU . 96.6 mt -84.14 -41.9 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.633 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 144' ' ' GLY . 3.8 m -72.31 -38.29 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.132 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 21.2 t -71.77 -60.91 1.99 Allowed 'General case' 0 C--N 1.348 0.502 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.701 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.6 m -56.86 -25.11 55.81 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.599 ' HB2' ' O ' ' A' ' 128' ' ' ILE . 4.3 tt -74.77 -48.27 26.44 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.586 0.176 . . . . 0.0 111.191 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -96.29 13.18 28.43 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 120.873 0.368 . . . . 0.0 111.645 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 130' ' ' SER . 4.5 tmt_? -76.03 -42.17 48.65 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.561 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 21.2 m-70 -88.85 -111.6 0.07 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 176.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -123.17 -89.54 0.59 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 141' ' ' LYS . 3.7 mm-40 55.48 89.87 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.487 1.115 . . . . 0.0 111.262 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.25 -15.64 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.021 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -94.02 -31.26 8.21 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.42 ' O ' HD21 ' A' ' 132' ' ' LEU . . . -89.62 -16.92 29.47 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.106 0.562 . . . . 0.0 111.204 178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 19.2 tptt -51.59 -28.83 15.24 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.424 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 1.3 p30 -78.34 -44.14 25.89 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.714 0.293 . . . . 0.0 110.495 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.4 tp -60.62 -66.55 0.51 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.964 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.419 ' O ' HG13 ' A' ' 129' ' ' VAL . . . -49.54 -34.71 20.62 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.332 177.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.72 77.71 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 117.218 0.509 . . . . 0.0 112.104 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.424 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -66.78 -50.55 62.3 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.1 0.25 . . . . 0.0 110.685 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 26.9 mt -61.79 -28.43 69.45 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.225 0.328 . . . . 0.0 111.423 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -80.77 -38.15 29.07 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 123.369 0.418 . . . . 0.0 110.773 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.83 0.27 27.76 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.239 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -82.93 -6.74 59.59 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.459 ' N ' HD22 ' A' ' 151' ' ' LEU . 1.3 mm? -102.67 -44.25 5.37 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.476 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -98.0 146.89 25.06 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.637 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -118.7 -43.27 2.69 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.304 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.469 -0.777 . . . . 0.0 111.121 179.98 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.6 p . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.475 0.179 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -127.82 122.25 32.19 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.871 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.37 -110.39 3.95 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.512 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 pp -120.08 -40.12 2.75 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.341 0.256 . . . . 0.0 111.27 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 152.57 -167.61 31.49 Favored Glycine 0 C--N 1.337 0.594 0 O-C-N 123.494 0.496 . . . . 0.0 112.764 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt 54.81 28.87 10.92 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.878 0.871 . . . . 0.0 112.795 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.62 -10.87 38.84 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.89 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -99.86 178.32 4.85 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.648 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -68.43 158.2 85.64 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 119.211 -0.424 . . . . 0.0 111.468 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -65.87 109.5 1.49 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.417 2.078 . . . . 0.0 113.268 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 tt -145.45 127.81 15.89 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.027 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -128.93 -43.17 1.36 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.451 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -113.51 138.41 50.17 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 123.345 0.403 . . . . 0.0 110.764 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.435 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 88.4 m-85 -100.81 -12.61 18.91 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.437 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -100.19 130.5 46.33 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.744 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.567 ' OG ' ' HA ' ' A' ' 91' ' ' ILE . 18.3 t -97.03 31.31 2.44 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.218 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -84.48 126.91 33.7 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.431 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.0 mt -109.99 -35.05 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.568 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.3 mp -63.73 -30.11 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 122.976 0.172 . . . . 0.0 110.81 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -92.04 9.54 32.88 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.42 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 t -87.13 171.72 10.48 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.828 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.34 13.58 39.24 Favored Glycine 0 C--N 1.344 1.014 0 C-N-CA 121.532 -0.366 . . . . 0.0 113.513 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -138.54 157.91 71.36 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 119.297 -0.382 . . . . 0.0 110.734 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.23 164.86 33.25 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.519 2.146 . . . . 0.0 112.821 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.474 ' O ' HG22 ' A' ' 131' ' ' THR . 0.2 OUTLIER -87.65 63.52 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.443 0.64 . . . . 0.0 111.209 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 83' ' ' SER . 7.0 tp10 -120.87 -55.68 1.98 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.428 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 m -64.49 -58.94 5.0 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.6 m -53.21 -62.06 1.9 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.443 ' CD2' HG12 ' A' ' 87' ' ' ILE . 44.9 m-85 -51.64 -33.51 33.79 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 178.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 6.3 t -65.78 -33.73 76.54 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.22 174.58 0.13 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.261 0.624 . . . . 0.0 112.643 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -98.22 119.04 36.18 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.198 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.04 51.14 1.66 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.058 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.443 HG12 ' CD2' ' A' ' 82' ' ' TYR . 3.8 tp -85.54 -42.29 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 122.47 0.308 . . . . 0.0 111.189 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -81.19 43.76 0.73 Allowed 'General case' 0 CA--C 1.55 0.95 0 CA-C-O 121.235 0.54 . . . . 0.0 111.939 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -141.7 -74.64 0.31 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.163 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -64.97 2.98 0.62 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.567 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 3.1 tp -86.68 -38.92 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 122.64 0.376 . . . . 0.0 111.57 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pt -105.05 15.38 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -93.72 -34.33 13.28 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.455 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.435 ' HB2' ' O ' ' A' ' 67' ' ' PHE . . . -83.17 -29.27 28.73 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.504 0.502 . . . . 0.0 112.178 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -85.89 -7.09 58.93 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 123.371 0.419 . . . . 0.0 111.727 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -84.47 6.48 23.32 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.051 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.5 mp -98.38 -57.06 2.29 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.155 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 56.18 110.79 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.956 0.902 . . . . 0.0 111.931 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.91 -45.1 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.77 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.9 m -91.29 150.49 21.29 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.482 0.489 . . . . 0.0 111.25 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -93.53 -15.06 25.88 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.113 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.6 t -91.95 108.4 19.91 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.99 0.424 . . . . 0.0 110.965 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -139.66 158.85 43.42 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.911 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t30 64.68 163.6 0.14 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.858 0.863 . . . . 0.0 111.911 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.98 149.56 56.51 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.417 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.83 134.3 52.89 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.84 2.36 . . . . 0.0 113.435 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 pt -140.76 158.54 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.294 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -91.6 -3.05 56.84 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.73 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -93.33 152.69 18.99 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.007 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.56 134.42 35.86 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.361 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.1 m -130.34 148.68 52.19 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.009 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.524 HG11 ' SD ' ' A' ' 113' ' ' MET . 12.2 p -118.49 -42.45 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.85 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.524 ' SD ' HG11 ' A' ' 112' ' ' VAL . 4.4 mpp? -123.61 165.23 17.53 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.523 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -78.28 -96.62 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.259 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.3 t80 54.87 172.98 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.905 0.882 . . . . 0.0 112.546 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.501 HD23 ' CZ ' ' A' ' 120' ' ' TYR . 9.2 mt -94.07 34.39 1.25 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.214 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -134.07 3.4 3.43 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.973 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.9 -48.96 13.63 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.44 10.48 6.74 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 123.394 0.434 . . . . 0.0 111.03 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.501 ' CZ ' HD23 ' A' ' 116' ' ' LEU . 63.5 m-85 -97.51 105.26 24.76 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.693 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.3 -35.38 14.11 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.653 2.236 . . . . 0.0 113.621 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 157.64 -56.85 0.37 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.868 -0.962 . . . . 0.0 113.122 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.16 -22.72 41.29 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.887 2.391 . . . . 0.0 114.028 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -74.31 -39.69 62.73 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.296 0.372 . . . . 0.0 111.293 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.0 mt -78.16 -30.91 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.371 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -62.38 -52.51 63.3 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.339 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.443 ' O ' ' OG1' ' A' ' 131' ' ' THR . 76.9 mtt180 -55.94 -27.72 53.65 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 177.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 69.2 mt -70.9 -50.48 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 121.999 0.12 . . . . 0.0 111.022 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.4 m -60.37 -39.72 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 43.2 p -78.73 -18.19 54.67 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 78' ' ' ILE . 89.1 m -86.62 -28.67 23.1 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 122.883 0.114 . . . . 0.0 111.224 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 144' ' ' GLY . 1.7 mp -80.43 -46.27 16.25 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.087 0.242 . . . . 0.0 110.444 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.413 ' OE1' ' HG2' ' A' ' 148' ' ' ARG . 44.4 mt-10 -80.18 12.87 2.59 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.881 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 130' ' ' SER . 4.6 tmt_? -79.71 -46.18 17.57 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.218 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.582 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 3.9 p80 -110.22 -12.45 14.47 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 70.31 78.83 0.19 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.337 1.055 . . . . 0.0 111.935 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.582 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 0.2 OUTLIER -99.77 130.44 45.98 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.923 179.08 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.89 -7.62 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.025 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -93.08 -22.11 28.5 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.512 -0.375 . . . . 0.0 112.705 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -126.93 5.25 6.56 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.18 -33.83 59.05 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.039 0.536 . . . . 0.0 111.753 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.561 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 3.1 t70 -74.95 -34.95 62.12 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.47 0.481 . . . . 0.0 111.232 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.9 tp -69.05 -59.61 2.92 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.825 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.439 ' N ' HD22 ' A' ' 132' ' ' LEU . . . -55.43 -56.25 24.44 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.852 -0.613 . . . . 0.0 113.934 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . -54.94 -43.63 73.57 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.561 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 14.3 mptt -62.24 -41.13 98.15 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.922 0.139 . . . . 0.0 111.246 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.4 mt -59.47 -34.42 72.54 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.44 0.463 . . . . 0.0 111.622 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 145' ' ' ALA . 0.1 OUTLIER -94.17 7.3 45.77 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 120.656 0.265 . . . . 0.0 111.029 178.544 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -108.18 17.65 22.02 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.245 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.16 -5.76 59.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.976 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.2 tt -98.95 -46.22 5.69 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.722 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -91.9 135.27 34.06 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.365 0.416 . . . . 0.0 111.266 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -111.86 151.64 28.87 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.931 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 . . . . . 0 N--CA 1.484 1.23 0 C-N-CA 123.945 0.898 . . . . 0.0 111.961 179.933 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.496 0.188 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -116.9 -42.46 2.95 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.155 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.82 106.84 0.96 Allowed Glycine 0 C--N 1.341 0.819 0 O-C-N 123.461 0.476 . . . . 0.0 112.545 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 tt -100.53 120.1 39.51 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 123.625 0.25 . . . . 0.0 110.431 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.14 -89.0 1.22 Allowed Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.494 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -120.08 130.89 54.87 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.401 0.28 . . . . 0.0 110.672 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.72 -12.44 23.75 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.007 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -132.41 122.77 25.5 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.369 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.06 106.48 13.73 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.823 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.62 -33.82 27.19 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.56 2.173 . . . . 0.0 113.161 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mt -100.71 130.03 46.69 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.475 0.485 . . . . 0.0 110.95 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.465 ' O ' ' HE1' ' A' ' 68' ' ' PHE . 3.2 t70 -119.2 -14.77 9.25 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.132 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -117.37 166.5 12.23 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.297 0.373 . . . . 0.0 110.693 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 65.96 93.31 0.07 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.07 0.948 . . . . 0.0 111.962 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.465 ' HE1' ' O ' ' A' ' 65' ' ' ASP . 86.0 m-85 -131.48 -41.21 1.08 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.866 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.8 p -113.39 178.57 4.23 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.71 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -71.6 156.96 38.8 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.553 0.341 . . . . 0.0 111.457 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -84.68 -172.2 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.656 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 33.3 mm 76.15 -48.87 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 124.054 0.942 . . . . 0.0 110.708 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.74 29.66 7.83 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.096 0.474 . . . . 0.0 111.012 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.8 t -88.39 -39.56 14.2 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.44 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.4 37.07 0.02 OUTLIER Glycine 0 C--N 1.337 0.614 0 O-C-N 123.673 0.608 . . . . 0.0 112.335 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.587 ' N ' ' HD3' ' A' ' 77' ' ' PRO . 33.7 tttm 53.38 47.41 4.01 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 124.211 1.004 . . . . 0.0 112.786 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.587 ' HD3' ' N ' ' A' ' 76' ' ' LYS . 6.7 Cg_endo -87.75 -62.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.537 2.158 . . . . 0.0 112.249 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER 46.93 19.25 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 124.906 1.282 . . . . 0.0 114.144 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -120.38 -77.99 0.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 35.2 m -41.63 -47.55 3.92 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.313 1.045 . . . . 0.0 112.715 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.4 t -61.54 -51.61 67.87 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.806 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -88.37 17.98 4.83 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.392 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m -119.73 -15.88 8.85 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.997 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.34 154.74 17.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.169 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.6 133.67 37.27 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.504 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 90' ' ' LYS . . . 94.44 34.12 6.5 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.669 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.7 tp -89.31 -24.06 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.544 ' CD2' ' HG3' ' A' ' 89' ' ' GLU . 29.2 p-80 -47.78 -36.91 12.39 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.544 ' HG3' ' CD2' ' A' ' 88' ' ' HIS . 41.4 mt-10 -108.46 -30.14 8.43 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 123.322 0.389 . . . . 0.0 111.429 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 36.5 tttt -54.18 -10.87 0.4 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.2 mt -83.82 -35.77 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 122.252 0.221 . . . . 0.0 110.559 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.5 tp -92.64 -35.13 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.481 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -92.94 -80.26 0.38 Allowed 'General case' 0 CA--C 1.533 0.307 0 O-C-N 123.395 0.434 . . . . 0.0 110.653 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' A' ' 90' ' ' LYS . . . 66.37 -35.7 0.24 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -133.42 -41.92 0.87 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.03 155.73 13.08 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.22 0.608 . . . . 0.0 112.205 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.8 mp -92.87 161.76 14.36 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.106 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -86.99 115.39 24.34 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.095 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.0 p -139.06 -38.57 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.959 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.1 m -112.81 112.49 24.02 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 123.443 0.464 . . . . 0.0 110.698 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -139.13 150.92 46.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.7 t -121.42 123.71 42.74 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.763 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -101.89 -42.74 6.03 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.836 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -111.94 131.02 55.64 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.797 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 108' ' ' GLN . . . -95.06 113.08 60.59 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.262 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -80.4 -39.69 0.24 Allowed 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 122.232 1.955 . . . . 0.0 113.535 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.5 pt -142.18 -8.0 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.411 ' O ' ' HB1' ' A' ' 105' ' ' ALA . 54.4 mt-30 -91.45 112.37 24.25 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.827 0.346 . . . . 0.0 111.276 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -137.68 119.61 15.35 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.232 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 58.97 115.36 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.029 0.931 . . . . 0.0 112.315 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.1 m -129.62 145.36 51.5 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.042 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.57 149.6 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.478 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.447 ' SD ' HD21 ' A' ' 147' ' ' LEU . 18.2 ptp -97.26 127.01 42.85 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.245 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -97.96 22.39 9.38 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.045 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -113.52 -44.34 3.22 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.087 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.5 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 6.2 mt -102.01 -42.03 6.24 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.37 0.419 . . . . 0.0 111.648 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -91.64 141.23 28.93 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.213 0.321 . . . . 0.0 111.062 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.2 mptt 70.64 -35.68 0.33 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.348 1.059 . . . . 0.0 113.018 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.99 -18.09 20.51 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 122.252 0.221 . . . . 0.0 111.324 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.507 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 19.3 t80 -133.57 50.55 5.48 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 123.335 0.397 . . . . 0.0 111.315 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.507 ' HD3' ' N ' ' A' ' 120' ' ' TYR . 3.5 Cg_exo -76.19 111.18 3.22 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.26 1.973 . . . . 0.0 112.287 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -172.91 -160.55 21.69 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.713 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.665 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 12.5 Cg_exo -70.29 -34.83 12.12 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 123.295 2.663 . . . . 0.0 112.803 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -56.09 -30.69 62.41 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.492 0.495 . . . . 0.0 111.62 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.451 HD13 ' O ' ' A' ' 116' ' ' LEU . 46.4 mm -67.12 -44.53 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.642 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -68.9 -18.71 64.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.237 0.615 . . . . 0.0 111.243 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.665 ' HG2' ' O ' ' A' ' 123' ' ' PRO . 24.2 mmm180 -79.99 -46.63 16.32 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.604 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.4 mt -61.23 -49.33 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.916 0.487 . . . . 0.0 110.744 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 125' ' ' ILE . 7.0 m -58.68 -52.11 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.699 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 57.9 m -59.48 -38.41 80.77 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.2 m -72.69 -24.12 60.97 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 19.3 mt -85.66 -30.91 22.85 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.075 0.235 . . . . 0.0 111.406 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -84.97 5.1 30.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.15 0.5 . . . . 0.0 111.167 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -98.04 -36.22 10.18 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.442 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -85.36 -33.41 22.03 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.436 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 67.18 69.84 0.38 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.225 1.01 . . . . 0.0 111.492 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -95.82 136.68 35.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.49 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.2 m -75.23 -48.71 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -77.43 -2.12 78.53 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.176 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -122.53 -4.79 8.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.737 0.415 . . . . 0.0 111.386 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -62.28 -37.61 86.19 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 122.798 0.439 . . . . 0.0 111.013 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.492 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 8.1 m-20 -73.42 -38.16 65.65 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.482 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.3 tp -66.74 -55.91 12.91 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.75 0.42 . . . . 0.0 110.781 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.05 -41.65 85.65 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.483 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -61.51 -41.21 96.96 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.492 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -62.13 -38.05 87.49 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.141 0.275 . . . . 0.0 111.464 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.447 HD21 ' SD ' ' A' ' 113' ' ' MET . 18.2 mt -66.41 -32.15 73.35 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.257 0.348 . . . . 0.0 110.328 177.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.41 12.47 31.19 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.423 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 5.4 t70 -106.47 43.32 1.16 Allowed 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.288 0.566 . . . . 0.0 110.375 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.26 -6.08 55.85 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.661 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 mp -97.47 -43.4 7.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.213 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.0 t70 57.23 176.75 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.886 0.874 . . . . 0.0 112.346 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.89 128.68 34.66 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.268 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.807 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.4 p . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 111.319 0.118 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 70.91 -50.63 0.68 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.414 1.086 . . . . 0.0 112.399 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.91 50.07 0.18 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 121.537 -0.363 . . . . 0.0 112.69 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.3 tp -120.02 -47.36 2.39 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.549 0.205 . . . . 0.0 110.747 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.08 52.01 1.82 Allowed Glycine 0 C--N 1.343 0.949 0 O-C-N 123.463 0.477 . . . . 0.0 112.689 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -103.99 136.02 44.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.618 0.247 . . . . 0.0 111.172 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.95 -3.52 10.17 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.802 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -91.13 141.09 29.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.061 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.34 -46.06 0.13 Allowed Pre-proline 0 CA--C 1.545 0.772 0 CA-C-O 118.719 -0.658 . . . . 0.0 111.949 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.51 145.87 30.23 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.333 2.022 . . . . 0.0 112.903 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 tp -99.53 150.23 22.43 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.525 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -104.33 93.57 4.88 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.199 0.523 . . . . 0.0 111.624 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.6 mttt 54.16 -89.14 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.151 0.981 . . . . 0.0 112.983 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 73.16 -46.05 0.63 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.017 1.327 . . . . 0.0 112.101 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 57.4 157.36 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.12 0.968 . . . . 0.0 112.821 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.9 m -110.91 95.1 5.34 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.81 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -139.71 102.63 4.48 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.556 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.463 HD13 ' OG ' ' A' ' 81' ' ' SER . 4.6 mt -125.13 -2.95 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.648 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.502 HG22 ' CD2' ' A' ' 73' ' ' PHE . 3.1 tp -73.04 -40.97 59.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.253 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.502 ' CD2' HG22 ' A' ' 72' ' ' ILE . 2.3 p90 -123.18 52.8 1.35 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.398 0.618 . . . . 0.0 110.939 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.7 t -93.33 -43.6 8.7 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.293 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.08 -63.04 0.21 Allowed Glycine 0 C--N 1.341 0.807 0 C-N-CA 121.161 -0.543 . . . . 0.0 113.092 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -130.26 -46.38 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.84 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.62 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.28 119.75 7.06 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.261 1.974 . . . . 0.0 113.764 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 tt -149.74 10.49 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.655 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -120.18 -57.57 1.92 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.272 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.9 m -47.35 -46.84 25.98 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.191 0.996 . . . . 0.0 112.7 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.463 ' OG ' HD13 ' A' ' 71' ' ' ILE . 43.2 t -61.19 -53.04 61.91 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.887 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.476 ' OH ' ' HB ' ' A' ' 72' ' ' ILE . 73.7 m-85 -79.62 5.28 13.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.926 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.508 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 23.3 t -91.32 -47.45 7.47 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.943 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.98 160.21 4.97 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -92.07 92.13 8.13 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.219 0.533 . . . . 0.0 110.921 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.5 48.31 0.05 OUTLIER Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.98 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.587 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 2.7 tp -91.84 -29.62 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 122.623 0.369 . . . . 0.0 111.929 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.434 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 32.4 t60 -85.68 -16.97 37.35 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -106.0 -73.72 0.67 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.987 0.179 . . . . 0.0 111.065 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -48.82 -7.21 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.587 ' HB ' ' O ' ' A' ' 87' ' ' ILE . 3.6 tp -66.53 -21.41 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 122.536 0.334 . . . . 0.0 111.229 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 tp -107.93 20.2 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.422 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -81.54 -31.99 32.48 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.769 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.08 -22.81 42.2 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -113.85 -19.54 11.45 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 123.403 0.439 . . . . 0.0 111.043 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -96.52 160.06 14.6 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.329 0.393 . . . . 0.0 110.931 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 tt -129.63 126.02 37.44 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.613 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 64.11 135.43 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.029 0.931 . . . . 0.0 111.961 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.8 m -107.06 155.46 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.402 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.6 p -126.31 -55.91 1.43 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.142 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt 56.83 115.2 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.926 0.89 . . . . 0.0 112.523 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 54.1 p -133.0 -61.78 0.82 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.107 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -145.78 27.16 1.22 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.635 0.374 . . . . 0.0 111.241 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.7 m120 64.73 133.97 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.935 0.894 . . . . 0.0 111.759 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.411 ' N ' ' HD2' ' A' ' 106' ' ' PRO . . . -92.55 -48.57 0.3 Allowed Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 118.679 -0.677 . . . . 0.0 112.766 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 105' ' ' ALA . 32.1 Cg_endo -64.2 133.73 39.27 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.053 1.836 . . . . 0.0 113.729 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.463 ' HB ' ' CE2' ' A' ' 109' ' ' TYR . 0.8 OUTLIER -125.08 158.55 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.673 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.443 ' HG2' ' NZ ' ' A' ' 146' ' ' LYS . 1.1 mp0 -97.3 124.19 41.35 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.649 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.463 ' CE2' ' HB ' ' A' ' 107' ' ' ILE . 74.9 m-85 -136.69 -54.43 0.72 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.133 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -142.84 172.42 12.73 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.409 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.0 p -81.68 -67.16 0.8 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.174 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.8 t 59.96 151.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 123.982 0.913 . . . . 0.0 112.014 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 72.9 mtm 63.09 152.68 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.921 0.888 . . . . 0.0 112.443 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -129.24 124.24 33.99 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.862 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -130.75 -43.88 1.09 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.102 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.4 mp -98.47 166.6 11.28 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.184 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 71.02 -3.48 2.02 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.376 1.07 . . . . 0.0 112.759 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -97.43 -45.1 6.57 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.396 0.278 . . . . 0.0 110.69 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.46 7.34 1.93 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.834 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -92.93 114.13 61.76 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.618 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.55 177.85 1.12 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.709 2.273 . . . . 0.0 112.863 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.68 -55.58 14.15 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.878 -0.957 . . . . 0.0 113.87 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.5 -15.17 39.51 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.732 2.288 . . . . 0.0 113.762 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.416 ' O ' HG13 ' A' ' 128' ' ' ILE . 3.2 t70 -80.05 -41.35 25.86 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.553 0.341 . . . . 0.0 111.021 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.0 mt -67.7 -39.11 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.472 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.8 -50.65 65.89 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.183 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -49.34 -40.67 36.27 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.828 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 124' ' ' ASP . 29.0 mt -66.64 -54.59 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.142 0.177 . . . . 0.0 111.436 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 144' ' ' GLY . 4.2 m -60.23 -51.78 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.571 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 75.2 m -62.91 -25.49 68.35 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.2 m -83.28 -26.0 31.06 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 117.54 0.154 . . . . 0.0 111.297 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.5 mt -81.15 -38.55 26.99 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.592 0.234 . . . . 0.0 111.031 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -88.45 8.81 26.1 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.822 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.571 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.1 tmt_? -82.17 -40.63 21.51 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.987 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.508 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 87.6 m-70 -100.4 -9.4 22.25 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.457 0.473 . . . . 0.0 111.298 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 67.67 70.21 0.35 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.178 0.991 . . . . 0.0 111.326 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' A' ' 141' ' ' LYS . 43.5 mt-10 -90.7 129.13 36.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.437 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.16 -45.15 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -178.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -76.16 -18.53 79.29 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.579 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.62 -11.58 17.61 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 124.041 0.495 . . . . 0.0 111.033 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -51.78 -34.76 41.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.643 0.777 . . . . 0.0 112.461 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.518 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 8.0 m-20 -74.57 -36.62 63.06 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.434 0.459 . . . . 0.0 111.495 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.434 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 14.3 tp -67.39 -60.24 2.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.74 0.416 . . . . 0.0 110.884 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.428 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -55.49 -43.6 85.42 Favored Glycine 0 C--N 1.343 0.947 0 O-C-N 123.618 0.574 . . . . 0.0 113.928 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -60.64 -43.6 97.35 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.518 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -61.97 -40.19 94.73 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.3 mt -67.11 -30.75 70.85 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 123.264 0.352 . . . . 0.0 110.302 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -94.25 9.84 36.44 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.367 0.417 . . . . 0.0 110.703 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 3.7 t70 -114.27 16.49 17.93 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.694 0.283 . . . . 0.0 111.082 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.6 -8.29 57.63 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.826 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.08 -58.35 1.91 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.635 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 4.2 t70 58.41 122.9 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.141 0.976 . . . . 0.0 112.347 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -97.79 148.9 22.91 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.142 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.137 -0.935 . . . . 0.0 110.87 179.938 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.8 t . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.539 0.209 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -116.51 -42.35 3.01 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.31 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.72 -45.69 1.13 Allowed Glycine 0 C--N 1.34 0.777 0 O-C-N 123.435 0.46 . . . . 0.0 112.687 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.63 158.53 15.41 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.404 0.282 . . . . 0.0 111.225 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.21 -95.83 1.07 Allowed Glycine 0 C--N 1.341 0.848 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.77 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -120.0 -48.5 2.34 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.579 0.223 . . . . 0.0 110.945 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.08 149.35 42.34 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 123.289 0.368 . . . . 0.0 111.492 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -127.07 119.36 26.38 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.796 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -132.54 -41.62 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.785 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -67.07 -34.75 27.66 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.13 1.887 . . . . 0.0 113.597 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mp -108.53 121.11 44.29 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.23 0.331 . . . . 0.0 111.114 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.42 ' OD2' ' HG2' ' A' ' 66' ' ' LYS . 2.6 p-10 -137.01 -57.4 0.72 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.047 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 52.2 pttt -152.84 111.33 3.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.515 0.326 . . . . 0.0 111.235 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -120.38 -60.8 1.65 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.076 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.435 ' HB2' ' OG ' ' A' ' 74' ' ' SER . 50.7 m-85 -146.32 -33.85 0.31 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.751 0.42 . . . . 0.0 111.218 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.503 ' N ' ' HB3' ' A' ' 74' ' ' SER . 57.3 m 62.28 22.21 13.03 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.095 0.958 . . . . 0.0 112.858 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -138.48 -20.12 1.06 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.411 ' N ' ' HB2' ' A' ' 74' ' ' SER . 0.7 OUTLIER -81.14 -174.4 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 122.448 0.299 . . . . 0.0 111.561 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 tt -59.8 -41.69 86.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -111.47 18.74 18.86 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 120.715 0.293 . . . . 0.0 111.773 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.503 ' HB3' ' N ' ' A' ' 69' ' ' SER . 0.4 OUTLIER -96.76 -43.03 7.7 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.03 -141.51 3.15 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.103 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -92.9 -44.49 0.33 Allowed Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 118.69 -0.672 . . . . 0.0 112.255 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.86 137.21 75.04 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.332 2.021 . . . . 0.0 113.432 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 tp -143.16 37.51 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.36 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 83' ' ' SER . 37.5 tt0 -120.03 -60.82 1.66 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.835 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.5 m -52.17 -56.42 14.7 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.589 0.755 . . . . 0.0 112.196 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.0 p -60.59 -53.72 54.02 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.958 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.455 ' CE1' HG23 ' A' ' 128' ' ' ILE . 3.9 m-85 -69.21 -0.31 5.88 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.586 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 10.9 t -95.55 -43.48 7.93 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.51 161.96 26.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.271 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.628 ' HA ' ' OE1' ' A' ' 137' ' ' GLU . 19.3 mtpp -86.19 145.99 26.75 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.083 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.65 18.68 27.15 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.255 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.563 HD12 ' O ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -79.23 -19.36 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 122.528 0.331 . . . . 0.0 111.717 179.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.53 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 75.2 t60 -82.83 -4.48 58.11 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.169 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -120.97 -46.39 2.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.525 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.528 ' O ' ' HD2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -68.81 -4.51 16.43 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.0 tt -80.55 -22.11 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 122.561 0.344 . . . . 0.0 111.681 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.9 mm -95.96 1.62 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 O-C-N 123.352 0.407 . . . . 0.0 110.459 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -87.67 -34.67 18.36 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.465 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.63 -16.84 58.31 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -95.45 -10.98 28.34 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.437 0.461 . . . . 0.0 111.175 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -95.27 104.53 16.42 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.943 0.402 . . . . 0.0 110.545 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.4 tp -143.04 -30.36 0.52 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.073 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 65.8 m80 64.39 122.4 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.942 0.897 . . . . 0.0 111.817 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 t -123.1 148.35 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.9 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 p -112.39 122.95 49.17 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.966 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt 56.36 105.59 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.949 0.899 . . . . 0.0 112.278 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.4 p -138.55 -50.52 0.55 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.895 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -139.89 153.49 47.0 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.384 0.427 . . . . 0.0 111.03 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -124.42 -44.47 1.99 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.049 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.634 ' H ' ' HD2' ' A' ' 106' ' ' PRO . . . -126.58 -50.93 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.812 0 CA-C-O 118.432 -0.794 . . . . 0.0 112.609 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.634 ' HD2' ' H ' ' A' ' 105' ' ' ALA . 28.1 Cg_endo -62.87 134.96 49.25 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.074 1.849 . . . . 0.0 113.646 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.5 pt -142.58 150.96 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.949 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -124.77 -61.36 1.32 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.233 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -145.37 -46.34 0.22 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.288 0.367 . . . . 0.0 110.883 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 66.47 -68.0 0.14 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.365 1.066 . . . . 0.0 112.774 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.7 p -142.18 161.46 37.96 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.086 0.241 . . . . 0.0 111.349 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.2 p -91.59 152.88 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.648 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 71.9 mtm -98.74 116.51 31.13 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.455 0.472 . . . . 0.0 111.576 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 59.51 -75.37 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.567 1.147 . . . . 0.0 113.246 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -131.97 162.51 30.53 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.384 0.274 . . . . 0.0 111.551 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.408 HD22 ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -88.38 123.35 32.86 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.637 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -147.33 -39.3 0.19 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.527 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.06 -8.09 46.89 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.632 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.2 -46.61 10.91 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.236 0.335 . . . . 0.0 111.08 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -98.28 161.36 25.61 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 123.495 0.497 . . . . 0.0 110.902 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.17 -31.01 24.06 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.467 2.112 . . . . 0.0 113.419 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 152.1 -52.66 0.48 Allowed Glycine 0 CA--C 1.531 1.077 0 CA-C-O 118.781 -1.01 . . . . 0.0 113.751 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.87 -17.52 18.92 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.986 2.457 . . . . 0.0 114.847 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -74.93 -42.1 58.36 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.313 0.245 . . . . 0.0 111.453 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 129' ' ' VAL . 4.6 mp -62.7 -32.69 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.794 0.438 . . . . 0.0 110.667 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -70.19 -50.53 39.2 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.68 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.62 -46.26 70.38 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.455 HG23 ' CE1' ' A' ' 82' ' ' TYR . 23.3 mt -61.17 -59.36 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 122.532 0.333 . . . . 0.0 111.488 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 125' ' ' ILE . 16.5 m -53.42 -41.94 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 123.49 0.494 . . . . 0.0 112.078 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 12.9 t -68.25 -26.48 65.7 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.5 m -72.06 -40.8 68.06 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.238 0.215 . . . . 0.0 110.933 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.51 HD21 ' N ' ' A' ' 144' ' ' GLY . 4.1 mp -77.1 -24.54 51.76 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.283 0.365 . . . . 0.0 111.508 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -91.13 12.1 21.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.272 0.558 . . . . 0.0 110.324 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.9 tmt_? -118.95 -36.64 3.38 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.128 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.586 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 52.2 m-70 -90.18 -32.17 16.73 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.912 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.9 t70 60.62 61.16 1.77 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.064 0.945 . . . . 0.0 111.674 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.628 ' OE1' ' HA ' ' A' ' 85' ' ' LYS . 37.1 mt-10 -84.99 130.22 34.66 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.641 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.452 ' O ' ' HD2' ' A' ' 141' ' ' LYS . 3.4 t -79.8 -22.42 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.404 0.44 . . . . 0.0 111.645 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -87.09 -19.05 56.66 Favored Glycine 0 C--N 1.342 0.884 0 C-N-CA 121.424 -0.417 . . . . 0.0 112.742 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.89 3.25 11.05 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.893 0.477 . . . . 0.0 111.374 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER -48.05 -42.33 28.25 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.783 0.833 . . . . 0.0 112.617 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 2.4 p-10 -68.21 -40.96 81.98 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.532 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.53 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 32.6 tp -56.18 -51.92 66.26 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.56 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.51 ' N ' HD21 ' A' ' 132' ' ' LEU . . . -60.92 -60.78 7.84 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.923 -0.581 . . . . 0.0 113.654 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -54.97 -42.11 72.01 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -63.54 -32.81 74.39 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.112 0.258 . . . . 0.0 111.518 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.0 mt -70.82 -30.93 67.5 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.295 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' A' ' 148' ' ' ARG . 1.0 OUTLIER -98.93 4.47 47.37 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 123.153 0.283 . . . . 0.0 111.041 178.806 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 1.8 t70 -99.24 24.77 7.55 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.84 0.352 . . . . 0.0 111.2 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.36 -4.81 58.82 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.022 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.7 tt -104.19 -48.92 3.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.763 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -120.08 153.18 36.49 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 123.297 0.373 . . . . 0.0 110.887 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.72 126.61 44.9 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.976 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 117.989 -1.005 . . . . 0.0 112.144 -179.868 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.451 0.167 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -111.32 -45.2 3.43 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.895 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.0 136.46 4.46 Favored Glycine 0 C--N 1.339 0.741 0 O-C-N 123.484 0.49 . . . . 0.0 112.668 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.91 158.25 27.08 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 122.422 0.289 . . . . 0.0 110.962 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.6 -143.82 11.39 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.725 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -99.75 -49.16 4.46 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 123.563 0.213 . . . . 0.0 111.122 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.21 124.61 46.11 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.309 0.38 . . . . 0.0 111.203 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -133.0 102.07 5.47 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.338 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -141.84 159.39 59.74 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.636 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.69 129.02 19.02 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.445 2.097 . . . . 0.0 112.787 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.454 ' O ' HD23 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -97.39 7.15 47.08 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.121 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.6 t70 65.29 176.0 0.21 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.898 0.879 . . . . 0.0 111.294 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.76 118.57 13.71 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.823 0.344 . . . . 0.0 111.507 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -112.91 -43.81 3.37 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.366 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -99.06 121.54 41.12 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.429 0.456 . . . . 0.0 110.414 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 40.4 p -120.11 126.2 50.16 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.146 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -130.62 103.79 6.83 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.296 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.442 ' O ' ' N ' ' A' ' 73' ' ' PHE . 3.4 mt -129.66 -71.69 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.681 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp 45.51 -74.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 124.969 1.308 . . . . 0.0 113.323 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.442 ' N ' ' O ' ' A' ' 71' ' ' ILE . 11.9 t80 -135.4 90.26 2.6 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.233 0.539 . . . . 0.0 110.231 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 t -97.28 -39.78 9.07 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.964 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.96 -84.75 0.05 OUTLIER Glycine 0 C--N 1.34 0.769 0 O-C-N 123.475 0.484 . . . . 0.0 112.501 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.446 ' N ' ' CD ' ' A' ' 77' ' ' PRO . 14.0 ptmt -136.87 -30.81 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 76' ' ' LYS . 12.4 Cg_exo -71.87 135.06 24.85 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.103 1.869 . . . . 0.0 113.583 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 tt -135.82 -0.08 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.461 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -103.96 -43.52 5.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.842 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 m -63.53 -63.06 1.28 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.415 ' OG ' HD11 ' A' ' 71' ' ' ILE . 11.4 t -45.24 -25.39 0.37 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -104.29 -10.9 17.5 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.8 t -91.91 -25.01 19.12 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.91 118.07 2.92 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.98 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.504 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 12.4 ptmt -60.64 105.61 0.46 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.86 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.23 75.58 1.3 Allowed Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.295 -0.866 . . . . 0.0 114.256 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.1 tt -106.65 -103.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.545 ' O ' ' HA3' ' A' ' 139' ' ' GLY . 0.3 OUTLIER -58.86 -2.94 0.27 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 178.285 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 92' ' ' ILE . 13.2 tt0 -69.08 -14.93 63.3 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.19 -21.04 24.79 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.529 HG21 ' O ' ' A' ' 88' ' ' HIS . 3.8 tp -89.48 26.71 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-O 121.195 0.521 . . . . 0.0 110.843 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.571 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 3.3 tp -136.8 -10.61 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.331 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -120.48 -36.07 3.28 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.289 0.368 . . . . 0.0 111.085 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.37 -31.95 71.85 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.953 0.501 . . . . 0.0 111.916 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -120.9 -53.84 2.05 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.95 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.571 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 17.8 t70 43.18 77.86 0.06 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.515 1.126 . . . . 0.0 112.52 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.0 mt -148.56 138.16 22.05 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.465 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -98.55 -44.56 6.42 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 123.491 0.495 . . . . 0.0 110.668 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 m -143.67 109.21 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.7 t -130.21 152.52 49.55 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.011 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.4 tptt -98.84 157.17 16.48 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.478 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.9 m -87.95 121.76 30.75 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.124 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -132.51 -45.89 0.9 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.406 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -122.68 -45.02 2.19 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.029 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -128.32 137.21 30.38 Favored Pre-proline 0 CA--C 1.534 0.353 0 O-C-N 123.306 0.379 . . . . 0.0 111.251 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.4 161.48 44.18 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.649 2.232 . . . . 0.0 113.117 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.4 tp -117.31 -27.5 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.392 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -93.07 130.1 38.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.278 0.361 . . . . 0.0 111.03 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -130.46 -39.72 1.29 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.138 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 64.05 132.05 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.929 0.892 . . . . 0.0 112.343 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 56.1 m -113.14 152.87 29.11 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.007 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.9 m -95.51 -26.94 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.108 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.6 mmt -89.9 34.11 0.85 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.147 0.498 . . . . 0.0 111.273 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -94.04 179.88 5.18 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.862 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 66.86 123.17 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.053 0.941 . . . . 0.0 111.863 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 120' ' ' TYR . 5.2 mt -107.59 16.5 23.68 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.501 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -92.47 -11.69 34.01 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.815 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -96.54 -38.4 10.0 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.108 0.255 . . . . 0.0 111.674 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.8 t -94.4 -42.45 8.87 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 123.316 0.385 . . . . 0.0 111.638 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.482 ' HB2' ' O ' ' A' ' 116' ' ' LEU . 6.3 m-30 -97.86 119.39 62.43 Favored Pre-proline 0 CA--C 1.543 0.707 0 O-C-N 123.429 0.455 . . . . 0.0 110.67 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.87 -48.81 0.35 Allowed 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.638 2.225 . . . . 0.0 114.041 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -171.03 -63.92 0.04 OUTLIER Glycine 0 C--N 1.342 0.891 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.448 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.08 -30.45 78.87 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.061 2.507 . . . . 0.0 113.85 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.8 -21.58 66.04 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.347 0.404 . . . . 0.0 111.977 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 6.9 mt -89.41 -50.13 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -45.53 -41.18 9.46 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.649 0.78 . . . . 0.0 112.082 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -62.17 -42.76 99.57 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.967 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 14.8 mt -61.51 -61.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.962 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.511 HG12 ' O ' ' A' ' 144' ' ' GLY . 3.4 m -49.16 -31.27 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 18.3 t -76.76 -50.36 13.75 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.04 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.5 m -56.55 -33.89 66.55 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.5 mp -79.24 -48.99 13.2 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.645 0.202 . . . . 0.0 111.243 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -56.29 -20.41 18.58 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -79.58 -45.27 19.49 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.28 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.504 ' NE2' ' HA ' ' A' ' 85' ' ' LYS . 50.0 t-80 -64.97 -41.51 95.39 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 72.9 80.4 0.14 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.032 0.933 . . . . 0.0 111.162 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.844 ' O ' ' HB2' ' A' ' 141' ' ' LYS . 20.5 mt-10 -125.09 153.59 42.71 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.157 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.3 t -83.9 -40.23 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 88' ' ' HIS . . . -86.9 -15.49 62.96 Favored Glycine 0 N--CA 1.47 0.931 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.402 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -95.98 -17.47 20.98 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 113.832 -1.184 . . . . 0.0 109.771 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.844 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 3.2 tptm -70.04 -22.38 63.09 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 9.8 m-20 -81.17 -28.42 35.0 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.767 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.2 tp -76.51 -63.38 1.35 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.867 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.511 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -61.87 -26.59 67.32 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.529 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . -85.27 -39.81 17.31 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.581 0.691 . . . . 0.0 112.409 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -70.47 -31.85 69.15 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 121.331 -0.148 . . . . 0.0 111.009 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.7 mt -71.27 -45.12 63.88 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 123.126 0.266 . . . . 0.0 110.406 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.529 ' HG3' ' O ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -66.07 -21.67 66.38 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 178.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -95.56 -13.19 24.64 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 123.322 0.389 . . . . 0.0 111.378 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -87.85 -8.31 56.03 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.193 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.1 tt -98.4 -41.76 7.66 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.525 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -90.25 124.23 34.7 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 123.353 0.408 . . . . 0.0 111.08 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -115.67 132.76 56.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.844 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 . . . . . 0 N--CA 1.484 1.268 0 C-N-CA 123.843 0.857 . . . . 0.0 112.076 -179.943 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.4 m . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.333 0.111 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -100.14 -43.03 6.46 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 123.389 0.431 . . . . 0.0 110.919 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.29 -53.38 0.07 OUTLIER Glycine 0 C--N 1.341 0.806 0 O-C-N 123.373 0.421 . . . . 0.0 112.585 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.71 141.0 33.09 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.642 0.26 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.72 179.32 17.21 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.739 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 56.23 25.55 9.37 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.789 0.836 . . . . 0.0 112.76 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.54 -12.63 29.14 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.93 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -133.84 127.41 32.54 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.64 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -127.15 96.97 32.85 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.786 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.36 135.49 22.51 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.608 2.205 . . . . 0.0 112.71 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.469 HD23 ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -118.51 -3.08 10.93 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.62 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 t70 72.18 -48.71 0.68 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.562 1.145 . . . . 0.0 111.97 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -128.98 130.62 46.92 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.239 0.337 . . . . 0.0 111.051 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.469 ' CE2' HD23 ' A' ' 64' ' ' LEU . 86.2 m-85 -94.9 -12.86 26.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.713 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -92.91 28.65 2.02 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 120.93 0.395 . . . . 0.0 111.77 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.6 p -91.09 -43.4 9.93 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.575 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? 63.88 155.64 0.06 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.938 0.895 . . . . 0.0 112.317 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.478 ' CG2' ' HZ3' ' A' ' 76' ' ' LYS . 0.8 OUTLIER -92.91 -8.74 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.808 -179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.9 tp -72.53 -41.42 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.471 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -89.71 15.57 9.42 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 123.375 0.422 . . . . 0.0 111.45 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.7 t -92.83 158.6 15.78 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.809 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.92 81.63 1.52 Allowed Glycine 0 C--N 1.34 0.759 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.771 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.478 ' HZ3' ' CG2' ' A' ' 71' ' ' ILE . 96.9 mttt -128.19 157.31 74.67 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 119.319 -0.372 . . . . 0.0 110.92 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.85 6.9 4.6 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.682 2.254 . . . . 0.0 113.564 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.411 HG23 ' O ' ' A' ' 78' ' ' ILE . 4.5 mp 58.2 51.29 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.636 0.774 . . . . 0.0 110.958 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -120.81 -89.41 0.6 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.695 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.9 m -54.04 -43.36 70.13 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.89 0.876 . . . . 0.0 112.602 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.493 ' O ' HG13 ' A' ' 87' ' ' ILE . 24.1 p -68.46 -41.14 80.63 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.71 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -94.33 13.05 24.83 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.247 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 26.3 t -110.02 -25.51 10.21 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.03 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.19 164.34 26.18 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.728 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -95.06 135.56 36.45 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.511 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.492 ' O ' ' HG3' ' A' ' 90' ' ' LYS . . . 77.36 55.82 4.17 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.898 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.543 HD11 ' O ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -113.61 -13.25 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.606 ' HB3' ' O ' ' A' ' 139' ' ' GLY . 61.5 t60 -102.67 -65.77 0.97 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 117.859 0.299 . . . . 0.0 111.732 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -94.52 50.19 1.33 Allowed 'General case' 0 C--O 1.239 0.551 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 86' ' ' GLY . 18.6 mmtp -121.32 -20.96 6.5 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.13 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.422 ' O ' ' HD2' ' A' ' 95' ' ' HIS . 2.0 tt -71.9 -13.35 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.747 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.0 tt -74.38 -23.94 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.658 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -73.23 -27.73 61.76 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.148 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.16 -29.71 24.54 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.849 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.422 ' HD2' ' O ' ' A' ' 91' ' ' ILE . 46.7 m-70 -85.97 -9.58 56.62 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.855 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -91.13 123.2 34.4 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.697 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 pp -134.82 141.01 46.29 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.094 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 67.9 m80 63.55 145.6 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.069 0.948 . . . . 0.0 112.374 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 m -110.07 -18.04 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.99 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.7 m -89.42 -13.99 36.46 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.325 0.391 . . . . 0.0 111.88 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.503 ' HD3' ' N ' ' A' ' 102' ' ' SER . 0.8 OUTLIER -92.15 158.67 16.05 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.557 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.503 ' N ' ' HD3' ' A' ' 101' ' ' LYS . 52.2 m -73.54 145.81 45.26 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.594 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -96.85 124.94 40.96 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.132 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -134.14 122.05 22.31 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.644 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -129.71 142.82 46.64 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.185 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.92 134.5 23.69 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.547 2.165 . . . . 0.0 113.048 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.426 HD12 ' N ' ' A' ' 108' ' ' GLN . 1.5 pp -139.8 -35.84 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.859 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.426 ' N ' HD12 ' A' ' 107' ' ' ILE . 38.6 mt-30 -102.25 147.79 26.23 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.354 0.409 . . . . 0.0 110.973 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 61.78 115.84 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.935 0.894 . . . . 0.0 111.984 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 58.67 112.96 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.949 0.9 . . . . 0.0 112.525 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.6 m -135.48 136.54 41.36 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.919 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.48 15.3 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.826 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 89.2 mtp -91.16 -41.68 10.87 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.679 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -129.72 -13.23 4.23 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.407 0.442 . . . . 0.0 111.869 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -91.67 109.29 20.59 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.03 0.443 . . . . 0.0 111.454 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mp -123.59 -156.72 0.72 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.422 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? 73.52 -0.27 3.42 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.203 1.001 . . . . 0.0 111.722 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.9 mmpt? -103.9 -33.47 8.84 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.018 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.28 -42.84 8.33 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.545 0.528 . . . . 0.0 111.27 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -85.55 159.27 55.94 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 119.336 -0.364 . . . . 0.0 111.425 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.83 -37.61 1.58 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.536 2.157 . . . . 0.0 113.389 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 160.94 -55.46 0.32 Allowed Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.776 -1.013 . . . . 0.0 113.646 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.58 -24.97 38.96 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.973 2.448 . . . . 0.0 114.364 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -65.63 -40.47 92.59 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.254 0.346 . . . . 0.0 111.327 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.561 ' O ' HG22 ' A' ' 129' ' ' VAL . 4.8 mp -69.25 -46.57 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.456 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -53.0 -39.03 62.81 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.145 0.578 . . . . 0.0 112.223 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -70.79 -48.44 54.25 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.378 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.2 mt -55.87 -48.86 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.088 0.555 . . . . 0.0 111.657 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 125' ' ' ILE . 4.9 m -61.66 -52.98 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.0 t -55.77 -51.59 66.88 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.3 m -60.13 -29.71 68.81 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.626 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 27.6 mt -79.25 -32.23 43.71 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -79.6 -4.95 53.87 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.307 0.243 . . . . 0.0 111.57 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -82.91 -47.14 12.12 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.887 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.626 ' NE2' ' HA ' ' A' ' 132' ' ' LEU . 9.2 p80 -85.03 -35.6 21.81 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.562 0.345 . . . . 0.0 111.584 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 t70 64.5 11.81 6.89 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.255 1.022 . . . . 0.0 113.622 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.53 ' HG2' ' CE1' ' A' ' 135' ' ' HIS . 12.7 pt-20 -47.09 153.29 0.46 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.98 -30.68 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.606 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -79.94 3.37 70.73 Favored Glycine 0 N--CA 1.466 0.645 0 O-C-N 123.374 0.421 . . . . 0.0 113.67 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -144.95 -3.49 0.77 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.388 0.675 . . . . 0.0 112.105 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.47 -42.24 70.43 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 123.822 0.849 . . . . 0.0 112.768 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 3.9 p-10 -65.98 -38.48 88.63 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.572 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.475 ' O ' HD13 ' A' ' 147' ' ' LEU . 44.6 tp -61.65 -50.63 71.73 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.44 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -62.69 -62.65 5.33 Favored Glycine 0 C--N 1.343 0.958 0 N-CA-C 115.171 0.828 . . . . 0.0 115.171 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -58.85 -36.91 75.36 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 14.1 mptt -71.97 -33.23 68.01 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.494 0.134 . . . . 0.0 111.326 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.475 HD13 ' O ' ' A' ' 143' ' ' LEU . 0.5 OUTLIER -72.92 -31.81 64.88 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 123.292 0.37 . . . . 0.0 110.845 177.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -79.75 -40.91 27.73 Favored 'General case' 0 C--N 1.348 0.523 0 O-C-N 123.415 0.447 . . . . 0.0 110.139 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -85.56 45.04 1.15 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.241 0.543 . . . . 0.0 111.446 179.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -87.25 -9.09 55.97 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.941 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 151' ' ' LEU . 1.3 mm? -119.9 -37.38 3.11 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.396 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -86.57 171.32 11.13 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.183 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 73.6 mtm180 -77.45 132.55 38.51 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.557 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.486 -0.769 . . . . 0.0 111.126 -179.976 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.3 p . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 111.307 0.114 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -99.09 -43.61 6.6 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.552 0.532 . . . . 0.0 111.152 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.09 112.12 4.16 Favored Glycine 0 C--N 1.34 0.769 0 O-C-N 123.464 0.477 . . . . 0.0 112.438 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.1 tt -99.77 -44.06 6.22 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 123.62 0.247 . . . . 0.0 111.044 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.36 -54.8 0.76 Allowed Glycine 0 C--N 1.34 0.803 0 C-N-CA 121.368 -0.444 . . . . 0.0 112.731 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.19 167.64 11.24 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.658 0.27 . . . . 0.0 111.318 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 64.89 124.67 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.048 0.939 . . . . 0.0 112.011 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -129.32 176.14 8.18 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.285 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -76.8 158.9 80.01 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 122.838 0.455 . . . . 0.0 111.412 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.21 -31.08 82.59 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.687 2.258 . . . . 0.0 113.925 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.8 tp -98.1 121.87 40.55 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.416 0.448 . . . . 0.0 110.49 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -132.02 -25.05 2.07 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.851 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -91.5 117.2 29.49 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.248 0.342 . . . . 0.0 111.049 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -120.22 10.56 11.36 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.396 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -81.75 -92.46 0.06 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.333 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.447 ' OG ' ' HB3' ' A' ' 109' ' ' TYR . 74.2 m 54.73 121.95 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.181 0.993 . . . . 0.0 112.686 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -96.44 161.08 14.07 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.347 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mt -86.14 6.24 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.97 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.5 tp -63.01 110.22 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.413 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.9 t80 55.88 71.71 0.54 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.981 0.913 . . . . 0.0 111.82 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.3 t -107.3 -42.05 4.94 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.914 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.69 -52.23 0.02 OUTLIER Glycine 0 C--N 1.341 0.811 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.357 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -98.24 161.85 23.98 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.648 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.524 ' O ' HG13 ' A' ' 78' ' ' ILE . 6.5 Cg_exo -74.47 59.67 4.82 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.562 2.174 . . . . 0.0 112.666 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.527 ' HB ' ' CD1' ' A' ' 82' ' ' TYR . 1.6 pp 42.63 66.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 124.665 1.186 . . . . 0.0 113.126 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -120.36 -59.11 1.8 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.338 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.9 m -62.33 -56.04 22.25 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.444 0.697 . . . . 0.0 112.86 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.8 m -56.51 -55.49 33.07 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.632 0.373 . . . . 0.0 111.937 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.527 ' CD1' ' HB ' ' A' ' 78' ' ' ILE . 36.2 m-85 -58.98 -27.99 65.91 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.9 t -70.82 -28.41 64.59 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.31 0.381 . . . . 0.0 110.608 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.77 171.45 11.59 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.561 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -100.02 78.59 2.11 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.224 0.535 . . . . 0.0 110.408 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 90' ' ' LYS . . . 143.87 70.21 0.02 OUTLIER Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.411 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.5 tp -100.6 -29.66 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 122.44 0.296 . . . . 0.0 111.73 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.46 ' ND1' HD22 ' A' ' 143' ' ' LEU . 18.1 t60 -111.53 -18.7 12.77 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.154 0.284 . . . . 0.0 110.55 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -116.64 48.31 1.31 Allowed 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.55 0.531 . . . . 0.0 110.694 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 54.8 tttt -121.1 -14.32 8.41 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.57 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.2 mt -74.35 -9.35 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 122.854 0.461 . . . . 0.0 111.225 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.0 mm -87.17 -15.57 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.346 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -82.42 -32.83 28.87 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.338 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.26 -26.47 58.84 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.222 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -90.68 -12.33 37.07 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 123.429 0.456 . . . . 0.0 111.303 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -97.19 106.46 18.79 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.939 0.4 . . . . 0.0 110.594 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.6 tp -141.54 152.03 43.75 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.476 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -100.71 -106.88 0.23 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.838 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 m -150.8 15.09 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.401 ' HG ' ' N ' ' A' ' 101' ' ' LYS . 38.8 p -89.79 -90.39 0.14 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.401 ' N ' ' HG ' ' A' ' 100' ' ' SER . 9.2 tptm -154.65 155.87 35.46 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.603 0.361 . . . . 0.0 110.785 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.6 m -109.0 -77.18 0.6 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.519 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -164.74 -62.62 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.039 0.536 . . . . 0.0 110.087 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -149.88 161.16 42.83 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.995 0.518 . . . . 0.0 110.082 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.07 -56.78 0.25 Allowed Pre-proline 0 CA--C 1.547 0.835 0 CA-C-O 118.67 -0.681 . . . . 0.0 111.665 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.18 102.54 0.92 Allowed 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.353 2.035 . . . . 0.0 112.553 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.2 pt -147.98 -49.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.664 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 50.54 149.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.171 1.388 . . . . 0.0 113.907 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.447 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 78.2 m-85 -106.61 156.16 18.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.101 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.65 153.0 19.99 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.388 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.7 p -94.45 144.29 25.69 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.309 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.2 t -101.54 141.44 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.869 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.8 ptp -131.59 148.0 52.57 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.207 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 64.03 159.45 0.09 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.005 0.922 . . . . 0.0 112.369 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -89.09 -178.3 5.65 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.425 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.469 HD21 ' CE1' ' A' ' 120' ' ' TYR . 5.2 mt -80.14 50.8 1.28 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.972 0.509 . . . . 0.0 111.608 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -140.3 -40.24 0.43 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.644 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -94.93 -39.27 10.29 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.85 -6.39 59.1 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.254 0.346 . . . . 0.0 111.901 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.469 ' CE1' HD21 ' A' ' 116' ' ' LEU . 39.8 m-85 -123.75 134.32 25.23 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.683 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.15 -45.45 0.27 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.586 2.191 . . . . 0.0 113.646 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 163.1 -61.85 0.26 Allowed Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.887 -0.951 . . . . 0.0 112.957 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.28 -30.01 78.69 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.898 2.399 . . . . 0.0 113.516 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.36 -25.66 67.68 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.508 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 13.4 mt -86.88 -36.52 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.725 178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.25 -36.54 68.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.61 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -77.02 -11.04 59.75 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.189 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.9 mt -83.73 -47.66 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.489 HG12 ' O ' ' A' ' 144' ' ' GLY . 4.4 m -69.28 -34.68 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.628 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.5 t -66.58 -52.4 45.79 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.651 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.3 m -64.71 -27.51 68.96 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.54 ' HA ' ' CE1' ' A' ' 135' ' ' HIS . 30.1 mt -79.14 -39.79 32.62 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 129' ' ' VAL . 12.1 pt-20 -71.52 -6.82 43.44 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -79.17 -69.41 0.58 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.141 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.566 ' ND1' ' HG2' ' A' ' 137' ' ' GLU . 5.7 p80 -65.01 -35.5 81.38 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.4 t70 57.49 61.65 2.41 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.871 0.868 . . . . 0.0 111.641 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.566 ' HG2' ' ND1' ' A' ' 135' ' ' HIS . 11.1 pt-20 -107.14 139.02 42.23 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.409 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.3 153.09 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.848 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . 96.73 -17.94 58.38 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -138.78 -16.67 1.12 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.113 0.965 . . . . 0.0 111.055 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -68.92 -29.57 67.86 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 123.906 0.883 . . . . 0.0 111.235 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.565 ' O ' ' HG2' ' A' ' 146' ' ' LYS . 2.4 p-10 -72.13 -43.7 64.29 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.604 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.46 HD22 ' ND1' ' A' ' 88' ' ' HIS . 12.3 tp -58.11 -63.97 1.07 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.578 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.489 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -48.96 -43.67 31.36 Favored Glycine 0 C--N 1.345 1.043 0 O-C-N 123.959 0.787 . . . . 0.0 114.38 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.42 -45.32 84.73 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 142' ' ' ASP . 5.7 mmmt -63.18 -45.39 92.01 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.0 mt -58.17 -36.96 73.79 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.676 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -77.99 -39.29 42.77 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 120.647 0.261 . . . . 0.0 110.554 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.91 3.99 18.17 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.406 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 151' ' ' LEU . . . -74.31 106.44 5.94 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.44 ' HB3' ' O ' ' A' ' 150' ' ' ALA . 8.5 tt 80.63 -25.72 0.17 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.958 0.903 . . . . 0.0 112.41 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.34 -74.8 0.08 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -150.66 106.97 3.47 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.8 0.333 . . . . 0.0 111.474 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.516 -0.754 . . . . 0.0 111.055 179.811 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.7 p . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.463 0.173 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 70.42 -53.77 0.64 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.444 1.098 . . . . 0.0 112.292 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.27 55.81 1.09 Allowed Glycine 0 C--N 1.341 0.838 0 C-N-CA 121.474 -0.393 . . . . 0.0 112.564 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 57' ' ' LEU . 2.4 pp -119.14 132.73 56.01 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 123.681 0.283 . . . . 0.0 111.174 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -145.15 120.22 1.34 Allowed Glycine 0 C--N 1.337 0.609 0 O-C-N 123.711 0.632 . . . . 0.0 112.534 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -119.98 -14.82 8.87 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.57 134.89 34.56 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.321 0.388 . . . . 0.0 111.34 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -127.61 163.68 23.68 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.681 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -86.8 142.83 34.73 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.732 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.89 141.83 66.57 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.489 2.126 . . . . 0.0 113.16 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.572 HD21 ' CZ ' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -129.52 175.11 9.04 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.582 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.28 43.93 1.05 Allowed 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.21 0.529 . . . . 0.0 111.358 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 64.19 138.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.083 0.953 . . . . 0.0 112.248 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.572 ' CZ ' HD21 ' A' ' 64' ' ' LEU . 68.6 m-85 -94.77 -46.22 7.0 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.322 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -113.37 128.43 56.46 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.416 0.448 . . . . 0.0 111.48 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.5 p -120.07 26.95 8.94 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.736 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.619 ' NZ ' ' HB ' ' A' ' 72' ' ' ILE . 1.4 ttpm? -85.59 -175.88 5.83 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.35 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.462 HD13 ' OG ' ' A' ' 81' ' ' SER . 3.3 mt -79.89 -0.24 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 122.968 0.507 . . . . 0.0 111.426 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.619 ' HB ' ' NZ ' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -67.86 -31.91 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.096 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -106.01 -3.04 22.11 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.193 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 t -84.29 110.78 18.83 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 120.848 0.356 . . . . 0.0 110.981 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.82 -133.88 12.11 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.404 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -137.13 -52.15 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.645 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.68 135.41 5.84 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.395 2.063 . . . . 0.0 113.261 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.513 ' HB ' ' CD1' ' A' ' 82' ' ' TYR . 1.2 pp -113.69 76.4 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 121.44 0.638 . . . . 0.0 110.254 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -120.42 -53.42 2.12 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.434 -178.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.5 m -56.71 -60.82 2.99 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.245 0.618 . . . . 0.0 112.506 -177.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.462 ' OG ' HD13 ' A' ' 71' ' ' ILE . 45.7 t -59.14 -53.99 52.11 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.082 0.239 . . . . 0.0 110.436 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.513 ' CD1' ' HB ' ' A' ' 78' ' ' ILE . 18.8 m-85 -57.16 -15.13 4.97 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.621 ' HA ' ' CD2' ' A' ' 135' ' ' HIS . 23.0 t -86.06 -34.96 20.56 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 122.459 0.304 . . . . 0.0 110.394 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.01 159.75 33.68 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.72 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.53 150.07 22.6 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.286 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 98.65 14.49 37.37 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.41 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.1 tt -77.14 -27.14 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.556 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 70.8 t60 -77.58 -11.36 59.85 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -102.71 -43.99 5.43 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -65.93 -8.64 23.65 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.399 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.4 tp -79.47 -13.06 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 122.785 0.434 . . . . 0.0 110.94 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 mt -95.62 -1.02 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.405 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -59.41 -29.66 67.91 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.056 0.542 . . . . 0.0 112.229 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.561 ' HB2' ' O ' ' A' ' 67' ' ' PHE . . . -76.94 -22.47 53.22 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.23 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -94.2 -19.08 21.07 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 123.473 0.483 . . . . 0.0 111.238 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.4 150.56 20.14 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.424 0.452 . . . . 0.0 110.864 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 65.47 9.26 5.65 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.856 0.863 . . . . 0.0 112.667 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -99.37 -40.94 7.65 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.2 t 63.82 98.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.628 0.771 . . . . 0.0 110.858 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.1 m -141.32 129.02 21.57 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.985 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -131.96 129.64 40.46 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.874 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.8 t -129.73 154.84 46.79 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.644 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.7 pttm 48.76 176.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.928 1.291 . . . . 0.0 113.56 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.442 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 43.5 t30 -128.78 -45.83 1.29 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.197 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.44 88.86 7.99 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 123.315 0.384 . . . . 0.0 111.506 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 104' ' ' ASN . 8.2 Cg_exo -75.2 137.42 21.27 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.915 2.41 . . . . 0.0 112.702 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 11.7 mm -123.58 -56.73 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.068 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -139.88 152.6 46.57 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.333 0.396 . . . . 0.0 110.802 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -114.93 130.33 56.89 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.686 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.98 60.7 0.66 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.428 0.632 . . . . 0.0 111.06 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.8 t 63.0 134.01 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.088 0.955 . . . . 0.0 112.184 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.1 p -113.67 -4.83 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.436 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 70.9 mtm -91.81 110.67 22.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.918 0.39 . . . . 0.0 111.076 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -143.64 15.21 1.78 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.002 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -87.23 -44.11 11.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.566 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.417 ' O ' HD11 ' A' ' 125' ' ' ILE . 12.8 mt -88.53 -10.0 50.41 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -112.35 97.16 6.43 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.371 0.605 . . . . 0.0 110.499 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.8 tptt -179.89 -55.85 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.899 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.6 -4.53 2.28 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.273 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.497 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -88.41 -29.94 0.37 Allowed Pre-proline 0 CA--C 1.549 0.936 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.759 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 120' ' ' TYR . 88.1 Cg_exo -49.65 112.18 0.64 Allowed 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 122.734 2.289 . . . . 0.0 113.516 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.473 ' O ' ' HG2' ' A' ' 126' ' ' GLU . . . 149.95 -135.82 5.44 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.768 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.64 -32.37 83.19 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.164 2.576 . . . . 0.0 114.322 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.561 ' O ' HG13 ' A' ' 128' ' ' ILE . 8.4 m-20 -70.5 -49.64 46.25 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.417 HD11 ' O ' ' A' ' 116' ' ' LEU . 5.3 mt -71.27 -39.11 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 122' ' ' GLY . 10.8 pt-20 -59.68 -47.63 84.87 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.037 0.211 . . . . 0.0 110.871 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -57.0 -35.34 69.09 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.561 HG13 ' O ' ' A' ' 124' ' ' ASP . 53.3 mt -61.49 -57.2 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 123.095 0.247 . . . . 0.0 110.81 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 8.0 m -57.44 -38.68 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 123.475 0.484 . . . . 0.0 111.746 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.1 t -70.48 -20.22 62.88 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.3 m -77.6 -44.84 27.05 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.45 HD11 ' O ' ' A' ' 128' ' ' ILE . 3.2 mp -72.14 -27.19 62.45 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.782 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -89.03 10.78 20.36 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.205 0.526 . . . . 0.0 110.551 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -115.93 -31.16 5.84 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.345 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.621 ' CD2' ' HA ' ' A' ' 83' ' ' SER . 42.9 m-70 -92.68 -32.71 14.64 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.812 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 63.67 64.43 0.79 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.028 0.931 . . . . 0.0 111.927 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -91.11 120.17 31.85 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.341 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.494 ' O ' ' HD3' ' A' ' 141' ' ' LYS . 3.5 t -78.49 -16.5 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.644 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -91.07 -22.19 33.47 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.022 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.88 4.25 14.8 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.327 0.651 . . . . 0.0 110.731 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.494 ' HD3' ' O ' ' A' ' 138' ' ' VAL . 42.6 pttt -50.92 -37.68 45.5 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.11 0.964 . . . . 0.0 112.948 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.516 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 3.4 t70 -73.91 -30.17 62.44 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.174 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.556 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 15.9 tp -67.7 -57.23 6.73 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.475 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.18 -49.67 62.48 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.87 -0.604 . . . . 0.0 114.035 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.73 87.9 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.516 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.2 mptm? -61.44 -40.2 93.61 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 30.1 mt -63.33 -32.86 74.39 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.417 0.448 . . . . 0.0 111.509 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -75.21 -39.32 60.17 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.14 0.275 . . . . 0.0 110.529 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -78.7 5.59 10.82 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.945 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.2 -5.34 54.06 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.628 0.371 . . . . 0.0 111.608 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.4 tt -92.15 -47.97 6.96 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.453 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -96.67 124.7 40.74 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.426 0.454 . . . . 0.0 110.816 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -132.94 153.6 51.25 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.129 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.916 -179.94 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.0 t . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.476 0.179 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.3 t80 70.13 -55.67 0.6 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.517 1.127 . . . . 0.0 112.039 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.41 64.99 0.9 Allowed Glycine 0 C--N 1.34 0.782 0 C-N-CA 121.555 -0.355 . . . . 0.0 112.48 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.405 HD23 ' N ' ' A' ' 58' ' ' GLY . 2.7 tt -112.76 146.65 38.41 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.602 0.236 . . . . 0.0 110.607 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.405 ' N ' HD23 ' A' ' 57' ' ' LEU . . . 155.84 49.44 0.01 OUTLIER Glycine 0 C--N 1.337 0.601 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.622 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -120.05 46.95 1.84 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.21 0.529 . . . . 0.0 110.872 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.09 -7.93 15.25 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.876 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -129.59 -10.41 4.52 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.817 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.83 -45.77 0.44 Allowed Pre-proline 0 CA--C 1.547 0.834 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.243 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.01 -12.98 28.72 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.365 2.044 . . . . 0.0 113.437 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.7 mp -97.18 126.34 42.29 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.294 0.371 . . . . 0.0 110.744 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -130.12 -59.68 1.04 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.361 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.468 ' O ' ' HD2' ' A' ' 66' ' ' LYS . 1.8 pptp? -147.7 123.08 10.32 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.696 0.284 . . . . 0.0 111.532 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -120.57 -45.49 2.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.969 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 54.81 -88.86 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.164 0.986 . . . . 0.0 112.521 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.3 m -120.82 123.25 42.14 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.677 0.275 . . . . 0.0 111.63 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 74' ' ' SER . 57.6 mmtt -136.64 -56.73 0.74 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.238 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -148.88 94.59 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.659 0.743 . . . . 0.0 110.381 178.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.9 mp 53.14 70.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.577 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 57.4 21.56 7.0 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.132 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 7.3 t -117.15 174.61 6.02 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.278 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.46 -36.98 2.93 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 116.208 -0.451 . . . . 0.0 113.426 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.484 ' HB2' ' OG ' ' A' ' 81' ' ' SER . 1.8 mptp? -85.94 166.07 31.18 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.472 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.583 ' O ' ' HB2' ' A' ' 81' ' ' SER . 8.8 Cg_exo -73.14 -165.22 0.23 Allowed 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.837 2.358 . . . . 0.0 112.836 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.577 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 1.3 mp -76.28 -14.45 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 83' ' ' SER . 5.0 pt-20 -85.78 -67.5 0.8 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.3 m -64.5 -56.99 10.47 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.583 ' HB2' ' O ' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -48.52 -57.24 6.44 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.636 0.374 . . . . 0.0 111.231 179.616 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.577 ' HB2' ' O ' ' A' ' 78' ' ' ILE . 27.6 m-85 -69.15 -11.47 60.83 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.532 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 7.4 t -100.23 -1.91 35.23 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.62 147.12 24.21 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.796 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.51 126.3 29.91 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.329 -0.396 . . . . 0.0 112.014 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.88 57.24 2.73 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.408 -0.814 . . . . 0.0 113.501 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.537 HG22 ' OE1' ' A' ' 137' ' ' GLU . 2.9 tp -79.27 -38.39 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 122.749 0.42 . . . . 0.0 111.348 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.595 ' CE1' ' HA3' ' A' ' 139' ' ' GLY . 21.6 p-80 -66.22 -17.77 64.94 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -101.43 -54.91 2.65 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.11 0.256 . . . . 0.0 111.541 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -52.95 -7.49 0.08 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 87' ' ' ILE . 1.8 pt -73.04 -9.16 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.3 mm -117.18 13.81 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.29 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -89.67 -34.8 16.13 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.699 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.58 -20.1 60.07 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -98.93 -12.61 20.54 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 123.346 0.404 . . . . 0.0 111.227 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -97.65 141.82 30.21 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.321 0.388 . . . . 0.0 110.893 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 11.7 mt -131.95 144.0 50.51 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.666 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -130.5 152.8 49.49 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.396 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.9 m 43.36 99.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 124.76 1.224 . . . . 0.0 113.775 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.3 m -139.2 119.33 13.55 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.796 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -132.31 99.04 4.56 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.329 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.0 m -145.17 -19.31 0.49 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.606 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt 70.65 -10.19 0.74 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.291 1.036 . . . . 0.0 112.738 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -101.74 127.01 48.7 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -127.11 147.2 60.75 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.325 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.48 177.52 4.61 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.729 2.286 . . . . 0.0 112.966 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.5 mp -88.84 42.94 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-O 121.048 0.452 . . . . 0.0 110.411 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 43.93 105.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 125.032 1.333 . . . . 0.0 113.802 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -129.85 127.04 39.43 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.799 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.65 128.85 48.48 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.105 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.5 t -110.62 127.01 55.07 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.694 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.49 121.64 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.837 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.0 ttt -99.48 153.37 19.08 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.786 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -95.6 164.36 12.81 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.013 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -79.56 169.48 17.96 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.357 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mt -75.91 97.87 4.08 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.981 0.419 . . . . 0.0 111.107 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -147.69 -45.84 0.17 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.209 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -112.45 -36.22 5.32 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.97 -33.48 39.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.555 0.342 . . . . 0.0 111.451 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -127.0 64.39 60.16 Favored Pre-proline 0 CA--C 1.549 0.904 0 O-C-N 123.523 0.514 . . . . 0.0 110.556 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -95.06 133.94 0.62 Allowed 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.778 2.319 . . . . 0.0 114.648 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.01 -110.99 3.28 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 119.087 -0.84 . . . . 0.0 114.923 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -46.72 -30.09 8.68 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.66 2.907 . . . . 0.0 114.911 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -72.23 -39.91 68.13 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.309 0.381 . . . . 0.0 111.355 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.543 ' O ' HG21 ' A' ' 129' ' ' VAL . 16.3 mt -76.59 -29.73 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.307 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.42 -56.41 16.44 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.629 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -55.86 -29.82 60.5 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.472 HG23 ' CZ ' ' A' ' 82' ' ' TYR . 50.6 mt -73.64 -45.03 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 120.563 0.221 . . . . 0.0 110.53 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.543 HG21 ' O ' ' A' ' 125' ' ' ILE . 12.6 m -77.79 -25.6 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.238 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.1 t -83.74 -19.05 35.83 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.781 0.676 . . . . 0.0 112.306 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.7 m -98.11 -27.3 14.26 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.072 0.232 . . . . 0.0 110.496 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.4 tt -80.41 -35.21 35.51 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.176 0.297 . . . . 0.0 110.884 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -72.65 -1.37 15.98 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -97.03 -76.19 0.52 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -46.34 -37.9 8.07 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.604 0.762 . . . . 0.0 112.676 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.8 t70 69.7 76.81 0.21 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.128 0.971 . . . . 0.0 111.203 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.537 ' OE1' HG22 ' A' ' 87' ' ' ILE . 10.4 mm-40 -83.94 123.44 29.97 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.063 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -78.7 -25.6 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.595 ' HA3' ' CE1' ' A' ' 88' ' ' HIS . . . -88.33 -27.83 24.2 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 178.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.421 ' CB ' ' HB3' ' A' ' 88' ' ' HIS . . . -100.49 -1.66 35.13 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.212 -0.494 . . . . 0.0 111.324 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -32.13 36.64 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.14 0.576 . . . . 0.0 112.533 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.553 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 19.8 m-20 -77.49 -40.21 43.77 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.258 0.349 . . . . 0.0 110.679 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.3 tp -65.59 -61.79 1.89 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.58 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -53.31 -47.35 62.16 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.724 -0.671 . . . . 0.0 114.511 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.13 -41.9 89.32 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.553 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -61.26 -41.09 96.32 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.021 0.2 . . . . 0.0 111.278 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.0 mt -62.36 -37.9 87.45 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.269 0.355 . . . . 0.0 111.345 177.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -88.44 3.16 51.03 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -120.12 -11.0 9.31 Favored 'General case' 0 C--N 1.345 0.373 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.1 -8.56 48.5 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.163 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.5 tt -108.38 -40.92 5.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.594 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.87 128.37 36.17 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.987 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -128.65 -42.79 1.43 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.145 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.102 -0.952 . . . . 0.0 111.123 -179.94 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 120.491 0.186 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 62.94 125.31 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.954 0.902 . . . . 0.0 112.056 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.79 138.43 5.19 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.44 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.5 mt -100.4 -43.34 6.27 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.617 0.245 . . . . 0.0 111.263 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.07 -41.08 1.98 Allowed Glycine 0 C--N 1.338 0.692 0 O-C-N 123.403 0.439 . . . . 0.0 112.931 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -93.52 146.9 23.45 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.406 0.282 . . . . 0.0 111.065 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.51 123.86 49.05 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.235 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -135.1 10.98 3.57 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.497 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.424 ' N ' ' CD ' ' A' ' 63' ' ' PRO . 2.7 p30 -85.07 -32.89 0.48 Allowed Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 62' ' ' ASP . 16.5 Cg_exo -69.36 -27.69 28.05 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.169 1.913 . . . . 0.0 113.347 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.4 mt -97.73 122.25 40.6 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 123.406 0.441 . . . . 0.0 110.741 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -137.28 -29.87 0.87 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.901 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -91.87 -6.81 50.88 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -103.53 -44.87 5.0 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.364 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 63.06 148.25 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.863 0.865 . . . . 0.0 112.368 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.4 m -101.78 -42.78 6.04 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.261 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -131.5 139.85 49.4 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.455 0.472 . . . . 0.0 110.935 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.0 mm -119.51 -26.85 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.565 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.7 tp -67.88 -19.75 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 122.975 0.51 . . . . 0.0 111.828 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.08 19.64 16.29 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.498 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.6 t -88.24 -39.72 14.22 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.008 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.22 -99.23 0.12 Allowed Glycine 0 C--N 1.338 0.683 0 O-C-N 123.7 0.625 . . . . 0.0 111.657 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.794 ' N ' ' HD3' ' A' ' 77' ' ' PRO . 32.2 mmtm -137.43 28.95 0.12 Allowed Pre-proline 0 CA--C 1.558 1.256 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.794 ' HD3' ' N ' ' A' ' 76' ' ' LYS . 5.1 Cg_endo -87.57 101.93 0.5 Allowed 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.241 1.961 . . . . 0.0 112.845 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 tt -145.73 7.01 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.102 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.19 -76.51 0.51 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.018 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.1 m -65.26 -60.75 2.65 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.683 0.393 . . . . 0.0 110.49 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.584 ' O ' HD12 ' A' ' 87' ' ' ILE . 25.6 p -44.45 -39.61 4.9 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.405 0.682 . . . . 0.0 112.687 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.527 ' CZ ' HG21 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -89.46 -10.09 47.69 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.2 t -95.04 -6.99 40.93 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.555 0.217 . . . . 0.0 110.685 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.47 149.63 27.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.464 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -74.68 87.03 2.17 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.377 0.608 . . . . 0.0 111.072 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.577 ' O ' ' HD3' ' A' ' 90' ' ' LYS . . . 133.57 63.19 0.07 OUTLIER Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.929 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 81' ' ' SER . 4.4 tp -105.79 -15.53 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.589 ' HB3' ' O ' ' A' ' 139' ' ' GLY . 49.2 t60 -104.13 -74.81 0.63 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -96.02 52.41 1.3 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.189 0.519 . . . . 0.0 112.06 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.577 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 4.6 ttpp -121.13 -33.26 3.75 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.558 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.5 pt -78.21 -27.01 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.712 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 pp -95.73 -1.79 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.667 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -80.85 -33.15 34.71 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.718 0.407 . . . . 0.0 111.336 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.19 -0.02 34.39 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.105 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -120.37 -13.9 8.79 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.643 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -92.22 -43.78 9.13 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 123.268 0.355 . . . . 0.0 111.384 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.9 tp -100.26 -43.27 6.34 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.314 0.384 . . . . 0.0 111.077 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -100.28 144.95 28.69 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 123.376 0.422 . . . . 0.0 110.713 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.8 t 64.63 129.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.757 0.823 . . . . 0.0 111.237 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.7 m 63.34 149.8 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.034 0.934 . . . . 0.0 112.446 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -97.82 144.33 27.52 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.906 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.0 m -101.15 138.24 38.44 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 123.634 0.584 . . . . 0.0 111.021 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -111.31 -43.39 3.71 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.045 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -130.0 153.34 48.5 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.705 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.1 -47.81 0.32 Allowed Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 118.579 -0.724 . . . . 0.0 112.322 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -90.51 117.0 0.58 Allowed 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.209 1.94 . . . . 0.0 113.153 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.67 111.7 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.0 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -138.34 -8.79 1.49 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.345 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -89.43 -4.37 58.02 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 122.509 0.324 . . . . 0.0 111.689 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.31 -47.7 6.49 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.603 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.8 p -137.09 136.08 38.03 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.141 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.433 ' O ' ' HE3' ' A' ' 113' ' ' MET . 13.6 p -137.95 122.49 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.567 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.433 ' HE3' ' O ' ' A' ' 112' ' ' VAL . 0.1 OUTLIER -138.7 161.29 37.54 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.685 -179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -90.69 140.62 29.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.977 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -117.51 -174.29 2.59 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.998 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.88 95.57 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.473 ' HA ' ' CD1' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -172.72 -24.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.048 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -52.96 -34.55 56.28 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.06 0.457 . . . . 0.0 110.998 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.6 t -129.6 46.5 2.63 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.664 177.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.56 ' CD1' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -57.34 -45.34 99.9 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.389 -178.349 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -78.79 37.86 0.68 Allowed 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.086 1.857 . . . . 0.0 112.116 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.5 -171.47 18.45 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 115.946 -0.57 . . . . 0.0 114.234 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.536 ' HA ' ' OE1' ' A' ' 126' ' ' GLU . 3.6 Cg_exo -75.24 -37.4 1.93 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.56 2.84 . . . . 0.0 113.33 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.423 ' OD2' HD12 ' A' ' 125' ' ' ILE . 6.9 p-10 -61.95 -19.74 63.07 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.56 HG12 ' CD1' ' A' ' 120' ' ' TYR . 1.1 mp -89.97 -51.81 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 123.372 0.42 . . . . 0.0 111.181 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.536 ' OE1' ' HA ' ' A' ' 123' ' ' PRO . 8.5 pt-20 -50.45 -27.78 7.12 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 177.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -72.04 -35.32 69.31 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.87 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.527 HG21 ' CZ ' ' A' ' 82' ' ' TYR . 75.1 mt -58.86 -52.31 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.713 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.7 m -59.91 -54.55 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 123.114 0.259 . . . . 0.0 111.639 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.7 t -56.06 -52.55 63.87 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.2 m -67.88 -17.66 64.55 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.416 HD13 ' O ' ' A' ' 140' ' ' ALA . 3.5 tt -88.33 -44.47 10.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 117.782 0.265 . . . . 0.0 111.09 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -79.01 -1.49 35.78 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -79.55 -50.0 11.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.191 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.483 ' HE1' ' OE2' ' A' ' 137' ' ' GLU . 5.8 p80 -89.13 -35.86 16.04 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.174 0.297 . . . . 0.0 111.772 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 74.84 87.72 0.09 Allowed 'General case' 0 C--N 1.357 0.91 0 C-N-CA 124.205 1.002 . . . . 0.0 112.159 177.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.546 ' OE2' HG23 ' A' ' 87' ' ' ILE . 6.6 pt-20 -114.96 151.7 33.66 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.709 178.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.2 m -76.44 -44.89 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.589 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -68.7 0.65 12.64 Favored Glycine 0 N--CA 1.471 1.012 0 N-CA-C 115.2 0.84 . . . . 0.0 115.2 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . 0.416 ' O ' HD13 ' A' ' 132' ' ' LEU . . . -136.74 -11.4 1.79 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.91 0.484 . . . . 0.0 112.036 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 6.4 tptm -53.65 -41.33 66.69 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.292 0.637 . . . . 0.0 112.084 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.455 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 2.1 p-10 -70.16 -42.46 72.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.585 ' O ' HD13 ' A' ' 147' ' ' LEU . 14.2 tp -63.81 -52.25 61.08 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.953 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -58.04 -38.6 89.89 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 123.697 0.623 . . . . 0.0 113.851 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.91 83.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.873 0.337 . . . . 0.0 111.867 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.455 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.3 mptm? -66.96 -33.82 76.41 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.211 0.319 . . . . 0.0 110.662 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.585 HD13 ' O ' ' A' ' 143' ' ' LEU . 0.6 OUTLIER -66.04 -41.11 91.3 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.548 0.53 . . . . 0.0 110.315 177.507 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -64.73 -38.41 90.88 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.85 1.03 48.85 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.091 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.23 104.93 1.0 Allowed 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.1 tm? 80.59 -28.16 0.14 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.099 0.959 . . . . 0.0 111.057 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -94.78 134.11 37.75 Favored 'General case' 0 C--N 1.344 0.364 0 O-C-N 123.064 0.227 . . . . 0.0 111.076 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -129.45 -42.43 1.32 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.149 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.479 -0.772 . . . . 0.0 110.501 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.0 m . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 111.279 0.103 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -99.87 -46.58 5.33 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 123.404 0.44 . . . . 0.0 110.82 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.71 -118.8 6.03 Favored Glycine 0 C--N 1.342 0.911 0 O-C-N 123.428 0.455 . . . . 0.0 112.585 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.97 -43.07 2.57 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.385 0.274 . . . . 0.0 110.898 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 171.25 97.6 0.11 Allowed Glycine 0 C--N 1.34 0.788 0 O-C-N 123.502 0.501 . . . . 0.0 112.463 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.9 ttmt -99.89 156.74 16.97 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.784 0.326 . . . . 0.0 110.618 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 59.15 101.36 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.819 0.848 . . . . 0.0 112.057 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.553 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 20.2 mm-40 -142.84 167.88 21.03 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.604 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -110.84 79.96 2.03 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.668 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 61' ' ' GLN . 1.7 Cg_endo -83.36 -168.0 0.52 Allowed 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.088 2.525 . . . . 0.0 112.697 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.1 tp -72.43 166.06 23.33 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.959 0.504 . . . . 0.0 110.834 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -67.69 -51.44 49.61 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.563 0.345 . . . . 0.0 111.826 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -137.15 100.23 4.21 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.105 0.479 . . . . 0.0 110.845 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -120.42 -13.42 8.83 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.712 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -112.67 128.69 56.46 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.412 0.445 . . . . 0.0 110.391 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.6 t -95.15 135.52 36.62 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.592 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -93.49 -0.06 56.52 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.076 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 77' ' ' PRO . 0.4 OUTLIER -90.93 -33.29 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.48 -179.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.0 tp -72.57 -24.84 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 O-C-N 123.134 0.271 . . . . 0.0 111.554 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -105.59 17.49 23.74 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 123.401 0.438 . . . . 0.0 110.485 178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.466 ' OG ' ' HD2' ' A' ' 77' ' ' PRO . 1.8 t -87.59 162.64 17.05 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.089 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.15 -63.92 1.76 Allowed Glycine 0 C--N 1.344 0.989 0 CA-C-N 116.239 -0.437 . . . . 0.0 113.483 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -90.73 -46.2 0.38 Allowed Pre-proline 0 CA--C 1.545 0.779 0 CA-C-O 118.551 -0.738 . . . . 0.0 112.545 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.466 ' HD2' ' OG ' ' A' ' 74' ' ' SER . 7.9 Cg_exo -73.06 94.69 0.82 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.296 1.997 . . . . 0.0 113.015 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 tt -154.27 -35.8 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.084 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -91.86 -28.84 17.06 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.059 179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.8 m -69.08 -61.48 1.78 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.842 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.456 ' O ' HD12 ' A' ' 87' ' ' ILE . 40.6 m -86.9 58.41 5.06 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-O 123.389 1.566 . . . . 0.0 109.727 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.547 ' CD2' HG12 ' A' ' 87' ' ' ILE . 0.9 OUTLIER -158.66 -41.62 0.06 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 111.651 -2.522 . . . . 0.0 105.327 -179.426 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.3 t -70.55 -23.76 62.67 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.097 176.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.86 1.03 4.82 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt 59.34 152.79 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.959 0.903 . . . . 0.0 112.949 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.65 2.6 78.78 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.66 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.547 HG12 ' CD2' ' A' ' 82' ' ' TYR . 7.6 tp -64.05 -9.12 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.508 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 70.1 t60 -90.49 51.78 2.08 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.599 0.714 . . . . 0.0 110.903 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.454 ' O ' HG21 ' A' ' 92' ' ' ILE . 10.2 mm-40 -145.82 -41.25 0.22 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.516 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -83.25 -2.9 56.75 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.004 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.1 tt -103.54 2.25 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.821 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.59 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 3.9 tp -114.2 -16.9 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.978 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -101.92 -42.33 6.17 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.041 0.213 . . . . 0.0 111.241 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.5 -29.35 28.03 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.271 0.357 . . . . 0.0 111.78 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -91.17 -4.79 55.8 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.063 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.59 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 12.2 t70 -67.75 129.95 41.48 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.07 0.548 . . . . 0.0 111.24 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.65 172.45 8.17 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.65 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 65.23 116.49 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.178 0.991 . . . . 0.0 111.905 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 m -145.2 2.14 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.052 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.9 m -86.99 154.11 21.03 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.496 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -93.51 105.62 17.66 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.002 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.3 m -146.1 -43.39 0.2 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.996 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -100.66 149.88 23.31 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.865 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -108.72 -13.58 14.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.763 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.99 147.02 33.97 Favored Pre-proline 0 CA--C 1.535 0.401 0 O-C-N 123.207 0.317 . . . . 0.0 111.504 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.59 165.83 31.6 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.683 2.255 . . . . 0.0 113.258 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.1 mt -96.06 122.79 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.04 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -106.67 -43.66 4.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.132 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -123.16 155.16 37.6 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 123.421 0.451 . . . . 0.0 111.15 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.03 128.34 40.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.364 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.8 t -127.16 4.66 6.4 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.388 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.88 159.27 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.448 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 20.6 ttp -85.46 164.93 17.57 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.943 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -83.78 146.18 28.29 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.366 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -98.1 -27.66 14.1 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.31 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.451 ' O ' HD12 ' A' ' 125' ' ' ILE . 12.2 mt -87.53 36.61 0.75 Allowed 'General case' 0 CA--C 1.542 0.635 0 O-C-N 123.283 0.364 . . . . 0.0 111.553 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -147.23 0.54 0.71 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.13 -54.01 4.01 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.09 8.44 2.49 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.873 0.368 . . . . 0.0 110.907 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -89.57 -30.68 0.36 Allowed Pre-proline 0 CA--C 1.55 0.953 0 CA-C-O 118.285 -0.864 . . . . 0.0 112.886 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' TYR . 78.0 Cg_exo -44.93 120.65 3.02 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.065 2.51 . . . . 0.0 114.046 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 165.27 -147.63 12.76 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.726 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -62.71 -22.78 74.25 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.971 2.448 . . . . 0.0 113.754 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.514 ' O ' HG13 ' A' ' 128' ' ' ILE . 9.4 m-20 -71.43 -49.49 41.17 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.594 0.358 . . . . 0.0 111.595 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.537 ' O ' HG21 ' A' ' 129' ' ' VAL . 10.2 mt -73.26 -34.97 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 123.271 0.357 . . . . 0.0 110.875 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -55.92 -48.22 76.08 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.72 0.637 . . . . 0.0 111.004 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -66.09 -35.65 81.08 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 124' ' ' ASP . 32.9 mt -61.27 -55.34 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 125' ' ' ILE . 5.5 m -65.12 -27.32 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.223 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.2 t -83.26 -13.89 54.31 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 26.9 m -92.09 -42.42 9.95 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 123.037 0.211 . . . . 0.0 110.913 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.453 HD23 ' N ' ' A' ' 144' ' ' GLY . 4.7 mp -77.74 -37.25 49.61 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 129' ' ' VAL . 10.3 mm-40 -76.97 7.53 4.76 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.295 0.372 . . . . 0.0 111.673 178.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -108.06 -80.25 0.57 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -47.81 -37.45 13.71 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.816 0.847 . . . . 0.0 112.789 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 65.69 68.24 0.48 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.995 0.918 . . . . 0.0 111.769 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -88.72 129.77 35.47 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.437 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.514 ' O ' ' HD3' ' A' ' 141' ' ' LYS . 3.1 t -73.41 -16.4 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -86.51 -32.02 17.23 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.43 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -110.0 5.74 22.51 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.84 0.456 . . . . 0.0 111.149 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.514 ' HD3' ' O ' ' A' ' 138' ' ' VAL . 21.3 pttm -47.32 -37.65 11.35 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.965 0.906 . . . . 0.0 113.087 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 2.5 p-10 -75.29 -41.6 56.75 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.303 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.508 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 17.6 tp -56.83 -55.04 39.53 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.218 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.453 ' N ' HD23 ' A' ' 132' ' ' LEU . . . -59.87 -59.5 10.37 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 115.793 -0.639 . . . . 0.0 114.049 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.71 78.17 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 14.1 mptt -62.51 -36.01 81.19 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 123.027 0.204 . . . . 0.0 111.418 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.6 mt -66.68 -35.71 80.8 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.417 0.448 . . . . 0.0 111.954 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.0 ttp180 -93.14 -2.66 55.15 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -105.94 28.94 7.1 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.938 0.399 . . . . 0.0 110.848 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.87 -9.95 59.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.266 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.1 tt -102.19 -53.53 2.9 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.263 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 41.53 -78.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.168 1.387 . . . . 0.0 114.198 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -128.12 -36.74 1.93 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 122.505 0.322 . . . . 0.0 111.136 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.493 179.931 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.405 ' O ' ' HE3' ' A' ' 59' ' ' LYS . 70.2 m . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.691 0.281 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -136.93 -41.58 0.59 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.524 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.52 -27.72 16.69 Favored Glycine 0 C--N 1.34 0.798 0 O-C-N 123.443 0.464 . . . . 0.0 113.424 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.27 -42.91 9.58 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.31 0.244 . . . . 0.0 111.454 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.92 133.94 3.28 Favored Glycine 0 C--N 1.339 0.716 0 O-C-N 123.472 0.482 . . . . 0.0 112.694 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HE3' ' O ' ' A' ' 54' ' ' SER . 8.1 ptpp? -104.29 123.9 48.2 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.677 0.281 . . . . 0.0 110.94 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 63.54 156.59 0.07 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.896 0.878 . . . . 0.0 112.383 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -91.94 -54.05 4.01 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.681 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 50.45 95.86 0.04 OUTLIER Pre-proline 0 N--CA 1.484 1.267 0 C-N-CA 123.969 0.908 . . . . 0.0 112.622 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.1 121.6 7.02 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.521 2.147 . . . . 0.0 112.501 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.2 mt -138.79 125.51 20.84 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.75 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.449 ' OD1' ' HG3' ' A' ' 66' ' ' LYS . 2.3 p30 -138.06 -44.64 0.52 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.579 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.449 ' HG3' ' OD1' ' A' ' 65' ' ' ASP . 97.6 mttt -101.53 1.81 38.42 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 123.407 0.442 . . . . 0.0 111.877 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -89.53 8.34 31.65 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.49 ' HB3' ' OG ' ' A' ' 74' ' ' SER . 97.2 m-85 -93.54 139.47 30.72 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.024 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.5 t -108.77 -94.58 0.4 Allowed 'General case' 0 CA--C 1.542 0.67 0 O-C-N 123.445 0.466 . . . . 0.0 111.588 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.569 ' O ' HG13 ' A' ' 71' ' ' ILE . 1.5 mptp? -136.33 90.23 2.55 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.389 0.614 . . . . 0.0 111.284 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 70' ' ' LYS . 4.7 mt -148.46 172.73 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.401 HD11 ' HH ' ' A' ' 82' ' ' TYR . 4.0 tp -46.56 -60.47 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -95.25 25.2 4.46 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.468 0.651 . . . . 0.0 109.866 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.542 ' HB3' ' N ' ' A' ' 71' ' ' ILE . 48.1 t -120.23 -50.74 2.23 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.623 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.6 -110.34 0.84 Allowed Glycine 0 C--N 1.342 0.906 0 O-C-N 123.39 0.432 . . . . 0.0 112.888 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.7 mtmm -132.47 -44.01 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.37 134.16 62.57 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.417 2.078 . . . . 0.0 113.753 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.19 21.49 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.946 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 83' ' ' SER . 4.5 pt-20 -93.2 -57.77 2.52 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.6 m -67.29 -50.07 61.71 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.4 p -53.96 -54.64 36.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.782 0.433 . . . . 0.0 111.595 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.574 ' CZ ' HG23 ' A' ' 128' ' ' ILE . 46.9 m-85 -58.94 -65.02 0.73 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.542 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -38.71 -32.79 0.09 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.19 144.93 44.55 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.274 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.485 ' HA ' ' OE2' ' A' ' 137' ' ' GLU . 58.9 mttp -77.95 105.31 9.07 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 123.439 0.462 . . . . 0.0 111.845 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.15 50.18 0.35 Allowed Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.817 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.0 tp -70.02 -23.41 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -87.04 13.29 9.52 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 120.978 0.418 . . . . 0.0 111.035 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.518 ' O ' HG22 ' A' ' 92' ' ' ILE . 11.7 mm-40 -136.65 -43.96 0.6 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.935 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -47.86 -10.55 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.22 1.008 . . . . 0.0 113.422 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.3 tp -69.57 -16.57 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 123.095 0.558 . . . . 0.0 110.963 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 89' ' ' GLU . 1.7 tt -90.1 -3.18 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.394 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -59.3 -31.41 69.1 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.075 0.55 . . . . 0.0 111.781 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.97 -15.12 62.56 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.206 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -92.36 -10.79 36.93 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.689 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -90.14 143.53 26.69 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.208 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.5 tp -92.23 128.4 38.07 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.346 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -132.69 -41.98 0.93 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.941 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.25 158.48 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 123.511 0.507 . . . . 0.0 109.826 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.5 t -86.08 -43.38 13.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.409 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -129.5 122.24 28.86 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 123.318 0.386 . . . . 0.0 110.725 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 54.6 m -133.7 -41.06 0.86 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.311 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.5 ttpp 62.96 121.51 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.924 0.89 . . . . 0.0 111.612 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -100.47 141.52 33.22 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.022 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.7 147.93 33.72 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.054 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.93 119.49 6.35 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.469 2.113 . . . . 0.0 113.049 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 pt -145.49 -45.13 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.689 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -96.67 126.31 41.74 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.436 0.46 . . . . 0.0 111.051 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -135.13 -2.39 2.55 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.444 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 63.68 123.33 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.01 0.924 . . . . 0.0 112.107 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.9 m -127.2 171.4 11.47 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.081 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.8 t -79.67 122.37 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.422 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.8 mmt 60.66 108.17 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.756 0.822 . . . . 0.0 111.755 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -132.3 126.47 33.42 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.771 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -132.87 158.87 41.45 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.628 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.457 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 13.5 mt -82.23 -1.18 48.4 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -114.84 2.54 14.38 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.38 -47.28 6.35 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.9 t -134.34 -1.98 2.83 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 116' ' ' LEU . 2.9 t80 -94.38 144.27 27.71 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 119.288 -0.387 . . . . 0.0 110.725 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -57.1 162.76 8.81 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.621 2.214 . . . . 0.0 113.54 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -86.44 -51.39 3.5 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.605 -1.108 . . . . 0.0 113.511 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.594 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 52.2 Cg_exo -55.15 -24.42 41.0 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.833 2.356 . . . . 0.0 114.134 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.48 -43.93 65.66 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.514 0.326 . . . . 0.0 111.423 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.412 ' O ' HG22 ' A' ' 129' ' ' VAL . 9.8 mt -61.99 -26.75 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 122.823 0.449 . . . . 0.0 110.764 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -73.2 -47.96 39.19 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.185 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 123' ' ' PRO . 25.5 mmm180 -56.04 -48.01 76.8 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.492 178.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.574 HG23 ' CZ ' ' A' ' 82' ' ' TYR . 17.4 mt -56.62 -64.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.114 0.566 . . . . 0.0 111.498 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.421 ' CG1' ' HB3' ' A' ' 148' ' ' ARG . 31.5 m -51.26 -38.22 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.203 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.0 t -73.03 -42.41 63.19 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.8 m -60.79 -29.8 69.66 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.217 0.207 . . . . 0.0 111.483 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 128' ' ' ILE . 1.9 mt -83.9 -33.79 24.68 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.314 0.384 . . . . 0.0 110.281 178.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -83.2 7.54 15.88 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.933 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -113.75 -41.02 3.66 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.149 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -88.1 -44.11 11.18 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 63.5 67.7 0.63 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.985 0.914 . . . . 0.0 111.185 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.485 ' OE2' ' HA ' ' A' ' 85' ' ' LYS . 22.5 mt-10 -87.37 139.21 30.78 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.887 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -77.7 -41.15 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.63 -1.61 62.04 Favored Glycine 0 CA--C 1.526 0.726 0 O-C-N 123.412 0.445 . . . . 0.0 113.93 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -137.06 -2.54 2.06 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.065 0.546 . . . . 0.0 111.53 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -50.85 -40.5 56.29 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.817 0.847 . . . . 0.0 113.002 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 7.9 m-20 -72.51 -36.41 68.35 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.22 0.325 . . . . 0.0 110.922 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.8 tp -65.64 -52.48 51.44 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.993 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -60.99 -62.75 5.58 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.58 -0.736 . . . . 0.0 114.007 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.58 ' HA ' ' NE ' ' A' ' 148' ' ' ARG . . . -53.37 -37.1 62.1 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 5.7 mptp? -72.79 -24.46 60.93 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.458 ' O ' HD21 ' A' ' 147' ' ' LEU . 0.6 OUTLIER -78.71 -30.88 46.25 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.422 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.58 ' NE ' ' HA ' ' A' ' 145' ' ' ALA . 8.6 ptt85 -84.31 -3.77 58.45 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 117.807 0.276 . . . . 0.0 110.848 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -81.44 -1.4 45.65 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.778 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.5 -6.56 57.53 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.579 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.7 tt -106.59 -44.43 4.48 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.736 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -89.72 144.95 25.55 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.383 0.427 . . . . 0.0 111.038 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -127.45 150.05 49.82 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.645 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 118.031 -0.985 . . . . 0.0 111.931 -179.966 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.5 ' HG ' HE21 ' A' ' 61' ' ' GLN . 55.3 m . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.52 0.2 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -99.97 -44.07 6.16 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.39 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -145.4 122.05 1.63 Allowed Glycine 0 C--N 1.34 0.803 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.443 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 pp -101.44 134.82 43.94 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.594 0.232 . . . . 0.0 111.127 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 147.86 -68.65 0.37 Allowed Glycine 0 C--N 1.337 0.618 0 O-C-N 123.652 0.595 . . . . 0.0 112.651 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -119.42 -31.47 4.61 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.359 0.264 . . . . 0.0 111.62 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.3 -10.75 48.52 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.5 HE21 ' HG ' ' A' ' 54' ' ' SER . 0.7 OUTLIER -131.94 120.3 22.31 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.535 179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -135.17 95.9 14.6 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.024 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.18 125.74 9.98 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.606 2.204 . . . . 0.0 112.589 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 64' ' ' LEU . 1.3 tt -134.96 -18.48 1.82 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.34 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -73.99 96.48 2.66 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.164 0.507 . . . . 0.0 111.24 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -143.24 -12.33 0.72 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.665 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -109.33 2.95 21.08 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 123.365 0.415 . . . . 0.0 112.078 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -87.62 139.51 30.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.221 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.0 p -114.39 -16.11 12.01 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.959 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.491 ' O ' HD11 ' A' ' 71' ' ' ILE . 4.4 ttmm -95.25 111.37 23.23 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.779 0.323 . . . . 0.0 110.888 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.491 HD11 ' O ' ' A' ' 70' ' ' LYS . 13.9 mm -129.7 -30.76 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.396 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.429 HG13 ' HH ' ' A' ' 120' ' ' TYR . 3.0 tp -63.47 -30.06 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 123.121 0.568 . . . . 0.0 111.724 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -106.08 25.59 10.77 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.411 0.444 . . . . 0.0 111.279 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 t -89.0 -44.08 10.65 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.26 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.54 -117.75 0.63 Allowed Glycine 0 C--N 1.34 0.751 0 O-C-N 123.521 0.513 . . . . 0.0 112.417 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -130.95 -47.47 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.818 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.613 ' HA ' ' NH2' ' A' ' 127' ' ' ARG . 3.4 Cg_exo -82.49 133.18 7.12 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.359 2.039 . . . . 0.0 113.375 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.5 73.07 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.397 0.618 . . . . 0.0 110.833 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 83' ' ' SER . 2.9 mt-10 -120.43 -41.79 2.59 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.155 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.9 m -65.82 -60.5 2.82 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.169 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.7 t -56.81 -55.25 36.74 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 123.218 0.324 . . . . 0.0 110.705 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -50.9 -31.36 17.3 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 5.7 t -73.57 -34.52 65.16 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 122.604 0.362 . . . . 0.0 111.713 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.5 146.34 20.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.854 0.462 . . . . 0.0 111.979 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 57.6 mmtt -79.96 99.99 7.88 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.189 0.518 . . . . 0.0 111.876 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.569 ' O ' HG12 ' A' ' 91' ' ' ILE . . . 126.52 47.9 0.19 Allowed Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.371 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.4 tp -88.8 -43.65 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 122.842 0.457 . . . . 0.0 111.187 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.47 ' CE1' HD11 ' A' ' 143' ' ' LEU . 47.4 t60 -84.97 26.85 0.81 Allowed 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.031 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.416 ' O ' HG21 ' A' ' 92' ' ' ILE . 3.3 tp10 -143.83 -81.02 0.18 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 122.361 -0.212 . . . . 0.0 111.21 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.587 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 8.9 mtmp? -70.87 -24.89 62.59 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 86' ' ' GLY . 13.3 mm -94.09 -0.77 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 120.603 0.24 . . . . 0.0 110.665 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.416 HG21 ' O ' ' A' ' 89' ' ' GLU . 1.6 tt -110.02 -36.01 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.854 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.475 ' OE1' ' HB3' ' A' ' 96' ' ' ASP . 1.7 tp10 -120.26 -84.96 0.66 Allowed 'General case' 0 CA--C 1.537 0.475 0 O-C-N 123.147 0.279 . . . . 0.0 110.529 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 90' ' ' LYS . . . 66.75 -45.56 0.45 Allowed 'General case' 0 C--N 1.36 1.057 0 C-N-CA 124.703 1.201 . . . . 0.0 113.355 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -148.2 -7.26 0.41 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.475 ' HB3' ' OE1' ' A' ' 93' ' ' GLU . 2.4 t70 -64.08 118.15 8.1 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.966 0.412 . . . . 0.0 112.041 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 tp -135.15 174.45 10.59 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.132 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -74.85 121.02 21.19 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.476 0.31 . . . . 0.0 111.073 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.43 -174.86 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.267 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.0 p -73.62 -11.28 60.37 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -94.7 121.63 36.48 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.701 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.6 m -130.71 163.61 26.88 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.146 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.0 mptt 64.37 122.97 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.021 0.929 . . . . 0.0 111.932 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -132.97 -41.74 0.91 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.153 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.99 142.39 24.53 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 123.396 0.435 . . . . 0.0 111.26 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.68 11.3 1.97 Allowed 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 122.572 2.181 . . . . 0.0 114.019 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 pt -87.87 126.15 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.72 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -130.13 -43.03 1.2 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.161 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -109.27 148.19 31.39 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 123.55 0.531 . . . . 0.0 110.94 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.3 130.66 50.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.166 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.8 t -125.09 -42.02 2.04 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.953 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.1 m -97.75 -4.21 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 O-C-N 123.364 0.415 . . . . 0.0 111.951 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 25.0 mmt 65.4 12.43 8.11 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.985 0.914 . . . . 0.0 112.508 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -110.69 154.07 24.37 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.952 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -92.16 -40.43 11.02 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.973 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 mt -95.85 -159.47 0.72 Allowed 'General case' 0 CA--C 1.539 0.524 0 O-C-N 123.507 0.504 . . . . 0.0 110.638 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.6 tptp 73.4 -2.1 2.85 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.205 1.002 . . . . 0.0 111.952 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -99.84 -37.09 9.2 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.948 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.5 t -93.83 -41.72 9.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.45 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.429 ' HH ' HG13 ' A' ' 72' ' ' ILE . 44.0 m-85 -96.66 159.3 32.02 Favored Pre-proline 0 CA--C 1.541 0.596 0 O-C-N 123.423 0.452 . . . . 0.0 111.115 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.58 -34.84 2.35 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.505 2.137 . . . . 0.0 113.289 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 157.6 -55.7 0.38 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-O 118.939 -0.923 . . . . 0.0 113.433 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.16 -19.72 28.31 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.971 2.447 . . . . 0.0 114.431 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 2.4 t70 -73.65 -35.07 65.22 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.181 0.301 . . . . 0.0 111.133 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.9 mp -72.71 -27.33 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.382 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.95 -53.33 18.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.728 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.613 ' NH2' ' HA ' ' A' ' 77' ' ' PRO . 13.6 ptm180 -53.83 -36.54 62.64 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 178.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.559 ' O ' HD12 ' A' ' 132' ' ' LEU . 44.7 mt -65.38 -56.51 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 122.199 0.2 . . . . 0.0 111.211 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.63 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 2.8 m -54.09 -43.96 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.562 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 12.4 t -64.67 -31.99 73.46 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.3 m -69.94 -38.57 76.23 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.559 HD12 ' O ' ' A' ' 128' ' ' ILE . 1.3 mp -73.83 -35.79 64.87 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.63 ' HG2' ' O ' ' A' ' 129' ' ' VAL . 10.6 pt-20 -89.08 14.02 11.7 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 120.954 0.407 . . . . 0.0 111.62 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.562 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.6 tmm_? -105.95 -41.29 5.44 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.851 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 49.5 t60 -94.64 -32.14 13.53 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.976 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 67.73 73.33 0.31 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.049 0.94 . . . . 0.0 111.633 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.33 132.12 43.36 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.99 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.55 -39.05 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 O-C-N 123.417 0.448 . . . . 0.0 111.684 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -74.26 -9.52 81.04 Favored Glycine 0 C--N 1.341 0.819 0 O-C-N 123.316 0.385 . . . . 0.0 113.914 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.6 2.34 5.54 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.726 0.411 . . . . 0.0 111.995 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -34.62 74.12 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.949 0.499 . . . . 0.0 111.732 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.618 ' O ' ' HG2' ' A' ' 146' ' ' LYS . 8.2 m-20 -75.08 -38.78 61.16 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.984 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.47 HD11 ' CE1' ' A' ' 88' ' ' HIS . 14.2 tp -60.49 -56.83 16.71 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.994 0.518 . . . . 0.0 110.609 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -54.77 -45.3 79.66 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.683 0.614 . . . . 0.0 113.756 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -54.89 -48.68 72.71 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.618 ' HG2' ' O ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -59.19 -42.57 91.18 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.716 0.234 . . . . 0.0 110.394 178.53 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.8 -41.42 82.12 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.41 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 144' ' ' GLY . 14.2 ptm180 -88.1 -14.19 39.45 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -87.47 27.06 1.14 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 122.784 0.433 . . . . 0.0 112.063 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.74 102.46 2.32 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.448 HD21 ' O ' ' A' ' 152' ' ' ASP . 8.2 tt 80.5 -31.14 0.12 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.269 1.028 . . . . 0.0 110.931 -177.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.448 ' O ' HD21 ' A' ' 151' ' ' LEU . 6.5 t70 59.63 157.17 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.874 0.87 . . . . 0.0 112.59 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -99.48 127.85 45.56 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.514 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.839 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.4 m . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 111.345 0.128 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -100.53 132.0 46.14 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 123.405 0.441 . . . . 0.0 110.878 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.5 55.33 0.02 OUTLIER Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.509 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 tp -113.17 -42.96 3.43 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 123.641 0.259 . . . . 0.0 110.911 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.82 -55.73 0.09 OUTLIER Glycine 0 C--N 1.34 0.791 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.431 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.78 127.17 50.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 122.331 0.253 . . . . 0.0 111.134 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.52 -8.41 20.11 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.662 0.602 . . . . 0.0 111.87 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -108.62 -40.7 5.01 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.336 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 57.25 85.88 0.18 Allowed Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 123.722 0.809 . . . . 0.0 112.055 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.95 149.91 26.26 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.788 2.325 . . . . 0.0 112.86 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.65 118.3 36.42 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.507 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -135.69 26.98 3.36 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.18 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -118.69 -18.01 9.09 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -120.86 69.82 0.89 Allowed 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.607 0.718 . . . . 0.0 110.223 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -66.46 152.54 44.94 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.045 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.9 p -102.89 -13.29 17.01 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.147 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -90.32 114.39 26.45 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.789 0.328 . . . . 0.0 110.98 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -116.1 -168.14 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.974 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.472 HG22 ' N ' ' A' ' 73' ' ' PHE . 0.7 OUTLIER 74.8 -36.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 124.716 1.206 . . . . 0.0 111.651 -179.461 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.472 ' N ' HG22 ' A' ' 72' ' ' ILE . 3.4 m-85 -139.65 36.88 2.01 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.026 0.531 . . . . 0.0 110.769 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.2 t -86.63 -47.6 9.04 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.457 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.87 -57.21 0.08 OUTLIER Glycine 0 C--N 1.339 0.716 0 O-C-N 123.357 0.411 . . . . 0.0 112.165 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.89 156.29 59.53 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.492 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.44 77.6 3.54 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.376 2.051 . . . . 0.0 112.746 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.403 HG21 ' C ' ' A' ' 127' ' ' ARG . 3.9 mp 57.85 57.12 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 123.628 0.771 . . . . 0.0 110.158 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.508 ' O ' ' HB2' ' A' ' 83' ' ' SER . 4.1 mm-40 -121.56 -86.63 0.65 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.09 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.2 m -55.1 -55.65 28.72 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.199 1.0 . . . . 0.0 113.601 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.41 ' O ' HD11 ' A' ' 87' ' ' ILE . 16.9 t -46.66 -55.58 7.49 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.728 0.643 . . . . 0.0 111.772 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -84.06 0.11 49.59 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.508 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 8.0 t -103.71 -2.64 26.17 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.696 0.284 . . . . 0.0 110.388 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.44 156.31 16.82 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.848 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.21 142.53 32.08 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.244 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' A' ' 90' ' ' LYS . . . 84.77 34.79 14.62 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.304 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.41 HD11 ' O ' ' A' ' 81' ' ' SER . 2.5 tp -84.38 -28.4 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 36.6 t60 -96.97 12.74 31.33 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 120.629 0.252 . . . . 0.0 111.356 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -137.12 -78.81 0.39 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.881 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 23.4 mmtp -42.82 -13.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.491 HG22 ' H ' ' A' ' 110' ' ' ALA . 2.0 pp -65.0 -33.4 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.4 ' N ' HD11 ' A' ' 91' ' ' ILE . 1.8 tt -111.07 10.38 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 CA-C-O 120.793 0.33 . . . . 0.0 111.214 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.57 -40.09 9.21 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.095 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.46 -25.88 52.27 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -89.56 -9.03 51.35 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 123.22 0.325 . . . . 0.0 111.849 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -103.32 -68.55 0.83 Allowed 'General case' 0 CA--C 1.537 0.469 0 O-C-N 123.078 0.236 . . . . 0.0 111.124 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 mp -146.5 167.82 22.74 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.571 0.348 . . . . 0.0 111.142 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -90.04 170.77 10.06 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.755 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.1 p -91.08 -55.25 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.1 t -146.18 -10.33 0.5 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt 64.09 97.87 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.837 0.855 . . . . 0.0 111.74 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.1 p -144.35 -36.65 0.33 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.093 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.1 tttm 64.02 92.57 0.07 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.05 0.94 . . . . 0.0 111.624 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -148.7 137.65 21.54 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.47 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 63.24 154.17 0.12 Allowed Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 123.785 0.834 . . . . 0.0 112.278 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.55 176.5 0.15 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 123.042 2.495 . . . . 0.0 113.334 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.1 tp -60.01 -63.07 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 122.687 0.395 . . . . 0.0 111.824 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 65.36 -18.07 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -98.64 154.15 18.16 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.655 0.264 . . . . 0.0 111.703 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.491 ' H ' HG22 ' A' ' 91' ' ' ILE . . . -94.57 166.97 11.77 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.845 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.7 t -96.07 -71.35 0.68 Allowed 'General case' 0 CA--C 1.536 0.435 0 O-C-N 123.095 0.247 . . . . 0.0 111.576 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.3 t -134.35 -55.4 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.5 ttt 64.39 158.74 0.09 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.934 0.894 . . . . 0.0 111.986 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -88.55 175.2 7.67 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.251 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -72.72 132.2 43.35 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.653 0.381 . . . . 0.0 111.275 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.7 mt -101.08 54.15 0.84 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.524 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -150.63 -30.13 0.2 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.096 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -83.76 -44.43 14.42 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.74 19.51 7.23 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.55 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -134.9 50.08 4.42 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 120' ' ' TYR . 9.4 Cg_endo -91.6 127.96 1.08 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.805 2.337 . . . . 0.0 113.369 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 135.96 -148.82 19.84 Favored Glycine 0 C--N 1.343 0.97 0 C-N-CA 120.485 -0.864 . . . . 0.0 114.575 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.618 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 49.1 Cg_exo -56.45 -32.55 89.56 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.634 2.889 . . . . 0.0 113.871 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.481 ' O ' HD12 ' A' ' 128' ' ' ILE . 6.3 m-20 -52.27 -37.86 56.67 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 123.457 0.473 . . . . 0.0 111.02 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.467 ' O ' HG22 ' A' ' 129' ' ' VAL . 15.8 mt -67.85 -43.61 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.412 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -61.9 -21.34 64.65 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.977 0.511 . . . . 0.0 112.134 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.618 ' HG2' ' O ' ' A' ' 123' ' ' PRO . 17.4 mmm180 -79.97 -46.67 16.26 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.825 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.481 HD12 ' O ' ' A' ' 124' ' ' ASP . 5.7 mt -62.95 -44.52 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.046 0.538 . . . . 0.0 111.278 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 144' ' ' GLY . 7.1 m -63.29 -55.1 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.523 0.514 . . . . 0.0 112.094 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 56.4 m -54.94 -34.79 63.55 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.7 m -82.41 -22.36 35.4 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 123.263 0.352 . . . . 0.0 111.831 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.429 ' HG ' ' OE2' ' A' ' 137' ' ' GLU . 3.0 tt -82.6 -40.31 21.01 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.474 0.31 . . . . 0.0 110.919 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -89.28 12.38 16.23 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.014 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -79.69 -49.15 12.52 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -96.08 -9.06 31.77 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 70.71 80.92 0.16 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.133 0.973 . . . . 0.0 112.46 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 141' ' ' LYS . 2.9 pt-20 -107.02 130.7 54.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.331 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -81.77 -26.43 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -84.98 -2.47 88.37 Favored Glycine 0 C--N 1.343 0.944 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.391 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.11 -9.76 3.39 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.903 0.481 . . . . 0.0 111.75 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 7.8 tptp -50.89 -33.29 23.46 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.866 0.867 . . . . 0.0 112.975 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.532 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 10.0 m-20 -74.82 -36.13 62.43 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.369 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.4 tp -66.13 -59.63 3.58 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.113 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.542 ' O ' HG13 ' A' ' 129' ' ' VAL . . . -58.94 -41.97 96.56 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-N 116.089 -0.505 . . . . 0.0 114.089 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.08 92.16 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.6 mptp? -68.66 -36.07 78.08 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.032 0.207 . . . . 0.0 111.511 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.1 mt -71.16 -34.21 70.75 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.236 0.335 . . . . 0.0 110.449 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -75.29 -39.47 59.63 Favored 'General case' 0 C--N 1.349 0.562 0 O-C-N 123.478 0.486 . . . . 0.0 110.882 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.55 42.27 0.35 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.134 0.492 . . . . 0.0 112.038 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -86.98 -7.65 57.96 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.854 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 mp -101.01 -45.88 5.26 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.489 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 4.5 t70 60.66 156.89 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.109 0.964 . . . . 0.0 112.42 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -94.72 149.9 20.77 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.059 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.89 179.997 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.6 p . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.551 0.215 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -127.74 144.71 51.07 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.487 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.31 56.7 0.11 Allowed Glycine 0 C--N 1.337 0.602 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.481 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.0 mt 63.13 126.48 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.923 0.889 . . . . 0.0 112.017 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 166.57 -89.98 0.1 OUTLIER Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.644 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.7 mmpp? -119.45 158.09 26.92 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.635 0.255 . . . . 0.0 111.077 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.434 ' HA ' ' CD1' ' A' ' 115' ' ' TYR . . . 63.52 121.57 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.958 0.903 . . . . 0.0 112.379 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -138.93 119.21 13.64 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.461 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 59.57 112.19 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.299 0 C-N-CA 123.929 0.892 . . . . 0.0 112.406 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.59 165.36 20.77 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.683 2.255 . . . . 0.0 113.006 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.5 mp -93.61 156.38 16.75 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.578 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -93.23 -177.84 4.58 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.802 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -75.99 125.15 28.57 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.486 0.315 . . . . 0.0 111.542 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.527 ' CD1' ' HD2' ' A' ' 70' ' ' LYS . 0.8 OUTLIER -119.77 -35.82 3.44 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.74 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 64.37 169.57 0.18 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.784 0.834 . . . . 0.0 111.937 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.1 t 72.28 -10.24 0.93 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.26 1.024 . . . . 0.0 112.694 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.527 ' HD2' ' CD1' ' A' ' 67' ' ' PHE . 64.7 mttm -95.4 136.4 35.81 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 122.366 0.266 . . . . 0.0 110.388 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.4 mt -134.13 135.35 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.095 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 tp -121.21 -49.81 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.856 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -135.37 5.47 3.22 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 123.313 0.383 . . . . 0.0 111.864 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.6 t -79.18 -41.89 27.34 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.249 0.22 . . . . 0.0 111.415 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.93 92.75 0.53 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.9 mptt 66.65 155.1 0.13 Allowed Pre-proline 0 N--CA 1.485 1.32 0 C-N-CA 124.059 0.944 . . . . 0.0 111.519 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.09 76.37 3.46 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.435 2.09 . . . . 0.0 112.758 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.537 HG22 ' CG ' ' A' ' 82' ' ' TYR . 4.6 mp 53.82 60.33 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 123.706 0.802 . . . . 0.0 110.865 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.622 ' O ' ' HB2' ' A' ' 83' ' ' SER . 3.6 tp10 -120.96 -81.27 0.64 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.47 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.5 m -70.59 -59.32 2.9 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.1 m -88.66 69.38 8.77 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 123.551 1.643 . . . . 0.0 109.62 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.537 ' CG ' HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -179.45 -34.29 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 111.304 -2.68 . . . . 0.0 108.038 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.622 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.7 t -75.67 -32.58 60.21 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.279 177.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -45.89 157.14 0.12 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.439 ' HA ' ' OE2' ' A' ' 137' ' ' GLU . 6.6 mptt -84.37 100.97 11.62 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.667 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.472 ' O ' ' HD2' ' A' ' 90' ' ' LYS . . . 106.53 74.27 0.9 Allowed Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.533 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 tp -103.71 -35.0 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 122.462 0.305 . . . . 0.0 111.558 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.572 ' ND1' HD22 ' A' ' 143' ' ' LEU . 39.9 t60 -97.88 -46.63 5.86 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 122.979 0.174 . . . . 0.0 111.172 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -96.86 51.29 1.13 Allowed 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.36 0.412 . . . . 0.0 110.888 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 86' ' ' GLY . 62.8 tttt -120.89 -5.63 9.6 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.8 tt -53.42 -24.08 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 123.589 0.756 . . . . 0.0 112.731 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.5 tp -72.0 -25.13 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 O-C-N 123.307 0.379 . . . . 0.0 110.855 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -95.31 -29.37 14.51 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.734 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.52 -23.64 58.86 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.585 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -91.04 -11.02 40.06 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 123.402 0.439 . . . . 0.0 111.452 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -97.81 126.36 43.13 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.33 0.394 . . . . 0.0 110.575 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.96 125.6 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.965 0.906 . . . . 0.0 111.847 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -118.14 120.75 38.67 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.1 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.23 153.4 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.274 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.4 t -104.98 129.25 53.45 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.741 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -130.52 -42.67 1.16 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.141 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.3 p -128.43 164.88 21.75 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.498 0.499 . . . . 0.0 111.053 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -84.17 157.69 21.58 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.337 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -87.76 -38.59 15.63 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.753 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 64.39 145.66 0.09 OUTLIER Pre-proline 0 N--CA 1.485 1.313 0 C-N-CA 124.007 0.923 . . . . 0.0 112.309 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.19 145.07 83.39 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.742 2.294 . . . . 0.0 113.311 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.9 158.64 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.048 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -85.6 128.28 34.72 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.951 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -98.75 112.11 24.29 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.231 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.14 -47.1 0.43 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.862 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.0 m -138.91 158.78 43.58 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.707 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.7 m -85.98 129.99 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.325 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.2 mmt -93.37 104.21 16.39 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.405 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -147.52 105.09 3.68 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.879 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.434 ' CD1' ' HA ' ' A' ' 60' ' ' ALA . 57.6 m-85 63.66 134.7 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.891 0.877 . . . . 0.0 111.815 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.2 mt -94.2 76.4 4.01 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.085 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -149.99 -46.4 0.13 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.897 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.3 tttm -116.88 -6.51 11.48 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.6 m -79.83 -41.15 26.97 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.459 0.304 . . . . 0.0 111.624 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -97.71 158.82 32.34 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 123.29 0.368 . . . . 0.0 111.345 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -78.22 -38.08 0.66 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.646 2.231 . . . . 0.0 113.352 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.72 -55.48 0.27 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.835 -0.981 . . . . 0.0 113.731 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.4 -34.52 71.57 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.163 2.576 . . . . 0.0 114.48 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 128' ' ' ILE . 6.1 m-20 -70.58 -42.96 70.35 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.521 ' O ' HG23 ' A' ' 129' ' ' VAL . 3.6 mt -73.08 -16.14 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 123.301 0.376 . . . . 0.0 110.276 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.78 -53.83 10.49 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.468 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -56.27 -33.57 65.61 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.436 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 29.3 mt -67.61 -57.95 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 122.358 0.263 . . . . 0.0 111.236 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.525 HG11 ' O ' ' A' ' 144' ' ' GLY . 4.1 m -56.55 -39.03 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.494 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 18.2 t -71.5 -54.83 9.26 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.166 0.291 . . . . 0.0 111.772 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.8 m -54.92 -25.03 26.46 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 128' ' ' ILE . 33.4 mt -85.66 -48.22 9.07 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.672 0.273 . . . . 0.0 110.386 178.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -83.28 18.04 1.89 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.244 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' A' ' 130' ' ' SER . 1.1 tmt_? -87.54 -38.83 15.67 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.351 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -105.22 -16.24 14.83 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.607 0.567 . . . . 0.0 110.971 -179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 68.93 72.5 0.27 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.178 0.991 . . . . 0.0 110.536 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.439 ' OE2' ' HA ' ' A' ' 85' ' ' LYS . 28.9 mt-10 -96.43 133.59 40.67 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.767 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 t -76.61 -12.58 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 123.557 0.536 . . . . 0.0 111.274 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -87.31 -27.52 27.6 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.023 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.77 1.65 12.17 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.69 0.396 . . . . 0.0 111.762 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 8.7 tptp -53.27 -41.73 65.83 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.54 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 8.2 m-20 -77.88 -32.99 52.23 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.042 0.214 . . . . 0.0 111.546 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.572 HD22 ' ND1' ' A' ' 88' ' ' HIS . 14.8 tp -69.7 -59.38 2.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.414 0.286 . . . . 0.0 110.391 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.525 ' O ' HG11 ' A' ' 129' ' ' VAL . . . -56.53 -55.39 30.03 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-N 115.775 -0.648 . . . . 0.0 114.163 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -58.59 -44.96 90.0 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.54 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -61.34 -42.66 99.05 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.718 0.235 . . . . 0.0 111.035 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.0 mt -60.15 -34.97 74.28 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.445 0.465 . . . . 0.0 111.36 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -88.18 -7.36 56.99 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.716 0.293 . . . . 0.0 110.522 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 1.4 m-20 -114.45 13.45 17.66 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.973 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 151' ' ' LEU . . . -72.51 109.29 6.08 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.409 ' HB3' ' O ' ' A' ' 150' ' ' ALA . 3.0 tm? 80.68 -26.63 0.15 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.98 0.912 . . . . 0.0 111.446 -178.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -68.16 -13.21 62.06 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 66.1 mtp180 -94.15 -45.63 7.46 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.227 0.211 . . . . 0.0 111.332 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.121 -0.942 . . . . 0.0 110.852 179.92 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.504 0.192 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -118.22 -44.36 2.69 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -140.2 131.1 4.91 Favored Glycine 0 C--N 1.339 0.746 0 O-C-N 123.477 0.486 . . . . 0.0 112.471 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.8 mp -119.96 -42.27 2.61 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.659 0.27 . . . . 0.0 111.353 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.09 -179.87 21.22 Favored Glycine 0 C--N 1.341 0.836 0 C-N-CA 121.445 -0.407 . . . . 0.0 112.831 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.1 tttp -98.83 -1.95 39.03 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.481 0.312 . . . . 0.0 111.314 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.45 3.02 48.84 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.93 152.65 21.12 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.824 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -90.0 130.53 42.15 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.272 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.48 34.18 0.52 Allowed 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.595 2.197 . . . . 0.0 113.122 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.7 tp -89.86 126.33 35.67 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.057 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -119.33 -39.2 2.92 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.673 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.546 ' NZ ' ' HB3' ' A' ' 68' ' ' PHE . 4.9 ttpp -97.52 132.89 42.78 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.538 0.524 . . . . 0.0 110.42 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -92.26 -12.01 33.76 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.06 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.546 ' HB3' ' NZ ' ' A' ' 66' ' ' LYS . 16.9 t80 -88.48 119.16 28.66 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.219 0.324 . . . . 0.0 110.191 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.448 ' OG ' ' HA ' ' A' ' 91' ' ' ILE . 54.7 p -102.8 101.75 11.84 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.378 0.609 . . . . 0.0 112.122 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.84 98.6 1.79 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.734 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 mt -123.07 -24.11 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.711 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.427 HD13 ' OH ' ' A' ' 82' ' ' TYR . 4.4 tp -71.78 141.77 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.453 ' HA ' ' HH ' ' A' ' 120' ' ' TYR . 12.0 t80 67.96 20.18 9.23 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.722 0.809 . . . . 0.0 111.047 -178.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.5 t -84.58 -43.22 14.68 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.377 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.5 -107.31 0.26 Allowed Glycine 0 C--N 1.339 0.729 0 O-C-N 123.555 0.535 . . . . 0.0 112.483 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -135.24 -44.13 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.775 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.531 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.9 134.32 17.84 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.33 2.02 . . . . 0.0 113.292 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.57 ' HB ' ' CD1' ' A' ' 82' ' ' TYR . 1.9 pp -144.71 46.16 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.855 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -103.99 -52.33 2.97 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.846 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.7 m -58.9 -59.35 5.6 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.207 0.603 . . . . 0.0 111.945 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.8 p -57.32 -55.21 37.73 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.761 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.57 ' CD1' ' HB ' ' A' ' 78' ' ' ILE . 17.2 m-85 -54.49 -24.47 20.58 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 177.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.546 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 11.8 t -75.66 -32.65 60.26 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 122.176 0.191 . . . . 0.0 110.752 178.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.05 162.03 1.09 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.334 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -94.16 103.55 15.59 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.864 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.89 65.04 0.56 Allowed Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.95 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.6 tt -93.12 -44.97 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 51.2 t60 -84.15 -13.7 52.19 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -95.5 -74.6 0.55 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -45.42 -15.35 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.448 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 1.7 tt -74.18 -10.93 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 O-C-N 123.219 0.324 . . . . 0.0 111.359 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mp -127.13 -25.38 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 122.833 0.453 . . . . 0.0 110.213 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.9 -53.71 4.75 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.325 0.65 . . . . 0.0 110.66 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 55.63 91.47 0.03 OUTLIER 'General case' 0 C--N 1.355 0.831 0 C-N-CA 124.014 0.926 . . . . 0.0 112.712 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 66.86 -6.89 0.51 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.244 1.017 . . . . 0.0 112.836 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -64.75 -53.51 46.0 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.059 0.544 . . . . 0.0 111.428 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 tp 52.63 -167.43 0.05 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.879 0.872 . . . . 0.0 112.349 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -91.78 -6.58 51.56 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.7 m -82.21 -19.9 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.8 m -92.43 -24.37 18.87 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.342 0.401 . . . . 0.0 111.519 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt 64.66 137.18 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.101 0.96 . . . . 0.0 112.161 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.7 t -96.43 -29.41 13.94 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.398 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.7 tttp 72.2 -44.59 0.6 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.378 1.071 . . . . 0.0 112.277 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -92.41 119.78 32.27 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.745 0.307 . . . . 0.0 111.131 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.436 ' H ' ' HD2' ' A' ' 106' ' ' PRO . . . -96.55 -48.77 0.24 Allowed Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.339 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.436 ' HD2' ' H ' ' A' ' 105' ' ' ALA . 28.1 Cg_endo -63.04 139.75 74.96 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.166 1.911 . . . . 0.0 113.449 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.1 pp -139.21 161.94 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.156 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -88.74 -47.25 8.36 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.306 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -137.69 -52.72 0.64 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.893 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 63.8 -67.48 0.1 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.259 1.024 . . . . 0.0 112.532 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.0 t -138.61 154.09 48.66 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 122.697 0.399 . . . . 0.0 110.66 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.6 m -93.0 158.9 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.339 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 64.5 mtt -88.69 -37.05 15.84 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.754 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -92.79 121.2 33.94 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.352 0.407 . . . . 0.0 110.922 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.19 124.19 31.99 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.043 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mp 49.82 97.65 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.253 1.021 . . . . 0.0 112.739 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.78 -38.85 0.12 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.011 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -93.72 -26.08 17.16 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.421 0.45 . . . . 0.0 111.972 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.44 -41.85 10.07 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.276 0.36 . . . . 0.0 111.681 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.453 ' HH ' ' HA ' ' A' ' 73' ' ' PHE . 2.8 m-30 -88.86 155.96 49.89 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 123.288 0.368 . . . . 0.0 111.624 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -80.84 -54.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.732 2.288 . . . . 0.0 113.942 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.65 -59.48 0.19 Allowed Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.876 -0.958 . . . . 0.0 113.591 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.485 ' HA ' ' OE2' ' A' ' 126' ' ' GLU . 52.2 Cg_exo -54.65 -30.84 68.0 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.079 2.519 . . . . 0.0 114.04 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 8.1 m-20 -71.25 -29.72 65.44 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.538 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 6.4 mt -86.64 -19.06 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.485 ' OE2' ' HA ' ' A' ' 123' ' ' PRO . 37.5 mt-10 -65.24 -51.88 58.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.782 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' A' ' 124' ' ' ASP . 1.9 ptp180 -57.9 -21.03 41.39 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.274 176.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 83.2 mt -77.72 -50.11 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 122.577 0.351 . . . . 0.0 111.027 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 144' ' ' GLY . 4.6 m -61.98 -36.28 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 4.3 m -70.71 -58.18 3.91 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.502 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.9 m -52.7 -29.03 24.51 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 17.8 mt -76.19 -46.81 26.62 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.026 0.13 . . . . 0.0 111.15 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -87.43 16.49 5.36 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 123.517 0.511 . . . . 0.0 110.96 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 130' ' ' SER . 3.3 tmt_? -99.58 -34.97 10.01 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.694 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.546 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 75.1 m-70 -96.72 -32.9 11.93 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.561 0.538 . . . . 0.0 111.914 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.7 t70 74.72 81.08 0.11 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.227 1.011 . . . . 0.0 110.096 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -137.11 128.18 27.7 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.088 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.68 159.47 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.396 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 96.25 -53.52 1.57 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -104.48 -12.87 16.27 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.916 0.421 . . . . 0.0 111.7 179.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.46 -36.27 75.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.346 0.658 . . . . 0.0 112.436 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.492 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 9.9 m-20 -74.82 -34.99 62.43 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.5 tp -61.41 -58.81 6.7 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.319 0.387 . . . . 0.0 110.148 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.531 ' O ' HG13 ' A' ' 129' ' ' VAL . . . -51.9 -46.7 54.99 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.934 178.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.77 -39.28 91.08 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.492 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -65.29 -49.45 69.47 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.992 0.183 . . . . 0.0 110.707 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 25.9 mt -59.3 -30.82 68.61 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.41 0.444 . . . . 0.0 111.64 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -83.25 -10.81 58.34 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 123.001 0.188 . . . . 0.0 111.381 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -97.15 0.13 47.89 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 123.162 0.288 . . . . 0.0 111.43 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.573 ' O ' HD12 ' A' ' 151' ' ' LEU . . . -65.68 112.89 3.89 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.573 HD12 ' O ' ' A' ' 150' ' ' ALA . 2.9 mp 72.61 -27.78 0.19 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.934 0.894 . . . . 0.0 110.873 -177.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -88.12 128.05 35.42 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 123.361 0.413 . . . . 0.0 111.255 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -100.1 -42.64 6.64 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.857 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.893 179.969 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.0 m . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 111.342 0.127 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -129.61 -7.62 4.61 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 123.384 0.427 . . . . 0.0 111.459 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.32 -62.28 1.05 Allowed Glycine 0 C--N 1.341 0.81 0 C-N-CA 121.47 -0.395 . . . . 0.0 113.004 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -98.94 -45.76 5.85 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.68 0.282 . . . . 0.0 111.209 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 159.73 -137.97 5.36 Favored Glycine 0 C--N 1.339 0.714 0 O-C-N 123.523 0.515 . . . . 0.0 112.255 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -98.03 79.37 2.61 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.318 0.58 . . . . 0.0 110.66 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.46 136.99 54.58 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.087 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -102.9 96.56 6.91 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 123.647 0.592 . . . . 0.0 110.607 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -135.34 70.4 67.98 Favored Pre-proline 0 CA--C 1.548 0.89 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.102 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.87 -47.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 123.044 2.496 . . . . 0.0 112.69 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 tt -143.57 -46.67 0.28 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.438 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 63.13 154.09 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.891 0.876 . . . . 0.0 111.988 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.54 83.35 7.26 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.253 0.549 . . . . 0.0 111.464 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -120.71 -35.14 3.43 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.528 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.482 ' HA ' ' HZ3' ' A' ' 90' ' ' LYS . 12.8 t80 -83.64 99.51 10.25 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.618 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 44.1 p -120.51 20.61 11.81 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.082 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.501 ' HB2' ' NZ ' ' A' ' 90' ' ' LYS . 16.4 ttmt -91.01 105.77 18.05 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.323 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 71' ' ' ILE . 1.4 tt -145.34 103.59 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.794 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -91.53 -23.2 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.644 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -78.94 17.96 0.68 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.4 t -85.77 137.34 32.87 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.955 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.6 -70.25 1.18 Allowed Glycine 0 C--N 1.34 0.792 0 O-C-N 123.531 0.52 . . . . 0.0 112.549 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -88.43 -42.75 0.47 Allowed Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.96 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.72 20.74 0.51 Allowed 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.415 2.077 . . . . 0.0 113.65 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.488 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 2.9 tp -78.48 -5.8 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 122.718 0.407 . . . . 0.0 111.038 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 83' ' ' SER . 37.9 tt0 -96.57 -49.73 5.01 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.817 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.7 p -54.26 -58.05 8.88 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.326 1.051 . . . . 0.0 112.595 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 t -60.16 -54.94 39.97 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.67 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 78' ' ' ILE . 3.4 m-85 -58.07 -16.73 14.02 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 8.4 t -86.36 -31.85 21.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.701 0.4 . . . . 0.0 111.255 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -46.08 165.18 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -90.37 113.88 25.87 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.212 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 90' ' ' LYS . . . 87.5 67.2 1.32 Allowed Glycine 0 C--N 1.34 0.787 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.635 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.494 HG22 ' OE1' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -91.96 -25.05 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -113.78 -32.32 6.16 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 93' ' ' GLU . 11.4 pt-20 -99.06 43.68 1.05 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 123.488 0.493 . . . . 0.0 110.707 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 86' ' ' GLY . 25.7 pttt -98.5 -35.92 10.09 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.956 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.6 mp -76.09 -11.06 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.273 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.546 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 3.6 tp -116.94 5.72 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 O-C-N 123.231 0.332 . . . . 0.0 111.302 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 14.1 tt0 -105.37 -41.47 5.51 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.996 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.87 -29.14 29.56 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.882 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -91.67 -5.49 53.7 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.206 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.546 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 6.2 t70 -74.87 142.88 44.06 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.859 0.464 . . . . 0.0 111.331 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.571 HD22 ' O ' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -122.84 162.88 21.31 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.047 -179.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -84.0 -36.39 23.2 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.08 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.571 ' O ' HD22 ' A' ' 97' ' ' LEU . 7.6 p -85.74 159.03 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 O-C-N 123.415 0.447 . . . . 0.0 110.84 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.7 m -85.22 -56.55 3.48 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.414 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm 55.33 178.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.77 0.828 . . . . 0.0 112.501 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.6 t -87.24 -8.11 57.17 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.78 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.512 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -95.43 39.02 1.13 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.161 0.505 . . . . 0.0 111.272 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -86.02 173.36 9.96 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.671 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 66.97 135.02 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.295 0 C-N-CA 124.105 0.962 . . . . 0.0 112.056 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.21 163.54 38.38 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.622 2.215 . . . . 0.0 113.319 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 mt -121.55 -8.87 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.843 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -93.43 126.46 38.58 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.147 0.28 . . . . 0.0 111.082 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -135.29 152.9 51.94 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.715 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 63.03 148.85 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.943 0.897 . . . . 0.0 112.883 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.1 p -97.38 155.95 16.68 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.998 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.0 p -93.76 -41.15 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.388 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 85.9 mmm -136.74 108.86 7.21 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.878 0.37 . . . . 0.0 111.053 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.9 91.16 1.9 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.371 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.91 126.29 11.55 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.752 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.8 mt -112.74 -40.83 3.93 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.805 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -89.07 100.72 13.44 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.42 0.628 . . . . 0.0 111.279 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -179.77 -44.04 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.197 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.91 -17.91 12.8 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.357 0.41 . . . . 0.0 111.665 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -94.15 135.22 24.75 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 119.323 -0.37 . . . . 0.0 111.184 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.21 -36.32 1.04 Allowed 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.467 2.111 . . . . 0.0 113.1 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.64 -59.21 0.26 Allowed Glycine 0 CA--C 1.53 0.976 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.227 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.539 ' HA ' ' OE2' ' A' ' 126' ' ' GLU . 52.0 Cg_exo -56.49 -30.38 82.01 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.931 2.421 . . . . 0.0 114.096 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -65.89 -30.04 70.57 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.269 0.355 . . . . 0.0 111.844 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 10.9 mt -81.68 -31.19 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.539 ' OE2' ' HA ' ' A' ' 123' ' ' PRO . 42.7 mt-10 -56.26 -47.65 78.14 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.55 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -16.8 61.65 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 177.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.0 mt -78.16 -51.06 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 144' ' ' GLY . 3.7 m -63.03 -35.32 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 4.9 m -73.2 -56.51 4.99 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.387 0.429 . . . . 0.0 111.37 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.8 m -56.13 -24.61 41.93 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 25.9 mt -79.97 -51.63 8.84 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.929 0.143 . . . . 0.0 111.017 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -85.06 16.16 3.65 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.453 0.47 . . . . 0.0 111.312 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.0 tmt_? -79.6 -42.78 24.21 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.27 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.424 ' CE1' HH11 ' A' ' 134' ' ' ARG . 91.2 m-70 -96.96 -11.88 24.07 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.135 0.272 . . . . 0.0 111.242 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.1 t70 67.83 55.85 0.58 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.129 0.972 . . . . 0.0 110.969 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.494 ' OE1' HG22 ' A' ' 87' ' ' ILE . 11.1 pt-20 -88.99 124.46 34.29 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.936 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.07 -8.17 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.825 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.99 -26.89 20.69 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.417 -0.42 . . . . 0.0 112.857 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -121.81 6.05 9.93 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 122.807 0.443 . . . . 0.0 111.613 -179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -34.63 78.61 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.527 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 2.8 t70 -78.81 -34.62 45.19 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.596 0.236 . . . . 0.0 110.899 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.7 tp -64.45 -68.97 0.31 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.846 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.55 ' O ' HG13 ' A' ' 129' ' ' VAL . . . -48.81 -43.72 30.4 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 114.843 0.697 . . . . 0.0 114.843 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.5 96.69 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.527 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 14.4 mptt -60.86 -49.74 76.24 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.995 0.184 . . . . 0.0 110.896 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 35.8 mt -57.56 -30.45 65.25 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.405 0.441 . . . . 0.0 112.05 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -80.18 -35.98 35.62 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 120.565 0.221 . . . . 0.0 110.67 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -78.84 8.93 4.71 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.988 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.83 -4.65 53.09 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.61 0.364 . . . . 0.0 111.749 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.1 tt -93.91 -42.89 8.83 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.583 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -83.31 157.88 22.43 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 123.407 0.442 . . . . 0.0 111.022 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 72.41 -45.57 0.62 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.474 1.11 . . . . 0.0 112.3 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.904 180.0 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.424 ' O ' ' HD2' ' A' ' 82' ' ' TYR . 1.2 tp . . . . . 0 CA--C 1.552 1.031 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -116.7 -65.98 1.13 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.901 -0.136 . . . . 0.0 110.93 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 51.6 p -41.66 -50.21 4.17 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.748 1.219 . . . . 0.0 112.848 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.561 ' O ' HD13 ' A' ' 87' ' ' ILE . 8.5 t -62.86 -49.37 75.14 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 113.367 -1.742 . . . . 0.0 110.371 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.424 ' HD2' ' O ' ' A' ' 78' ' ' ILE . 64.3 m-85 -86.79 17.22 4.14 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.639 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.544 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 13.1 t -119.15 -17.47 8.92 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.405 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.54 164.91 22.59 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.768 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -88.68 117.84 27.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.026 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.23 68.13 1.21 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.284 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.561 HD13 ' O ' ' A' ' 81' ' ' SER . 2.4 tp -96.95 -29.05 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.635 ' HB3' ' O ' ' A' ' 139' ' ' GLY . 39.1 t60 . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.549 ' HA ' ' CD1' ' A' ' 120' ' ' TYR . 10.2 mt . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -130.28 -6.1 4.31 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -96.11 -43.42 7.76 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.81 -5.59 18.29 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.294 0.371 . . . . 0.0 111.892 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.549 ' CD1' ' HA ' ' A' ' 116' ' ' LEU . 36.0 m-85 -97.16 139.29 21.4 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.786 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.13 -58.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.523 2.149 . . . . 0.0 114.074 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.33 -60.73 0.08 OUTLIER Glycine 0 C--N 1.343 0.972 0 CA-C-O 118.919 -0.934 . . . . 0.0 113.596 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.27 -31.98 69.18 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.078 2.519 . . . . 0.0 114.017 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.94 -41.81 97.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.38 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.515 ' O ' HG22 ' A' ' 129' ' ' VAL . 7.1 mt -70.54 -40.11 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.574 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.98 -24.12 66.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.793 0.437 . . . . 0.0 111.941 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -77.76 -45.09 25.64 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.407 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.7 mt -63.06 -47.24 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 122.844 0.457 . . . . 0.0 111.197 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 125' ' ' ILE . 5.3 m -58.64 -51.56 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.791 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.1 m -58.35 -39.03 78.4 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 m -71.38 -26.17 62.67 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.9 mt -85.65 -37.6 19.29 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -83.81 6.38 21.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.598 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.488 HH11 ' CE1' ' A' ' 135' ' ' HIS . 4.5 tmt_? -86.9 -42.82 12.9 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.28 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.544 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 88.5 m-70 -91.64 -25.38 19.18 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.982 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.2 t70 70.54 76.12 0.2 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.115 0.966 . . . . 0.0 110.535 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -101.02 130.02 46.95 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.503 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.69 -14.91 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 123.437 0.461 . . . . 0.0 111.695 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.635 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -96.76 -7.57 57.64 Favored Glycine 0 C--N 1.336 0.575 0 O-C-N 123.344 0.403 . . . . 0.0 112.293 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -130.02 1.59 4.77 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.363 0.665 . . . . 0.0 111.607 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -62.59 -27.39 69.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.003 0.521 . . . . 0.0 111.398 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.517 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 1.5 p30 -76.21 -39.06 55.59 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.441 0.463 . . . . 0.0 110.887 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.0 tp -64.07 -59.97 3.81 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.885 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -58.41 -56.3 25.99 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.799 -0.637 . . . . 0.0 114.66 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.4 -41.84 76.98 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.517 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -65.98 -40.25 91.05 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.929 0.143 . . . . 0.0 111.357 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 22.0 mt -69.85 -27.9 65.23 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.336 0.398 . . . . 0.0 110.781 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -95.6 5.56 51.16 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 123.142 0.276 . . . . 0.0 110.937 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -85.38 -2.71 58.39 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.329 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.627 179.575 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.5 tp . . . . . 0 CA--C 1.551 1.012 0 CA-C-O 121.15 0.5 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 83' ' ' SER . 7.1 tp10 -119.8 -53.89 2.17 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.137 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.1 m -56.46 -56.78 16.89 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.419 0.688 . . . . 0.0 112.235 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.8 m -59.51 -55.81 29.86 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.289 0.368 . . . . 0.0 111.043 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.468 ' HB3' HG21 ' A' ' 131' ' ' THR . 2.1 m-85 -61.43 -11.88 12.29 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.492 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 8.3 t -87.94 -40.09 14.21 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.624 0.193 . . . . 0.0 111.324 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.71 152.62 30.56 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -82.88 131.56 35.19 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.081 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.78 28.05 5.79 Favored Glycine 0 C--N 1.336 0.536 0 O-C-N 123.731 0.644 . . . . 0.0 112.783 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.592 ' O ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -91.51 -19.54 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 122.735 0.414 . . . . 0.0 111.049 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.8 p80 . . . . . 0 CA--C 1.547 0.832 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.641 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 120' ' ' TYR . 3.0 mp . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -98.87 146.6 25.8 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.142 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt 70.77 -34.59 0.3 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.455 1.102 . . . . 0.0 112.889 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.5 -31.78 19.78 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.505 ' CE2' HD23 ' A' ' 116' ' ' LEU . 13.6 m-85 -88.82 158.14 48.01 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 119.241 -0.409 . . . . 0.0 111.095 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.67 -44.43 0.14 Allowed 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.412 2.074 . . . . 0.0 113.832 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.35 -59.58 0.42 Allowed Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.9 -0.944 . . . . 0.0 113.508 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.09 -18.03 41.48 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.905 2.403 . . . . 0.0 114.049 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -78.13 -40.03 39.38 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.299 0.374 . . . . 0.0 111.254 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.537 ' O ' HG22 ' A' ' 129' ' ' VAL . 6.1 mt -68.71 -33.14 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.626 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -69.43 -50.53 44.82 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.466 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -51.77 -44.52 63.39 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.617 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.579 ' O ' HD12 ' A' ' 132' ' ' LEU . 23.7 mt -63.61 -57.02 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 122.356 0.262 . . . . 0.0 111.546 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 125' ' ' ILE . 5.0 m -55.49 -45.07 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.8 t -64.38 -30.1 71.15 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.468 HG21 ' HB3' ' A' ' 82' ' ' TYR . 22.8 m -72.78 -34.91 67.25 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.994 0.184 . . . . 0.0 111.349 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.68 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 0.9 OUTLIER -75.02 -28.86 60.66 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.154 0.284 . . . . 0.0 111.336 178.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -90.01 18.93 5.28 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.373 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -109.97 -41.31 4.51 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.38 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.68 ' NE2' ' HA ' ' A' ' 132' ' ' LEU . 5.7 p80 -87.21 -41.98 13.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.94 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 70.95 81.06 0.16 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.254 1.022 . . . . 0.0 112.015 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.529 ' HG2' ' CE1' ' A' ' 135' ' ' HIS . 10.3 pt-20 -128.23 139.79 52.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.645 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.98 -13.5 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.709 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -79.76 -28.77 50.04 Favored Glycine 0 C--N 1.34 0.792 0 O-C-N 123.341 0.4 . . . . 0.0 113.849 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -123.11 1.95 9.22 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -58.79 -25.18 62.87 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.953 0.501 . . . . 0.0 112.22 179.427 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.577 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 7.6 m-20 -81.43 -32.99 32.42 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.784 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.8 tp -68.61 -56.84 6.9 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.532 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.413 ' H ' HD22 ' A' ' 132' ' ' LEU . . . -60.82 -48.28 87.04 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.851 -0.613 . . . . 0.0 114.153 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.7 -41.49 86.4 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.577 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 14.4 mptt -65.45 -34.57 78.61 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 30.8 mt -72.83 -30.89 64.4 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.205 0.316 . . . . 0.0 111.616 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.491 ' O ' ' HD2' ' A' ' 148' ' ' ARG . 1.8 tmm_? -87.67 -19.64 27.4 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 123.173 0.296 . . . . 0.0 111.189 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.49 22.65 3.33 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 123.382 0.426 . . . . 0.0 111.153 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.513 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.932 179.867 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.493 ' O ' HD13 ' A' ' 78' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.8 0 CA-C-O 120.642 0.258 . . . . 0.0 110.379 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -75.13 -53.35 9.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.099 0.56 . . . . 0.0 111.974 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 83' ' ' SER . 37.3 m -49.57 -47.9 48.99 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.097 0.959 . . . . 0.0 112.815 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.9 p -54.65 -58.64 6.72 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.523 0.514 . . . . 0.0 111.943 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -74.45 -4.79 38.74 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.574 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 4.4 m -78.65 -37.01 43.01 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.85 0.46 . . . . 0.0 110.987 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.98 161.93 12.21 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.91 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -96.36 98.25 10.12 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.602 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.76 60.04 0.16 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.876 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.554 HG22 ' OE2' ' A' ' 137' ' ' GLU . 3.9 tp -86.44 -31.3 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 122.43 0.292 . . . . 0.0 111.181 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.8 t60 . . . . . 0 N--CA 1.466 0.369 0 O-C-N 123.387 0.43 . . . . 0.0 109.997 179.408 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.514 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 4.6 mt . . . . . 0 C--O 1.238 0.47 0 CA-C-O 120.748 0.309 . . . . 0.0 111.766 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 116' ' ' LEU . 36.0 mmtt -157.86 -48.64 0.06 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.89 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -94.22 -43.72 8.31 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -83.71 0.37 47.38 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 123.177 0.298 . . . . 0.0 111.688 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.407 ' CD1' HD23 ' A' ' 116' ' ' LEU . 58.7 m-85 -127.68 123.34 22.94 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.795 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -73.41 -49.61 0.21 Allowed 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.658 2.239 . . . . 0.0 113.871 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 172.81 -61.21 0.14 Allowed Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.94 -0.922 . . . . 0.0 113.556 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.96 -31.41 73.93 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.928 2.419 . . . . 0.0 113.926 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -70.5 -20.47 62.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.644 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.748 ' HA ' HD12 ' A' ' 128' ' ' ILE . 8.8 mt -95.1 -28.29 4.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.13 -36.49 84.19 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.745 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -77.73 -10.64 59.64 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.877 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.748 HD12 ' HA ' ' A' ' 125' ' ' ILE . 96.6 mt -84.14 -41.9 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.633 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.8 m -72.31 -38.29 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.132 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 21.2 t -71.77 -60.91 1.99 Allowed 'General case' 0 C--N 1.348 0.502 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.701 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.6 m -56.86 -25.11 55.81 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.615 ' HB2' ' O ' ' A' ' 128' ' ' ILE . 4.3 tt -74.77 -48.27 26.44 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.586 0.176 . . . . 0.0 111.191 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -96.29 13.18 28.43 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 120.873 0.368 . . . . 0.0 111.645 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 130' ' ' SER . 4.5 tmt_? -76.03 -42.17 48.65 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.574 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 21.2 m-70 -88.85 -111.6 0.07 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 176.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.428 ' H ' ' HB2' ' A' ' 135' ' ' HIS . 8.7 m-20 -123.17 -89.54 0.59 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.554 ' OE2' HG22 ' A' ' 87' ' ' ILE . 3.7 mm-40 55.48 89.87 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.487 1.115 . . . . 0.0 111.262 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.25 -15.64 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.021 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -94.02 -31.26 8.21 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.62 -16.92 29.47 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.106 0.562 . . . . 0.0 111.204 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 19.2 tptt -51.59 -28.83 15.24 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.445 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 1.3 p30 -78.34 -44.14 25.89 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.714 0.293 . . . . 0.0 110.495 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.4 tp -60.62 -66.55 0.51 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.964 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.54 -34.71 20.62 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.332 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.72 77.71 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 117.218 0.509 . . . . 0.0 112.104 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -66.78 -50.55 62.3 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.1 0.25 . . . . 0.0 110.685 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 26.9 mt -61.79 -28.43 69.45 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.225 0.328 . . . . 0.0 111.423 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -80.77 -38.15 29.07 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 123.369 0.418 . . . . 0.0 110.773 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.83 0.27 27.76 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.239 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.499 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.509 ' O ' HG21 ' A' ' 131' ' ' THR . 0.2 OUTLIER . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 121.443 0.64 . . . . 0.0 111.209 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 83' ' ' SER . 7.0 tp10 -120.87 -55.68 1.98 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.428 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 m -64.49 -58.94 5.0 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.6 m -53.21 -62.06 1.9 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.449 ' CD2' HG12 ' A' ' 87' ' ' ILE . 44.9 m-85 -51.64 -33.51 33.79 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 178.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 6.3 t -65.78 -33.73 76.54 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.22 174.58 0.13 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.261 0.624 . . . . 0.0 112.643 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -98.22 119.04 36.18 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.198 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.04 51.14 1.66 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.058 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.449 HG12 ' CD2' ' A' ' 82' ' ' TYR . 3.8 tp -85.54 -42.29 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 122.47 0.308 . . . . 0.0 111.189 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 140' ' ' ALA . 59.1 t60 . . . . . 0 CA--C 1.55 0.95 0 CA-C-O 121.235 0.54 . . . . 0.0 111.939 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.511 HD23 ' CZ ' ' A' ' 120' ' ' TYR . 9.2 mt . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 120.985 0.422 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -134.07 3.4 3.43 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.973 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.9 -48.96 13.63 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.44 10.48 6.74 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 123.394 0.434 . . . . 0.0 111.03 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.511 ' CZ ' HD23 ' A' ' 116' ' ' LEU . 63.5 m-85 -97.51 105.26 24.76 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.693 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.3 -35.38 14.11 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.653 2.236 . . . . 0.0 113.621 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 157.64 -56.85 0.37 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.868 -0.962 . . . . 0.0 113.122 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.16 -22.72 41.29 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.887 2.391 . . . . 0.0 114.028 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -74.31 -39.69 62.73 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.296 0.372 . . . . 0.0 111.293 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.696 ' HA ' HD12 ' A' ' 128' ' ' ILE . 5.0 mt -78.16 -30.91 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.371 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -62.38 -52.51 63.3 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.339 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.443 ' O ' ' OG1' ' A' ' 131' ' ' THR . 76.9 mtt180 -55.94 -27.72 53.65 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 177.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 125' ' ' ILE . 69.2 mt -70.9 -50.48 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 121.999 0.12 . . . . 0.0 111.022 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.4 m -60.37 -39.72 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 43.2 p -78.73 -18.19 54.67 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.509 HG21 ' O ' ' A' ' 78' ' ' ILE . 89.1 m -86.62 -28.67 23.1 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 122.883 0.114 . . . . 0.0 111.224 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 144' ' ' GLY . 1.7 mp -80.43 -46.27 16.25 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.087 0.242 . . . . 0.0 110.444 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.416 ' OE1' ' HG2' ' A' ' 148' ' ' ARG . 44.4 mt-10 -80.18 12.87 2.59 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.881 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 130' ' ' SER . 4.6 tmt_? -79.71 -46.18 17.57 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.218 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.593 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 3.9 p80 -110.22 -12.45 14.47 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 70.31 78.83 0.19 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.337 1.055 . . . . 0.0 111.935 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.593 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 0.2 OUTLIER -99.77 130.44 45.98 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.923 179.08 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.89 -7.62 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.025 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -93.08 -22.11 28.5 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.512 -0.375 . . . . 0.0 112.705 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.468 ' HB3' ' CG ' ' A' ' 137' ' ' GLU . . . -126.93 5.25 6.56 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.18 -33.83 59.05 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.039 0.536 . . . . 0.0 111.753 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.57 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 3.1 t70 -74.95 -34.95 62.12 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.47 0.481 . . . . 0.0 111.232 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.9 tp -69.05 -59.61 2.92 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.825 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.483 ' N ' HD22 ' A' ' 132' ' ' LEU . . . -55.43 -56.25 24.44 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.852 -0.613 . . . . 0.0 113.934 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . -54.94 -43.63 73.57 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.57 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 14.3 mptt -62.24 -41.13 98.15 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.922 0.139 . . . . 0.0 111.246 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.4 mt -59.47 -34.42 72.54 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.44 0.463 . . . . 0.0 111.622 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 145' ' ' ALA . 0.1 OUTLIER -94.17 7.3 45.77 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 120.656 0.265 . . . . 0.0 111.029 178.544 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -108.18 17.65 22.02 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.245 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.447 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.976 179.963 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.56 1.335 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -120.38 -77.99 0.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 35.2 m -41.63 -47.55 3.92 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.313 1.045 . . . . 0.0 112.715 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.4 t -61.54 -51.61 67.87 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.806 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -88.37 17.98 4.83 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.392 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m -119.73 -15.88 8.85 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.997 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.34 154.74 17.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.169 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.522 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -78.6 133.67 37.27 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.504 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 94.44 34.12 6.5 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.669 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.7 tp -89.31 -24.06 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 140' ' ' ALA . 29.2 p-80 . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.514 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 6.2 mt . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -91.64 141.23 28.93 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.213 0.321 . . . . 0.0 111.062 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.2 mptt 70.64 -35.68 0.33 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.348 1.059 . . . . 0.0 113.018 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.99 -18.09 20.51 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 122.252 0.221 . . . . 0.0 111.324 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.514 ' HB3' ' O ' ' A' ' 116' ' ' LEU . 19.3 t80 -133.57 50.55 5.48 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 123.335 0.397 . . . . 0.0 111.315 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 120' ' ' TYR . 3.5 Cg_exo -76.19 111.18 3.22 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.26 1.973 . . . . 0.0 112.287 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -172.91 -160.55 21.69 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.713 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.677 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 12.5 Cg_exo -70.29 -34.83 12.12 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 123.295 2.663 . . . . 0.0 112.803 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -56.09 -30.69 62.41 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.492 0.495 . . . . 0.0 111.62 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.476 ' O ' HG22 ' A' ' 129' ' ' VAL . 46.4 mm -67.12 -44.53 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.642 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -68.9 -18.71 64.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.237 0.615 . . . . 0.0 111.243 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.677 ' HG2' ' O ' ' A' ' 123' ' ' PRO . 24.2 mmm180 -79.99 -46.63 16.32 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.604 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.4 mt -61.23 -49.33 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.916 0.487 . . . . 0.0 110.744 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 125' ' ' ILE . 7.0 m -58.68 -52.11 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.699 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 57.9 m -59.48 -38.41 80.77 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.2 m -72.69 -24.12 60.97 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 19.3 mt -85.66 -30.91 22.85 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.075 0.235 . . . . 0.0 111.406 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -84.97 5.1 30.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.15 0.5 . . . . 0.0 111.167 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -98.04 -36.22 10.18 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.442 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -85.36 -33.41 22.03 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.436 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 67.18 69.84 0.38 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.225 1.01 . . . . 0.0 111.492 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 140' ' ' ALA . 36.1 mt-10 -95.82 136.68 35.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.49 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.2 m -75.23 -48.71 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -77.43 -2.12 78.53 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.176 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.768 ' HB2' ' HB3' ' A' ' 88' ' ' HIS . . . -122.53 -4.79 8.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.737 0.415 . . . . 0.0 111.386 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -62.28 -37.61 86.19 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 122.798 0.439 . . . . 0.0 111.013 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.511 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 8.1 m-20 -73.42 -38.16 65.65 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.482 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.3 tp -66.74 -55.91 12.91 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.75 0.42 . . . . 0.0 110.781 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.05 -41.65 85.65 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.483 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -61.51 -41.21 96.96 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.511 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -62.13 -38.05 87.49 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.141 0.275 . . . . 0.0 111.464 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.2 mt -66.41 -32.15 73.35 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.257 0.348 . . . . 0.0 110.328 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.41 12.47 31.19 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.423 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 5.4 t70 -106.47 43.32 1.16 Allowed 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.288 0.566 . . . . 0.0 110.375 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.503 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.661 179.826 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 tt . . . . . 0 CA--C 1.554 1.103 0 CA-C-O 120.732 0.301 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -120.18 -57.57 1.92 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.272 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.9 m -47.35 -46.84 25.98 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.191 0.996 . . . . 0.0 112.7 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.2 t -61.19 -53.04 61.91 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.887 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -79.62 5.28 13.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.926 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.523 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 23.3 t -91.32 -47.45 7.47 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.943 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.98 160.21 4.97 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -92.07 92.13 8.13 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.219 0.533 . . . . 0.0 110.921 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.5 48.31 0.05 OUTLIER Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.98 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.522 HG22 ' OE1' ' A' ' 137' ' ' GLU . 2.7 tp -91.84 -29.62 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 122.623 0.369 . . . . 0.0 111.929 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.445 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 32.4 t60 . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.4 mp . . . . . 0 C--O 1.236 0.367 0 CA-C-O 120.528 0.204 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 71.02 -3.48 2.02 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.376 1.07 . . . . 0.0 112.759 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -97.43 -45.1 6.57 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.396 0.278 . . . . 0.0 110.69 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.46 7.34 1.93 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.834 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -92.93 114.13 61.76 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.618 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.55 177.85 1.12 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.709 2.273 . . . . 0.0 112.863 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.68 -55.58 14.15 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.878 -0.957 . . . . 0.0 113.87 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.5 -15.17 39.51 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.732 2.288 . . . . 0.0 113.762 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.408 ' O ' HG13 ' A' ' 128' ' ' ILE . 3.2 t70 -80.05 -41.35 25.86 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.553 0.341 . . . . 0.0 111.021 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.0 mt -67.7 -39.11 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.472 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.8 -50.65 65.89 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.183 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -49.34 -40.67 36.27 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.828 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 124' ' ' ASP . 29.0 mt -66.64 -54.59 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.142 0.177 . . . . 0.0 111.436 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.2 m -60.23 -51.78 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 75.2 m -62.91 -25.49 68.35 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.2 m -83.28 -26.0 31.06 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 117.54 0.154 . . . . 0.0 111.297 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.5 mt -81.15 -38.55 26.99 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.592 0.234 . . . . 0.0 111.031 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -88.45 8.81 26.1 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.822 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.577 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.1 tmt_? -82.17 -40.63 21.51 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.987 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.523 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 87.6 m-70 -100.4 -9.4 22.25 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.457 0.473 . . . . 0.0 111.298 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 67.67 70.21 0.35 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.178 0.991 . . . . 0.0 111.326 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.522 ' OE1' HG22 ' A' ' 87' ' ' ILE . 43.5 mt-10 -90.7 129.13 36.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.437 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 138' ' ' VAL . 0.5 OUTLIER -78.16 -45.15 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -178.386 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -76.16 -18.53 79.29 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.579 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.62 -11.58 17.61 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 124.041 0.495 . . . . 0.0 111.033 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -51.78 -34.76 41.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.643 0.777 . . . . 0.0 112.461 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.533 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 8.0 m-20 -74.57 -36.62 63.06 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.434 0.459 . . . . 0.0 111.495 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.445 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 14.3 tp -67.39 -60.24 2.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.74 0.416 . . . . 0.0 110.884 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.49 -43.6 85.42 Favored Glycine 0 C--N 1.343 0.947 0 O-C-N 123.618 0.574 . . . . 0.0 113.928 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -60.64 -43.6 97.35 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.533 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -61.97 -40.19 94.73 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.3 mt -67.11 -30.75 70.85 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 123.264 0.352 . . . . 0.0 110.302 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -94.25 9.84 36.44 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.367 0.417 . . . . 0.0 110.703 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 3.7 t70 -114.27 16.49 17.93 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.694 0.283 . . . . 0.0 111.082 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.611 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.826 179.736 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 tp . . . . . 0 CA--C 1.554 1.096 0 CA-C-O 121.114 0.483 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 83' ' ' SER . 37.5 tt0 -120.03 -60.82 1.66 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.835 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.5 m -52.17 -56.42 14.7 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.589 0.755 . . . . 0.0 112.196 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.0 p -60.59 -53.72 54.02 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.958 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.501 ' HB3' HG21 ' A' ' 131' ' ' THR . 3.9 m-85 -69.21 -0.31 5.88 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.6 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 10.9 t -95.55 -43.48 7.93 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.51 161.96 26.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.271 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.637 ' HA ' ' OE1' ' A' ' 137' ' ' GLU . 19.3 mtpp -86.19 145.99 26.75 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.083 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.65 18.68 27.15 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.255 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.576 ' O ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -79.23 -19.36 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 122.528 0.331 . . . . 0.0 111.717 179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.538 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 75.2 t60 . . . . . 0 CA--C 1.546 0.79 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.169 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 120.943 0.401 . . . . 0.0 111.637 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -147.33 -39.3 0.19 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.527 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.06 -8.09 46.89 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.632 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.2 -46.61 10.91 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.236 0.335 . . . . 0.0 111.08 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -98.28 161.36 25.61 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 123.495 0.497 . . . . 0.0 110.902 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.17 -31.01 24.06 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.467 2.112 . . . . 0.0 113.419 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 152.1 -52.66 0.48 Allowed Glycine 0 CA--C 1.531 1.077 0 CA-C-O 118.781 -1.01 . . . . 0.0 113.751 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.87 -17.52 18.92 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.986 2.457 . . . . 0.0 114.847 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -74.93 -42.1 58.36 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.313 0.245 . . . . 0.0 111.453 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.535 ' O ' HG22 ' A' ' 129' ' ' VAL . 4.6 mp -62.7 -32.69 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.794 0.438 . . . . 0.0 110.667 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -70.19 -50.53 39.2 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.68 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.62 -46.26 70.38 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.476 HG23 ' CE1' ' A' ' 82' ' ' TYR . 23.3 mt -61.17 -59.36 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 122.532 0.333 . . . . 0.0 111.488 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 125' ' ' ILE . 16.5 m -53.42 -41.94 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 123.49 0.494 . . . . 0.0 112.078 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 12.9 t -68.25 -26.48 65.7 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.501 HG21 ' HB3' ' A' ' 82' ' ' TYR . 20.5 m -72.06 -40.8 68.06 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.238 0.215 . . . . 0.0 110.933 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.526 HD22 ' N ' ' A' ' 144' ' ' GLY . 4.1 mp -77.1 -24.54 51.76 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.283 0.365 . . . . 0.0 111.508 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -91.13 12.1 21.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.272 0.558 . . . . 0.0 110.324 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.9 tmt_? -118.95 -36.64 3.38 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.128 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.6 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 52.2 m-70 -90.18 -32.17 16.73 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.912 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.9 t70 60.62 61.16 1.77 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.064 0.945 . . . . 0.0 111.674 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.637 ' OE1' ' HA ' ' A' ' 85' ' ' LYS . 37.1 mt-10 -84.99 130.22 34.66 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.641 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.474 ' O ' ' HD2' ' A' ' 141' ' ' LYS . 3.4 t -79.8 -22.42 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.404 0.44 . . . . 0.0 111.645 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -87.09 -19.05 56.66 Favored Glycine 0 C--N 1.342 0.884 0 C-N-CA 121.424 -0.417 . . . . 0.0 112.742 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.89 3.25 11.05 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.893 0.477 . . . . 0.0 111.374 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER -48.05 -42.33 28.25 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.783 0.833 . . . . 0.0 112.617 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 2.4 p-10 -68.21 -40.96 81.98 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.532 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.538 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 32.6 tp -56.18 -51.92 66.26 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.56 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.526 ' N ' HD22 ' A' ' 132' ' ' LEU . . . -60.92 -60.78 7.84 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.923 -0.581 . . . . 0.0 113.654 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -54.97 -42.11 72.01 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -63.54 -32.81 74.39 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.112 0.258 . . . . 0.0 111.518 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.0 mt -70.82 -30.93 67.5 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.295 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.413 ' O ' ' HD3' ' A' ' 148' ' ' ARG . 1.0 OUTLIER -98.93 4.47 47.37 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 123.153 0.283 . . . . 0.0 111.041 178.806 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 1.8 t70 -99.24 24.77 7.55 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.84 0.352 . . . . 0.0 111.2 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.453 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.022 179.885 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 tt . . . . . 0 CA--C 1.549 0.923 0 CA-C-O 120.644 0.259 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -103.96 -43.52 5.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.842 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 m -63.53 -63.06 1.28 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.4 t -45.24 -25.39 0.37 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -104.29 -10.9 17.5 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.8 t -91.91 -25.01 19.12 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.91 118.07 2.92 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.98 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.506 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 12.4 ptmt -60.64 105.61 0.46 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.86 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.23 75.58 1.3 Allowed Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.295 -0.866 . . . . 0.0 114.256 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.67 HG23 ' H ' ' A' ' 88' ' ' HIS . 8.1 tt -106.65 -103.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.67 ' H ' HG23 ' A' ' 87' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 120' ' ' TYR . 5.2 mt . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 120.745 0.307 . . . . 0.0 111.501 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -92.47 -11.69 34.01 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.815 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -96.54 -38.4 10.0 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.108 0.255 . . . . 0.0 111.674 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.8 t -94.4 -42.45 8.87 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 123.316 0.385 . . . . 0.0 111.638 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 116' ' ' LEU . 6.3 m-30 -97.86 119.39 62.43 Favored Pre-proline 0 CA--C 1.543 0.707 0 O-C-N 123.429 0.455 . . . . 0.0 110.67 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.87 -48.81 0.35 Allowed 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.638 2.225 . . . . 0.0 114.041 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -171.03 -63.92 0.04 OUTLIER Glycine 0 C--N 1.342 0.891 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.448 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.08 -30.45 78.87 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.061 2.507 . . . . 0.0 113.85 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.8 -21.58 66.04 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.347 0.404 . . . . 0.0 111.977 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.575 ' HA ' HD12 ' A' ' 128' ' ' ILE . 6.9 mt -89.41 -50.13 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -45.53 -41.18 9.46 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.649 0.78 . . . . 0.0 112.082 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -62.17 -42.76 99.57 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.967 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.575 HD12 ' HA ' ' A' ' 125' ' ' ILE . 14.8 mt -61.51 -61.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.962 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 144' ' ' GLY . 3.4 m -49.16 -31.27 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 18.3 t -76.76 -50.36 13.75 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.04 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.5 m -56.55 -33.89 66.55 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.748 HD23 ' HB1' ' A' ' 140' ' ' ALA . 4.5 mp -79.24 -48.99 13.2 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.645 0.202 . . . . 0.0 111.243 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -56.29 -20.41 18.58 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -79.58 -45.27 19.49 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.28 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.506 ' NE2' ' HA ' ' A' ' 85' ' ' LYS . 50.0 t-80 -64.97 -41.51 95.39 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 72.9 80.4 0.14 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.032 0.933 . . . . 0.0 111.162 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.866 ' HB2' ' HB3' ' A' ' 140' ' ' ALA . 20.5 mt-10 -125.09 153.59 42.71 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.157 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.3 t -83.9 -40.23 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 88' ' ' HIS . . . -86.9 -15.49 62.96 Favored Glycine 0 N--CA 1.47 0.931 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.402 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.866 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . . . -95.98 -17.47 20.98 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 113.832 -1.184 . . . . 0.0 109.771 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.838 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 3.2 tptm -70.04 -22.38 63.09 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 9.8 m-20 -81.17 -28.42 35.0 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.767 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.2 tp -76.51 -63.38 1.35 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.867 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.5 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -61.87 -26.59 67.32 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.541 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . -85.27 -39.81 17.31 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.581 0.691 . . . . 0.0 112.409 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -70.47 -31.85 69.15 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 121.331 -0.148 . . . . 0.0 111.009 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.7 mt -71.27 -45.12 63.88 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 123.126 0.266 . . . . 0.0 110.406 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -66.07 -21.67 66.38 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 178.564 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -95.56 -13.19 24.64 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 123.322 0.389 . . . . 0.0 111.378 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.193 179.307 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.434 HG23 ' CG ' ' A' ' 82' ' ' TYR . 4.5 mp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 121.474 0.654 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 83' ' ' SER . 4.9 mm-40 -120.81 -89.41 0.6 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.695 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.9 m -54.04 -43.36 70.13 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.89 0.876 . . . . 0.0 112.602 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.49 ' O ' HG13 ' A' ' 87' ' ' ILE . 24.1 p -68.46 -41.14 80.63 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.71 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.434 ' CG ' HG23 ' A' ' 78' ' ' ILE . 10.2 m-85 -94.33 13.05 24.83 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.247 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 26.3 t -110.02 -25.51 10.21 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.03 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.19 164.34 26.18 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.728 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -95.06 135.56 36.45 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.511 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.36 55.82 4.17 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.898 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.549 ' O ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -113.61 -13.25 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.596 ' HB3' ' O ' ' A' ' 139' ' ' GLY . 61.5 t60 . . . . . 0 CA--C 1.54 0.562 0 CA-C-N 117.859 0.299 . . . . 0.0 111.732 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.66 HD13 HD21 ' A' ' 147' ' ' LEU . 1.2 mp . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? 73.52 -0.27 3.42 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.203 1.001 . . . . 0.0 111.722 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.9 mmpt? -103.9 -33.47 8.84 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.018 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.28 -42.84 8.33 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.545 0.528 . . . . 0.0 111.27 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -85.55 159.27 55.94 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 119.336 -0.364 . . . . 0.0 111.425 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.83 -37.61 1.58 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.536 2.157 . . . . 0.0 113.389 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 160.94 -55.46 0.32 Allowed Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.776 -1.013 . . . . 0.0 113.646 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.58 -24.97 38.96 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.973 2.448 . . . . 0.0 114.364 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -65.63 -40.47 92.59 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.254 0.346 . . . . 0.0 111.327 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.581 ' O ' HG22 ' A' ' 129' ' ' VAL . 4.8 mp -69.25 -46.57 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.456 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -53.0 -39.03 62.81 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.145 0.578 . . . . 0.0 112.223 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -70.79 -48.44 54.25 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.378 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.2 mt -55.87 -48.86 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.088 0.555 . . . . 0.0 111.657 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 125' ' ' ILE . 4.9 m -61.66 -52.98 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.0 t -55.77 -51.59 66.88 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.3 m -60.13 -29.71 68.81 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.636 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 27.6 mt -79.25 -32.23 43.71 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -79.6 -4.95 53.87 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.307 0.243 . . . . 0.0 111.57 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -82.91 -47.14 12.12 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.887 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.636 ' NE2' ' HA ' ' A' ' 132' ' ' LEU . 9.2 p80 -85.03 -35.6 21.81 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.562 0.345 . . . . 0.0 111.584 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 t70 64.5 11.81 6.89 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.255 1.022 . . . . 0.0 113.622 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.537 ' HG2' ' CE1' ' A' ' 135' ' ' HIS . 12.7 pt-20 -47.09 153.29 0.46 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.98 -30.68 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -79.94 3.37 70.73 Favored Glycine 0 N--CA 1.466 0.645 0 O-C-N 123.374 0.421 . . . . 0.0 113.67 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -144.95 -3.49 0.77 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.388 0.675 . . . . 0.0 112.105 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.47 -42.24 70.43 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 123.822 0.849 . . . . 0.0 112.768 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 3.9 p-10 -65.98 -38.48 88.63 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.572 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.484 ' HB2' ' CE1' ' A' ' 88' ' ' HIS . 44.6 tp -61.65 -50.63 71.73 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.44 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -62.69 -62.65 5.33 Favored Glycine 0 C--N 1.343 0.958 0 N-CA-C 115.171 0.828 . . . . 0.0 115.171 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -58.85 -36.91 75.36 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 14.1 mptt -71.97 -33.23 68.01 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.494 0.134 . . . . 0.0 111.326 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.66 HD21 HD13 ' A' ' 116' ' ' LEU . 0.5 OUTLIER -72.92 -31.81 64.88 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 123.292 0.37 . . . . 0.0 110.845 177.737 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -79.75 -40.91 27.73 Favored 'General case' 0 C--N 1.348 0.523 0 O-C-N 123.415 0.447 . . . . 0.0 110.139 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -85.56 45.04 1.15 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.241 0.543 . . . . 0.0 111.446 179.218 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.528 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.941 179.922 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.518 ' HB ' ' CD1' ' A' ' 82' ' ' TYR . 1.6 pp . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -120.36 -59.11 1.8 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.338 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.9 m -62.33 -56.04 22.25 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.444 0.697 . . . . 0.0 112.86 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.8 m -56.51 -55.49 33.07 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.632 0.373 . . . . 0.0 111.937 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.518 ' CD1' ' HB ' ' A' ' 78' ' ' ILE . 36.2 m-85 -58.98 -27.99 65.91 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.9 t -70.82 -28.41 64.59 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.31 0.381 . . . . 0.0 110.608 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.77 171.45 11.59 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.561 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -100.02 78.59 2.11 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.224 0.535 . . . . 0.0 110.408 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 143.87 70.21 0.02 OUTLIER Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.411 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.5 tp -100.6 -29.66 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 122.44 0.296 . . . . 0.0 111.73 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.474 ' ND1' HD22 ' A' ' 143' ' ' LEU . 18.1 t60 . . . . . 0 C--O 1.235 0.335 0 O-C-N 123.154 0.284 . . . . 0.0 110.55 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.487 HD23 ' CE1' ' A' ' 120' ' ' TYR . 5.2 mt . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.112 0.482 . . . . 0.0 111.608 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -140.3 -40.24 0.43 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.644 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -94.93 -39.27 10.29 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.85 -6.39 59.1 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.254 0.346 . . . . 0.0 111.901 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.487 ' CE1' HD23 ' A' ' 116' ' ' LEU . 39.8 m-85 -123.75 134.32 25.23 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.683 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 2.9 Cg_exo -75.15 -45.45 0.27 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.586 2.191 . . . . 0.0 113.646 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 163.1 -61.85 0.26 Allowed Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.887 -0.951 . . . . 0.0 112.957 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.28 -30.01 78.69 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.898 2.399 . . . . 0.0 113.516 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.36 -25.66 67.68 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.508 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.697 ' HA ' HD12 ' A' ' 128' ' ' ILE . 13.4 mt -86.88 -36.52 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.725 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.25 -36.54 68.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.61 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -77.02 -11.04 59.75 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.189 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.697 HD12 ' HA ' ' A' ' 125' ' ' ILE . 80.9 mt -83.73 -47.66 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 144' ' ' GLY . 4.4 m -69.28 -34.68 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.628 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.5 t -66.58 -52.4 45.79 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.651 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.3 m -64.71 -27.51 68.96 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.547 ' HA ' ' CE1' ' A' ' 135' ' ' HIS . 30.1 mt -79.14 -39.79 32.62 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 129' ' ' VAL . 12.1 pt-20 -71.52 -6.82 43.44 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -79.17 -69.41 0.58 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.141 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.572 ' ND1' ' HG2' ' A' ' 137' ' ' GLU . 5.7 p80 -65.01 -35.5 81.38 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.4 t70 57.49 61.65 2.41 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.871 0.868 . . . . 0.0 111.641 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.572 ' HG2' ' ND1' ' A' ' 135' ' ' HIS . 11.1 pt-20 -107.14 139.02 42.23 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.409 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.3 153.09 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.848 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . 96.73 -17.94 58.38 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -138.78 -16.67 1.12 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.113 0.965 . . . . 0.0 111.055 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -68.92 -29.57 67.86 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 123.906 0.883 . . . . 0.0 111.235 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.571 ' O ' ' HG2' ' A' ' 146' ' ' LYS . 2.4 p-10 -72.13 -43.7 64.29 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.604 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.474 HD22 ' ND1' ' A' ' 88' ' ' HIS . 12.3 tp -58.11 -63.97 1.07 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.578 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.497 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -48.96 -43.67 31.36 Favored Glycine 0 C--N 1.345 1.043 0 O-C-N 123.959 0.787 . . . . 0.0 114.38 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.42 -45.32 84.73 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 142' ' ' ASP . 5.7 mmmt -63.18 -45.39 92.01 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.0 mt -58.17 -36.96 73.79 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.676 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -77.99 -39.29 42.77 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 120.647 0.261 . . . . 0.0 110.554 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.91 3.99 18.17 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.406 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.524 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.969 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.507 ' HB ' ' CD1' ' A' ' 82' ' ' TYR . 1.2 pp . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 121.44 0.638 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 83' ' ' SER . 7.3 tp10 -120.42 -53.42 2.12 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.434 -178.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.5 m -56.71 -60.82 2.99 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.245 0.618 . . . . 0.0 112.506 -177.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.7 t -59.14 -53.99 52.11 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.082 0.239 . . . . 0.0 110.436 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.507 ' CD1' ' HB ' ' A' ' 78' ' ' ILE . 18.8 m-85 -57.16 -15.13 4.97 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.625 ' HA ' ' CD2' ' A' ' 135' ' ' HIS . 23.0 t -86.06 -34.96 20.56 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 122.459 0.304 . . . . 0.0 110.394 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.01 159.75 33.68 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.72 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.53 150.07 22.6 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.286 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 98.65 14.49 37.37 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.41 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.1 tt -77.14 -27.14 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.566 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 70.8 t60 . . . . . 0 CA--C 1.544 0.736 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.469 ' O ' HD11 ' A' ' 125' ' ' ILE . 12.8 mt . . . . . 0 N--CA 1.468 0.461 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -112.35 97.16 6.43 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.371 0.605 . . . . 0.0 110.499 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.8 tptt -179.89 -55.85 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.899 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.6 -4.53 2.28 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.273 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.497 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -88.41 -29.94 0.37 Allowed Pre-proline 0 CA--C 1.549 0.936 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.759 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 120' ' ' TYR . 88.1 Cg_exo -49.65 112.18 0.64 Allowed 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 122.734 2.289 . . . . 0.0 113.516 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 126' ' ' GLU . . . 149.95 -135.82 5.44 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.768 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.416 ' HA ' ' CD ' ' A' ' 126' ' ' GLU . 51.0 Cg_exo -55.64 -32.37 83.19 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.164 2.576 . . . . 0.0 114.322 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.563 ' O ' HG13 ' A' ' 128' ' ' ILE . 8.4 m-20 -70.5 -49.64 46.25 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.596 ' HA ' HD12 ' A' ' 128' ' ' ILE . 5.3 mt -71.27 -39.11 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 122' ' ' GLY . 10.8 pt-20 -59.68 -47.63 84.87 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.037 0.211 . . . . 0.0 110.871 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -57.0 -35.34 69.09 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 125' ' ' ILE . 53.3 mt -61.49 -57.2 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 123.095 0.247 . . . . 0.0 110.81 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 8.0 m -57.44 -38.68 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 123.475 0.484 . . . . 0.0 111.746 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 12.1 t -70.48 -20.22 62.88 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.3 m -77.6 -44.84 27.05 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 128' ' ' ILE . 3.2 mp -72.14 -27.19 62.45 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.782 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -89.03 10.78 20.36 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.205 0.526 . . . . 0.0 110.551 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.2 tmt_? -115.93 -31.16 5.84 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.345 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.625 ' CD2' ' HA ' ' A' ' 83' ' ' SER . 42.9 m-70 -92.68 -32.71 14.64 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.812 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 63.67 64.43 0.79 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.028 0.931 . . . . 0.0 111.927 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -91.11 120.17 31.85 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.341 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.481 ' O ' ' HD3' ' A' ' 141' ' ' LYS . 3.5 t -78.49 -16.5 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.644 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -91.07 -22.19 33.47 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.022 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.88 4.25 14.8 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.327 0.651 . . . . 0.0 110.731 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 138' ' ' VAL . 42.6 pttt -50.92 -37.68 45.5 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.11 0.964 . . . . 0.0 112.948 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.53 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 3.4 t70 -73.91 -30.17 62.44 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.174 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.566 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 15.9 tp -67.7 -57.23 6.73 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.475 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.18 -49.67 62.48 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.87 -0.604 . . . . 0.0 114.035 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.73 87.9 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.53 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.2 mptm? -61.44 -40.2 93.61 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 30.1 mt -63.33 -32.86 74.39 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.417 0.448 . . . . 0.0 111.509 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -75.21 -39.32 60.17 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.14 0.275 . . . . 0.0 110.529 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -78.7 5.59 10.82 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.945 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.44 0 C-N-CA 122.628 0.371 . . . . 0.0 111.608 179.396 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.583 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 1.3 mp . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 83' ' ' SER . 5.0 pt-20 -85.78 -67.5 0.8 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.409 ' H ' ' HG3' ' A' ' 79' ' ' GLU . 18.3 m -64.5 -56.99 10.47 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.416 ' C ' HD13 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -48.52 -57.24 6.44 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.636 0.374 . . . . 0.0 111.231 179.616 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.583 ' HB2' ' O ' ' A' ' 78' ' ' ILE . 27.6 m-85 -69.15 -11.47 60.83 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.551 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 7.4 t -100.23 -1.91 35.23 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.62 147.12 24.21 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.796 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.537 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.9 OUTLIER -73.51 126.3 29.91 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.329 -0.396 . . . . 0.0 112.014 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.88 57.24 2.73 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.408 -0.814 . . . . 0.0 113.501 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.546 HG22 ' OE1' ' A' ' 137' ' ' GLU . 2.9 tp -79.27 -38.39 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 122.749 0.42 . . . . 0.0 111.348 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.837 ' HB3' ' HB2' ' A' ' 140' ' ' ALA . 6.2 p80 . . . . . 0 CA--C 1.547 0.853 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mt . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 120.981 0.419 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -147.69 -45.84 0.17 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.209 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -112.45 -36.22 5.32 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.401 ' C ' ' HD3' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -79.97 -33.48 39.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.555 0.342 . . . . 0.0 111.451 -179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -127.0 64.39 60.16 Favored Pre-proline 0 CA--C 1.549 0.904 0 O-C-N 123.523 0.514 . . . . 0.0 110.556 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.401 ' HD3' ' C ' ' A' ' 119' ' ' THR . 18.7 Cg_endo -95.06 133.94 0.62 Allowed 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.778 2.319 . . . . 0.0 114.648 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.473 ' H ' HD12 ' A' ' 125' ' ' ILE . . . 74.01 -110.99 3.28 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 119.087 -0.84 . . . . 0.0 114.923 177.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -46.72 -30.09 8.68 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.66 2.907 . . . . 0.0 114.911 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -72.23 -39.91 68.13 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.309 0.381 . . . . 0.0 111.355 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 129' ' ' VAL . 16.3 mt -76.59 -29.73 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.307 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.42 -56.41 16.44 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.629 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -55.86 -29.82 60.5 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.491 HG23 ' CZ ' ' A' ' 82' ' ' TYR . 50.6 mt -73.64 -45.03 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 120.563 0.221 . . . . 0.0 110.53 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 125' ' ' ILE . 12.6 m -77.79 -25.6 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.238 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.1 t -83.74 -19.05 35.83 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.781 0.676 . . . . 0.0 112.306 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.7 m -98.11 -27.3 14.26 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.072 0.232 . . . . 0.0 110.496 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.479 HD13 ' HA3' ' A' ' 144' ' ' GLY . 2.4 tt -80.41 -35.21 35.51 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.176 0.297 . . . . 0.0 110.884 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -72.65 -1.37 15.98 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -97.03 -76.19 0.52 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -46.34 -37.9 8.07 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.604 0.762 . . . . 0.0 112.676 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.8 t70 69.7 76.81 0.21 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.128 0.971 . . . . 0.0 111.203 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.546 ' OE1' HG22 ' A' ' 87' ' ' ILE . 10.4 mm-40 -83.94 123.44 29.97 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.063 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -78.7 -25.6 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -88.33 -27.83 24.2 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.837 ' HB2' ' HB3' ' A' ' 88' ' ' HIS . . . -100.49 -1.66 35.13 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.212 -0.494 . . . . 0.0 111.324 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -32.13 36.64 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.14 0.576 . . . . 0.0 112.533 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.569 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 19.8 m-20 -77.49 -40.21 43.77 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.258 0.349 . . . . 0.0 110.679 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.3 tp -65.59 -61.79 1.89 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.58 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.479 ' HA3' HD13 ' A' ' 132' ' ' LEU . . . -53.31 -47.35 62.16 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.724 -0.671 . . . . 0.0 114.511 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.13 -41.9 89.32 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.569 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -61.26 -41.09 96.32 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.021 0.2 . . . . 0.0 111.278 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.0 mt -62.36 -37.9 87.45 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.269 0.355 . . . . 0.0 111.345 177.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -88.44 3.16 51.03 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -120.12 -11.0 9.31 Favored 'General case' 0 C--N 1.345 0.373 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.365 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.163 179.387 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 tt . . . . . 0 CA--C 1.548 0.901 0 CA-C-O 120.466 0.174 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.19 -76.51 0.51 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.018 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.1 m -65.26 -60.75 2.65 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.683 0.393 . . . . 0.0 110.49 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.523 ' O ' HD13 ' A' ' 87' ' ' ILE . 25.6 p -44.45 -39.61 4.9 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.405 0.682 . . . . 0.0 112.687 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.573 ' CE1' HG23 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -89.46 -10.09 47.69 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.2 t -95.04 -6.99 40.93 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.555 0.217 . . . . 0.0 110.685 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.47 149.63 27.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.464 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -74.68 87.03 2.17 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.377 0.608 . . . . 0.0 111.072 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 133.57 63.19 0.07 OUTLIER Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.929 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.602 HG22 ' OE2' ' A' ' 137' ' ' GLU . 4.4 tp -105.79 -15.53 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.596 ' HB3' ' O ' ' A' ' 139' ' ' GLY . 49.2 t60 . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.482 ' HA ' ' CD1' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -172.72 -24.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.048 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -52.96 -34.55 56.28 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.06 0.457 . . . . 0.0 110.998 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.455 ' O ' HD13 ' A' ' 125' ' ' ILE . 6.6 t -129.6 46.5 2.63 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.664 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.574 ' CD1' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -57.34 -45.34 99.9 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.389 -178.349 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -78.79 37.86 0.68 Allowed 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.086 1.857 . . . . 0.0 112.116 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.5 -171.47 18.45 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 115.946 -0.57 . . . . 0.0 114.234 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.537 ' HA ' ' OE1' ' A' ' 126' ' ' GLU . 3.6 Cg_exo -75.24 -37.4 1.93 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.56 2.84 . . . . 0.0 113.33 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.409 ' OD2' HD12 ' A' ' 125' ' ' ILE . 6.9 p-10 -61.95 -19.74 63.07 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.574 HG12 ' CD1' ' A' ' 120' ' ' TYR . 1.1 mp -89.97 -51.81 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 123.372 0.42 . . . . 0.0 111.181 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.537 ' OE1' ' HA ' ' A' ' 123' ' ' PRO . 8.5 pt-20 -50.45 -27.78 7.12 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 177.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -72.04 -35.32 69.31 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.87 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.573 HG23 ' CE1' ' A' ' 82' ' ' TYR . 75.1 mt -58.86 -52.31 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.713 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.7 m -59.91 -54.55 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 123.114 0.259 . . . . 0.0 111.639 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.7 t -56.06 -52.55 63.87 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.2 m -67.88 -17.66 64.55 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.776 HD11 ' HB1' ' A' ' 140' ' ' ALA . 3.5 tt -88.33 -44.47 10.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 117.782 0.265 . . . . 0.0 111.09 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -79.01 -1.49 35.78 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -79.55 -50.0 11.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.191 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -89.13 -35.86 16.04 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.174 0.297 . . . . 0.0 111.772 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.412 ' OD2' ' HE3' ' A' ' 141' ' ' LYS . 5.5 m-20 74.84 87.72 0.09 Allowed 'General case' 0 C--N 1.357 0.91 0 C-N-CA 124.205 1.002 . . . . 0.0 112.159 177.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.602 ' OE2' HG22 ' A' ' 87' ' ' ILE . 6.6 pt-20 -114.96 151.7 33.66 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.709 178.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.2 m -76.44 -44.89 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -68.7 0.65 12.64 Favored Glycine 0 N--CA 1.471 1.012 0 N-CA-C 115.2 0.84 . . . . 0.0 115.2 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.776 ' HB1' HD11 ' A' ' 132' ' ' LEU . . . -136.74 -11.4 1.79 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.91 0.484 . . . . 0.0 112.036 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 6.4 tptm -53.65 -41.33 66.69 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.292 0.637 . . . . 0.0 112.084 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 2.1 p-10 -70.16 -42.46 72.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.574 ' O ' HD12 ' A' ' 147' ' ' LEU . 14.2 tp -63.81 -52.25 61.08 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.953 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.442 ' CA ' HD13 ' A' ' 132' ' ' LEU . . . -58.04 -38.6 89.89 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 123.697 0.623 . . . . 0.0 113.851 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.91 83.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.873 0.337 . . . . 0.0 111.867 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.477 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.3 mptm? -66.96 -33.82 76.41 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.211 0.319 . . . . 0.0 110.662 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.574 HD12 ' O ' ' A' ' 143' ' ' LEU . 0.6 OUTLIER -66.04 -41.11 91.3 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.548 0.53 . . . . 0.0 110.315 177.507 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -64.73 -38.41 90.88 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.85 1.03 48.85 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.091 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.513 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.129 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 tt . . . . . 0 CA--C 1.544 0.726 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 83' ' ' SER . 1.9 mt-10 -91.86 -28.84 17.06 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.059 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.8 m -69.08 -61.48 1.78 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.842 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.518 ' O ' HD13 ' A' ' 87' ' ' ILE . 40.6 m -86.9 58.41 5.06 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-O 123.389 1.566 . . . . 0.0 109.727 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.56 ' CD2' HG12 ' A' ' 87' ' ' ILE . 0.9 OUTLIER -158.66 -41.62 0.06 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 111.651 -2.522 . . . . 0.0 105.327 -179.426 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.406 ' HA ' ' CD2' ' A' ' 135' ' ' HIS . 8.3 t -70.55 -23.76 62.67 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.097 176.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.86 1.03 4.82 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt 59.34 152.79 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.959 0.903 . . . . 0.0 112.949 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.65 2.6 78.78 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.66 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.56 HG12 ' CD2' ' A' ' 82' ' ' TYR . 7.6 tp -64.05 -9.12 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.517 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 70.1 t60 . . . . . 0 CA--C 1.546 0.825 0 CA-C-O 121.599 0.714 . . . . 0.0 110.903 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 CA--C 1.542 0.635 0 CA-C-O 120.838 0.351 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -147.23 0.54 0.71 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.13 -54.01 4.01 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.09 8.44 2.49 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.873 0.368 . . . . 0.0 110.907 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -89.57 -30.68 0.36 Allowed Pre-proline 0 CA--C 1.55 0.953 0 CA-C-O 118.285 -0.864 . . . . 0.0 112.886 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' TYR . 78.0 Cg_exo -44.93 120.65 3.02 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.065 2.51 . . . . 0.0 114.046 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 165.27 -147.63 12.76 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.726 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -62.71 -22.78 74.25 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.971 2.448 . . . . 0.0 113.754 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.516 ' O ' HG13 ' A' ' 128' ' ' ILE . 9.4 m-20 -71.43 -49.49 41.17 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.594 0.358 . . . . 0.0 111.595 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.623 ' HA ' HD12 ' A' ' 128' ' ' ILE . 10.2 mt -73.26 -34.97 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 123.271 0.357 . . . . 0.0 110.875 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -55.92 -48.22 76.08 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.72 0.637 . . . . 0.0 111.004 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -66.09 -35.65 81.08 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.623 HD12 ' HA ' ' A' ' 125' ' ' ILE . 32.9 mt -61.27 -55.34 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 125' ' ' ILE . 5.5 m -65.12 -27.32 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.223 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.2 t -83.26 -13.89 54.31 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 26.9 m -92.09 -42.42 9.95 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 123.037 0.211 . . . . 0.0 110.913 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 144' ' ' GLY . 4.7 mp -77.74 -37.25 49.61 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -76.97 7.53 4.76 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.295 0.372 . . . . 0.0 111.673 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -108.06 -80.25 0.57 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.406 ' CD2' ' HA ' ' A' ' 83' ' ' SER . 8.2 m-70 -47.81 -37.45 13.71 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.816 0.847 . . . . 0.0 112.789 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 65.69 68.24 0.48 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.995 0.918 . . . . 0.0 111.769 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -88.72 129.77 35.47 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.437 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.505 ' O ' ' HD3' ' A' ' 141' ' ' LYS . 3.1 t -73.41 -16.4 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -86.51 -32.02 17.23 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.43 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.416 ' CB ' ' HB2' ' A' ' 88' ' ' HIS . . . -110.0 5.74 22.51 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.84 0.456 . . . . 0.0 111.149 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.505 ' HD3' ' O ' ' A' ' 138' ' ' VAL . 21.3 pttm -47.32 -37.65 11.35 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.965 0.906 . . . . 0.0 113.087 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 2.5 p-10 -75.29 -41.6 56.75 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.303 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.517 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 17.6 tp -56.83 -55.04 39.53 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.218 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.495 ' N ' HD22 ' A' ' 132' ' ' LEU . . . -59.87 -59.5 10.37 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 115.793 -0.639 . . . . 0.0 114.049 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.71 78.17 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 14.1 mptt -62.51 -36.01 81.19 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 123.027 0.204 . . . . 0.0 111.418 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.6 mt -66.68 -35.71 80.8 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.417 0.448 . . . . 0.0 111.954 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.0 ttp180 -93.14 -2.66 55.15 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -105.94 28.94 7.1 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.938 0.399 . . . . 0.0 110.848 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.47 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.266 -179.917 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.544 0.714 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 83' ' ' SER . 4.5 pt-20 -93.2 -57.77 2.52 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.6 m -67.29 -50.07 61.71 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.4 p -53.96 -54.64 36.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.782 0.433 . . . . 0.0 111.595 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.549 ' CZ ' HG23 ' A' ' 128' ' ' ILE . 46.9 m-85 -58.94 -65.02 0.73 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.542 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -38.71 -32.79 0.09 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.19 144.93 44.55 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.274 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.498 ' HA ' ' OE2' ' A' ' 137' ' ' GLU . 58.9 mttp -77.95 105.31 9.07 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 123.439 0.462 . . . . 0.0 111.845 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.15 50.18 0.35 Allowed Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.817 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.0 tp -70.02 -23.41 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 79.2 t60 . . . . . 0 CA--C 1.553 1.08 0 CA-C-O 120.978 0.418 . . . . 0.0 111.035 179.37 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.475 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 13.5 mt . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -114.84 2.54 14.38 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.38 -47.28 6.35 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.9 t -134.34 -1.98 2.83 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 116' ' ' LEU . 2.9 t80 -94.38 144.27 27.71 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 119.288 -0.387 . . . . 0.0 110.725 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.407 ' HD2' ' CD2' ' A' ' 120' ' ' TYR . 46.3 Cg_exo -57.1 162.76 8.81 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.621 2.214 . . . . 0.0 113.54 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -86.44 -51.39 3.5 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.605 -1.108 . . . . 0.0 113.511 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.604 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 52.2 Cg_exo -55.15 -24.42 41.0 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.833 2.356 . . . . 0.0 114.134 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.48 -43.93 65.66 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.514 0.326 . . . . 0.0 111.423 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.479 ' O ' HG22 ' A' ' 129' ' ' VAL . 9.8 mt -61.99 -26.75 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 122.823 0.449 . . . . 0.0 110.764 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -73.2 -47.96 39.19 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.185 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 123' ' ' PRO . 25.5 mmm180 -56.04 -48.01 76.8 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.492 178.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.549 HG23 ' CZ ' ' A' ' 82' ' ' TYR . 17.4 mt -56.62 -64.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.114 0.566 . . . . 0.0 111.498 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 125' ' ' ILE . 31.5 m -51.26 -38.22 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.203 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.0 t -73.03 -42.41 63.19 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.8 m -60.79 -29.8 69.66 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.217 0.207 . . . . 0.0 111.483 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.448 HD13 ' CA ' ' A' ' 144' ' ' GLY . 1.9 mt -83.9 -33.79 24.68 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.314 0.384 . . . . 0.0 110.281 178.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -83.2 7.54 15.88 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.933 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -113.75 -41.02 3.66 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.149 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -88.1 -44.11 11.18 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 63.5 67.7 0.63 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.985 0.914 . . . . 0.0 111.185 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.498 ' OE2' ' HA ' ' A' ' 85' ' ' LYS . 22.5 mt-10 -87.37 139.21 30.78 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.887 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 138' ' ' VAL . 0.2 OUTLIER -77.7 -41.15 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.28 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.63 -1.61 62.04 Favored Glycine 0 CA--C 1.526 0.726 0 O-C-N 123.412 0.445 . . . . 0.0 113.93 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -137.06 -2.54 2.06 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.065 0.546 . . . . 0.0 111.53 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.436 ' HD3' ' O ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -50.85 -40.5 56.29 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.817 0.847 . . . . 0.0 113.002 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 7.9 m-20 -72.51 -36.41 68.35 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.22 0.325 . . . . 0.0 110.922 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.8 tp -65.64 -52.48 51.44 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.993 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.448 ' CA ' HD13 ' A' ' 132' ' ' LEU . . . -60.99 -62.75 5.58 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.58 -0.736 . . . . 0.0 114.007 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.574 ' HA ' ' NE ' ' A' ' 148' ' ' ARG . . . -53.37 -37.1 62.1 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 5.7 mptp? -72.79 -24.46 60.93 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.469 ' O ' HD22 ' A' ' 147' ' ' LEU . 0.6 OUTLIER -78.71 -30.88 46.25 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.422 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.574 ' NE ' ' HA ' ' A' ' 145' ' ' ALA . 8.6 ptt85 -84.31 -3.77 58.45 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 117.807 0.276 . . . . 0.0 110.848 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -81.44 -1.4 45.65 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.778 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.377 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.579 179.552 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 121.397 0.618 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 83' ' ' SER . 2.9 mt-10 -120.43 -41.79 2.59 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.155 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.9 m -65.82 -60.5 2.82 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.169 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.7 t -56.81 -55.25 36.74 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 123.218 0.324 . . . . 0.0 110.705 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -50.9 -31.36 17.3 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 5.7 t -73.57 -34.52 65.16 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 122.604 0.362 . . . . 0.0 111.713 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.5 146.34 20.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.854 0.462 . . . . 0.0 111.979 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.406 ' HE2' ' NE2' ' A' ' 135' ' ' HIS . 57.6 mmtt -79.96 99.99 7.88 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.189 0.518 . . . . 0.0 111.876 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 126.52 47.9 0.19 Allowed Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.371 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.4 tp -88.8 -43.65 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 122.842 0.457 . . . . 0.0 111.187 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.531 ' CE1' HD13 ' A' ' 143' ' ' LEU . 47.4 t60 . . . . . 0 CA--C 1.552 1.021 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.031 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 mt . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 110.638 -0.134 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.6 tptp 73.4 -2.1 2.85 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.205 1.002 . . . . 0.0 111.952 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -99.84 -37.09 9.2 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.948 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.5 t -93.83 -41.72 9.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.45 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -96.66 159.3 32.02 Favored Pre-proline 0 CA--C 1.541 0.596 0 O-C-N 123.423 0.452 . . . . 0.0 111.115 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.58 -34.84 2.35 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.505 2.137 . . . . 0.0 113.289 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 157.6 -55.7 0.38 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-O 118.939 -0.923 . . . . 0.0 113.433 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.16 -19.72 28.31 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.971 2.447 . . . . 0.0 114.431 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 2.4 t70 -73.65 -35.07 65.22 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.181 0.301 . . . . 0.0 111.133 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.9 mp -72.71 -27.33 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.382 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.95 -53.33 18.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.728 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 124' ' ' ASP . 13.6 ptm180 -53.83 -36.54 62.64 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 178.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.576 ' O ' HD12 ' A' ' 132' ' ' LEU . 44.7 mt -65.38 -56.51 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 122.199 0.2 . . . . 0.0 111.211 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.634 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 2.8 m -54.09 -43.96 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 12.4 t -64.67 -31.99 73.46 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.3 m -69.94 -38.57 76.23 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.576 HD12 ' O ' ' A' ' 128' ' ' ILE . 1.3 mp -73.83 -35.79 64.87 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 129' ' ' VAL . 10.6 pt-20 -89.08 14.02 11.7 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 120.954 0.407 . . . . 0.0 111.62 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.575 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.6 tmm_? -105.95 -41.29 5.44 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.851 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.406 ' NE2' ' HE2' ' A' ' 85' ' ' LYS . 49.5 t60 -94.64 -32.14 13.53 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.976 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 67.73 73.33 0.31 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.049 0.94 . . . . 0.0 111.633 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.33 132.12 43.36 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.99 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.55 -39.05 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 O-C-N 123.417 0.448 . . . . 0.0 111.684 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -74.26 -9.52 81.04 Favored Glycine 0 C--N 1.341 0.819 0 O-C-N 123.316 0.385 . . . . 0.0 113.914 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.6 2.34 5.54 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.726 0.411 . . . . 0.0 111.995 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -34.62 74.12 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.949 0.499 . . . . 0.0 111.732 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.627 ' O ' ' HG2' ' A' ' 146' ' ' LYS . 8.2 m-20 -75.08 -38.78 61.16 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.984 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.531 HD13 ' CE1' ' A' ' 88' ' ' HIS . 14.2 tp -60.49 -56.83 16.71 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.994 0.518 . . . . 0.0 110.609 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -54.77 -45.3 79.66 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.683 0.614 . . . . 0.0 113.756 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -54.89 -48.68 72.71 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.627 ' HG2' ' O ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -59.19 -42.57 91.18 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.716 0.234 . . . . 0.0 110.394 178.53 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.8 -41.42 82.12 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.41 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 144' ' ' GLY . 14.2 ptm180 -88.1 -14.19 39.45 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -87.47 27.06 1.14 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 122.784 0.433 . . . . 0.0 112.063 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.507 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.53 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.504 HG23 ' CD2' ' A' ' 82' ' ' TYR . 3.9 mp . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 121.216 0.532 . . . . 0.0 110.158 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 83' ' ' SER . 4.1 mm-40 -121.56 -86.63 0.65 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.09 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.2 m -55.1 -55.65 28.72 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.199 1.0 . . . . 0.0 113.601 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.406 ' O ' HD13 ' A' ' 87' ' ' ILE . 16.9 t -46.66 -55.58 7.49 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.728 0.643 . . . . 0.0 111.772 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.504 ' CD2' HG23 ' A' ' 78' ' ' ILE . 88.1 m-85 -84.06 0.11 49.59 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.53 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 8.0 t -103.71 -2.64 26.17 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.696 0.284 . . . . 0.0 110.388 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.44 156.31 16.82 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.848 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.522 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -82.21 142.53 32.08 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.244 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.77 34.79 14.62 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.304 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.406 HD13 ' O ' ' A' ' 81' ' ' SER . 2.5 tp -84.38 -28.4 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 36.6 t60 . . . . . 0 CA--C 1.547 0.83 0 CA-C-O 120.629 0.252 . . . . 0.0 111.356 178.991 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.7 mt . . . . . 0 CA--C 1.537 0.475 0 CA-C-O 121.182 0.515 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -150.63 -30.13 0.2 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.096 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -83.76 -44.43 14.42 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.74 19.51 7.23 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.546 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -134.9 50.08 4.42 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.546 ' HD3' ' N ' ' A' ' 120' ' ' TYR . 9.4 Cg_endo -91.6 127.96 1.08 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.805 2.337 . . . . 0.0 113.369 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 135.96 -148.82 19.84 Favored Glycine 0 C--N 1.343 0.97 0 C-N-CA 120.485 -0.864 . . . . 0.0 114.575 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.633 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 49.1 Cg_exo -56.45 -32.55 89.56 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.634 2.889 . . . . 0.0 113.871 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -52.27 -37.86 56.67 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 123.457 0.473 . . . . 0.0 111.02 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.539 ' O ' HG22 ' A' ' 129' ' ' VAL . 15.8 mt -67.85 -43.61 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.412 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -61.9 -21.34 64.65 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.977 0.511 . . . . 0.0 112.134 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 123' ' ' PRO . 17.4 mmm180 -79.97 -46.67 16.26 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.825 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.7 mt -62.95 -44.52 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.046 0.538 . . . . 0.0 111.278 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 125' ' ' ILE . 7.1 m -63.29 -55.1 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.523 0.514 . . . . 0.0 112.094 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 56.4 m -54.94 -34.79 63.55 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.7 m -82.41 -22.36 35.4 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 123.263 0.352 . . . . 0.0 111.831 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.433 ' HG ' ' OE2' ' A' ' 137' ' ' GLU . 3.0 tt -82.6 -40.31 21.01 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.474 0.31 . . . . 0.0 110.919 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -89.28 12.38 16.23 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.014 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -79.69 -49.15 12.52 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -96.08 -9.06 31.77 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 70.71 80.92 0.16 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.133 0.973 . . . . 0.0 112.46 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 141' ' ' LYS . 2.9 pt-20 -107.02 130.7 54.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.331 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -81.77 -26.43 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -84.98 -2.47 88.37 Favored Glycine 0 C--N 1.343 0.944 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.391 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.11 -9.76 3.39 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.903 0.481 . . . . 0.0 111.75 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 7.8 tptp -50.89 -33.29 23.46 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.866 0.867 . . . . 0.0 112.975 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.547 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 10.0 m-20 -74.82 -36.13 62.43 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.369 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.4 tp -66.13 -59.63 3.58 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.113 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.511 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -58.94 -41.97 96.56 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-N 116.089 -0.505 . . . . 0.0 114.089 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.08 92.16 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.547 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.6 mptp? -68.66 -36.07 78.08 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.032 0.207 . . . . 0.0 111.511 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.1 mt -71.16 -34.21 70.75 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.236 0.335 . . . . 0.0 110.449 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -75.29 -39.47 59.63 Favored 'General case' 0 C--N 1.349 0.562 0 O-C-N 123.478 0.486 . . . . 0.0 110.882 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.55 42.27 0.35 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.134 0.492 . . . . 0.0 112.038 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.46 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.854 179.598 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.571 HG23 ' CG ' ' A' ' 82' ' ' TYR . 4.6 mp . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 121.297 0.57 . . . . 0.0 110.865 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.639 ' O ' ' HB2' ' A' ' 83' ' ' SER . 3.6 tp10 -120.96 -81.27 0.64 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.47 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.5 m -70.59 -59.32 2.9 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.1 m -88.66 69.38 8.77 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 123.551 1.643 . . . . 0.0 109.62 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.571 ' CG ' HG23 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -179.45 -34.29 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 111.304 -2.68 . . . . 0.0 108.038 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.639 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.7 t -75.67 -32.58 60.21 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.279 177.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -45.89 157.14 0.12 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.446 ' HA ' ' OE2' ' A' ' 137' ' ' GLU . 6.6 mptt -84.37 100.97 11.62 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.667 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.53 74.27 0.9 Allowed Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.533 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 tp -103.71 -35.0 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 122.462 0.305 . . . . 0.0 111.558 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.585 ' ND1' HD22 ' A' ' 143' ' ' LEU . 39.9 t60 . . . . . 0 N--CA 1.468 0.469 0 O-C-N 122.979 0.174 . . . . 0.0 111.172 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.2 mt . . . . . 0 C--O 1.239 0.517 0 CA-C-O 121.048 0.451 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -149.99 -46.4 0.13 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.897 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.3 tttm -116.88 -6.51 11.48 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.6 m -79.83 -41.15 26.97 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.459 0.304 . . . . 0.0 111.624 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -97.71 158.82 32.34 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 123.29 0.368 . . . . 0.0 111.345 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -78.22 -38.08 0.66 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.646 2.231 . . . . 0.0 113.352 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.72 -55.48 0.27 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.835 -0.981 . . . . 0.0 113.731 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.4 -34.52 71.57 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.163 2.576 . . . . 0.0 114.48 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.417 ' O ' HG13 ' A' ' 128' ' ' ILE . 6.1 m-20 -70.58 -42.96 70.35 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.678 ' HA ' HD12 ' A' ' 128' ' ' ILE . 3.6 mt -73.08 -16.14 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 123.301 0.376 . . . . 0.0 110.276 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.78 -53.83 10.49 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.468 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -56.27 -33.57 65.61 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 125' ' ' ILE . 29.3 mt -67.61 -57.95 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 122.358 0.263 . . . . 0.0 111.236 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 125' ' ' ILE . 4.1 m -56.55 -39.03 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 18.2 t -71.5 -54.83 9.26 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.166 0.291 . . . . 0.0 111.772 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.493 HG21 ' HB3' ' A' ' 82' ' ' TYR . 11.8 m -54.92 -25.03 26.46 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 128' ' ' ILE . 33.4 mt -85.66 -48.22 9.07 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.672 0.273 . . . . 0.0 110.386 178.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -83.28 18.04 1.89 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.244 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 130' ' ' SER . 1.1 tmt_? -87.54 -38.83 15.67 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.351 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.402 ' CE1' HH11 ' A' ' 134' ' ' ARG . 64.7 m-70 -105.22 -16.24 14.83 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.607 0.567 . . . . 0.0 110.971 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 68.93 72.5 0.27 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.178 0.991 . . . . 0.0 110.536 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.446 ' OE2' ' HA ' ' A' ' 85' ' ' LYS . 28.9 mt-10 -96.43 133.59 40.67 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.767 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 t -76.61 -12.58 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 123.557 0.536 . . . . 0.0 111.274 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -87.31 -27.52 27.6 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.023 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.77 1.65 12.17 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.69 0.396 . . . . 0.0 111.762 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 8.7 tptp -53.27 -41.73 65.83 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.549 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 8.2 m-20 -77.88 -32.99 52.23 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.042 0.214 . . . . 0.0 111.546 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.585 HD22 ' ND1' ' A' ' 88' ' ' HIS . 14.8 tp -69.7 -59.38 2.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.414 0.286 . . . . 0.0 110.391 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.49 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -56.53 -55.39 30.03 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-N 115.775 -0.648 . . . . 0.0 114.163 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -58.59 -44.96 90.0 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.549 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -61.34 -42.66 99.05 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.718 0.235 . . . . 0.0 111.035 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.0 mt -60.15 -34.97 74.28 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.445 0.465 . . . . 0.0 111.36 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -88.18 -7.36 56.99 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.716 0.293 . . . . 0.0 110.522 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 1.4 m-20 -114.45 13.45 17.66 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.973 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.376 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.799 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.569 ' HB ' ' CD1' ' A' ' 82' ' ' TYR . 1.9 pp . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 121.382 0.611 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -103.99 -52.33 2.97 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.846 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.7 m -58.9 -59.35 5.6 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.207 0.603 . . . . 0.0 111.945 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.8 p -57.32 -55.21 37.73 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.761 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.569 ' CD1' ' HB ' ' A' ' 78' ' ' ILE . 17.2 m-85 -54.49 -24.47 20.58 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 177.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.549 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 11.8 t -75.66 -32.65 60.26 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 122.176 0.191 . . . . 0.0 110.752 178.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.05 162.03 1.09 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.334 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -94.16 103.55 15.59 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.864 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.89 65.04 0.56 Allowed Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.95 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.6 tt -93.12 -44.97 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 140' ' ' ALA . 51.2 t60 . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.78 -38.85 0.12 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.011 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -93.72 -26.08 17.16 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.421 0.45 . . . . 0.0 111.972 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.44 -41.85 10.07 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.276 0.36 . . . . 0.0 111.681 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -88.86 155.96 49.89 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 123.288 0.368 . . . . 0.0 111.624 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -80.84 -54.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.732 2.288 . . . . 0.0 113.942 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.65 -59.48 0.19 Allowed Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.876 -0.958 . . . . 0.0 113.591 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.441 ' HA ' ' OE2' ' A' ' 126' ' ' GLU . 52.2 Cg_exo -54.65 -30.84 68.0 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.079 2.519 . . . . 0.0 114.04 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 8.1 m-20 -71.25 -29.72 65.44 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.538 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.701 ' HA ' HD12 ' A' ' 128' ' ' ILE . 6.4 mt -86.64 -19.06 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.441 ' OE2' ' HA ' ' A' ' 123' ' ' PRO . 37.5 mt-10 -65.24 -51.88 58.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.782 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 124' ' ' ASP . 1.9 ptp180 -57.9 -21.03 41.39 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.274 176.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 125' ' ' ILE . 83.2 mt -77.72 -50.11 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 122.577 0.351 . . . . 0.0 111.027 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 144' ' ' GLY . 4.6 m -61.98 -36.28 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 4.3 m -70.71 -58.18 3.91 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.502 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.9 m -52.7 -29.03 24.51 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.406 HD22 ' HB1' ' A' ' 140' ' ' ALA . 17.8 mt -76.19 -46.81 26.62 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.026 0.13 . . . . 0.0 111.15 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -87.43 16.49 5.36 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 123.517 0.511 . . . . 0.0 110.96 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 130' ' ' SER . 3.3 tmt_? -99.58 -34.97 10.01 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.694 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.549 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 75.1 m-70 -96.72 -32.9 11.93 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.561 0.538 . . . . 0.0 111.914 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.7 t70 74.72 81.08 0.11 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.227 1.011 . . . . 0.0 110.096 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.405 ' OE2' ' HB2' ' A' ' 135' ' ' HIS . 1.5 pm0 -137.11 128.18 27.7 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.088 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.68 159.47 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.396 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 96.25 -53.52 1.57 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 88' ' ' HIS . . . -104.48 -12.87 16.27 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.916 0.421 . . . . 0.0 111.7 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.46 -36.27 75.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.346 0.658 . . . . 0.0 112.436 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.508 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 9.9 m-20 -74.82 -34.99 62.43 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.5 tp -61.41 -58.81 6.7 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.319 0.387 . . . . 0.0 110.148 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.488 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -51.9 -46.7 54.99 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.934 178.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.77 -39.28 91.08 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.508 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -65.29 -49.45 69.47 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.992 0.183 . . . . 0.0 110.707 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 25.9 mt -59.3 -30.82 68.61 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.41 0.444 . . . . 0.0 111.64 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -83.25 -10.81 58.34 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 123.001 0.188 . . . . 0.0 111.381 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -97.15 0.13 47.89 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 123.162 0.288 . . . . 0.0 111.43 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.319 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.987 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.489 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 2.9 tp . . . . . 0 CA--C 1.55 0.98 0 CA-C-O 120.716 0.294 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 83' ' ' SER . 37.9 tt0 -96.57 -49.73 5.01 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.817 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.7 p -54.26 -58.05 8.88 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.326 1.051 . . . . 0.0 112.595 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 t -60.16 -54.94 39.97 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.67 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.489 ' HB2' ' O ' ' A' ' 78' ' ' ILE . 3.4 m-85 -58.07 -16.73 14.02 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 8.4 t -86.36 -31.85 21.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.701 0.4 . . . . 0.0 111.255 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -46.08 165.18 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -90.37 113.88 25.87 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.212 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.5 67.2 1.32 Allowed Glycine 0 C--N 1.34 0.787 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.635 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.495 HG22 ' OE1' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -91.96 -25.05 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' HIS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 140' ' ' ALA . 15.6 t60 . . . . . 0 N--CA 1.467 0.412 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.8 mt . . . . . 0 N--CA 1.466 0.369 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -89.07 100.72 13.44 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.42 0.628 . . . . 0.0 111.279 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -179.77 -44.04 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.197 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.91 -17.91 12.8 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.357 0.41 . . . . 0.0 111.665 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 31.4 m-85 -94.15 135.22 24.75 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 119.323 -0.37 . . . . 0.0 111.184 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 5.4 Cg_exo -78.21 -36.32 1.04 Allowed 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.467 2.111 . . . . 0.0 113.1 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.64 -59.21 0.26 Allowed Glycine 0 CA--C 1.53 0.976 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.227 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.503 ' HA ' ' OE2' ' A' ' 126' ' ' GLU . 52.0 Cg_exo -56.49 -30.38 82.01 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.931 2.421 . . . . 0.0 114.096 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -65.89 -30.04 70.57 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.269 0.355 . . . . 0.0 111.844 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.546 ' HA ' HD12 ' A' ' 128' ' ' ILE . 10.9 mt -81.68 -31.19 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.503 ' OE2' ' HA ' ' A' ' 123' ' ' PRO . 42.7 mt-10 -56.26 -47.65 78.14 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.55 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -16.8 61.65 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 177.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 125' ' ' ILE . 76.0 mt -78.16 -51.06 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 144' ' ' GLY . 3.7 m -63.03 -35.32 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 4.9 m -73.2 -56.51 4.99 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.387 0.429 . . . . 0.0 111.37 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.8 m -56.13 -24.61 41.93 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.401 HD22 ' HB1' ' A' ' 140' ' ' ALA . 25.9 mt -79.97 -51.63 8.84 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.929 0.143 . . . . 0.0 111.017 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -85.06 16.16 3.65 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.453 0.47 . . . . 0.0 111.312 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.0 tmt_? -79.6 -42.78 24.21 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.27 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.438 ' CE1' HH11 ' A' ' 134' ' ' ARG . 91.2 m-70 -96.96 -11.88 24.07 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.135 0.272 . . . . 0.0 111.242 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.1 t70 67.83 55.85 0.58 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.129 0.972 . . . . 0.0 110.969 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.495 ' OE1' HG22 ' A' ' 87' ' ' ILE . 11.1 pt-20 -88.99 124.46 34.29 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.936 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.07 -8.17 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.825 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.99 -26.89 20.69 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.417 -0.42 . . . . 0.0 112.857 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.483 ' HB2' ' HB2' ' A' ' 88' ' ' HIS . . . -121.81 6.05 9.93 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 122.807 0.443 . . . . 0.0 111.613 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -34.63 78.61 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.541 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 2.8 t70 -78.81 -34.62 45.19 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.596 0.236 . . . . 0.0 110.899 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.7 tp -64.45 -68.97 0.31 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.846 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.524 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -48.81 -43.72 30.4 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 114.843 0.697 . . . . 0.0 114.843 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.5 96.69 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.541 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 14.4 mptt -60.86 -49.74 76.24 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.995 0.184 . . . . 0.0 110.896 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 35.8 mt -57.56 -30.45 65.25 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.405 0.441 . . . . 0.0 112.05 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -80.18 -35.98 35.62 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 120.565 0.221 . . . . 0.0 110.67 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -78.84 8.93 4.71 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.988 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.47 0 C-N-CA 122.61 0.364 . . . . 0.0 111.749 179.56 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.0 t . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.516 0.198 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -100.4 136.27 40.54 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.895 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.91 151.02 23.23 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.612 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 tt -101.35 140.71 35.26 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.646 0.263 . . . . 0.0 110.521 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.38 30.69 6.82 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.999 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -120.21 -18.8 7.93 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.343 0.257 . . . . 0.0 111.225 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.71 151.78 20.49 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.375 0.422 . . . . 0.0 111.523 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -95.71 159.76 14.83 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.159 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -86.82 159.43 51.99 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.149 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.27 140.79 45.41 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.5 2.134 . . . . 0.0 112.961 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.84 151.93 20.72 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.065 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -94.91 11.97 29.89 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.499 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? 63.99 125.75 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.013 0.925 . . . . 0.0 111.947 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -105.19 -2.96 23.51 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.791 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -90.09 137.23 32.51 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.305 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.8 p -102.88 0.4 32.43 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.67 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -89.09 42.49 1.09 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.222 0.534 . . . . 0.0 111.245 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.0 mm -92.99 -21.85 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.809 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 tp -62.88 -24.82 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 123.169 0.587 . . . . 0.0 111.747 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -109.55 29.04 7.94 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.753 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.6 t -87.44 -55.86 3.61 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.239 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.31 -72.68 0.46 Allowed Glycine 0 C--N 1.343 0.95 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.631 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -83.5 -48.02 0.76 Allowed Pre-proline 0 CA--C 1.547 0.857 0 CA-C-O 118.421 -0.799 . . . . 0.0 113.151 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.48 112.75 3.54 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.089 1.86 . . . . 0.0 112.467 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.424 ' O ' ' HD2' ' A' ' 82' ' ' TYR . 1.2 tp -143.71 5.15 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.536 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -116.7 -65.98 1.13 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.901 -0.136 . . . . 0.0 110.93 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 51.6 p -41.66 -50.21 4.17 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.748 1.219 . . . . 0.0 112.848 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.561 ' O ' HD13 ' A' ' 87' ' ' ILE . 8.5 t -62.86 -49.37 75.14 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 113.367 -1.742 . . . . 0.0 110.371 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.424 ' HD2' ' O ' ' A' ' 78' ' ' ILE . 64.3 m-85 -86.79 17.22 4.14 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.639 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.544 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 13.1 t -119.15 -17.47 8.92 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.405 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.54 164.91 22.59 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.768 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -88.68 117.84 27.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.026 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.23 68.13 1.21 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.284 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.561 HD13 ' O ' ' A' ' 81' ' ' SER . 2.4 tp -96.95 -29.05 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.635 ' HB3' ' O ' ' A' ' 139' ' ' GLY . 39.1 t60 -112.98 -31.92 6.53 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.579 ' OE2' ' HA2' ' A' ' 139' ' ' GLY . 26.3 mt-10 -117.16 46.44 1.68 Allowed 'General case' 0 C--O 1.24 0.583 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 50.0 tttt -121.01 -20.35 6.88 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.513 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.503 ' H ' HD12 ' A' ' 91' ' ' ILE . 1.2 mp -79.57 -6.02 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 123.424 0.452 . . . . 0.0 111.454 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 3.4 mp -94.3 -22.36 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 123.071 0.232 . . . . 0.0 110.848 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -93.78 -33.14 13.7 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.239 0.337 . . . . 0.0 111.285 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.28 -29.86 66.16 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.241 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -117.56 -56.82 2.18 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 123.624 0.577 . . . . 0.0 109.82 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 14.3 t70 42.47 91.14 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.58 1.152 . . . . 0.0 112.472 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.3 tp -144.8 135.67 24.79 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.184 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 68.7 m80 63.65 158.73 0.08 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.876 0.87 . . . . 0.0 112.218 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 m -90.2 122.42 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.561 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.0 m 62.7 124.68 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.037 0.935 . . . . 0.0 112.026 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -102.69 116.28 32.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.262 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.1 t -134.77 129.51 34.73 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.461 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.428 ' O ' ' HE2' ' A' ' 103' ' ' LYS . 0.3 OUTLIER -131.02 -48.96 1.02 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.588 0.555 . . . . 0.0 111.037 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.491 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 3.3 t-20 -128.68 -9.94 5.02 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 123.26 0.35 . . . . 0.0 111.789 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.0 104.45 9.5 Favored Pre-proline 0 CA--C 1.542 0.658 0 O-C-N 123.06 0.225 . . . . 0.0 111.483 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 104' ' ' ASN . 66.1 Cg_endo -82.52 162.07 16.93 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.406 2.071 . . . . 0.0 113.088 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.2 mt -124.15 99.35 6.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.773 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -136.35 -51.51 0.7 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.88 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -138.95 -60.35 0.58 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.399 0.437 . . . . 0.0 110.747 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -148.53 142.26 25.6 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.282 0.364 . . . . 0.0 111.028 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.8 p -133.32 113.84 13.05 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.661 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.7 p -145.38 134.79 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.886 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 23.1 mmt -134.72 120.02 18.95 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.448 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -133.22 130.81 39.57 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.847 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -133.75 -0.93 3.11 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.348 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.549 ' HA ' ' CD1' ' A' ' 120' ' ' TYR . 10.2 mt -88.85 11.97 16.48 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.044 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -130.28 -6.1 4.31 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -96.11 -43.42 7.76 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.81 -5.59 18.29 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.294 0.371 . . . . 0.0 111.892 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.549 ' CD1' ' HA ' ' A' ' 116' ' ' LEU . 36.0 m-85 -97.16 139.29 21.4 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.786 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.13 -58.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.523 2.149 . . . . 0.0 114.074 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.33 -60.73 0.08 OUTLIER Glycine 0 C--N 1.343 0.972 0 CA-C-O 118.919 -0.934 . . . . 0.0 113.596 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.27 -31.98 69.18 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.078 2.519 . . . . 0.0 114.017 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.94 -41.81 97.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.38 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.515 ' O ' HG22 ' A' ' 129' ' ' VAL . 7.1 mt -70.54 -40.11 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.574 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.98 -24.12 66.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.793 0.437 . . . . 0.0 111.941 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -77.76 -45.09 25.64 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.407 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.7 mt -63.06 -47.24 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 122.844 0.457 . . . . 0.0 111.197 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 125' ' ' ILE . 5.3 m -58.64 -51.56 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.791 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.1 m -58.35 -39.03 78.4 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 m -71.38 -26.17 62.67 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.9 mt -85.65 -37.6 19.29 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -83.81 6.38 21.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.598 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.488 HH11 ' CE1' ' A' ' 135' ' ' HIS . 4.5 tmt_? -86.9 -42.82 12.9 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.28 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.544 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 88.5 m-70 -91.64 -25.38 19.18 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.982 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.2 t70 70.54 76.12 0.2 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.115 0.966 . . . . 0.0 110.535 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -101.02 130.02 46.95 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.503 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.69 -14.91 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 123.437 0.461 . . . . 0.0 111.695 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.635 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -96.76 -7.57 57.64 Favored Glycine 0 C--N 1.336 0.575 0 O-C-N 123.344 0.403 . . . . 0.0 112.293 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -130.02 1.59 4.77 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.363 0.665 . . . . 0.0 111.607 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -62.59 -27.39 69.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.003 0.521 . . . . 0.0 111.398 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.517 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 1.5 p30 -76.21 -39.06 55.59 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.441 0.463 . . . . 0.0 110.887 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.0 tp -64.07 -59.97 3.81 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.885 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -58.41 -56.3 25.99 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.799 -0.637 . . . . 0.0 114.66 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.4 -41.84 76.98 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.517 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -65.98 -40.25 91.05 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.929 0.143 . . . . 0.0 111.357 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 22.0 mt -69.85 -27.9 65.23 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.336 0.398 . . . . 0.0 110.781 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -95.6 5.56 51.16 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 123.142 0.276 . . . . 0.0 110.937 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -85.38 -2.71 58.39 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.17 -8.14 49.49 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.627 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.9 mp -103.83 -37.88 7.26 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.711 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -86.91 -43.41 12.43 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.318 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -106.47 130.21 54.3 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.3 0.375 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.505 -179.978 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.0 p . . . . . 0 N--CA 1.487 1.419 0 N-CA-C 111.252 0.093 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -127.81 125.7 40.31 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 123.366 0.417 . . . . 0.0 110.838 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.63 -60.07 1.24 Allowed Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.598 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 63.11 122.87 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.956 0.903 . . . . 0.0 111.824 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.2 73.71 0.22 Allowed Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.559 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 61.97 136.34 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.051 0.941 . . . . 0.0 112.477 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.88 -11.44 26.73 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.954 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -132.08 129.44 39.97 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.45 ' H ' ' CD ' ' A' ' 63' ' ' PRO . 6.4 m-20 -117.11 -44.76 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 118.549 -0.738 . . . . 0.0 112.224 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.45 ' CD ' ' H ' ' A' ' 62' ' ' ASP . 2.9 Cg_exo -76.8 -35.59 1.88 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.224 1.949 . . . . 0.0 113.029 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.6 mt -99.13 132.49 44.4 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.387 0.43 . . . . 0.0 110.974 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -126.48 23.16 6.92 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.085 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 63.81 122.59 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.995 0.918 . . . . 0.0 111.935 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -118.37 21.78 12.47 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.163 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.531 ' O ' ' HB2' ' A' ' 102' ' ' SER . 91.9 m-85 -82.67 -32.68 28.02 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.165 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.0 t -92.16 105.53 17.74 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 120.993 0.425 . . . . 0.0 111.085 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.9 ttmt -137.64 174.84 10.15 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.359 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.534 HD11 ' O ' ' A' ' 90' ' ' LYS . 0.5 OUTLIER -82.26 -30.96 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.158 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 tt -67.16 122.77 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 O-C-N 123.257 0.348 . . . . 0.0 110.3 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.7 t80 62.75 31.29 16.63 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.44 0.696 . . . . 0.0 111.006 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.1 t -79.58 -40.67 28.86 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.011 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.03 -37.04 0.46 Allowed Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.157 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -90.07 159.93 41.49 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.456 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.11 148.44 69.23 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.453 2.102 . . . . 0.0 113.394 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.5 tp -88.75 28.43 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.99 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 83' ' ' SER . 7.1 tp10 -119.8 -53.89 2.17 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.137 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.1 m -56.46 -56.78 16.89 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.419 0.688 . . . . 0.0 112.235 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.8 m -59.51 -55.81 29.86 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.289 0.368 . . . . 0.0 111.043 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.468 ' HB3' HG21 ' A' ' 131' ' ' THR . 2.1 m-85 -61.43 -11.88 12.29 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.492 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 8.3 t -87.94 -40.09 14.21 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.624 0.193 . . . . 0.0 111.324 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.71 152.62 30.56 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -82.88 131.56 35.19 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.081 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.78 28.05 5.79 Favored Glycine 0 C--N 1.336 0.536 0 O-C-N 123.731 0.644 . . . . 0.0 112.783 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.592 HD13 ' O ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -91.51 -19.54 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 122.735 0.414 . . . . 0.0 111.049 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.483 ' CE1' ' HG3' ' A' ' 89' ' ' GLU . 2.8 p80 -56.49 -29.84 62.27 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.483 ' HG3' ' CE1' ' A' ' 88' ' ' HIS . 40.5 mt-10 -93.11 -24.82 18.14 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.301 0.375 . . . . 0.0 111.07 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.534 ' O ' HD11 ' A' ' 71' ' ' ILE . 91.8 mttt -62.0 -4.97 1.85 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.92 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.6 mm -83.12 -16.84 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 mt -90.06 0.33 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.297 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -67.14 -18.56 65.34 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.219 0.608 . . . . 0.0 111.891 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.58 -18.18 64.9 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.303 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -94.02 -28.64 15.64 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.801 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.418 ' OD1' HD12 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -96.24 129.99 43.42 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.755 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.418 HD12 ' OD1' ' A' ' 96' ' ' ASP . 4.7 mp 64.1 147.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.981 0.912 . . . . 0.0 112.067 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -128.01 111.21 13.28 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.796 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.1 p -148.24 133.65 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.493 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.0 m 63.06 149.22 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.954 0.902 . . . . 0.0 112.444 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -109.44 126.72 53.78 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.56 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.531 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 55.4 m -130.12 157.88 41.21 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.912 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -90.14 124.67 35.01 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.203 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -131.31 165.06 24.24 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.926 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.87 122.52 72.86 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.713 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.473 ' HG2' ' OE1' ' A' ' 108' ' ' GLN . 60.6 Cg_endo -77.12 169.62 21.15 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.438 2.092 . . . . 0.0 113.033 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.4 tp -91.43 134.3 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.473 ' OE1' ' HG2' ' A' ' 106' ' ' PRO . 2.4 mp0 -126.29 -35.4 2.41 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.306 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -88.51 166.19 14.35 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.199 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.25 -37.52 57.53 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.753 0.421 . . . . 0.0 112.089 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.8 p -96.83 122.92 40.32 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.709 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.9 p -100.62 116.29 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.014 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.42 ' HB3' ' OE2' ' A' ' 114' ' ' GLU . 23.2 mmt -141.85 -46.38 0.36 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.831 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.42 ' OE2' ' HB3' ' A' ' 113' ' ' MET . 4.6 mp0 -128.97 134.91 48.36 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.474 0.484 . . . . 0.0 110.644 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -128.75 -4.25 5.23 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 123.619 0.574 . . . . 0.0 111.889 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 120' ' ' TYR . 3.0 mp -89.77 7.27 37.8 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -98.87 146.6 25.8 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.142 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt 70.77 -34.59 0.3 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.455 1.102 . . . . 0.0 112.889 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.5 -31.78 19.78 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.505 ' CE2' HD23 ' A' ' 116' ' ' LEU . 13.6 m-85 -88.82 158.14 48.01 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 119.241 -0.409 . . . . 0.0 111.095 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.67 -44.43 0.14 Allowed 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.412 2.074 . . . . 0.0 113.832 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.35 -59.58 0.42 Allowed Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.9 -0.944 . . . . 0.0 113.508 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.09 -18.03 41.48 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.905 2.403 . . . . 0.0 114.049 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -78.13 -40.03 39.38 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.299 0.374 . . . . 0.0 111.254 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.537 ' O ' HG22 ' A' ' 129' ' ' VAL . 6.1 mt -68.71 -33.14 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.626 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -69.43 -50.53 44.82 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.466 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -51.77 -44.52 63.39 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.617 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.579 ' O ' HD12 ' A' ' 132' ' ' LEU . 23.7 mt -63.61 -57.02 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 122.356 0.262 . . . . 0.0 111.546 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 125' ' ' ILE . 5.0 m -55.49 -45.07 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.8 t -64.38 -30.1 71.15 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.468 HG21 ' HB3' ' A' ' 82' ' ' TYR . 22.8 m -72.78 -34.91 67.25 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.994 0.184 . . . . 0.0 111.349 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.68 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 0.9 OUTLIER -75.02 -28.86 60.66 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.154 0.284 . . . . 0.0 111.336 178.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -90.01 18.93 5.28 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.373 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -109.97 -41.31 4.51 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.38 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.68 ' NE2' ' HA ' ' A' ' 132' ' ' LEU . 5.7 p80 -87.21 -41.98 13.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.94 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 70.95 81.06 0.16 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.254 1.022 . . . . 0.0 112.015 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.529 ' HG2' ' CE1' ' A' ' 135' ' ' HIS . 10.3 pt-20 -128.23 139.79 52.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.645 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.98 -13.5 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.709 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -79.76 -28.77 50.04 Favored Glycine 0 C--N 1.34 0.792 0 O-C-N 123.341 0.4 . . . . 0.0 113.849 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -123.11 1.95 9.22 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -58.79 -25.18 62.87 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.953 0.501 . . . . 0.0 112.22 179.427 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.577 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 7.6 m-20 -81.43 -32.99 32.42 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.784 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.8 tp -68.61 -56.84 6.9 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.532 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.413 ' H ' HD22 ' A' ' 132' ' ' LEU . . . -60.82 -48.28 87.04 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.851 -0.613 . . . . 0.0 114.153 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.7 -41.49 86.4 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.577 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 14.4 mptt -65.45 -34.57 78.61 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 30.8 mt -72.83 -30.89 64.4 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.205 0.316 . . . . 0.0 111.616 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.491 ' HD2' ' O ' ' A' ' 148' ' ' ARG . 1.8 tmm_? -87.67 -19.64 27.4 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 123.173 0.296 . . . . 0.0 111.189 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.49 22.65 3.33 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 123.382 0.426 . . . . 0.0 111.153 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -81.51 -7.18 59.55 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.932 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.3 tt -97.55 -49.44 4.88 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.3 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -120.01 108.19 14.0 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 123.442 0.464 . . . . 0.0 110.482 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -137.63 -44.34 0.54 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.853 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.561 -179.863 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.5 p . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 111.376 0.139 . . . . 0.0 111.376 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -99.98 -44.16 6.12 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.962 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.21 -159.16 12.32 Favored Glycine 0 C--N 1.339 0.743 0 O-C-N 123.44 0.462 . . . . 0.0 112.64 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.8 mt 70.77 -51.62 0.67 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.382 1.073 . . . . 0.0 112.319 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.71 -136.59 13.17 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 121.45 -0.405 . . . . 0.0 112.499 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.46 153.06 26.67 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.711 0.301 . . . . 0.0 111.042 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.62 21.31 7.45 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.656 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -89.02 156.65 18.73 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.264 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -90.56 143.53 29.29 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.807 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.36 -38.4 6.53 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.464 2.109 . . . . 0.0 113.224 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 tt -130.16 123.66 30.81 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 123.301 0.376 . . . . 0.0 110.643 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -137.41 160.2 39.77 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.029 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.4 tttt 64.56 175.3 0.19 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.876 0.871 . . . . 0.0 111.891 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 68.05 94.05 0.07 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.166 0.987 . . . . 0.0 111.378 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -123.86 -168.6 1.81 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.451 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.1 p -106.9 156.52 18.61 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.341 0.256 . . . . 0.0 110.985 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -87.48 116.01 25.29 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.022 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.612 HG12 ' H ' ' A' ' 74' ' ' SER . 2.9 tt -149.58 162.7 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.624 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.447 HG23 ' CD2' ' A' ' 73' ' ' PHE . 2.9 tp -112.47 -37.62 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.573 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.447 ' CD2' HG23 ' A' ' 72' ' ' ILE . 66.5 m-85 -90.95 -42.18 10.72 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.612 ' H ' HG12 ' A' ' 71' ' ' ILE . 30.7 t 54.66 26.79 7.84 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.866 0.866 . . . . 0.0 112.249 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.7 -72.93 0.48 Allowed Glycine 0 C--N 1.34 0.768 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.362 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.544 ' H ' ' CD ' ' A' ' 77' ' ' PRO . 20.8 tttm -139.29 -45.86 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.852 0 CA-C-O 118.801 -0.618 . . . . 0.0 112.058 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.544 ' CD ' ' H ' ' A' ' 76' ' ' LYS . 7.0 Cg_exo -75.07 157.05 42.69 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.406 2.071 . . . . 0.0 113.61 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.493 ' O ' HD13 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -122.56 -18.5 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.379 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -75.13 -53.35 9.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.099 0.56 . . . . 0.0 111.974 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 83' ' ' SER . 37.3 m -49.57 -47.9 48.99 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.097 0.959 . . . . 0.0 112.815 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.9 p -54.65 -58.64 6.72 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.523 0.514 . . . . 0.0 111.943 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -74.45 -4.79 38.74 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.574 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 4.4 m -78.65 -37.01 43.01 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.85 0.46 . . . . 0.0 110.987 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.98 161.93 12.21 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.91 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -96.36 98.25 10.12 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.602 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 90' ' ' LYS . . . 125.76 60.04 0.16 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.876 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.554 HG22 ' OE2' ' A' ' 137' ' ' GLU . 3.9 tp -86.44 -31.3 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 122.43 0.292 . . . . 0.0 111.181 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -122.41 -38.46 2.67 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.387 0.43 . . . . 0.0 109.997 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.558 ' O ' ' HB2' ' A' ' 93' ' ' GLU . 7.3 tt0 -87.07 26.57 1.15 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.095 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 13.4 ttpp -76.45 -28.8 56.7 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.345 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.6 tp -78.62 0.35 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 O-C-N 123.354 0.409 . . . . 0.0 111.712 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.519 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 1.0 OUTLIER -132.88 -4.35 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.722 179.12 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 2.7 tp10 -89.23 -37.61 14.85 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.82 -0.78 36.03 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -119.69 -11.36 9.42 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.341 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 2.1 t70 -94.76 -26.14 16.38 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.33 0.394 . . . . 0.0 111.606 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.8 mt -90.21 137.39 32.39 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.35 0.406 . . . . 0.0 111.454 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -109.4 125.78 52.76 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.077 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.3 154.08 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.622 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.4 t -92.24 144.01 25.83 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.918 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.3 tttm 62.18 114.84 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.844 0.858 . . . . 0.0 111.43 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.7 m -131.17 150.91 51.94 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.094 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -115.87 157.99 23.64 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.802 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.5 2.38 50.82 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.001 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.414 ' N ' ' HD2' ' A' ' 106' ' ' PRO . . . -90.95 -49.57 0.34 Allowed Pre-proline 0 CA--C 1.547 0.831 0 CA-C-O 118.673 -0.68 . . . . 0.0 112.406 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 105' ' ' ALA . 33.6 Cg_endo -64.8 165.13 21.93 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.1 1.866 . . . . 0.0 113.32 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.0 mt 65.77 126.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.791 0.836 . . . . 0.0 110.988 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -129.45 147.15 51.24 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.77 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -100.35 113.84 26.88 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.563 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -139.92 130.05 25.07 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.024 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.0 p -131.79 113.08 13.08 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.909 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.8 t -131.18 148.79 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.093 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.02 133.28 45.75 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.139 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.438 ' OE2' ' HB ' ' A' ' 72' ' ' ILE . 9.1 pt-20 -130.75 150.45 51.92 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.563 0.539 . . . . 0.0 111.619 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -129.51 125.39 36.23 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.939 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.514 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 4.6 mt -109.75 77.32 1.05 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.766 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 116' ' ' LEU . 36.0 mmtt -157.86 -48.64 0.06 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.89 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -94.22 -43.72 8.31 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -83.71 0.37 47.38 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 123.177 0.298 . . . . 0.0 111.688 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.407 ' CD1' HD23 ' A' ' 116' ' ' LEU . 58.7 m-85 -127.68 123.34 22.94 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.795 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -73.41 -49.61 0.21 Allowed 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.658 2.239 . . . . 0.0 113.871 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 172.81 -61.21 0.14 Allowed Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.94 -0.922 . . . . 0.0 113.556 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.96 -31.41 73.93 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.928 2.419 . . . . 0.0 113.926 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -70.5 -20.47 62.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.644 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.748 ' HA ' HD12 ' A' ' 128' ' ' ILE . 8.8 mt -95.1 -28.29 4.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.13 -36.49 84.19 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.745 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -77.73 -10.64 59.64 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.877 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.748 HD12 ' HA ' ' A' ' 125' ' ' ILE . 96.6 mt -84.14 -41.9 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.633 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.8 m -72.31 -38.29 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.132 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 21.2 t -71.77 -60.91 1.99 Allowed 'General case' 0 C--N 1.348 0.502 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.701 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.6 m -56.86 -25.11 55.81 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.615 ' HB2' ' O ' ' A' ' 128' ' ' ILE . 4.3 tt -74.77 -48.27 26.44 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.586 0.176 . . . . 0.0 111.191 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -96.29 13.18 28.43 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 120.873 0.368 . . . . 0.0 111.645 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 130' ' ' SER . 4.5 tmt_? -76.03 -42.17 48.65 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.574 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 21.2 m-70 -88.85 -111.6 0.07 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 176.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.428 ' H ' ' HB2' ' A' ' 135' ' ' HIS . 8.7 m-20 -123.17 -89.54 0.59 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.554 ' OE2' HG22 ' A' ' 87' ' ' ILE . 3.7 mm-40 55.48 89.87 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.487 1.115 . . . . 0.0 111.262 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.25 -15.64 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.021 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -94.02 -31.26 8.21 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.62 -16.92 29.47 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.106 0.562 . . . . 0.0 111.204 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 19.2 tptt -51.59 -28.83 15.24 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.445 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 1.3 p30 -78.34 -44.14 25.89 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.714 0.293 . . . . 0.0 110.495 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.4 tp -60.62 -66.55 0.51 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.964 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.54 -34.71 20.62 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.332 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.72 77.71 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 117.218 0.509 . . . . 0.0 112.104 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -66.78 -50.55 62.3 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.1 0.25 . . . . 0.0 110.685 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 26.9 mt -61.79 -28.43 69.45 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.225 0.328 . . . . 0.0 111.423 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -80.77 -38.15 29.07 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 123.369 0.418 . . . . 0.0 110.773 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.83 0.27 27.76 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.239 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -82.93 -6.74 59.59 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 151' ' ' LEU . 1.3 mm? -102.67 -44.25 5.37 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.476 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -98.0 146.89 25.06 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.637 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -118.7 -43.27 2.69 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.304 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.469 -0.777 . . . . 0.0 111.121 179.98 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.6 p . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.475 0.179 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -127.82 122.25 32.19 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.871 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.37 -110.39 3.95 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.512 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 58' ' ' GLY . 2.5 pp -120.08 -40.12 2.75 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.341 0.256 . . . . 0.0 111.27 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.405 ' N ' HD12 ' A' ' 57' ' ' LEU . . . 152.57 -167.61 31.49 Favored Glycine 0 C--N 1.337 0.594 0 O-C-N 123.494 0.496 . . . . 0.0 112.764 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt 54.81 28.87 10.92 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.878 0.871 . . . . 0.0 112.795 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.62 -10.87 38.84 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.89 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -99.86 178.32 4.85 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.648 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -68.43 158.2 85.64 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 119.211 -0.424 . . . . 0.0 111.468 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -65.87 109.5 1.49 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.417 2.078 . . . . 0.0 113.268 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 tt -145.45 127.81 15.89 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.027 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -128.93 -43.17 1.36 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.451 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -113.51 138.41 50.17 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 123.345 0.403 . . . . 0.0 110.764 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.539 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 88.4 m-85 -100.81 -12.61 18.91 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.437 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -100.19 130.5 46.33 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.744 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.58 ' OG ' ' HA ' ' A' ' 91' ' ' ILE . 18.3 t -97.03 31.31 2.44 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.218 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -84.48 126.91 33.7 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.431 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.0 mt -109.99 -35.05 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.568 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.3 mp -63.73 -30.11 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 122.976 0.172 . . . . 0.0 110.81 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -92.04 9.54 32.88 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.42 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 t -87.13 171.72 10.48 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.828 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.34 13.58 39.24 Favored Glycine 0 C--N 1.344 1.014 0 C-N-CA 121.532 -0.366 . . . . 0.0 113.513 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -138.54 157.91 71.36 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 119.297 -0.382 . . . . 0.0 110.734 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.23 164.86 33.25 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.519 2.146 . . . . 0.0 112.821 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.778 ' H ' HD13 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -87.65 63.52 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.443 0.64 . . . . 0.0 111.209 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 83' ' ' SER . 7.0 tp10 -120.87 -55.68 1.98 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.428 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 m -64.49 -58.94 5.0 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.6 m -53.21 -62.06 1.9 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.449 ' CD2' HG12 ' A' ' 87' ' ' ILE . 44.9 m-85 -51.64 -33.51 33.79 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 178.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 6.3 t -65.78 -33.73 76.54 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.22 174.58 0.13 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.261 0.624 . . . . 0.0 112.643 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -98.22 119.04 36.18 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.198 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.04 51.14 1.66 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.058 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.449 HG12 ' CD2' ' A' ' 82' ' ' TYR . 3.8 tp -85.54 -42.29 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 122.47 0.308 . . . . 0.0 111.189 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 140' ' ' ALA . 59.1 t60 -81.19 43.76 0.73 Allowed 'General case' 0 CA--C 1.55 0.95 0 CA-C-O 121.235 0.54 . . . . 0.0 111.939 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -141.7 -74.64 0.31 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.163 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -64.97 2.98 0.62 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.58 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 3.1 tp -86.68 -38.92 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 122.64 0.376 . . . . 0.0 111.57 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pt -105.05 15.38 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -93.72 -34.33 13.28 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.455 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.539 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -83.17 -29.27 28.73 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.504 0.502 . . . . 0.0 112.178 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -85.89 -7.09 58.93 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 123.371 0.419 . . . . 0.0 111.727 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -84.47 6.48 23.32 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.051 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.5 mp -98.38 -57.06 2.29 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.155 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 56.18 110.79 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.956 0.902 . . . . 0.0 111.931 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.91 -45.1 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.77 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.9 m -91.29 150.49 21.29 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.482 0.489 . . . . 0.0 111.25 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.423 ' H ' ' HG3' ' A' ' 101' ' ' LYS . 2.1 pptp? -93.53 -15.06 25.88 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.113 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.6 t -91.95 108.4 19.91 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.99 0.424 . . . . 0.0 110.965 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -139.66 158.85 43.42 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.911 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 64.68 163.6 0.14 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.858 0.863 . . . . 0.0 111.911 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.98 149.56 56.51 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.417 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.83 134.3 52.89 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.84 2.36 . . . . 0.0 113.435 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 pt -140.76 158.54 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.294 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -91.6 -3.05 56.84 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.73 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -93.33 152.69 18.99 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.007 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.56 134.42 35.86 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.361 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.1 m -130.34 148.68 52.19 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.009 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.53 HG13 ' SD ' ' A' ' 113' ' ' MET . 12.2 p -118.49 -42.45 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.85 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.53 ' SD ' HG13 ' A' ' 112' ' ' VAL . 4.4 mpp? -123.61 165.23 17.53 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.523 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -78.28 -96.62 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.259 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.3 t80 54.87 172.98 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.905 0.882 . . . . 0.0 112.546 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.511 HD23 ' CZ ' ' A' ' 120' ' ' TYR . 9.2 mt -94.07 34.39 1.25 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.214 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -134.07 3.4 3.43 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.973 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.9 -48.96 13.63 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.44 10.48 6.74 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 123.394 0.434 . . . . 0.0 111.03 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.511 ' CZ ' HD23 ' A' ' 116' ' ' LEU . 63.5 m-85 -97.51 105.26 24.76 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.693 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.3 -35.38 14.11 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.653 2.236 . . . . 0.0 113.621 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 157.64 -56.85 0.37 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.868 -0.962 . . . . 0.0 113.122 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.16 -22.72 41.29 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.887 2.391 . . . . 0.0 114.028 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -74.31 -39.69 62.73 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.296 0.372 . . . . 0.0 111.293 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.696 ' HA ' HD12 ' A' ' 128' ' ' ILE . 5.0 mt -78.16 -30.91 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.371 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -62.38 -52.51 63.3 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.339 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.443 ' O ' ' OG1' ' A' ' 131' ' ' THR . 76.9 mtt180 -55.94 -27.72 53.65 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 177.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 125' ' ' ILE . 69.2 mt -70.9 -50.48 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 121.999 0.12 . . . . 0.0 111.022 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.4 m -60.37 -39.72 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 43.2 p -78.73 -18.19 54.67 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.509 HG21 ' O ' ' A' ' 78' ' ' ILE . 89.1 m -86.62 -28.67 23.1 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 122.883 0.114 . . . . 0.0 111.224 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 144' ' ' GLY . 1.7 mp -80.43 -46.27 16.25 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.087 0.242 . . . . 0.0 110.444 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.416 ' OE1' ' HG2' ' A' ' 148' ' ' ARG . 44.4 mt-10 -80.18 12.87 2.59 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.881 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 130' ' ' SER . 4.6 tmt_? -79.71 -46.18 17.57 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.218 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.593 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 3.9 p80 -110.22 -12.45 14.47 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 70.31 78.83 0.19 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.337 1.055 . . . . 0.0 111.935 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.593 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 0.2 OUTLIER -99.77 130.44 45.98 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.923 179.08 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.89 -7.62 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.025 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -93.08 -22.11 28.5 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.512 -0.375 . . . . 0.0 112.705 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.468 ' HB3' ' CG ' ' A' ' 137' ' ' GLU . . . -126.93 5.25 6.56 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.18 -33.83 59.05 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.039 0.536 . . . . 0.0 111.753 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.57 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 3.1 t70 -74.95 -34.95 62.12 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.47 0.481 . . . . 0.0 111.232 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.9 tp -69.05 -59.61 2.92 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.825 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.483 ' N ' HD22 ' A' ' 132' ' ' LEU . . . -55.43 -56.25 24.44 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.852 -0.613 . . . . 0.0 113.934 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . -54.94 -43.63 73.57 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.57 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 14.3 mptt -62.24 -41.13 98.15 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.922 0.139 . . . . 0.0 111.246 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.4 mt -59.47 -34.42 72.54 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.44 0.463 . . . . 0.0 111.622 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 145' ' ' ALA . 0.1 OUTLIER -94.17 7.3 45.77 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 120.656 0.265 . . . . 0.0 111.029 178.544 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -108.18 17.65 22.02 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.245 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.16 -5.76 59.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.976 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.2 tt -98.95 -46.22 5.69 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.722 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -91.9 135.27 34.06 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.365 0.416 . . . . 0.0 111.266 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -111.86 151.64 28.87 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.931 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 . . . . . 0 N--CA 1.484 1.23 0 C-N-CA 123.945 0.898 . . . . 0.0 111.961 179.933 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.496 0.188 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -116.9 -42.46 2.95 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.155 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.82 106.84 0.96 Allowed Glycine 0 C--N 1.341 0.819 0 O-C-N 123.461 0.476 . . . . 0.0 112.545 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 tt -100.53 120.1 39.51 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 123.625 0.25 . . . . 0.0 110.431 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.14 -89.0 1.22 Allowed Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.494 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -120.08 130.89 54.87 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.401 0.28 . . . . 0.0 110.672 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.72 -12.44 23.75 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.007 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -132.41 122.77 25.5 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.369 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.06 106.48 13.73 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.823 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.62 -33.82 27.19 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.56 2.173 . . . . 0.0 113.161 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mt -100.71 130.03 46.69 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.475 0.485 . . . . 0.0 110.95 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.465 ' O ' ' HE1' ' A' ' 68' ' ' PHE . 3.2 t70 -119.2 -14.77 9.25 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.132 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -117.37 166.5 12.23 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.297 0.373 . . . . 0.0 110.693 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 65.96 93.31 0.07 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.07 0.948 . . . . 0.0 111.962 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.465 ' HE1' ' O ' ' A' ' 65' ' ' ASP . 86.0 m-85 -131.48 -41.21 1.08 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.866 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.8 p -113.39 178.57 4.23 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.71 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -71.6 156.96 38.8 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.553 0.341 . . . . 0.0 111.457 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -84.68 -172.2 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.656 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.496 ' H ' HG22 ' A' ' 71' ' ' ILE . 33.3 mm 76.15 -48.87 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 124.054 0.942 . . . . 0.0 110.708 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.74 29.66 7.83 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.096 0.474 . . . . 0.0 111.012 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.8 t -88.39 -39.56 14.2 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.44 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.4 37.07 0.02 OUTLIER Glycine 0 C--N 1.337 0.614 0 O-C-N 123.673 0.608 . . . . 0.0 112.335 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.584 ' N ' ' HD3' ' A' ' 77' ' ' PRO . 33.7 tttm 53.38 47.41 4.01 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 124.211 1.004 . . . . 0.0 112.786 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.584 ' HD3' ' N ' ' A' ' 76' ' ' LYS . 6.7 Cg_endo -87.75 -62.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.537 2.158 . . . . 0.0 112.249 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER 46.93 19.25 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 124.906 1.282 . . . . 0.0 114.144 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -120.38 -77.99 0.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 35.2 m -41.63 -47.55 3.92 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.313 1.045 . . . . 0.0 112.715 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.4 t -61.54 -51.61 67.87 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.806 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -88.37 17.98 4.83 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.392 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m -119.73 -15.88 8.85 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.997 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.34 154.74 17.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.169 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.522 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -78.6 133.67 37.27 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.504 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.533 ' O ' ' HB2' ' A' ' 90' ' ' LYS . . . 94.44 34.12 6.5 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.669 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.7 tp -89.31 -24.06 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 140' ' ' ALA . 29.2 p-80 -47.78 -36.91 12.39 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.545 ' HG3' ' CD2' ' A' ' 88' ' ' HIS . 41.4 mt-10 -108.46 -30.14 8.43 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 123.322 0.389 . . . . 0.0 111.429 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 36.5 tttt -54.18 -10.87 0.4 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.2 mt -83.82 -35.77 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 122.252 0.221 . . . . 0.0 110.559 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.5 tp -92.64 -35.13 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.481 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -92.94 -80.26 0.38 Allowed 'General case' 0 CA--C 1.533 0.307 0 O-C-N 123.395 0.434 . . . . 0.0 110.653 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 90' ' ' LYS . . . 66.37 -35.7 0.24 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -133.42 -41.92 0.87 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.03 155.73 13.08 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.22 0.608 . . . . 0.0 112.205 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.8 mp -92.87 161.76 14.36 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.106 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -86.99 115.39 24.34 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.095 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.0 p -139.06 -38.57 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.959 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.1 m -112.81 112.49 24.02 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 123.443 0.464 . . . . 0.0 110.698 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -139.13 150.92 46.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.7 t -121.42 123.71 42.74 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.763 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -101.89 -42.74 6.03 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.836 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -111.94 131.02 55.64 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.797 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 108' ' ' GLN . . . -95.06 113.08 60.59 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.262 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -80.4 -39.69 0.24 Allowed 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 122.232 1.955 . . . . 0.0 113.535 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.5 pt -142.18 -8.0 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.413 ' O ' ' HB1' ' A' ' 105' ' ' ALA . 54.4 mt-30 -91.45 112.37 24.25 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.827 0.346 . . . . 0.0 111.276 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -137.68 119.61 15.35 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.232 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 58.97 115.36 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.029 0.931 . . . . 0.0 112.315 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.1 m -129.62 145.36 51.5 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.042 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.57 149.6 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.478 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.443 ' SD ' HD21 ' A' ' 147' ' ' LEU . 18.2 ptp -97.26 127.01 42.85 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.245 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -97.96 22.39 9.38 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.045 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -113.52 -44.34 3.22 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.087 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.514 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 6.2 mt -102.01 -42.03 6.24 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.37 0.419 . . . . 0.0 111.648 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -91.64 141.23 28.93 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.213 0.321 . . . . 0.0 111.062 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.2 mptt 70.64 -35.68 0.33 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.348 1.059 . . . . 0.0 113.018 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.99 -18.09 20.51 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 122.252 0.221 . . . . 0.0 111.324 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.514 ' HB3' ' O ' ' A' ' 116' ' ' LEU . 19.3 t80 -133.57 50.55 5.48 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 123.335 0.397 . . . . 0.0 111.315 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 120' ' ' TYR . 3.5 Cg_exo -76.19 111.18 3.22 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.26 1.973 . . . . 0.0 112.287 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -172.91 -160.55 21.69 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.713 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.677 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 12.5 Cg_exo -70.29 -34.83 12.12 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 123.295 2.663 . . . . 0.0 112.803 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -56.09 -30.69 62.41 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.492 0.495 . . . . 0.0 111.62 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.476 ' O ' HG22 ' A' ' 129' ' ' VAL . 46.4 mm -67.12 -44.53 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.642 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -68.9 -18.71 64.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.237 0.615 . . . . 0.0 111.243 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.677 ' HG2' ' O ' ' A' ' 123' ' ' PRO . 24.2 mmm180 -79.99 -46.63 16.32 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.604 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.4 mt -61.23 -49.33 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.916 0.487 . . . . 0.0 110.744 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 125' ' ' ILE . 7.0 m -58.68 -52.11 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.699 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 57.9 m -59.48 -38.41 80.77 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.2 m -72.69 -24.12 60.97 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 19.3 mt -85.66 -30.91 22.85 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.075 0.235 . . . . 0.0 111.406 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -84.97 5.1 30.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.15 0.5 . . . . 0.0 111.167 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -98.04 -36.22 10.18 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.442 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -85.36 -33.41 22.03 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.436 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 67.18 69.84 0.38 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.225 1.01 . . . . 0.0 111.492 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 140' ' ' ALA . 36.1 mt-10 -95.82 136.68 35.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.49 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.2 m -75.23 -48.71 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -77.43 -2.12 78.53 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.176 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.768 ' HB2' ' HB3' ' A' ' 88' ' ' HIS . . . -122.53 -4.79 8.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.737 0.415 . . . . 0.0 111.386 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -62.28 -37.61 86.19 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 122.798 0.439 . . . . 0.0 111.013 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.511 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 8.1 m-20 -73.42 -38.16 65.65 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.482 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.3 tp -66.74 -55.91 12.91 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.75 0.42 . . . . 0.0 110.781 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.05 -41.65 85.65 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.483 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -61.51 -41.21 96.96 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.511 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -62.13 -38.05 87.49 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.141 0.275 . . . . 0.0 111.464 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.443 HD21 ' SD ' ' A' ' 113' ' ' MET . 18.2 mt -66.41 -32.15 73.35 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.257 0.348 . . . . 0.0 110.328 177.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.41 12.47 31.19 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.423 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 5.4 t70 -106.47 43.32 1.16 Allowed 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.288 0.566 . . . . 0.0 110.375 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.26 -6.08 55.85 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.661 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 mp -97.47 -43.4 7.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.213 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.0 t70 57.23 176.75 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.886 0.874 . . . . 0.0 112.346 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.89 128.68 34.66 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.268 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.807 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.4 p . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 111.319 0.118 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 70.91 -50.63 0.68 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.414 1.086 . . . . 0.0 112.399 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.91 50.07 0.18 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 121.537 -0.363 . . . . 0.0 112.69 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.3 tp -120.02 -47.36 2.39 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.549 0.205 . . . . 0.0 110.747 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.08 52.01 1.82 Allowed Glycine 0 C--N 1.343 0.949 0 O-C-N 123.463 0.477 . . . . 0.0 112.689 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -103.99 136.02 44.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.618 0.247 . . . . 0.0 111.172 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.95 -3.52 10.17 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.802 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -91.13 141.09 29.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.061 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.34 -46.06 0.13 Allowed Pre-proline 0 CA--C 1.545 0.772 0 CA-C-O 118.719 -0.658 . . . . 0.0 111.949 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.51 145.87 30.23 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.333 2.022 . . . . 0.0 112.903 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 tp -99.53 150.23 22.43 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.525 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -104.33 93.57 4.88 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.199 0.523 . . . . 0.0 111.624 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.6 mttt 54.16 -89.14 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.151 0.981 . . . . 0.0 112.983 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 73.16 -46.05 0.63 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.017 1.327 . . . . 0.0 112.101 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 57.4 157.36 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.12 0.968 . . . . 0.0 112.821 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.9 m -110.91 95.1 5.34 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.81 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -139.71 102.63 4.48 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.556 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.468 HD12 ' OG ' ' A' ' 81' ' ' SER . 4.6 mt -125.13 -2.95 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.648 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.512 HG23 ' CD2' ' A' ' 73' ' ' PHE . 3.1 tp -73.04 -40.97 59.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.253 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.512 ' CD2' HG23 ' A' ' 72' ' ' ILE . 2.3 p90 -123.18 52.8 1.35 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.398 0.618 . . . . 0.0 110.939 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.7 t -93.33 -43.6 8.7 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.293 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.08 -63.04 0.21 Allowed Glycine 0 C--N 1.341 0.807 0 C-N-CA 121.161 -0.543 . . . . 0.0 113.092 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.506 ' H ' ' CD ' ' A' ' 77' ' ' PRO . 4.4 tptp -130.26 -46.38 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.84 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.62 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.506 ' CD ' ' H ' ' A' ' 76' ' ' LYS . 35.6 Cg_exo -61.28 119.75 7.06 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.261 1.974 . . . . 0.0 113.764 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 tt -149.74 10.49 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.655 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -120.18 -57.57 1.92 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.272 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.9 m -47.35 -46.84 25.98 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.191 0.996 . . . . 0.0 112.7 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.468 ' OG ' HD12 ' A' ' 71' ' ' ILE . 43.2 t -61.19 -53.04 61.91 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.887 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.493 ' OH ' ' HB ' ' A' ' 72' ' ' ILE . 73.7 m-85 -79.62 5.28 13.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.926 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.523 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 23.3 t -91.32 -47.45 7.47 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.943 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.98 160.21 4.97 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -92.07 92.13 8.13 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.219 0.533 . . . . 0.0 110.921 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.5 48.31 0.05 OUTLIER Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.98 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.584 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 2.7 tp -91.84 -29.62 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 122.623 0.369 . . . . 0.0 111.929 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.445 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 32.4 t60 -85.68 -16.97 37.35 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.526 ' HG3' ' H ' ' A' ' 90' ' ' LYS . 5.1 pt-20 -106.0 -73.72 0.67 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.987 0.179 . . . . 0.0 111.065 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.526 ' H ' ' HG3' ' A' ' 89' ' ' GLU . 2.2 ttmm -48.82 -7.21 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.584 ' HB ' ' O ' ' A' ' 87' ' ' ILE . 3.6 tp -66.53 -21.41 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 122.536 0.334 . . . . 0.0 111.229 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 tp -107.93 20.2 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.422 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -81.54 -31.99 32.48 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.769 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.08 -22.81 42.2 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -113.85 -19.54 11.45 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 123.403 0.439 . . . . 0.0 111.043 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -96.52 160.06 14.6 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.329 0.393 . . . . 0.0 110.931 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 tt -129.63 126.02 37.44 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.613 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 64.11 135.43 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.029 0.931 . . . . 0.0 111.961 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.8 m -107.06 155.46 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.402 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.6 p -126.31 -55.91 1.43 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.142 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt 56.83 115.2 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.926 0.89 . . . . 0.0 112.523 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 54.1 p -133.0 -61.78 0.82 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.107 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -145.78 27.16 1.22 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.635 0.374 . . . . 0.0 111.241 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.7 m120 64.73 133.97 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.935 0.894 . . . . 0.0 111.759 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.422 ' H ' ' HD2' ' A' ' 106' ' ' PRO . . . -92.55 -48.57 0.3 Allowed Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 118.679 -0.677 . . . . 0.0 112.766 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.422 ' HD2' ' H ' ' A' ' 105' ' ' ALA . 32.1 Cg_endo -64.2 133.73 39.27 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.053 1.836 . . . . 0.0 113.729 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.462 ' HB ' ' CE2' ' A' ' 109' ' ' TYR . 0.8 OUTLIER -125.08 158.55 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.673 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.463 ' HG2' ' NZ ' ' A' ' 146' ' ' LYS . 1.1 mp0 -97.3 124.19 41.35 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.649 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.462 ' CE2' ' HB ' ' A' ' 107' ' ' ILE . 74.9 m-85 -136.69 -54.43 0.72 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.133 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -142.84 172.42 12.73 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.409 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.0 p -81.68 -67.16 0.8 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.174 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.8 t 59.96 151.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 123.982 0.913 . . . . 0.0 112.014 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 72.9 mtm 63.09 152.68 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.921 0.888 . . . . 0.0 112.443 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -129.24 124.24 33.99 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.862 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -130.75 -43.88 1.09 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.102 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.4 mp -98.47 166.6 11.28 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.184 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 71.02 -3.48 2.02 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.376 1.07 . . . . 0.0 112.759 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -97.43 -45.1 6.57 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.396 0.278 . . . . 0.0 110.69 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.46 7.34 1.93 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.834 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -92.93 114.13 61.76 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.618 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.55 177.85 1.12 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.709 2.273 . . . . 0.0 112.863 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.68 -55.58 14.15 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.878 -0.957 . . . . 0.0 113.87 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.5 -15.17 39.51 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.732 2.288 . . . . 0.0 113.762 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.408 ' O ' HG13 ' A' ' 128' ' ' ILE . 3.2 t70 -80.05 -41.35 25.86 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.553 0.341 . . . . 0.0 111.021 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.0 mt -67.7 -39.11 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.472 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.8 -50.65 65.89 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.183 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -49.34 -40.67 36.27 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.828 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 124' ' ' ASP . 29.0 mt -66.64 -54.59 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.142 0.177 . . . . 0.0 111.436 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.2 m -60.23 -51.78 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 75.2 m -62.91 -25.49 68.35 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.2 m -83.28 -26.0 31.06 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 117.54 0.154 . . . . 0.0 111.297 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.5 mt -81.15 -38.55 26.99 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.592 0.234 . . . . 0.0 111.031 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -88.45 8.81 26.1 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.822 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.577 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.1 tmt_? -82.17 -40.63 21.51 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.987 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.523 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 87.6 m-70 -100.4 -9.4 22.25 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.457 0.473 . . . . 0.0 111.298 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 67.67 70.21 0.35 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.178 0.991 . . . . 0.0 111.326 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.522 ' OE1' HG22 ' A' ' 87' ' ' ILE . 43.5 mt-10 -90.7 129.13 36.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.437 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 138' ' ' VAL . 0.5 OUTLIER -78.16 -45.15 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -178.386 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -76.16 -18.53 79.29 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.579 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.62 -11.58 17.61 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 124.041 0.495 . . . . 0.0 111.033 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -51.78 -34.76 41.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.643 0.777 . . . . 0.0 112.461 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.533 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 8.0 m-20 -74.57 -36.62 63.06 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.434 0.459 . . . . 0.0 111.495 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.445 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 14.3 tp -67.39 -60.24 2.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.74 0.416 . . . . 0.0 110.884 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.49 -43.6 85.42 Favored Glycine 0 C--N 1.343 0.947 0 O-C-N 123.618 0.574 . . . . 0.0 113.928 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -60.64 -43.6 97.35 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.533 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -61.97 -40.19 94.73 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.3 mt -67.11 -30.75 70.85 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 123.264 0.352 . . . . 0.0 110.302 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -94.25 9.84 36.44 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.367 0.417 . . . . 0.0 110.703 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 3.7 t70 -114.27 16.49 17.93 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.694 0.283 . . . . 0.0 111.082 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.6 -8.29 57.63 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.826 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.466 ' HG ' ' H ' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -101.08 -58.35 1.91 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.635 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.466 ' H ' ' HG ' ' A' ' 151' ' ' LEU . 4.2 t70 58.41 122.9 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.141 0.976 . . . . 0.0 112.347 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -97.79 148.9 22.91 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.142 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.137 -0.935 . . . . 0.0 110.87 179.938 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.8 t . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.539 0.209 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -116.51 -42.35 3.01 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.31 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.72 -45.69 1.13 Allowed Glycine 0 C--N 1.34 0.777 0 O-C-N 123.435 0.46 . . . . 0.0 112.687 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.438 ' H ' HD23 ' A' ' 57' ' ' LEU . 0.5 OUTLIER -95.63 158.53 15.41 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.404 0.282 . . . . 0.0 111.225 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.21 -95.83 1.07 Allowed Glycine 0 C--N 1.341 0.848 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.77 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -120.0 -48.5 2.34 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.579 0.223 . . . . 0.0 110.945 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.08 149.35 42.34 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 123.289 0.368 . . . . 0.0 111.492 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -127.07 119.36 26.38 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.796 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.582 ' H ' ' CD ' ' A' ' 63' ' ' PRO . 7.0 m-20 -132.54 -41.62 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.785 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.582 ' CD ' ' H ' ' A' ' 62' ' ' ASP . 19.6 Cg_exo -67.07 -34.75 27.66 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.13 1.887 . . . . 0.0 113.597 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mp -108.53 121.11 44.29 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.23 0.331 . . . . 0.0 111.114 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.442 ' OD2' ' HG2' ' A' ' 66' ' ' LYS . 2.6 p-10 -137.01 -57.4 0.72 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.047 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.442 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 52.2 pttt -152.84 111.33 3.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.515 0.326 . . . . 0.0 111.235 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -120.38 -60.8 1.65 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.076 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.453 ' HB2' ' OG ' ' A' ' 74' ' ' SER . 50.7 m-85 -146.32 -33.85 0.31 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.751 0.42 . . . . 0.0 111.218 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.508 ' N ' ' HB3' ' A' ' 74' ' ' SER . 57.3 m 62.28 22.21 13.03 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.095 0.958 . . . . 0.0 112.858 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -138.48 -20.12 1.06 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.508 ' H ' ' HB2' ' A' ' 74' ' ' SER . 0.7 OUTLIER -81.14 -174.4 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 122.448 0.299 . . . . 0.0 111.561 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.465 HG23 ' CD2' ' A' ' 73' ' ' PHE . 1.6 tt -59.8 -41.69 86.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.465 ' CD2' HG23 ' A' ' 72' ' ' ILE . 66.0 m-85 -111.47 18.74 18.86 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 120.715 0.293 . . . . 0.0 111.773 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.508 ' HB2' ' H ' ' A' ' 71' ' ' ILE . 0.4 OUTLIER -96.76 -43.03 7.7 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.03 -141.51 3.15 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.103 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -92.9 -44.49 0.33 Allowed Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 118.69 -0.672 . . . . 0.0 112.255 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.86 137.21 75.04 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.332 2.021 . . . . 0.0 113.432 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 tp -143.16 37.51 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.36 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 83' ' ' SER . 37.5 tt0 -120.03 -60.82 1.66 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.835 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.5 m -52.17 -56.42 14.7 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.589 0.755 . . . . 0.0 112.196 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.0 p -60.59 -53.72 54.02 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.958 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.501 ' HB3' HG21 ' A' ' 131' ' ' THR . 3.9 m-85 -69.21 -0.31 5.88 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.6 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 10.9 t -95.55 -43.48 7.93 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.51 161.96 26.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.271 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.637 ' HA ' ' OE1' ' A' ' 137' ' ' GLU . 19.3 mtpp -86.19 145.99 26.75 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.083 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.65 18.68 27.15 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.255 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -79.23 -19.36 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 122.528 0.331 . . . . 0.0 111.717 179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.538 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 75.2 t60 -82.83 -4.48 58.11 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.169 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -120.97 -46.39 2.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.525 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.541 ' HD2' ' O ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -68.81 -4.51 16.43 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.0 tt -80.55 -22.11 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 122.561 0.344 . . . . 0.0 111.681 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.9 mm -95.96 1.62 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 O-C-N 123.352 0.407 . . . . 0.0 110.459 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -87.67 -34.67 18.36 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.465 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.63 -16.84 58.31 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -95.45 -10.98 28.34 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.437 0.461 . . . . 0.0 111.175 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -95.27 104.53 16.42 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.943 0.402 . . . . 0.0 110.545 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.4 tp -143.04 -30.36 0.52 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.073 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 65.8 m80 64.39 122.4 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.942 0.897 . . . . 0.0 111.817 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 t -123.1 148.35 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.9 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 p -112.39 122.95 49.17 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.966 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt 56.36 105.59 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.949 0.899 . . . . 0.0 112.278 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.4 p -138.55 -50.52 0.55 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.895 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -139.89 153.49 47.0 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.384 0.427 . . . . 0.0 111.03 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -124.42 -44.47 1.99 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.049 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.726 ' H ' ' HD2' ' A' ' 106' ' ' PRO . . . -126.58 -50.93 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.812 0 CA-C-O 118.432 -0.794 . . . . 0.0 112.609 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.726 ' HD2' ' H ' ' A' ' 105' ' ' ALA . 28.1 Cg_endo -62.87 134.96 49.25 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.074 1.849 . . . . 0.0 113.646 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.5 pt -142.58 150.96 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.949 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -124.77 -61.36 1.32 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.233 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -145.37 -46.34 0.22 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.288 0.367 . . . . 0.0 110.883 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 66.47 -68.0 0.14 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.365 1.066 . . . . 0.0 112.774 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.7 p -142.18 161.46 37.96 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.086 0.241 . . . . 0.0 111.349 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.2 p -91.59 152.88 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.648 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 71.9 mtm -98.74 116.51 31.13 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.455 0.472 . . . . 0.0 111.576 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 59.51 -75.37 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.567 1.147 . . . . 0.0 113.246 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -131.97 162.51 30.53 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.384 0.274 . . . . 0.0 111.551 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.612 HD22 ' H ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -88.38 123.35 32.86 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.637 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -147.33 -39.3 0.19 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.527 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.06 -8.09 46.89 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.632 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.2 -46.61 10.91 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.236 0.335 . . . . 0.0 111.08 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -98.28 161.36 25.61 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 123.495 0.497 . . . . 0.0 110.902 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.17 -31.01 24.06 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.467 2.112 . . . . 0.0 113.419 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 152.1 -52.66 0.48 Allowed Glycine 0 CA--C 1.531 1.077 0 CA-C-O 118.781 -1.01 . . . . 0.0 113.751 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.87 -17.52 18.92 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.986 2.457 . . . . 0.0 114.847 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -74.93 -42.1 58.36 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.313 0.245 . . . . 0.0 111.453 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.535 ' O ' HG22 ' A' ' 129' ' ' VAL . 4.6 mp -62.7 -32.69 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.794 0.438 . . . . 0.0 110.667 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -70.19 -50.53 39.2 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.68 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.62 -46.26 70.38 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.476 HG23 ' CE1' ' A' ' 82' ' ' TYR . 23.3 mt -61.17 -59.36 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 122.532 0.333 . . . . 0.0 111.488 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 125' ' ' ILE . 16.5 m -53.42 -41.94 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 123.49 0.494 . . . . 0.0 112.078 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 12.9 t -68.25 -26.48 65.7 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.501 HG21 ' HB3' ' A' ' 82' ' ' TYR . 20.5 m -72.06 -40.8 68.06 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.238 0.215 . . . . 0.0 110.933 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.526 HD22 ' N ' ' A' ' 144' ' ' GLY . 4.1 mp -77.1 -24.54 51.76 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.283 0.365 . . . . 0.0 111.508 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -91.13 12.1 21.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.272 0.558 . . . . 0.0 110.324 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.9 tmt_? -118.95 -36.64 3.38 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.128 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.6 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 52.2 m-70 -90.18 -32.17 16.73 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.912 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.9 t70 60.62 61.16 1.77 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.064 0.945 . . . . 0.0 111.674 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.637 ' OE1' ' HA ' ' A' ' 85' ' ' LYS . 37.1 mt-10 -84.99 130.22 34.66 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.641 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.474 ' O ' ' HD2' ' A' ' 141' ' ' LYS . 3.4 t -79.8 -22.42 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.404 0.44 . . . . 0.0 111.645 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -87.09 -19.05 56.66 Favored Glycine 0 C--N 1.342 0.884 0 C-N-CA 121.424 -0.417 . . . . 0.0 112.742 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.89 3.25 11.05 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.893 0.477 . . . . 0.0 111.374 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER -48.05 -42.33 28.25 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.783 0.833 . . . . 0.0 112.617 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 2.4 p-10 -68.21 -40.96 81.98 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.532 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.538 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 32.6 tp -56.18 -51.92 66.26 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.56 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.526 ' N ' HD22 ' A' ' 132' ' ' LEU . . . -60.92 -60.78 7.84 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.923 -0.581 . . . . 0.0 113.654 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -54.97 -42.11 72.01 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -63.54 -32.81 74.39 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.112 0.258 . . . . 0.0 111.518 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.0 mt -70.82 -30.93 67.5 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.295 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.413 ' HD3' ' O ' ' A' ' 148' ' ' ARG . 1.0 OUTLIER -98.93 4.47 47.37 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 123.153 0.283 . . . . 0.0 111.041 178.806 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 1.8 t70 -99.24 24.77 7.55 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.84 0.352 . . . . 0.0 111.2 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.36 -4.81 58.82 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.022 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.7 tt -104.19 -48.92 3.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.763 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -120.08 153.18 36.49 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 123.297 0.373 . . . . 0.0 110.887 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.72 126.61 44.9 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.976 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 117.989 -1.005 . . . . 0.0 112.144 -179.868 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.451 0.167 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -111.32 -45.2 3.43 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.895 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.0 136.46 4.46 Favored Glycine 0 C--N 1.339 0.741 0 O-C-N 123.484 0.49 . . . . 0.0 112.668 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.91 158.25 27.08 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 122.422 0.289 . . . . 0.0 110.962 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.6 -143.82 11.39 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.725 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -99.75 -49.16 4.46 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 123.563 0.213 . . . . 0.0 111.122 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.21 124.61 46.11 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.309 0.38 . . . . 0.0 111.203 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -133.0 102.07 5.47 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.338 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -141.84 159.39 59.74 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.636 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.69 129.02 19.02 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.445 2.097 . . . . 0.0 112.787 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.46 ' O ' HD23 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -97.39 7.15 47.08 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.121 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.6 t70 65.29 176.0 0.21 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.898 0.879 . . . . 0.0 111.294 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.43 ' HD3' ' H ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -70.76 118.57 13.71 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.823 0.344 . . . . 0.0 111.507 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -112.91 -43.81 3.37 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.366 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -99.06 121.54 41.12 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.429 0.456 . . . . 0.0 110.414 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 40.4 p -120.11 126.2 50.16 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.146 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -130.62 103.79 6.83 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.296 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.442 ' O ' ' N ' ' A' ' 73' ' ' PHE . 3.4 mt -129.66 -71.69 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.681 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.644 HG23 ' H ' ' A' ' 73' ' ' PHE . 4.4 tp 45.51 -74.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 124.969 1.308 . . . . 0.0 113.323 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.644 ' H ' HG23 ' A' ' 72' ' ' ILE . 11.9 t80 -135.4 90.26 2.6 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.233 0.539 . . . . 0.0 110.231 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 t -97.28 -39.78 9.07 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.964 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.96 -84.75 0.05 OUTLIER Glycine 0 C--N 1.34 0.769 0 O-C-N 123.475 0.484 . . . . 0.0 112.501 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.701 ' H ' ' CD ' ' A' ' 77' ' ' PRO . 14.0 ptmt -136.87 -30.81 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.701 ' CD ' ' H ' ' A' ' 76' ' ' LYS . 12.4 Cg_exo -71.87 135.06 24.85 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.103 1.869 . . . . 0.0 113.583 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 tt -135.82 -0.08 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.461 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -103.96 -43.52 5.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.842 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 m -63.53 -63.06 1.28 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.402 ' OG ' HD13 ' A' ' 71' ' ' ILE . 11.4 t -45.24 -25.39 0.37 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -104.29 -10.9 17.5 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.8 t -91.91 -25.01 19.12 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.91 118.07 2.92 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.98 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.506 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 12.4 ptmt -60.64 105.61 0.46 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.86 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.23 75.58 1.3 Allowed Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.295 -0.866 . . . . 0.0 114.256 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.67 HG23 ' H ' ' A' ' 88' ' ' HIS . 8.1 tt -106.65 -103.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.67 ' H ' HG23 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -58.86 -2.94 0.27 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 178.285 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 138' ' ' VAL . 13.2 tt0 -69.08 -14.93 63.3 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.19 -21.04 24.79 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 88' ' ' HIS . 3.8 tp -89.48 26.71 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-O 121.195 0.521 . . . . 0.0 110.843 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.553 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 3.3 tp -136.8 -10.61 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.331 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -120.48 -36.07 3.28 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.289 0.368 . . . . 0.0 111.085 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.37 -31.95 71.85 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.953 0.501 . . . . 0.0 111.916 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -120.9 -53.84 2.05 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.95 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 17.8 t70 43.18 77.86 0.06 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.515 1.126 . . . . 0.0 112.52 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.0 mt -148.56 138.16 22.05 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.465 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -98.55 -44.56 6.42 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 123.491 0.495 . . . . 0.0 110.668 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 m -143.67 109.21 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.7 t -130.21 152.52 49.55 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.011 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.4 tptt -98.84 157.17 16.48 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.478 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.9 m -87.95 121.76 30.75 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.124 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -132.51 -45.89 0.9 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.406 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -122.68 -45.02 2.19 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.029 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -128.32 137.21 30.38 Favored Pre-proline 0 CA--C 1.534 0.353 0 O-C-N 123.306 0.379 . . . . 0.0 111.251 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.4 161.48 44.18 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.649 2.232 . . . . 0.0 113.117 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.4 tp -117.31 -27.5 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.392 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -93.07 130.1 38.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.278 0.361 . . . . 0.0 111.03 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -130.46 -39.72 1.29 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.138 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 64.05 132.05 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.929 0.892 . . . . 0.0 112.343 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 56.1 m -113.14 152.87 29.11 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.007 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.9 m -95.51 -26.94 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.108 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.6 mmt -89.9 34.11 0.85 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.147 0.498 . . . . 0.0 111.273 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -94.04 179.88 5.18 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.862 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 66.86 123.17 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.053 0.941 . . . . 0.0 111.863 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 120' ' ' TYR . 5.2 mt -107.59 16.5 23.68 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.501 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -92.47 -11.69 34.01 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.815 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -96.54 -38.4 10.0 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.108 0.255 . . . . 0.0 111.674 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.8 t -94.4 -42.45 8.87 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 123.316 0.385 . . . . 0.0 111.638 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 116' ' ' LEU . 6.3 m-30 -97.86 119.39 62.43 Favored Pre-proline 0 CA--C 1.543 0.707 0 O-C-N 123.429 0.455 . . . . 0.0 110.67 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.87 -48.81 0.35 Allowed 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.638 2.225 . . . . 0.0 114.041 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -171.03 -63.92 0.04 OUTLIER Glycine 0 C--N 1.342 0.891 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.448 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.08 -30.45 78.87 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.061 2.507 . . . . 0.0 113.85 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.8 -21.58 66.04 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.347 0.404 . . . . 0.0 111.977 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.575 ' HA ' HD12 ' A' ' 128' ' ' ILE . 6.9 mt -89.41 -50.13 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -45.53 -41.18 9.46 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.649 0.78 . . . . 0.0 112.082 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -62.17 -42.76 99.57 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.967 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.575 HD12 ' HA ' ' A' ' 125' ' ' ILE . 14.8 mt -61.51 -61.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.962 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 144' ' ' GLY . 3.4 m -49.16 -31.27 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 18.3 t -76.76 -50.36 13.75 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.04 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.5 m -56.55 -33.89 66.55 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.748 HD23 ' HB1' ' A' ' 140' ' ' ALA . 4.5 mp -79.24 -48.99 13.2 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.645 0.202 . . . . 0.0 111.243 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -56.29 -20.41 18.58 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -79.58 -45.27 19.49 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.28 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.506 ' NE2' ' HA ' ' A' ' 85' ' ' LYS . 50.0 t-80 -64.97 -41.51 95.39 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 72.9 80.4 0.14 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.032 0.933 . . . . 0.0 111.162 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.866 ' HB2' ' HB3' ' A' ' 140' ' ' ALA . 20.5 mt-10 -125.09 153.59 42.71 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.157 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.456 ' H ' ' HG3' ' A' ' 89' ' ' GLU . 5.3 t -83.9 -40.23 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 88' ' ' HIS . . . -86.9 -15.49 62.96 Favored Glycine 0 N--CA 1.47 0.931 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.402 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.866 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . . . -95.98 -17.47 20.98 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 113.832 -1.184 . . . . 0.0 109.771 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.838 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 3.2 tptm -70.04 -22.38 63.09 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 9.8 m-20 -81.17 -28.42 35.0 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.767 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.2 tp -76.51 -63.38 1.35 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.867 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.5 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -61.87 -26.59 67.32 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.541 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . -85.27 -39.81 17.31 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.581 0.691 . . . . 0.0 112.409 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -70.47 -31.85 69.15 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 121.331 -0.148 . . . . 0.0 111.009 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.7 mt -71.27 -45.12 63.88 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 123.126 0.266 . . . . 0.0 110.406 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -66.07 -21.67 66.38 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 178.564 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -95.56 -13.19 24.64 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 123.322 0.389 . . . . 0.0 111.378 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -87.85 -8.31 56.03 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.193 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.1 tt -98.4 -41.76 7.66 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.525 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -90.25 124.23 34.7 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 123.353 0.408 . . . . 0.0 111.08 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -115.67 132.76 56.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.844 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 . . . . . 0 N--CA 1.484 1.268 0 C-N-CA 123.843 0.857 . . . . 0.0 112.076 -179.943 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.4 m . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.333 0.111 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -100.14 -43.03 6.46 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 123.389 0.431 . . . . 0.0 110.919 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.29 -53.38 0.07 OUTLIER Glycine 0 C--N 1.341 0.806 0 O-C-N 123.373 0.421 . . . . 0.0 112.585 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.71 141.0 33.09 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.642 0.26 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.72 179.32 17.21 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.739 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 56.23 25.55 9.37 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.789 0.836 . . . . 0.0 112.76 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.54 -12.63 29.14 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.93 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -133.84 127.41 32.54 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.64 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -127.15 96.97 32.85 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.786 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.36 135.49 22.51 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.608 2.205 . . . . 0.0 112.71 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.479 HD21 ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -118.51 -3.08 10.93 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.62 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 t70 72.18 -48.71 0.68 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.562 1.145 . . . . 0.0 111.97 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -128.98 130.62 46.92 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.239 0.337 . . . . 0.0 111.051 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.479 ' CE2' HD21 ' A' ' 64' ' ' LEU . 86.2 m-85 -94.9 -12.86 26.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.713 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -92.91 28.65 2.02 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 120.93 0.395 . . . . 0.0 111.77 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.6 p -91.09 -43.4 9.93 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.575 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.593 ' HB3' HG22 ' A' ' 72' ' ' ILE . 1.8 mptp? 63.88 155.64 0.06 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.938 0.895 . . . . 0.0 112.317 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -92.91 -8.74 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.808 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.593 HG22 ' HB3' ' A' ' 70' ' ' LYS . 3.9 tp -72.53 -41.42 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.471 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.408 ' CD1' HG23 ' A' ' 72' ' ' ILE . 47.1 m-85 -89.71 15.57 9.42 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 123.375 0.422 . . . . 0.0 111.45 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.7 t -92.83 158.6 15.78 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.809 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.92 81.63 1.52 Allowed Glycine 0 C--N 1.34 0.759 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.771 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -128.19 157.31 74.67 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 119.319 -0.372 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.85 6.9 4.6 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.682 2.254 . . . . 0.0 113.564 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.434 HG23 ' CG ' ' A' ' 82' ' ' TYR . 4.5 mp 58.2 51.29 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.636 0.774 . . . . 0.0 110.958 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 83' ' ' SER . 4.9 mm-40 -120.81 -89.41 0.6 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.695 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.9 m -54.04 -43.36 70.13 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.89 0.876 . . . . 0.0 112.602 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.49 ' O ' HG13 ' A' ' 87' ' ' ILE . 24.1 p -68.46 -41.14 80.63 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.71 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.434 ' CG ' HG23 ' A' ' 78' ' ' ILE . 10.2 m-85 -94.33 13.05 24.83 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.247 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 26.3 t -110.02 -25.51 10.21 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.03 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.19 164.34 26.18 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.728 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -95.06 135.56 36.45 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.511 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' A' ' 90' ' ' LYS . . . 77.36 55.82 4.17 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.898 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.549 HD13 ' O ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -113.61 -13.25 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.596 ' HB3' ' O ' ' A' ' 139' ' ' GLY . 61.5 t60 -102.67 -65.77 0.97 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 117.859 0.299 . . . . 0.0 111.732 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -94.52 50.19 1.33 Allowed 'General case' 0 C--O 1.239 0.551 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 86' ' ' GLY . 18.6 mmtp -121.32 -20.96 6.5 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.13 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.422 ' O ' ' HD2' ' A' ' 95' ' ' HIS . 2.0 tt -71.9 -13.35 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.747 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.0 tt -74.38 -23.94 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.658 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -73.23 -27.73 61.76 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.148 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.16 -29.71 24.54 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.849 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.433 ' NE2' ' HB3' ' A' ' 67' ' ' PHE . 46.7 m-70 -85.97 -9.58 56.62 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.855 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -91.13 123.2 34.4 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.697 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 pp -134.82 141.01 46.29 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.094 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 67.9 m80 63.55 145.6 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.069 0.948 . . . . 0.0 112.374 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 m -110.07 -18.04 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.99 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.7 m -89.42 -13.99 36.46 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.325 0.391 . . . . 0.0 111.88 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.51 ' HD3' ' N ' ' A' ' 102' ' ' SER . 0.8 OUTLIER -92.15 158.67 16.05 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.557 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.51 ' N ' ' HD3' ' A' ' 101' ' ' LYS . 52.2 m -73.54 145.81 45.26 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.594 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -96.85 124.94 40.96 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.132 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -134.14 122.05 22.31 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.644 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -129.71 142.82 46.64 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.185 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.92 134.5 23.69 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.547 2.165 . . . . 0.0 113.048 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.504 HD12 ' N ' ' A' ' 108' ' ' GLN . 1.5 pp -139.8 -35.84 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.859 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.504 ' N ' HD12 ' A' ' 107' ' ' ILE . 38.6 mt-30 -102.25 147.79 26.23 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.354 0.409 . . . . 0.0 110.973 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 61.78 115.84 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.935 0.894 . . . . 0.0 111.984 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 58.67 112.96 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.949 0.9 . . . . 0.0 112.525 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.6 m -135.48 136.54 41.36 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.919 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.48 15.3 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.826 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 89.2 mtp -91.16 -41.68 10.87 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.679 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -129.72 -13.23 4.23 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.407 0.442 . . . . 0.0 111.869 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -91.67 109.29 20.59 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.03 0.443 . . . . 0.0 111.454 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.66 HD13 HD21 ' A' ' 147' ' ' LEU . 1.2 mp -123.59 -156.72 0.72 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.422 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? 73.52 -0.27 3.42 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.203 1.001 . . . . 0.0 111.722 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.9 mmpt? -103.9 -33.47 8.84 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.018 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.28 -42.84 8.33 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.545 0.528 . . . . 0.0 111.27 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -85.55 159.27 55.94 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 119.336 -0.364 . . . . 0.0 111.425 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.83 -37.61 1.58 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.536 2.157 . . . . 0.0 113.389 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 160.94 -55.46 0.32 Allowed Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.776 -1.013 . . . . 0.0 113.646 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.58 -24.97 38.96 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.973 2.448 . . . . 0.0 114.364 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -65.63 -40.47 92.59 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.254 0.346 . . . . 0.0 111.327 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.581 ' O ' HG22 ' A' ' 129' ' ' VAL . 4.8 mp -69.25 -46.57 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.456 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -53.0 -39.03 62.81 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.145 0.578 . . . . 0.0 112.223 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -70.79 -48.44 54.25 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.378 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.2 mt -55.87 -48.86 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.088 0.555 . . . . 0.0 111.657 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 125' ' ' ILE . 4.9 m -61.66 -52.98 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.0 t -55.77 -51.59 66.88 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.3 m -60.13 -29.71 68.81 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.636 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 27.6 mt -79.25 -32.23 43.71 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -79.6 -4.95 53.87 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.307 0.243 . . . . 0.0 111.57 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -82.91 -47.14 12.12 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.887 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.636 ' NE2' ' HA ' ' A' ' 132' ' ' LEU . 9.2 p80 -85.03 -35.6 21.81 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.562 0.345 . . . . 0.0 111.584 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 t70 64.5 11.81 6.89 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.255 1.022 . . . . 0.0 113.622 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.537 ' HG2' ' CE1' ' A' ' 135' ' ' HIS . 12.7 pt-20 -47.09 153.29 0.46 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.98 -30.68 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -79.94 3.37 70.73 Favored Glycine 0 N--CA 1.466 0.645 0 O-C-N 123.374 0.421 . . . . 0.0 113.67 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -144.95 -3.49 0.77 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.388 0.675 . . . . 0.0 112.105 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.47 -42.24 70.43 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 123.822 0.849 . . . . 0.0 112.768 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 3.9 p-10 -65.98 -38.48 88.63 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.572 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.484 ' HB2' ' CE1' ' A' ' 88' ' ' HIS . 44.6 tp -61.65 -50.63 71.73 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.44 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -62.69 -62.65 5.33 Favored Glycine 0 C--N 1.343 0.958 0 N-CA-C 115.171 0.828 . . . . 0.0 115.171 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -58.85 -36.91 75.36 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 14.1 mptt -71.97 -33.23 68.01 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.494 0.134 . . . . 0.0 111.326 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.66 HD21 HD13 ' A' ' 116' ' ' LEU . 0.5 OUTLIER -72.92 -31.81 64.88 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 123.292 0.37 . . . . 0.0 110.845 177.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -79.75 -40.91 27.73 Favored 'General case' 0 C--N 1.348 0.523 0 O-C-N 123.415 0.447 . . . . 0.0 110.139 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -85.56 45.04 1.15 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.241 0.543 . . . . 0.0 111.446 179.218 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -87.25 -9.09 55.97 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.941 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 151' ' ' LEU . 1.3 mm? -119.9 -37.38 3.11 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.396 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -86.57 171.32 11.13 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.183 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 73.6 mtm180 -77.45 132.55 38.51 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.557 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.486 -0.769 . . . . 0.0 111.126 -179.976 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.3 p . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 111.307 0.114 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -99.09 -43.61 6.6 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.552 0.532 . . . . 0.0 111.152 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.09 112.12 4.16 Favored Glycine 0 C--N 1.34 0.769 0 O-C-N 123.464 0.477 . . . . 0.0 112.438 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.1 tt -99.77 -44.06 6.22 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 123.62 0.247 . . . . 0.0 111.044 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.36 -54.8 0.76 Allowed Glycine 0 C--N 1.34 0.803 0 C-N-CA 121.368 -0.444 . . . . 0.0 112.731 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.19 167.64 11.24 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.658 0.27 . . . . 0.0 111.318 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 64.89 124.67 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.048 0.939 . . . . 0.0 112.011 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -129.32 176.14 8.18 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.285 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -76.8 158.9 80.01 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 122.838 0.455 . . . . 0.0 111.412 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.21 -31.08 82.59 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.687 2.258 . . . . 0.0 113.925 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.8 tp -98.1 121.87 40.55 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.416 0.448 . . . . 0.0 110.49 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -132.02 -25.05 2.07 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.851 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -91.5 117.2 29.49 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.248 0.342 . . . . 0.0 111.049 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -120.22 10.56 11.36 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.396 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -81.75 -92.46 0.06 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.333 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.458 ' OG ' ' HB3' ' A' ' 109' ' ' TYR . 74.2 m 54.73 121.95 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.181 0.993 . . . . 0.0 112.686 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -96.44 161.08 14.07 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.347 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mt -86.14 6.24 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.97 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.5 tp -63.01 110.22 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.413 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.9 t80 55.88 71.71 0.54 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.981 0.913 . . . . 0.0 111.82 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.3 t -107.3 -42.05 4.94 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.914 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.69 -52.23 0.02 OUTLIER Glycine 0 C--N 1.341 0.811 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.357 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -98.24 161.85 23.98 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.648 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.528 ' O ' HG13 ' A' ' 78' ' ' ILE . 6.5 Cg_exo -74.47 59.67 4.82 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.562 2.174 . . . . 0.0 112.666 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 77' ' ' PRO . 1.6 pp 42.63 66.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 124.665 1.186 . . . . 0.0 113.126 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -120.36 -59.11 1.8 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.338 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.9 m -62.33 -56.04 22.25 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.444 0.697 . . . . 0.0 112.86 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.8 m -56.51 -55.49 33.07 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.632 0.373 . . . . 0.0 111.937 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.518 ' CD1' ' HB ' ' A' ' 78' ' ' ILE . 36.2 m-85 -58.98 -27.99 65.91 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.9 t -70.82 -28.41 64.59 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.31 0.381 . . . . 0.0 110.608 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.77 171.45 11.59 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.561 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -100.02 78.59 2.11 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.224 0.535 . . . . 0.0 110.408 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 90' ' ' LYS . . . 143.87 70.21 0.02 OUTLIER Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.411 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.5 tp -100.6 -29.66 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 122.44 0.296 . . . . 0.0 111.73 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.474 ' ND1' HD22 ' A' ' 143' ' ' LEU . 18.1 t60 -111.53 -18.7 12.77 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.154 0.284 . . . . 0.0 110.55 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -116.64 48.31 1.31 Allowed 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.55 0.531 . . . . 0.0 110.694 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 54.8 tttt -121.1 -14.32 8.41 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.57 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.2 mt -74.35 -9.35 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 122.854 0.461 . . . . 0.0 111.225 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.0 mm -87.17 -15.57 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.346 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -82.42 -32.83 28.87 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.338 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.26 -26.47 58.84 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.222 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -90.68 -12.33 37.07 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 123.429 0.456 . . . . 0.0 111.303 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -97.19 106.46 18.79 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.939 0.4 . . . . 0.0 110.594 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.6 tp -141.54 152.03 43.75 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.476 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -100.71 -106.88 0.23 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.838 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 m -150.8 15.09 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.8 p -89.79 -90.39 0.14 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -154.65 155.87 35.46 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.603 0.361 . . . . 0.0 110.785 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.6 m -109.0 -77.18 0.6 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.519 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -164.74 -62.62 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.039 0.536 . . . . 0.0 110.087 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -149.88 161.16 42.83 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.995 0.518 . . . . 0.0 110.082 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.633 ' HB3' ' HD3' ' A' ' 106' ' ' PRO . . . -91.07 -56.78 0.25 Allowed Pre-proline 0 CA--C 1.547 0.835 0 CA-C-O 118.67 -0.681 . . . . 0.0 111.665 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.633 ' HD3' ' HB3' ' A' ' 105' ' ' ALA . 2.1 Cg_endo -84.18 102.54 0.92 Allowed 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.353 2.035 . . . . 0.0 112.553 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.2 pt -147.98 -49.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.664 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 50.54 149.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.171 1.388 . . . . 0.0 113.907 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.458 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 78.2 m-85 -106.61 156.16 18.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.101 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.65 153.0 19.99 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.388 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.7 p -94.45 144.29 25.69 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.309 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.2 t -101.54 141.44 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.869 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.8 ptp -131.59 148.0 52.57 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.207 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 64.03 159.45 0.09 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.005 0.922 . . . . 0.0 112.369 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -89.09 -178.3 5.65 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.425 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.487 HD23 ' CE1' ' A' ' 120' ' ' TYR . 5.2 mt -80.14 50.8 1.28 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.972 0.509 . . . . 0.0 111.608 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -140.3 -40.24 0.43 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.644 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -94.93 -39.27 10.29 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.85 -6.39 59.1 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.254 0.346 . . . . 0.0 111.901 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.487 ' CE1' HD23 ' A' ' 116' ' ' LEU . 39.8 m-85 -123.75 134.32 25.23 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.683 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 2.9 Cg_exo -75.15 -45.45 0.27 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.586 2.191 . . . . 0.0 113.646 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 163.1 -61.85 0.26 Allowed Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.887 -0.951 . . . . 0.0 112.957 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.28 -30.01 78.69 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.898 2.399 . . . . 0.0 113.516 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.36 -25.66 67.68 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.508 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.697 ' HA ' HD12 ' A' ' 128' ' ' ILE . 13.4 mt -86.88 -36.52 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.725 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.25 -36.54 68.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.61 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -77.02 -11.04 59.75 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.189 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.697 HD12 ' HA ' ' A' ' 125' ' ' ILE . 80.9 mt -83.73 -47.66 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 144' ' ' GLY . 4.4 m -69.28 -34.68 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.628 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.5 t -66.58 -52.4 45.79 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.651 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.3 m -64.71 -27.51 68.96 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.547 ' HA ' ' CE1' ' A' ' 135' ' ' HIS . 30.1 mt -79.14 -39.79 32.62 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 129' ' ' VAL . 12.1 pt-20 -71.52 -6.82 43.44 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -79.17 -69.41 0.58 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.141 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.572 ' ND1' ' HG2' ' A' ' 137' ' ' GLU . 5.7 p80 -65.01 -35.5 81.38 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.4 t70 57.49 61.65 2.41 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.871 0.868 . . . . 0.0 111.641 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.572 ' HG2' ' ND1' ' A' ' 135' ' ' HIS . 11.1 pt-20 -107.14 139.02 42.23 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.409 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.3 153.09 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.848 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . 96.73 -17.94 58.38 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -138.78 -16.67 1.12 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.113 0.965 . . . . 0.0 111.055 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -68.92 -29.57 67.86 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 123.906 0.883 . . . . 0.0 111.235 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.571 ' O ' ' HG2' ' A' ' 146' ' ' LYS . 2.4 p-10 -72.13 -43.7 64.29 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.604 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.474 HD22 ' ND1' ' A' ' 88' ' ' HIS . 12.3 tp -58.11 -63.97 1.07 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.578 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.497 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -48.96 -43.67 31.36 Favored Glycine 0 C--N 1.345 1.043 0 O-C-N 123.959 0.787 . . . . 0.0 114.38 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.42 -45.32 84.73 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 142' ' ' ASP . 5.7 mmmt -63.18 -45.39 92.01 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.0 mt -58.17 -36.96 73.79 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.676 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -77.99 -39.29 42.77 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 120.647 0.261 . . . . 0.0 110.554 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.91 3.99 18.17 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.406 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 151' ' ' LEU . . . -74.31 106.44 5.94 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.447 ' HB3' ' O ' ' A' ' 150' ' ' ALA . 8.5 tt 80.63 -25.72 0.17 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.958 0.903 . . . . 0.0 112.41 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.34 -74.8 0.08 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -150.66 106.97 3.47 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.8 0.333 . . . . 0.0 111.474 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.516 -0.754 . . . . 0.0 111.055 179.811 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.7 p . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.463 0.173 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 70.42 -53.77 0.64 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.444 1.098 . . . . 0.0 112.292 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.27 55.81 1.09 Allowed Glycine 0 C--N 1.341 0.838 0 C-N-CA 121.474 -0.393 . . . . 0.0 112.564 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.411 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.4 pp -119.14 132.73 56.01 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 123.681 0.283 . . . . 0.0 111.174 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -145.15 120.22 1.34 Allowed Glycine 0 C--N 1.337 0.609 0 O-C-N 123.711 0.632 . . . . 0.0 112.534 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -119.98 -14.82 8.87 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.57 134.89 34.56 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.321 0.388 . . . . 0.0 111.34 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -127.61 163.68 23.68 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.681 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -86.8 142.83 34.73 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.732 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.89 141.83 66.57 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.489 2.126 . . . . 0.0 113.16 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.58 HD22 ' CZ ' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -129.52 175.11 9.04 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.582 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.432 ' H ' ' HG ' ' A' ' 64' ' ' LEU . 7.3 m-20 -85.28 43.93 1.05 Allowed 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.21 0.529 . . . . 0.0 111.358 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 64.19 138.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.083 0.953 . . . . 0.0 112.248 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.58 ' CZ ' HD22 ' A' ' 64' ' ' LEU . 68.6 m-85 -94.77 -46.22 7.0 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.322 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -113.37 128.43 56.46 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.416 0.448 . . . . 0.0 111.48 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.5 p -120.07 26.95 8.94 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.736 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.63 ' NZ ' ' HB ' ' A' ' 72' ' ' ILE . 1.4 ttpm? -85.59 -175.88 5.83 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.35 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.472 HD12 ' OG ' ' A' ' 81' ' ' SER . 3.3 mt -79.89 -0.24 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 122.968 0.507 . . . . 0.0 111.426 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.63 ' HB ' ' NZ ' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -67.86 -31.91 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.096 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -106.01 -3.04 22.11 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.193 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 t -84.29 110.78 18.83 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 120.848 0.356 . . . . 0.0 110.981 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.82 -133.88 12.11 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.404 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.404 ' H ' ' CD ' ' A' ' 77' ' ' PRO . 4.3 mtpt -137.13 -52.15 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.645 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.404 ' CD ' ' H ' ' A' ' 76' ' ' LYS . 1.7 Cg_endo -84.68 135.41 5.84 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.395 2.063 . . . . 0.0 113.261 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.507 ' HB ' ' CD1' ' A' ' 82' ' ' TYR . 1.2 pp -113.69 76.4 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 121.44 0.638 . . . . 0.0 110.254 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 83' ' ' SER . 7.3 tp10 -120.42 -53.42 2.12 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.434 -178.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.5 m -56.71 -60.82 2.99 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.245 0.618 . . . . 0.0 112.506 -177.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.472 ' OG ' HD12 ' A' ' 71' ' ' ILE . 45.7 t -59.14 -53.99 52.11 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.082 0.239 . . . . 0.0 110.436 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.507 ' CD1' ' HB ' ' A' ' 78' ' ' ILE . 18.8 m-85 -57.16 -15.13 4.97 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.625 ' HA ' ' CD2' ' A' ' 135' ' ' HIS . 23.0 t -86.06 -34.96 20.56 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 122.459 0.304 . . . . 0.0 110.394 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.01 159.75 33.68 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.72 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.53 150.07 22.6 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.286 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 98.65 14.49 37.37 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.41 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.1 tt -77.14 -27.14 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.566 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 70.8 t60 -77.58 -11.36 59.85 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -102.71 -43.99 5.43 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -65.93 -8.64 23.65 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.399 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.4 tp -79.47 -13.06 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 122.785 0.434 . . . . 0.0 110.94 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 mt -95.62 -1.02 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.405 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -59.41 -29.66 67.91 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.056 0.542 . . . . 0.0 112.229 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.562 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -76.94 -22.47 53.22 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.23 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -94.2 -19.08 21.07 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 123.473 0.483 . . . . 0.0 111.238 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.4 150.56 20.14 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.424 0.452 . . . . 0.0 110.864 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 65.47 9.26 5.65 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.856 0.863 . . . . 0.0 112.667 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -99.37 -40.94 7.65 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.2 t 63.82 98.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.628 0.771 . . . . 0.0 110.858 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.1 m -141.32 129.02 21.57 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.985 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -131.96 129.64 40.46 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.874 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.8 t -129.73 154.84 46.79 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.644 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.7 pttm 48.76 176.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.928 1.291 . . . . 0.0 113.56 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.463 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 43.5 t30 -128.78 -45.83 1.29 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.197 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.44 88.86 7.99 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 123.315 0.384 . . . . 0.0 111.506 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 104' ' ' ASN . 8.2 Cg_exo -75.2 137.42 21.27 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.915 2.41 . . . . 0.0 112.702 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 11.7 mm -123.58 -56.73 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.068 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -139.88 152.6 46.57 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.333 0.396 . . . . 0.0 110.802 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -114.93 130.33 56.89 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.686 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.98 60.7 0.66 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.428 0.632 . . . . 0.0 111.06 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.8 t 63.0 134.01 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.088 0.955 . . . . 0.0 112.184 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.1 p -113.67 -4.83 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.436 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 70.9 mtm -91.81 110.67 22.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.918 0.39 . . . . 0.0 111.076 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -143.64 15.21 1.78 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.002 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -87.23 -44.11 11.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.566 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.469 ' O ' HD11 ' A' ' 125' ' ' ILE . 12.8 mt -88.53 -10.0 50.41 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -112.35 97.16 6.43 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.371 0.605 . . . . 0.0 110.499 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.8 tptt -179.89 -55.85 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.899 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.6 -4.53 2.28 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.273 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.497 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -88.41 -29.94 0.37 Allowed Pre-proline 0 CA--C 1.549 0.936 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.759 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 120' ' ' TYR . 88.1 Cg_exo -49.65 112.18 0.64 Allowed 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 122.734 2.289 . . . . 0.0 113.516 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 126' ' ' GLU . . . 149.95 -135.82 5.44 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.768 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.416 ' HA ' ' CD ' ' A' ' 126' ' ' GLU . 51.0 Cg_exo -55.64 -32.37 83.19 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.164 2.576 . . . . 0.0 114.322 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.563 ' O ' HG13 ' A' ' 128' ' ' ILE . 8.4 m-20 -70.5 -49.64 46.25 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.596 ' HA ' HD12 ' A' ' 128' ' ' ILE . 5.3 mt -71.27 -39.11 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 122' ' ' GLY . 10.8 pt-20 -59.68 -47.63 84.87 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.037 0.211 . . . . 0.0 110.871 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -57.0 -35.34 69.09 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 125' ' ' ILE . 53.3 mt -61.49 -57.2 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 123.095 0.247 . . . . 0.0 110.81 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 8.0 m -57.44 -38.68 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 123.475 0.484 . . . . 0.0 111.746 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 12.1 t -70.48 -20.22 62.88 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.3 m -77.6 -44.84 27.05 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 128' ' ' ILE . 3.2 mp -72.14 -27.19 62.45 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.782 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -89.03 10.78 20.36 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.205 0.526 . . . . 0.0 110.551 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.2 tmt_? -115.93 -31.16 5.84 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.345 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.625 ' CD2' ' HA ' ' A' ' 83' ' ' SER . 42.9 m-70 -92.68 -32.71 14.64 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.812 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 63.67 64.43 0.79 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.028 0.931 . . . . 0.0 111.927 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -91.11 120.17 31.85 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.341 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.481 ' O ' ' HD3' ' A' ' 141' ' ' LYS . 3.5 t -78.49 -16.5 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.644 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -91.07 -22.19 33.47 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.022 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.88 4.25 14.8 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.327 0.651 . . . . 0.0 110.731 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 138' ' ' VAL . 42.6 pttt -50.92 -37.68 45.5 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.11 0.964 . . . . 0.0 112.948 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.53 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 3.4 t70 -73.91 -30.17 62.44 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.174 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.566 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 15.9 tp -67.7 -57.23 6.73 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.475 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.18 -49.67 62.48 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.87 -0.604 . . . . 0.0 114.035 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.73 87.9 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.53 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.2 mptm? -61.44 -40.2 93.61 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 30.1 mt -63.33 -32.86 74.39 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.417 0.448 . . . . 0.0 111.509 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -75.21 -39.32 60.17 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.14 0.275 . . . . 0.0 110.529 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -78.7 5.59 10.82 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.945 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.2 -5.34 54.06 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.628 0.371 . . . . 0.0 111.608 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.4 tt -92.15 -47.97 6.96 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.453 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -96.67 124.7 40.74 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.426 0.454 . . . . 0.0 110.816 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -132.94 153.6 51.25 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.129 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.916 -179.94 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.0 t . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.476 0.179 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.3 t80 70.13 -55.67 0.6 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.517 1.127 . . . . 0.0 112.039 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.41 64.99 0.9 Allowed Glycine 0 C--N 1.34 0.782 0 C-N-CA 121.555 -0.355 . . . . 0.0 112.48 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 58' ' ' GLY . 2.7 tt -112.76 146.65 38.41 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.602 0.236 . . . . 0.0 110.607 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.414 ' N ' HD23 ' A' ' 57' ' ' LEU . . . 155.84 49.44 0.01 OUTLIER Glycine 0 C--N 1.337 0.601 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.622 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -120.05 46.95 1.84 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.21 0.529 . . . . 0.0 110.872 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.09 -7.93 15.25 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.876 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -129.59 -10.41 4.52 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.817 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.83 -45.77 0.44 Allowed Pre-proline 0 CA--C 1.547 0.834 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.243 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.01 -12.98 28.72 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.365 2.044 . . . . 0.0 113.437 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.7 mp -97.18 126.34 42.29 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.294 0.371 . . . . 0.0 110.744 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -130.12 -59.68 1.04 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.361 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.469 ' HD2' ' O ' ' A' ' 66' ' ' LYS . 1.8 pptp? -147.7 123.08 10.32 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.696 0.284 . . . . 0.0 111.532 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -120.57 -45.49 2.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.969 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 54.81 -88.86 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.164 0.986 . . . . 0.0 112.521 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.3 m -120.82 123.25 42.14 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.677 0.275 . . . . 0.0 111.63 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 74' ' ' SER . 57.6 mmtt -136.64 -56.73 0.74 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.238 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.434 ' O ' ' CG2' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -148.88 94.59 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.659 0.743 . . . . 0.0 110.381 178.702 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.9 mp 53.14 70.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.577 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 57.4 21.56 7.0 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.132 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 7.3 t -117.15 174.61 6.02 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.278 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.46 -36.98 2.93 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 116.208 -0.451 . . . . 0.0 113.426 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.496 ' HB2' ' OG ' ' A' ' 81' ' ' SER . 1.8 mptp? -85.94 166.07 31.18 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.472 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.6 ' O ' ' HB2' ' A' ' 81' ' ' SER . 8.8 Cg_exo -73.14 -165.22 0.23 Allowed 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.837 2.358 . . . . 0.0 112.836 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.583 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 1.3 mp -76.28 -14.45 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 83' ' ' SER . 5.0 pt-20 -85.78 -67.5 0.8 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.409 ' H ' ' HG3' ' A' ' 79' ' ' GLU . 18.3 m -64.5 -56.99 10.47 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.6 ' HB2' ' O ' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -48.52 -57.24 6.44 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.636 0.374 . . . . 0.0 111.231 179.616 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.583 ' HB2' ' O ' ' A' ' 78' ' ' ILE . 27.6 m-85 -69.15 -11.47 60.83 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.551 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 7.4 t -100.23 -1.91 35.23 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.62 147.12 24.21 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.796 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.537 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.9 OUTLIER -73.51 126.3 29.91 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.329 -0.396 . . . . 0.0 112.014 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.88 57.24 2.73 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.408 -0.814 . . . . 0.0 113.501 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.546 HG22 ' OE1' ' A' ' 137' ' ' GLU . 2.9 tp -79.27 -38.39 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 122.749 0.42 . . . . 0.0 111.348 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.837 ' HB3' ' HB2' ' A' ' 140' ' ' ALA . 6.2 p80 -66.22 -17.77 64.94 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -101.43 -54.91 2.65 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.11 0.256 . . . . 0.0 111.541 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -52.95 -7.49 0.08 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 87' ' ' ILE . 1.8 pt -73.04 -9.16 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.3 mm -117.18 13.81 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.29 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -89.67 -34.8 16.13 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.699 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.58 -20.1 60.07 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -98.93 -12.61 20.54 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 123.346 0.404 . . . . 0.0 111.227 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -97.65 141.82 30.21 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.321 0.388 . . . . 0.0 110.893 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 11.7 mt -131.95 144.0 50.51 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.666 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -130.5 152.8 49.49 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.396 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.9 m 43.36 99.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 124.76 1.224 . . . . 0.0 113.775 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.3 m -139.2 119.33 13.55 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.796 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -132.31 99.04 4.56 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.329 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.0 m -145.17 -19.31 0.49 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.606 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt 70.65 -10.19 0.74 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.291 1.036 . . . . 0.0 112.738 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -101.74 127.01 48.7 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -127.11 147.2 60.75 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.325 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.48 177.52 4.61 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.729 2.286 . . . . 0.0 112.966 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 107' ' ' ILE . 1.5 mp -88.84 42.94 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-O 121.048 0.452 . . . . 0.0 110.411 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 43.93 105.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 125.032 1.333 . . . . 0.0 113.802 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -129.85 127.04 39.43 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.799 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.65 128.85 48.48 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.105 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.5 t -110.62 127.01 55.07 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.694 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.49 121.64 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.837 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.0 ttt -99.48 153.37 19.08 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.786 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -95.6 164.36 12.81 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.013 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -79.56 169.48 17.96 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.357 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mt -75.91 97.87 4.08 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.981 0.419 . . . . 0.0 111.107 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -147.69 -45.84 0.17 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.209 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -112.45 -36.22 5.32 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.401 ' C ' ' HD3' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -79.97 -33.48 39.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.555 0.342 . . . . 0.0 111.451 -179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -127.0 64.39 60.16 Favored Pre-proline 0 CA--C 1.549 0.904 0 O-C-N 123.523 0.514 . . . . 0.0 110.556 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.401 ' HD3' ' C ' ' A' ' 119' ' ' THR . 18.7 Cg_endo -95.06 133.94 0.62 Allowed 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.778 2.319 . . . . 0.0 114.648 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.473 ' H ' HD12 ' A' ' 125' ' ' ILE . . . 74.01 -110.99 3.28 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 119.087 -0.84 . . . . 0.0 114.923 177.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -46.72 -30.09 8.68 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.66 2.907 . . . . 0.0 114.911 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -72.23 -39.91 68.13 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.309 0.381 . . . . 0.0 111.355 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 129' ' ' VAL . 16.3 mt -76.59 -29.73 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.307 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.42 -56.41 16.44 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.629 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -55.86 -29.82 60.5 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.491 HG23 ' CZ ' ' A' ' 82' ' ' TYR . 50.6 mt -73.64 -45.03 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 120.563 0.221 . . . . 0.0 110.53 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 125' ' ' ILE . 12.6 m -77.79 -25.6 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.238 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.1 t -83.74 -19.05 35.83 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.781 0.676 . . . . 0.0 112.306 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.7 m -98.11 -27.3 14.26 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.072 0.232 . . . . 0.0 110.496 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.479 HD13 ' HA3' ' A' ' 144' ' ' GLY . 2.4 tt -80.41 -35.21 35.51 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.176 0.297 . . . . 0.0 110.884 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -72.65 -1.37 15.98 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -97.03 -76.19 0.52 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -46.34 -37.9 8.07 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.604 0.762 . . . . 0.0 112.676 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.8 t70 69.7 76.81 0.21 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.128 0.971 . . . . 0.0 111.203 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.546 ' OE1' HG22 ' A' ' 87' ' ' ILE . 10.4 mm-40 -83.94 123.44 29.97 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.063 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -78.7 -25.6 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -88.33 -27.83 24.2 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.837 ' HB2' ' HB3' ' A' ' 88' ' ' HIS . . . -100.49 -1.66 35.13 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.212 -0.494 . . . . 0.0 111.324 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -32.13 36.64 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.14 0.576 . . . . 0.0 112.533 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.569 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 19.8 m-20 -77.49 -40.21 43.77 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.258 0.349 . . . . 0.0 110.679 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.3 tp -65.59 -61.79 1.89 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.58 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.479 ' HA3' HD13 ' A' ' 132' ' ' LEU . . . -53.31 -47.35 62.16 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.724 -0.671 . . . . 0.0 114.511 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.13 -41.9 89.32 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.569 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -61.26 -41.09 96.32 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.021 0.2 . . . . 0.0 111.278 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.0 mt -62.36 -37.9 87.45 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.269 0.355 . . . . 0.0 111.345 177.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -88.44 3.16 51.03 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -120.12 -11.0 9.31 Favored 'General case' 0 C--N 1.345 0.373 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.1 -8.56 48.5 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.163 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.5 tt -108.38 -40.92 5.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.594 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.87 128.37 36.17 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.987 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -128.65 -42.79 1.43 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.145 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.102 -0.952 . . . . 0.0 111.123 -179.94 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 120.491 0.186 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 62.94 125.31 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.954 0.902 . . . . 0.0 112.056 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.79 138.43 5.19 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.44 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.5 mt -100.4 -43.34 6.27 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.617 0.245 . . . . 0.0 111.263 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.07 -41.08 1.98 Allowed Glycine 0 C--N 1.338 0.692 0 O-C-N 123.403 0.439 . . . . 0.0 112.931 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -93.52 146.9 23.45 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.406 0.282 . . . . 0.0 111.065 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.51 123.86 49.05 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.235 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -135.1 10.98 3.57 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.497 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.424 ' N ' ' CD ' ' A' ' 63' ' ' PRO . 2.7 p30 -85.07 -32.89 0.48 Allowed Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 62' ' ' ASP . 16.5 Cg_exo -69.36 -27.69 28.05 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.169 1.913 . . . . 0.0 113.347 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.4 mt -97.73 122.25 40.6 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 123.406 0.441 . . . . 0.0 110.741 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -137.28 -29.87 0.87 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.901 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -91.87 -6.81 50.88 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -103.53 -44.87 5.0 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.364 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 63.06 148.25 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.863 0.865 . . . . 0.0 112.368 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.4 m -101.78 -42.78 6.04 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.261 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -131.5 139.85 49.4 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.455 0.472 . . . . 0.0 110.935 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.0 mm -119.51 -26.85 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.565 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.402 HD13 HD11 ' A' ' 116' ' ' LEU . 3.7 tp -67.88 -19.75 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 122.975 0.51 . . . . 0.0 111.828 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.08 19.64 16.29 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.498 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.6 t -88.24 -39.72 14.22 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.008 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.22 -99.23 0.12 Allowed Glycine 0 C--N 1.338 0.683 0 O-C-N 123.7 0.625 . . . . 0.0 111.657 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.799 ' N ' ' HD3' ' A' ' 77' ' ' PRO . 32.2 mmtm -137.43 28.95 0.12 Allowed Pre-proline 0 CA--C 1.558 1.256 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.799 ' HD3' ' N ' ' A' ' 76' ' ' LYS . 5.1 Cg_endo -87.57 101.93 0.5 Allowed 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.241 1.961 . . . . 0.0 112.845 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 tt -145.73 7.01 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.102 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.19 -76.51 0.51 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.018 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.1 m -65.26 -60.75 2.65 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.683 0.393 . . . . 0.0 110.49 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.523 ' O ' HD13 ' A' ' 87' ' ' ILE . 25.6 p -44.45 -39.61 4.9 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.405 0.682 . . . . 0.0 112.687 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.573 ' CE1' HG23 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -89.46 -10.09 47.69 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.2 t -95.04 -6.99 40.93 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.555 0.217 . . . . 0.0 110.685 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.47 149.63 27.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.464 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -74.68 87.03 2.17 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.377 0.608 . . . . 0.0 111.072 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.579 ' O ' ' HD3' ' A' ' 90' ' ' LYS . . . 133.57 63.19 0.07 OUTLIER Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.929 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.602 HG22 ' OE2' ' A' ' 137' ' ' GLU . 4.4 tp -105.79 -15.53 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.596 ' HB3' ' O ' ' A' ' 139' ' ' GLY . 49.2 t60 -104.13 -74.81 0.63 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -96.02 52.41 1.3 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.189 0.519 . . . . 0.0 112.06 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.579 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 4.6 ttpp -121.13 -33.26 3.75 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.558 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.5 pt -78.21 -27.01 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.712 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.402 HG13 ' H ' ' A' ' 92' ' ' ILE . 2.2 pp -95.73 -1.79 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.667 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -80.85 -33.15 34.71 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.718 0.407 . . . . 0.0 111.336 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.19 -0.02 34.39 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.105 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -120.37 -13.9 8.79 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.643 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -92.22 -43.78 9.13 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 123.268 0.355 . . . . 0.0 111.384 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.9 tp -100.26 -43.27 6.34 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.314 0.384 . . . . 0.0 111.077 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -100.28 144.95 28.69 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 123.376 0.422 . . . . 0.0 110.713 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.8 t 64.63 129.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.757 0.823 . . . . 0.0 111.237 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.7 m 63.34 149.8 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.034 0.934 . . . . 0.0 112.446 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -97.82 144.33 27.52 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.906 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.0 m -101.15 138.24 38.44 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 123.634 0.584 . . . . 0.0 111.021 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -111.31 -43.39 3.71 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.045 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -130.0 153.34 48.5 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.705 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.1 -47.81 0.32 Allowed Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 118.579 -0.724 . . . . 0.0 112.322 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -90.51 117.0 0.58 Allowed 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.209 1.94 . . . . 0.0 113.153 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -146.67 111.7 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.0 179.139 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -138.34 -8.79 1.49 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.345 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -89.43 -4.37 58.02 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 122.509 0.324 . . . . 0.0 111.689 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.31 -47.7 6.49 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.603 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.8 p -137.09 136.08 38.03 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.141 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.6 p -137.95 122.49 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.567 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -138.7 161.29 37.54 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.685 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -90.69 140.62 29.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.977 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -117.51 -174.29 2.59 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.998 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.402 HD11 HD13 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -54.88 95.57 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.482 ' HA ' ' CD1' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -172.72 -24.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.048 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -52.96 -34.55 56.28 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.06 0.457 . . . . 0.0 110.998 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.455 ' O ' HD13 ' A' ' 125' ' ' ILE . 6.6 t -129.6 46.5 2.63 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.664 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.574 ' CD1' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -57.34 -45.34 99.9 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.389 -178.349 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -78.79 37.86 0.68 Allowed 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.086 1.857 . . . . 0.0 112.116 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.5 -171.47 18.45 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 115.946 -0.57 . . . . 0.0 114.234 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.537 ' HA ' ' OE1' ' A' ' 126' ' ' GLU . 3.6 Cg_exo -75.24 -37.4 1.93 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.56 2.84 . . . . 0.0 113.33 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.409 ' OD2' HD12 ' A' ' 125' ' ' ILE . 6.9 p-10 -61.95 -19.74 63.07 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.574 HG12 ' CD1' ' A' ' 120' ' ' TYR . 1.1 mp -89.97 -51.81 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 123.372 0.42 . . . . 0.0 111.181 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.537 ' OE1' ' HA ' ' A' ' 123' ' ' PRO . 8.5 pt-20 -50.45 -27.78 7.12 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 177.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -72.04 -35.32 69.31 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.87 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.573 HG23 ' CE1' ' A' ' 82' ' ' TYR . 75.1 mt -58.86 -52.31 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.713 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.7 m -59.91 -54.55 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 123.114 0.259 . . . . 0.0 111.639 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.7 t -56.06 -52.55 63.87 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.2 m -67.88 -17.66 64.55 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.776 HD11 ' HB1' ' A' ' 140' ' ' ALA . 3.5 tt -88.33 -44.47 10.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 117.782 0.265 . . . . 0.0 111.09 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -79.01 -1.49 35.78 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -79.55 -50.0 11.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.191 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 29.1 p-80 -89.13 -35.86 16.04 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.174 0.297 . . . . 0.0 111.772 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.412 ' OD2' ' HE3' ' A' ' 141' ' ' LYS . 5.5 m-20 74.84 87.72 0.09 Allowed 'General case' 0 C--N 1.357 0.91 0 C-N-CA 124.205 1.002 . . . . 0.0 112.159 177.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.602 ' OE2' HG22 ' A' ' 87' ' ' ILE . 6.6 pt-20 -114.96 151.7 33.66 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.709 178.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.2 m -76.44 -44.89 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -68.7 0.65 12.64 Favored Glycine 0 N--CA 1.471 1.012 0 N-CA-C 115.2 0.84 . . . . 0.0 115.2 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.776 ' HB1' HD11 ' A' ' 132' ' ' LEU . . . -136.74 -11.4 1.79 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.91 0.484 . . . . 0.0 112.036 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 6.4 tptm -53.65 -41.33 66.69 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.292 0.637 . . . . 0.0 112.084 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 2.1 p-10 -70.16 -42.46 72.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.574 ' O ' HD12 ' A' ' 147' ' ' LEU . 14.2 tp -63.81 -52.25 61.08 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.953 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.442 ' CA ' HD13 ' A' ' 132' ' ' LEU . . . -58.04 -38.6 89.89 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 123.697 0.623 . . . . 0.0 113.851 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.91 83.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.873 0.337 . . . . 0.0 111.867 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.477 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.3 mptm? -66.96 -33.82 76.41 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.211 0.319 . . . . 0.0 110.662 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.574 HD12 ' O ' ' A' ' 143' ' ' LEU . 0.6 OUTLIER -66.04 -41.11 91.3 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.548 0.53 . . . . 0.0 110.315 177.507 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -64.73 -38.41 90.88 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.85 1.03 48.85 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.091 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.23 104.93 1.0 Allowed 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 151' ' ' LEU . 3.1 tm? 80.59 -28.16 0.14 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.099 0.959 . . . . 0.0 111.057 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -94.78 134.11 37.75 Favored 'General case' 0 C--N 1.344 0.364 0 O-C-N 123.064 0.227 . . . . 0.0 111.076 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -129.45 -42.43 1.32 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.149 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.479 -0.772 . . . . 0.0 110.501 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.0 m . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 111.279 0.103 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -99.87 -46.58 5.33 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 123.404 0.44 . . . . 0.0 110.82 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.71 -118.8 6.03 Favored Glycine 0 C--N 1.342 0.911 0 O-C-N 123.428 0.455 . . . . 0.0 112.585 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.97 -43.07 2.57 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.385 0.274 . . . . 0.0 110.898 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 171.25 97.6 0.11 Allowed Glycine 0 C--N 1.34 0.788 0 O-C-N 123.502 0.501 . . . . 0.0 112.463 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.9 ttmt -99.89 156.74 16.97 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.784 0.326 . . . . 0.0 110.618 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 59.15 101.36 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.819 0.848 . . . . 0.0 112.057 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.568 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 20.2 mm-40 -142.84 167.88 21.03 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.604 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -110.84 79.96 2.03 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.668 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.568 ' HD3' ' O ' ' A' ' 61' ' ' GLN . 1.7 Cg_endo -83.36 -168.0 0.52 Allowed 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.088 2.525 . . . . 0.0 112.697 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.447 ' HG ' ' H ' ' A' ' 65' ' ' ASP . 5.1 tp -72.43 166.06 23.33 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.959 0.504 . . . . 0.0 110.834 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.447 ' H ' ' HG ' ' A' ' 64' ' ' LEU . 5.0 t70 -67.69 -51.44 49.61 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.563 0.345 . . . . 0.0 111.826 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -137.15 100.23 4.21 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.105 0.479 . . . . 0.0 110.845 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -120.42 -13.42 8.83 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.712 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -112.67 128.69 56.46 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.412 0.445 . . . . 0.0 110.391 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.6 t -95.15 135.52 36.62 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.592 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -93.49 -0.06 56.52 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.076 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -90.93 -33.29 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.48 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.571 HG23 ' CD1' ' A' ' 73' ' ' PHE . 5.0 tp -72.57 -24.84 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 O-C-N 123.134 0.271 . . . . 0.0 111.554 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.571 ' CD1' HG23 ' A' ' 72' ' ' ILE . 63.9 m-85 -105.59 17.49 23.74 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 123.401 0.438 . . . . 0.0 110.485 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.465 ' OG ' ' HD2' ' A' ' 77' ' ' PRO . 1.8 t -87.59 162.64 17.05 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.089 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.15 -63.92 1.76 Allowed Glycine 0 C--N 1.344 0.989 0 CA-C-N 116.239 -0.437 . . . . 0.0 113.483 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -90.73 -46.2 0.38 Allowed Pre-proline 0 CA--C 1.545 0.779 0 CA-C-O 118.551 -0.738 . . . . 0.0 112.545 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.465 ' HD2' ' OG ' ' A' ' 74' ' ' SER . 7.9 Cg_exo -73.06 94.69 0.82 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.296 1.997 . . . . 0.0 113.015 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 tt -154.27 -35.8 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.084 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 83' ' ' SER . 1.9 mt-10 -91.86 -28.84 17.06 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.059 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.8 m -69.08 -61.48 1.78 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.842 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.518 ' O ' HD13 ' A' ' 87' ' ' ILE . 40.6 m -86.9 58.41 5.06 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-O 123.389 1.566 . . . . 0.0 109.727 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.56 ' CD2' HG12 ' A' ' 87' ' ' ILE . 0.9 OUTLIER -158.66 -41.62 0.06 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 111.651 -2.522 . . . . 0.0 105.327 -179.426 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.406 ' HA ' ' CD2' ' A' ' 135' ' ' HIS . 8.3 t -70.55 -23.76 62.67 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.097 176.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.86 1.03 4.82 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt 59.34 152.79 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.959 0.903 . . . . 0.0 112.949 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.65 2.6 78.78 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.66 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.56 HG12 ' CD2' ' A' ' 82' ' ' TYR . 7.6 tp -64.05 -9.12 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.517 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 70.1 t60 -90.49 51.78 2.08 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.599 0.714 . . . . 0.0 110.903 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.459 ' O ' HG22 ' A' ' 92' ' ' ILE . 10.2 mm-40 -145.82 -41.25 0.22 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.516 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -83.25 -2.9 56.75 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.004 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.1 tt -103.54 2.25 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.821 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.597 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 3.9 tp -114.2 -16.9 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.978 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -101.92 -42.33 6.17 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.041 0.213 . . . . 0.0 111.241 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.5 -29.35 28.03 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.271 0.357 . . . . 0.0 111.78 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -91.17 -4.79 55.8 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.063 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.597 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 12.2 t70 -67.75 129.95 41.48 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.07 0.548 . . . . 0.0 111.24 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.446 HD13 ' H ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -94.65 172.45 8.17 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.65 -179.162 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 65.23 116.49 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.178 0.991 . . . . 0.0 111.905 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 m -145.2 2.14 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.052 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.9 m -86.99 154.11 21.03 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.496 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -93.51 105.62 17.66 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.002 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.3 m -146.1 -43.39 0.2 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.996 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -100.66 149.88 23.31 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.865 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -108.72 -13.58 14.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.763 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.99 147.02 33.97 Favored Pre-proline 0 CA--C 1.535 0.401 0 O-C-N 123.207 0.317 . . . . 0.0 111.504 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.59 165.83 31.6 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.683 2.255 . . . . 0.0 113.258 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.1 mt -96.06 122.79 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.04 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -106.67 -43.66 4.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.132 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -123.16 155.16 37.6 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 123.421 0.451 . . . . 0.0 111.15 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.03 128.34 40.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.364 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.8 t -127.16 4.66 6.4 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.388 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.88 159.27 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.448 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 20.6 ttp -85.46 164.93 17.57 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.943 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -83.78 146.18 28.29 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.366 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -98.1 -27.66 14.1 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.31 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.2 mt -87.53 36.61 0.75 Allowed 'General case' 0 CA--C 1.542 0.635 0 O-C-N 123.283 0.364 . . . . 0.0 111.553 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -147.23 0.54 0.71 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.13 -54.01 4.01 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.09 8.44 2.49 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.873 0.368 . . . . 0.0 110.907 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -89.57 -30.68 0.36 Allowed Pre-proline 0 CA--C 1.55 0.953 0 CA-C-O 118.285 -0.864 . . . . 0.0 112.886 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' TYR . 78.0 Cg_exo -44.93 120.65 3.02 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.065 2.51 . . . . 0.0 114.046 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 165.27 -147.63 12.76 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.726 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -62.71 -22.78 74.25 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.971 2.448 . . . . 0.0 113.754 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.516 ' O ' HG13 ' A' ' 128' ' ' ILE . 9.4 m-20 -71.43 -49.49 41.17 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.594 0.358 . . . . 0.0 111.595 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.623 ' HA ' HD12 ' A' ' 128' ' ' ILE . 10.2 mt -73.26 -34.97 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 123.271 0.357 . . . . 0.0 110.875 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -55.92 -48.22 76.08 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.72 0.637 . . . . 0.0 111.004 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -66.09 -35.65 81.08 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.623 HD12 ' HA ' ' A' ' 125' ' ' ILE . 32.9 mt -61.27 -55.34 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 125' ' ' ILE . 5.5 m -65.12 -27.32 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.223 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.2 t -83.26 -13.89 54.31 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 26.9 m -92.09 -42.42 9.95 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 123.037 0.211 . . . . 0.0 110.913 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 144' ' ' GLY . 4.7 mp -77.74 -37.25 49.61 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -76.97 7.53 4.76 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.295 0.372 . . . . 0.0 111.673 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -108.06 -80.25 0.57 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.406 ' CD2' ' HA ' ' A' ' 83' ' ' SER . 8.2 m-70 -47.81 -37.45 13.71 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.816 0.847 . . . . 0.0 112.789 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 65.69 68.24 0.48 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.995 0.918 . . . . 0.0 111.769 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -88.72 129.77 35.47 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.437 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.505 ' O ' ' HD3' ' A' ' 141' ' ' LYS . 3.1 t -73.41 -16.4 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -86.51 -32.02 17.23 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.43 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.416 ' CB ' ' HB2' ' A' ' 88' ' ' HIS . . . -110.0 5.74 22.51 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.84 0.456 . . . . 0.0 111.149 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.505 ' HD3' ' O ' ' A' ' 138' ' ' VAL . 21.3 pttm -47.32 -37.65 11.35 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.965 0.906 . . . . 0.0 113.087 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 2.5 p-10 -75.29 -41.6 56.75 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.303 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.517 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 17.6 tp -56.83 -55.04 39.53 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.218 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.495 ' N ' HD22 ' A' ' 132' ' ' LEU . . . -59.87 -59.5 10.37 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 115.793 -0.639 . . . . 0.0 114.049 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.71 78.17 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 14.1 mptt -62.51 -36.01 81.19 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 123.027 0.204 . . . . 0.0 111.418 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.6 mt -66.68 -35.71 80.8 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.417 0.448 . . . . 0.0 111.954 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.0 ttp180 -93.14 -2.66 55.15 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -105.94 28.94 7.1 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.938 0.399 . . . . 0.0 110.848 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.87 -9.95 59.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.266 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.1 tt -102.19 -53.53 2.9 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.263 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 41.53 -78.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.168 1.387 . . . . 0.0 114.198 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -128.12 -36.74 1.93 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 122.505 0.322 . . . . 0.0 111.136 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.493 179.931 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.414 ' O ' ' HE3' ' A' ' 59' ' ' LYS . 70.2 m . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.691 0.281 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -136.93 -41.58 0.59 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.524 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.52 -27.72 16.69 Favored Glycine 0 C--N 1.34 0.798 0 O-C-N 123.443 0.464 . . . . 0.0 113.424 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.475 ' H ' HD23 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -92.27 -42.91 9.58 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.31 0.244 . . . . 0.0 111.454 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.92 133.94 3.28 Favored Glycine 0 C--N 1.339 0.716 0 O-C-N 123.472 0.482 . . . . 0.0 112.694 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 54' ' ' SER . 8.1 ptpp? -104.29 123.9 48.2 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.677 0.281 . . . . 0.0 110.94 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 63.54 156.59 0.07 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.896 0.878 . . . . 0.0 112.383 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -91.94 -54.05 4.01 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.681 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 50.45 95.86 0.04 OUTLIER Pre-proline 0 N--CA 1.484 1.267 0 C-N-CA 123.969 0.908 . . . . 0.0 112.622 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.1 121.6 7.02 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.521 2.147 . . . . 0.0 112.501 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.2 mt -138.79 125.51 20.84 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.75 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.447 ' OD1' ' HG3' ' A' ' 66' ' ' LYS . 2.3 p30 -138.06 -44.64 0.52 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.579 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.447 ' HG3' ' OD1' ' A' ' 65' ' ' ASP . 97.6 mttt -101.53 1.81 38.42 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 123.407 0.442 . . . . 0.0 111.877 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.403 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 46.4 m-85 -89.53 8.34 31.65 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.497 ' HB3' ' OG ' ' A' ' 74' ' ' SER . 97.2 m-85 -93.54 139.47 30.72 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.024 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.5 t -108.77 -94.58 0.4 Allowed 'General case' 0 CA--C 1.542 0.67 0 O-C-N 123.445 0.466 . . . . 0.0 111.588 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.578 ' O ' HG13 ' A' ' 71' ' ' ILE . 1.5 mptp? -136.33 90.23 2.55 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.389 0.614 . . . . 0.0 111.284 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.604 ' H ' ' HB3' ' A' ' 74' ' ' SER . 4.7 mt -148.46 172.73 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.472 ' N ' HG22 ' A' ' 71' ' ' ILE . 4.0 tp -46.56 -60.47 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.416 ' H ' HG23 ' A' ' 72' ' ' ILE . 6.2 t80 -95.25 25.2 4.46 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.468 0.651 . . . . 0.0 109.866 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.604 ' HB3' ' H ' ' A' ' 71' ' ' ILE . 48.1 t -120.23 -50.74 2.23 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.623 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.6 -110.34 0.84 Allowed Glycine 0 C--N 1.342 0.906 0 O-C-N 123.39 0.432 . . . . 0.0 112.888 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.536 ' H ' ' CD ' ' A' ' 77' ' ' PRO . 20.7 mtmm -132.47 -44.01 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.536 ' CD ' ' H ' ' A' ' 76' ' ' LYS . 50.7 Cg_exo -56.37 134.16 62.57 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.417 2.078 . . . . 0.0 113.753 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.19 21.49 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.946 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 83' ' ' SER . 4.5 pt-20 -93.2 -57.77 2.52 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.6 m -67.29 -50.07 61.71 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.4 p -53.96 -54.64 36.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.782 0.433 . . . . 0.0 111.595 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.549 ' CZ ' HG23 ' A' ' 128' ' ' ILE . 46.9 m-85 -58.94 -65.02 0.73 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.542 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -38.71 -32.79 0.09 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.19 144.93 44.55 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.274 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.498 ' HA ' ' OE2' ' A' ' 137' ' ' GLU . 58.9 mttp -77.95 105.31 9.07 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 123.439 0.462 . . . . 0.0 111.845 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.15 50.18 0.35 Allowed Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.817 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.0 tp -70.02 -23.41 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -87.04 13.29 9.52 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 120.978 0.418 . . . . 0.0 111.035 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.527 ' O ' HG22 ' A' ' 92' ' ' ILE . 11.7 mm-40 -136.65 -43.96 0.6 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.935 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -47.86 -10.55 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.22 1.008 . . . . 0.0 113.422 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.409 HD12 HG21 ' A' ' 71' ' ' ILE . 3.3 tp -69.57 -16.57 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 123.095 0.558 . . . . 0.0 110.963 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 89' ' ' GLU . 1.7 tt -90.1 -3.18 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.394 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -59.3 -31.41 69.1 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.075 0.55 . . . . 0.0 111.781 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -70.97 -15.12 62.56 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.206 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -92.36 -10.79 36.93 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.689 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -90.14 143.53 26.69 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.208 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.5 tp -92.23 128.4 38.07 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.346 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -132.69 -41.98 0.93 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.941 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.25 158.48 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 123.511 0.507 . . . . 0.0 109.826 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.5 t -86.08 -43.38 13.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.409 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -129.5 122.24 28.86 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 123.318 0.386 . . . . 0.0 110.725 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 54.6 m -133.7 -41.06 0.86 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.311 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.5 ttpp 62.96 121.51 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.924 0.89 . . . . 0.0 111.612 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -100.47 141.52 33.22 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.022 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.7 147.93 33.72 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.054 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.93 119.49 6.35 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.469 2.113 . . . . 0.0 113.049 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 pt -145.49 -45.13 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.689 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -96.67 126.31 41.74 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.436 0.46 . . . . 0.0 111.051 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -135.13 -2.39 2.55 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.444 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 63.68 123.33 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.01 0.924 . . . . 0.0 112.107 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.9 m -127.2 171.4 11.47 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.081 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.8 t -79.67 122.37 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.422 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.8 mmt 60.66 108.17 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.756 0.822 . . . . 0.0 111.755 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -132.3 126.47 33.42 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.771 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -132.87 158.87 41.45 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.628 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.475 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 13.5 mt -82.23 -1.18 48.4 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -114.84 2.54 14.38 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.38 -47.28 6.35 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.9 t -134.34 -1.98 2.83 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 116' ' ' LEU . 2.9 t80 -94.38 144.27 27.71 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 119.288 -0.387 . . . . 0.0 110.725 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.407 ' HD2' ' CD2' ' A' ' 120' ' ' TYR . 46.3 Cg_exo -57.1 162.76 8.81 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.621 2.214 . . . . 0.0 113.54 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -86.44 -51.39 3.5 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.605 -1.108 . . . . 0.0 113.511 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.604 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 52.2 Cg_exo -55.15 -24.42 41.0 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.833 2.356 . . . . 0.0 114.134 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.48 -43.93 65.66 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.514 0.326 . . . . 0.0 111.423 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.479 ' O ' HG22 ' A' ' 129' ' ' VAL . 9.8 mt -61.99 -26.75 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 122.823 0.449 . . . . 0.0 110.764 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -73.2 -47.96 39.19 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.185 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 123' ' ' PRO . 25.5 mmm180 -56.04 -48.01 76.8 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.492 178.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.549 HG23 ' CZ ' ' A' ' 82' ' ' TYR . 17.4 mt -56.62 -64.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.114 0.566 . . . . 0.0 111.498 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 125' ' ' ILE . 31.5 m -51.26 -38.22 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.203 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.0 t -73.03 -42.41 63.19 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.8 m -60.79 -29.8 69.66 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.217 0.207 . . . . 0.0 111.483 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.448 HD13 ' CA ' ' A' ' 144' ' ' GLY . 1.9 mt -83.9 -33.79 24.68 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.314 0.384 . . . . 0.0 110.281 178.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -83.2 7.54 15.88 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.933 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -113.75 -41.02 3.66 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.149 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -88.1 -44.11 11.18 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 63.5 67.7 0.63 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.985 0.914 . . . . 0.0 111.185 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.498 ' OE2' ' HA ' ' A' ' 85' ' ' LYS . 22.5 mt-10 -87.37 139.21 30.78 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.887 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 138' ' ' VAL . 0.2 OUTLIER -77.7 -41.15 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.28 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.63 -1.61 62.04 Favored Glycine 0 CA--C 1.526 0.726 0 O-C-N 123.412 0.445 . . . . 0.0 113.93 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -137.06 -2.54 2.06 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.065 0.546 . . . . 0.0 111.53 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.436 ' HD3' ' O ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -50.85 -40.5 56.29 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.817 0.847 . . . . 0.0 113.002 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 7.9 m-20 -72.51 -36.41 68.35 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.22 0.325 . . . . 0.0 110.922 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.8 tp -65.64 -52.48 51.44 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.993 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.448 ' CA ' HD13 ' A' ' 132' ' ' LEU . . . -60.99 -62.75 5.58 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.58 -0.736 . . . . 0.0 114.007 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.574 ' HA ' ' NE ' ' A' ' 148' ' ' ARG . . . -53.37 -37.1 62.1 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 5.7 mptp? -72.79 -24.46 60.93 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.469 ' O ' HD22 ' A' ' 147' ' ' LEU . 0.6 OUTLIER -78.71 -30.88 46.25 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.422 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.574 ' NE ' ' HA ' ' A' ' 145' ' ' ALA . 8.6 ptt85 -84.31 -3.77 58.45 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 117.807 0.276 . . . . 0.0 110.848 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -81.44 -1.4 45.65 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.778 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.5 -6.56 57.53 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.579 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.7 tt -106.59 -44.43 4.48 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.736 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -89.72 144.95 25.55 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.383 0.427 . . . . 0.0 111.038 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -127.45 150.05 49.82 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.645 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 118.031 -0.985 . . . . 0.0 111.931 -179.966 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.3 m . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.52 0.2 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -99.97 -44.07 6.16 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.39 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -145.4 122.05 1.63 Allowed Glycine 0 C--N 1.34 0.803 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.443 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 pp -101.44 134.82 43.94 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.594 0.232 . . . . 0.0 111.127 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 147.86 -68.65 0.37 Allowed Glycine 0 C--N 1.337 0.618 0 O-C-N 123.652 0.595 . . . . 0.0 112.651 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -119.42 -31.47 4.61 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.359 0.264 . . . . 0.0 111.62 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.3 -10.75 48.52 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.94 120.3 22.31 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.535 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -135.17 95.9 14.6 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.024 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.18 125.74 9.98 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.606 2.204 . . . . 0.0 112.589 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.493 ' O ' HD23 ' A' ' 64' ' ' LEU . 1.3 tt -134.96 -18.48 1.82 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.34 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -73.99 96.48 2.66 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.164 0.507 . . . . 0.0 111.24 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -143.24 -12.33 0.72 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.665 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -109.33 2.95 21.08 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 123.365 0.415 . . . . 0.0 112.078 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -87.62 139.51 30.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.221 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.0 p -114.39 -16.11 12.01 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.959 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.5 ' O ' HD13 ' A' ' 71' ' ' ILE . 4.4 ttmm -95.25 111.37 23.23 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.779 0.323 . . . . 0.0 110.888 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.5 HD13 ' O ' ' A' ' 70' ' ' LYS . 13.9 mm -129.7 -30.76 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.396 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.0 tp -63.47 -30.06 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 123.121 0.568 . . . . 0.0 111.724 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -106.08 25.59 10.77 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.411 0.444 . . . . 0.0 111.279 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 t -89.0 -44.08 10.65 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.26 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.54 -117.75 0.63 Allowed Glycine 0 C--N 1.34 0.751 0 O-C-N 123.521 0.513 . . . . 0.0 112.417 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.501 ' H ' ' CD ' ' A' ' 77' ' ' PRO . 19.3 tttm -130.95 -47.47 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.818 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.591 ' HA ' ' NH2' ' A' ' 127' ' ' ARG . 3.4 Cg_exo -82.49 133.18 7.12 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.359 2.039 . . . . 0.0 113.375 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.5 73.07 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.397 0.618 . . . . 0.0 110.833 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 83' ' ' SER . 2.9 mt-10 -120.43 -41.79 2.59 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.155 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.9 m -65.82 -60.5 2.82 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.169 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.7 t -56.81 -55.25 36.74 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 123.218 0.324 . . . . 0.0 110.705 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -50.9 -31.36 17.3 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 5.7 t -73.57 -34.52 65.16 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 122.604 0.362 . . . . 0.0 111.713 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.5 146.34 20.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.854 0.462 . . . . 0.0 111.979 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.406 ' HE2' ' NE2' ' A' ' 135' ' ' HIS . 57.6 mmtt -79.96 99.99 7.88 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.189 0.518 . . . . 0.0 111.876 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.589 ' O ' HG12 ' A' ' 91' ' ' ILE . . . 126.52 47.9 0.19 Allowed Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.371 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.4 tp -88.8 -43.65 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 122.842 0.457 . . . . 0.0 111.187 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.531 ' CE1' HD13 ' A' ' 143' ' ' LEU . 47.4 t60 -84.97 26.85 0.81 Allowed 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.031 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 92' ' ' ILE . 3.3 tp10 -143.83 -81.02 0.18 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 122.361 -0.212 . . . . 0.0 111.21 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 8.9 mtmp? -70.87 -24.89 62.59 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 86' ' ' GLY . 13.3 mm -94.09 -0.77 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 120.603 0.24 . . . . 0.0 110.665 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 89' ' ' GLU . 1.6 tt -110.02 -36.01 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.854 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.487 ' OE1' ' HB3' ' A' ' 96' ' ' ASP . 1.7 tp10 -120.26 -84.96 0.66 Allowed 'General case' 0 CA--C 1.537 0.475 0 O-C-N 123.147 0.279 . . . . 0.0 110.529 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 90' ' ' LYS . . . 66.75 -45.56 0.45 Allowed 'General case' 0 C--N 1.36 1.057 0 C-N-CA 124.703 1.201 . . . . 0.0 113.355 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -148.2 -7.26 0.41 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.487 ' HB3' ' OE1' ' A' ' 93' ' ' GLU . 2.4 t70 -64.08 118.15 8.1 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.966 0.412 . . . . 0.0 112.041 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.461 ' HG ' ' H ' ' A' ' 98' ' ' HIS . 3.4 tp -135.15 174.45 10.59 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.132 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.461 ' H ' ' HG ' ' A' ' 97' ' ' LEU . 4.5 t60 -74.85 121.02 21.19 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.476 0.31 . . . . 0.0 111.073 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.43 -174.86 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.267 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.0 p -73.62 -11.28 60.37 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -94.7 121.63 36.48 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.701 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.6 m -130.71 163.61 26.88 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.146 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.0 mptt 64.37 122.97 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.021 0.929 . . . . 0.0 111.932 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -132.97 -41.74 0.91 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.153 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.99 142.39 24.53 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 123.396 0.435 . . . . 0.0 111.26 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.68 11.3 1.97 Allowed 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 122.572 2.181 . . . . 0.0 114.019 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 pt -87.87 126.15 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.72 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -130.13 -43.03 1.2 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.161 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -109.27 148.19 31.39 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 123.55 0.531 . . . . 0.0 110.94 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.3 130.66 50.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.166 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.8 t -125.09 -42.02 2.04 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.953 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.1 m -97.75 -4.21 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 O-C-N 123.364 0.415 . . . . 0.0 111.951 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 25.0 mmt 65.4 12.43 8.11 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.985 0.914 . . . . 0.0 112.508 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -110.69 154.07 24.37 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.952 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -92.16 -40.43 11.02 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.973 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 mt -95.85 -159.47 0.72 Allowed 'General case' 0 CA--C 1.539 0.524 0 O-C-N 123.507 0.504 . . . . 0.0 110.638 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.6 tptp 73.4 -2.1 2.85 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.205 1.002 . . . . 0.0 111.952 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -99.84 -37.09 9.2 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.948 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.5 t -93.83 -41.72 9.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.45 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -96.66 159.3 32.02 Favored Pre-proline 0 CA--C 1.541 0.596 0 O-C-N 123.423 0.452 . . . . 0.0 111.115 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.58 -34.84 2.35 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.505 2.137 . . . . 0.0 113.289 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 157.6 -55.7 0.38 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-O 118.939 -0.923 . . . . 0.0 113.433 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.16 -19.72 28.31 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.971 2.447 . . . . 0.0 114.431 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 2.4 t70 -73.65 -35.07 65.22 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.181 0.301 . . . . 0.0 111.133 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.9 mp -72.71 -27.33 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.382 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.95 -53.33 18.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.728 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.591 ' NH2' ' HA ' ' A' ' 77' ' ' PRO . 13.6 ptm180 -53.83 -36.54 62.64 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 178.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.576 ' O ' HD12 ' A' ' 132' ' ' LEU . 44.7 mt -65.38 -56.51 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 122.199 0.2 . . . . 0.0 111.211 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.634 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 2.8 m -54.09 -43.96 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 12.4 t -64.67 -31.99 73.46 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.3 m -69.94 -38.57 76.23 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.576 HD12 ' O ' ' A' ' 128' ' ' ILE . 1.3 mp -73.83 -35.79 64.87 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 129' ' ' VAL . 10.6 pt-20 -89.08 14.02 11.7 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 120.954 0.407 . . . . 0.0 111.62 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.575 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.6 tmm_? -105.95 -41.29 5.44 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.851 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.406 ' NE2' ' HE2' ' A' ' 85' ' ' LYS . 49.5 t60 -94.64 -32.14 13.53 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.976 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 67.73 73.33 0.31 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.049 0.94 . . . . 0.0 111.633 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.33 132.12 43.36 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.99 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.55 -39.05 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 O-C-N 123.417 0.448 . . . . 0.0 111.684 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -74.26 -9.52 81.04 Favored Glycine 0 C--N 1.341 0.819 0 O-C-N 123.316 0.385 . . . . 0.0 113.914 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.6 2.34 5.54 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.726 0.411 . . . . 0.0 111.995 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -34.62 74.12 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.949 0.499 . . . . 0.0 111.732 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.627 ' O ' ' HG2' ' A' ' 146' ' ' LYS . 8.2 m-20 -75.08 -38.78 61.16 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.984 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.531 HD13 ' CE1' ' A' ' 88' ' ' HIS . 14.2 tp -60.49 -56.83 16.71 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.994 0.518 . . . . 0.0 110.609 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -54.77 -45.3 79.66 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.683 0.614 . . . . 0.0 113.756 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -54.89 -48.68 72.71 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.627 ' HG2' ' O ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -59.19 -42.57 91.18 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.716 0.234 . . . . 0.0 110.394 178.53 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.8 -41.42 82.12 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.41 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 144' ' ' GLY . 14.2 ptm180 -88.1 -14.19 39.45 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -87.47 27.06 1.14 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 122.784 0.433 . . . . 0.0 112.063 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 151' ' ' LEU . . . -70.74 102.46 2.32 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 152' ' ' ASP . 8.2 tt 80.5 -31.14 0.12 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.269 1.028 . . . . 0.0 110.931 -177.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.508 ' O ' HD23 ' A' ' 151' ' ' LEU . 6.5 t70 59.63 157.17 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.874 0.87 . . . . 0.0 112.59 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -99.48 127.85 45.56 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.514 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.839 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.4 m . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 111.345 0.128 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -100.53 132.0 46.14 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 123.405 0.441 . . . . 0.0 110.878 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.5 55.33 0.02 OUTLIER Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.509 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 tp -113.17 -42.96 3.43 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 123.641 0.259 . . . . 0.0 110.911 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.82 -55.73 0.09 OUTLIER Glycine 0 C--N 1.34 0.791 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.431 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.78 127.17 50.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 122.331 0.253 . . . . 0.0 111.134 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.52 -8.41 20.11 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.662 0.602 . . . . 0.0 111.87 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -108.62 -40.7 5.01 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.336 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 57.25 85.88 0.18 Allowed Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 123.722 0.809 . . . . 0.0 112.055 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.95 149.91 26.26 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.788 2.325 . . . . 0.0 112.86 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.65 118.3 36.42 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.507 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -135.69 26.98 3.36 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.18 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -118.69 -18.01 9.09 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -120.86 69.82 0.89 Allowed 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.607 0.718 . . . . 0.0 110.223 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -66.46 152.54 44.94 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.045 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.9 p -102.89 -13.29 17.01 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.147 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -90.32 114.39 26.45 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.789 0.328 . . . . 0.0 110.98 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.652 ' O ' HG22 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -116.1 -168.14 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.974 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.652 HG22 ' O ' ' A' ' 71' ' ' ILE . 0.7 OUTLIER 74.8 -36.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 124.716 1.206 . . . . 0.0 111.651 -179.461 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.48 ' HD2' HG23 ' A' ' 72' ' ' ILE . 3.4 m-85 -139.65 36.88 2.01 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.026 0.531 . . . . 0.0 110.769 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.2 t -86.63 -47.6 9.04 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.457 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.87 -57.21 0.08 OUTLIER Glycine 0 C--N 1.339 0.716 0 O-C-N 123.357 0.411 . . . . 0.0 112.165 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.89 156.29 59.53 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.492 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.44 77.6 3.54 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.376 2.051 . . . . 0.0 112.746 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.504 HG23 ' CD2' ' A' ' 82' ' ' TYR . 3.9 mp 57.85 57.12 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 123.628 0.771 . . . . 0.0 110.158 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 83' ' ' SER . 4.1 mm-40 -121.56 -86.63 0.65 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.09 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.2 m -55.1 -55.65 28.72 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.199 1.0 . . . . 0.0 113.601 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.406 ' O ' HD13 ' A' ' 87' ' ' ILE . 16.9 t -46.66 -55.58 7.49 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.728 0.643 . . . . 0.0 111.772 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.504 ' CD2' HG23 ' A' ' 78' ' ' ILE . 88.1 m-85 -84.06 0.11 49.59 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.53 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 8.0 t -103.71 -2.64 26.17 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.696 0.284 . . . . 0.0 110.388 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.44 156.31 16.82 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.848 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.522 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -82.21 142.53 32.08 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.244 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 90' ' ' LYS . . . 84.77 34.79 14.62 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.304 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.406 HD13 ' O ' ' A' ' 81' ' ' SER . 2.5 tp -84.38 -28.4 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 36.6 t60 -96.97 12.74 31.33 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 120.629 0.252 . . . . 0.0 111.356 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -137.12 -78.81 0.39 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.881 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 23.4 mmtp -42.82 -13.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.562 HG22 ' H ' ' A' ' 110' ' ' ALA . 2.0 pp -65.0 -33.4 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 91' ' ' ILE . 1.8 tt -111.07 10.38 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 CA-C-O 120.793 0.33 . . . . 0.0 111.214 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.57 -40.09 9.21 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.095 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.46 -25.88 52.27 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -89.56 -9.03 51.35 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 123.22 0.325 . . . . 0.0 111.849 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -103.32 -68.55 0.83 Allowed 'General case' 0 CA--C 1.537 0.469 0 O-C-N 123.078 0.236 . . . . 0.0 111.124 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 mp -146.5 167.82 22.74 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.571 0.348 . . . . 0.0 111.142 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -90.04 170.77 10.06 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.755 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.1 p -91.08 -55.25 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.1 t -146.18 -10.33 0.5 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt 64.09 97.87 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.837 0.855 . . . . 0.0 111.74 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.1 p -144.35 -36.65 0.33 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.093 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.1 tttm 64.02 92.57 0.07 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.05 0.94 . . . . 0.0 111.624 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -148.7 137.65 21.54 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.47 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 63.24 154.17 0.12 Allowed Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 123.785 0.834 . . . . 0.0 112.278 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.55 176.5 0.15 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 123.042 2.495 . . . . 0.0 113.334 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.486 HG23 ' H ' ' A' ' 108' ' ' GLN . 3.1 tp -60.01 -63.07 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 122.687 0.395 . . . . 0.0 111.824 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.486 ' H ' HG23 ' A' ' 107' ' ' ILE . 46.3 mt-30 65.36 -18.07 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.413 ' H ' ' C ' ' A' ' 107' ' ' ILE . 98.1 m-85 -98.64 154.15 18.16 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.655 0.264 . . . . 0.0 111.703 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.562 ' H ' HG22 ' A' ' 91' ' ' ILE . . . -94.57 166.97 11.77 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.845 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.7 t -96.07 -71.35 0.68 Allowed 'General case' 0 CA--C 1.536 0.435 0 O-C-N 123.095 0.247 . . . . 0.0 111.576 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.3 t -134.35 -55.4 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.5 ttt 64.39 158.74 0.09 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.934 0.894 . . . . 0.0 111.986 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -88.55 175.2 7.67 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.251 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -72.72 132.2 43.35 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.653 0.381 . . . . 0.0 111.275 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.7 mt -101.08 54.15 0.84 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.524 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -150.63 -30.13 0.2 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.096 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -83.76 -44.43 14.42 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.74 19.51 7.23 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.546 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -134.9 50.08 4.42 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.546 ' HD3' ' N ' ' A' ' 120' ' ' TYR . 9.4 Cg_endo -91.6 127.96 1.08 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.805 2.337 . . . . 0.0 113.369 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 135.96 -148.82 19.84 Favored Glycine 0 C--N 1.343 0.97 0 C-N-CA 120.485 -0.864 . . . . 0.0 114.575 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.633 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 49.1 Cg_exo -56.45 -32.55 89.56 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.634 2.889 . . . . 0.0 113.871 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -52.27 -37.86 56.67 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 123.457 0.473 . . . . 0.0 111.02 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.539 ' O ' HG22 ' A' ' 129' ' ' VAL . 15.8 mt -67.85 -43.61 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.412 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -61.9 -21.34 64.65 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.977 0.511 . . . . 0.0 112.134 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 123' ' ' PRO . 17.4 mmm180 -79.97 -46.67 16.26 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.825 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.7 mt -62.95 -44.52 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.046 0.538 . . . . 0.0 111.278 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 125' ' ' ILE . 7.1 m -63.29 -55.1 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.523 0.514 . . . . 0.0 112.094 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 56.4 m -54.94 -34.79 63.55 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.7 m -82.41 -22.36 35.4 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 123.263 0.352 . . . . 0.0 111.831 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.433 ' HG ' ' OE2' ' A' ' 137' ' ' GLU . 3.0 tt -82.6 -40.31 21.01 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.474 0.31 . . . . 0.0 110.919 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -89.28 12.38 16.23 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.014 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -79.69 -49.15 12.52 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -96.08 -9.06 31.77 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 70.71 80.92 0.16 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.133 0.973 . . . . 0.0 112.46 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 141' ' ' LYS . 2.9 pt-20 -107.02 130.7 54.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.331 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -81.77 -26.43 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -84.98 -2.47 88.37 Favored Glycine 0 C--N 1.343 0.944 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.391 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.11 -9.76 3.39 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.903 0.481 . . . . 0.0 111.75 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 7.8 tptp -50.89 -33.29 23.46 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.866 0.867 . . . . 0.0 112.975 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.547 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 10.0 m-20 -74.82 -36.13 62.43 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.369 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.4 tp -66.13 -59.63 3.58 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.113 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.511 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -58.94 -41.97 96.56 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-N 116.089 -0.505 . . . . 0.0 114.089 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.08 92.16 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.547 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.6 mptp? -68.66 -36.07 78.08 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.032 0.207 . . . . 0.0 111.511 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.1 mt -71.16 -34.21 70.75 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.236 0.335 . . . . 0.0 110.449 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -75.29 -39.47 59.63 Favored 'General case' 0 C--N 1.349 0.562 0 O-C-N 123.478 0.486 . . . . 0.0 110.882 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.55 42.27 0.35 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.134 0.492 . . . . 0.0 112.038 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -86.98 -7.65 57.96 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.854 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 mp -101.01 -45.88 5.26 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.489 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 4.5 t70 60.66 156.89 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.109 0.964 . . . . 0.0 112.42 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -94.72 149.9 20.77 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.059 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.89 179.997 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.6 p . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.551 0.215 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -127.74 144.71 51.07 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.487 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.31 56.7 0.11 Allowed Glycine 0 C--N 1.337 0.602 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.481 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.0 mt 63.13 126.48 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.923 0.889 . . . . 0.0 112.017 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 166.57 -89.98 0.1 OUTLIER Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.644 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.7 mmpp? -119.45 158.09 26.92 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.635 0.255 . . . . 0.0 111.077 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.43 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . . . 63.52 121.57 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.958 0.903 . . . . 0.0 112.379 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -138.93 119.21 13.64 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.461 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 59.57 112.19 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.299 0 C-N-CA 123.929 0.892 . . . . 0.0 112.406 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.59 165.36 20.77 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.683 2.255 . . . . 0.0 113.006 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.5 mp -93.61 156.38 16.75 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.578 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -93.23 -177.84 4.58 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.802 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -75.99 125.15 28.57 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.486 0.315 . . . . 0.0 111.542 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.533 ' CD1' ' HD2' ' A' ' 70' ' ' LYS . 0.8 OUTLIER -119.77 -35.82 3.44 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.74 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 64.37 169.57 0.18 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.784 0.834 . . . . 0.0 111.937 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.1 t 72.28 -10.24 0.93 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.26 1.024 . . . . 0.0 112.694 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.533 ' HD2' ' CD1' ' A' ' 67' ' ' PHE . 64.7 mttm -95.4 136.4 35.81 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 122.366 0.266 . . . . 0.0 110.388 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.452 ' CG2' ' H ' ' A' ' 75' ' ' GLY . 6.4 mt -134.13 135.35 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.095 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 tp -121.21 -49.81 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.856 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -135.37 5.47 3.22 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 123.313 0.383 . . . . 0.0 111.864 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.6 t -79.18 -41.89 27.34 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.249 0.22 . . . . 0.0 111.415 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.452 ' H ' ' CG2' ' A' ' 71' ' ' ILE . . . -119.93 92.75 0.53 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.9 mptt 66.65 155.1 0.13 Allowed Pre-proline 0 N--CA 1.485 1.32 0 C-N-CA 124.059 0.944 . . . . 0.0 111.519 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.09 76.37 3.46 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.435 2.09 . . . . 0.0 112.758 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.571 HG23 ' CG ' ' A' ' 82' ' ' TYR . 4.6 mp 53.82 60.33 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 123.706 0.802 . . . . 0.0 110.865 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.639 ' O ' ' HB2' ' A' ' 83' ' ' SER . 3.6 tp10 -120.96 -81.27 0.64 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.47 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.5 m -70.59 -59.32 2.9 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.1 m -88.66 69.38 8.77 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 123.551 1.643 . . . . 0.0 109.62 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.571 ' CG ' HG23 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -179.45 -34.29 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 111.304 -2.68 . . . . 0.0 108.038 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.639 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.7 t -75.67 -32.58 60.21 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.279 177.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -45.89 157.14 0.12 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.446 ' HA ' ' OE2' ' A' ' 137' ' ' GLU . 6.6 mptt -84.37 100.97 11.62 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.667 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.476 ' O ' ' HD2' ' A' ' 90' ' ' LYS . . . 106.53 74.27 0.9 Allowed Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.533 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 tp -103.71 -35.0 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 122.462 0.305 . . . . 0.0 111.558 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.585 ' ND1' HD22 ' A' ' 143' ' ' LEU . 39.9 t60 -97.88 -46.63 5.86 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 122.979 0.174 . . . . 0.0 111.172 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -96.86 51.29 1.13 Allowed 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.36 0.412 . . . . 0.0 110.888 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' A' ' 86' ' ' GLY . 62.8 tttt -120.89 -5.63 9.6 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.8 tt -53.42 -24.08 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 123.589 0.756 . . . . 0.0 112.731 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.5 tp -72.0 -25.13 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 O-C-N 123.307 0.379 . . . . 0.0 110.855 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -95.31 -29.37 14.51 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.734 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.52 -23.64 58.86 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.585 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -91.04 -11.02 40.06 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 123.402 0.439 . . . . 0.0 111.452 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -97.81 126.36 43.13 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.33 0.394 . . . . 0.0 110.575 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.96 125.6 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.965 0.906 . . . . 0.0 111.847 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -118.14 120.75 38.67 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.1 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.23 153.4 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.274 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.4 t -104.98 129.25 53.45 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.741 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -130.52 -42.67 1.16 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.141 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.3 p -128.43 164.88 21.75 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.498 0.499 . . . . 0.0 111.053 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -84.17 157.69 21.58 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.337 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -87.76 -38.59 15.63 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.753 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 64.39 145.66 0.09 OUTLIER Pre-proline 0 N--CA 1.485 1.313 0 C-N-CA 124.007 0.923 . . . . 0.0 112.309 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.19 145.07 83.39 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.742 2.294 . . . . 0.0 113.311 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.9 158.64 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.048 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -85.6 128.28 34.72 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.951 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -98.75 112.11 24.29 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.231 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.14 -47.1 0.43 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.862 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.0 m -138.91 158.78 43.58 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.707 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.7 m -85.98 129.99 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.325 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.2 mmt -93.37 104.21 16.39 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.405 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -147.52 105.09 3.68 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.879 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.43 ' CE1' ' HA ' ' A' ' 60' ' ' ALA . 57.6 m-85 63.66 134.7 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.891 0.877 . . . . 0.0 111.815 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.2 mt -94.2 76.4 4.01 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.085 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -149.99 -46.4 0.13 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.897 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.3 tttm -116.88 -6.51 11.48 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.6 m -79.83 -41.15 26.97 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.459 0.304 . . . . 0.0 111.624 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -97.71 158.82 32.34 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 123.29 0.368 . . . . 0.0 111.345 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -78.22 -38.08 0.66 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.646 2.231 . . . . 0.0 113.352 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.72 -55.48 0.27 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.835 -0.981 . . . . 0.0 113.731 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.4 -34.52 71.57 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.163 2.576 . . . . 0.0 114.48 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.417 ' O ' HG13 ' A' ' 128' ' ' ILE . 6.1 m-20 -70.58 -42.96 70.35 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.678 ' HA ' HD12 ' A' ' 128' ' ' ILE . 3.6 mt -73.08 -16.14 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 123.301 0.376 . . . . 0.0 110.276 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.78 -53.83 10.49 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.468 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -56.27 -33.57 65.61 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 125' ' ' ILE . 29.3 mt -67.61 -57.95 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 122.358 0.263 . . . . 0.0 111.236 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 125' ' ' ILE . 4.1 m -56.55 -39.03 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 18.2 t -71.5 -54.83 9.26 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.166 0.291 . . . . 0.0 111.772 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.493 HG21 ' HB3' ' A' ' 82' ' ' TYR . 11.8 m -54.92 -25.03 26.46 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 128' ' ' ILE . 33.4 mt -85.66 -48.22 9.07 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.672 0.273 . . . . 0.0 110.386 178.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -83.28 18.04 1.89 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.244 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 130' ' ' SER . 1.1 tmt_? -87.54 -38.83 15.67 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.351 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.402 ' CE1' HH11 ' A' ' 134' ' ' ARG . 64.7 m-70 -105.22 -16.24 14.83 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.607 0.567 . . . . 0.0 110.971 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 68.93 72.5 0.27 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.178 0.991 . . . . 0.0 110.536 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.446 ' OE2' ' HA ' ' A' ' 85' ' ' LYS . 28.9 mt-10 -96.43 133.59 40.67 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.767 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 t -76.61 -12.58 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 123.557 0.536 . . . . 0.0 111.274 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -87.31 -27.52 27.6 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.023 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.77 1.65 12.17 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.69 0.396 . . . . 0.0 111.762 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 8.7 tptp -53.27 -41.73 65.83 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.549 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 8.2 m-20 -77.88 -32.99 52.23 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.042 0.214 . . . . 0.0 111.546 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.585 HD22 ' ND1' ' A' ' 88' ' ' HIS . 14.8 tp -69.7 -59.38 2.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.414 0.286 . . . . 0.0 110.391 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.49 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -56.53 -55.39 30.03 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-N 115.775 -0.648 . . . . 0.0 114.163 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -58.59 -44.96 90.0 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.549 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -61.34 -42.66 99.05 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.718 0.235 . . . . 0.0 111.035 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.0 mt -60.15 -34.97 74.28 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.445 0.465 . . . . 0.0 111.36 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -88.18 -7.36 56.99 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.716 0.293 . . . . 0.0 110.522 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 1.4 m-20 -114.45 13.45 17.66 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.973 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 151' ' ' LEU . . . -72.51 109.29 6.08 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.429 HD13 ' O ' ' A' ' 151' ' ' LEU . 3.0 tm? 80.68 -26.63 0.15 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.98 0.912 . . . . 0.0 111.446 -178.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -68.16 -13.21 62.06 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 66.1 mtp180 -94.15 -45.63 7.46 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.227 0.211 . . . . 0.0 111.332 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.121 -0.942 . . . . 0.0 110.852 179.92 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.504 0.192 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -118.22 -44.36 2.69 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -140.2 131.1 4.91 Favored Glycine 0 C--N 1.339 0.746 0 O-C-N 123.477 0.486 . . . . 0.0 112.471 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.8 mp -119.96 -42.27 2.61 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.659 0.27 . . . . 0.0 111.353 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.09 -179.87 21.22 Favored Glycine 0 C--N 1.341 0.836 0 C-N-CA 121.445 -0.407 . . . . 0.0 112.831 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.1 tttp -98.83 -1.95 39.03 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.481 0.312 . . . . 0.0 111.314 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.45 3.02 48.84 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.93 152.65 21.12 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.824 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -90.0 130.53 42.15 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.272 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.48 34.18 0.52 Allowed 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.595 2.197 . . . . 0.0 113.122 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.7 tp -89.86 126.33 35.67 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.057 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -119.33 -39.2 2.92 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.673 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.559 ' NZ ' ' HB3' ' A' ' 68' ' ' PHE . 4.9 ttpp -97.52 132.89 42.78 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.538 0.524 . . . . 0.0 110.42 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -92.26 -12.01 33.76 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.06 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.559 ' HB3' ' NZ ' ' A' ' 66' ' ' LYS . 16.9 t80 -88.48 119.16 28.66 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.219 0.324 . . . . 0.0 110.191 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.462 ' OG ' ' HA ' ' A' ' 91' ' ' ILE . 54.7 p -102.8 101.75 11.84 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.378 0.609 . . . . 0.0 112.122 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.84 98.6 1.79 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.734 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 mt -123.07 -24.11 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.711 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.446 HD13 ' OH ' ' A' ' 82' ' ' TYR . 4.4 tp -71.78 141.77 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 12.0 t80 67.96 20.18 9.23 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.722 0.809 . . . . 0.0 111.047 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.5 t -84.58 -43.22 14.68 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.377 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.5 -107.31 0.26 Allowed Glycine 0 C--N 1.339 0.729 0 O-C-N 123.555 0.535 . . . . 0.0 112.483 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.559 ' H ' ' CD ' ' A' ' 77' ' ' PRO . 37.1 mtmt -135.24 -44.13 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.775 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.531 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.559 ' CD ' ' H ' ' A' ' 76' ' ' LYS . 6.7 Cg_exo -74.9 134.32 17.84 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.33 2.02 . . . . 0.0 113.292 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.569 ' HB ' ' CD1' ' A' ' 82' ' ' TYR . 1.9 pp -144.71 46.16 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.855 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -103.99 -52.33 2.97 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.846 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.7 m -58.9 -59.35 5.6 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.207 0.603 . . . . 0.0 111.945 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.8 p -57.32 -55.21 37.73 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.761 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.569 ' CD1' ' HB ' ' A' ' 78' ' ' ILE . 17.2 m-85 -54.49 -24.47 20.58 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 177.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.549 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 11.8 t -75.66 -32.65 60.26 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 122.176 0.191 . . . . 0.0 110.752 178.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.05 162.03 1.09 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.334 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -94.16 103.55 15.59 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.864 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.89 65.04 0.56 Allowed Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.95 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.6 tt -93.12 -44.97 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 140' ' ' ALA . 51.2 t60 -84.15 -13.7 52.19 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -95.5 -74.6 0.55 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -45.42 -15.35 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.462 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 1.7 tt -74.18 -10.93 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 O-C-N 123.219 0.324 . . . . 0.0 111.359 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mp -127.13 -25.38 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 122.833 0.453 . . . . 0.0 110.213 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.9 -53.71 4.75 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.325 0.65 . . . . 0.0 110.66 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 55.63 91.47 0.03 OUTLIER 'General case' 0 C--N 1.355 0.831 0 C-N-CA 124.014 0.926 . . . . 0.0 112.712 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 66.86 -6.89 0.51 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.244 1.017 . . . . 0.0 112.836 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -64.75 -53.51 46.0 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.059 0.544 . . . . 0.0 111.428 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.425 ' HG ' ' H ' ' A' ' 98' ' ' HIS . 1.1 tp 52.63 -167.43 0.05 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.879 0.872 . . . . 0.0 112.349 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.425 ' H ' ' HG ' ' A' ' 97' ' ' LEU . 63.7 m-70 -91.78 -6.58 51.56 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.7 m -82.21 -19.9 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.8 m -92.43 -24.37 18.87 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.342 0.401 . . . . 0.0 111.519 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt 64.66 137.18 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.101 0.96 . . . . 0.0 112.161 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.7 t -96.43 -29.41 13.94 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.398 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.7 tttp 72.2 -44.59 0.6 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.378 1.071 . . . . 0.0 112.277 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -92.41 119.78 32.27 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.745 0.307 . . . . 0.0 111.131 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.494 ' H ' ' HD2' ' A' ' 106' ' ' PRO . . . -96.55 -48.77 0.24 Allowed Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.339 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.494 ' HD2' ' H ' ' A' ' 105' ' ' ALA . 28.1 Cg_endo -63.04 139.75 74.96 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.166 1.911 . . . . 0.0 113.449 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.1 pp -139.21 161.94 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.156 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -88.74 -47.25 8.36 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.306 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -137.69 -52.72 0.64 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.893 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 63.8 -67.48 0.1 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.259 1.024 . . . . 0.0 112.532 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.0 t -138.61 154.09 48.66 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 122.697 0.399 . . . . 0.0 110.66 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.6 m -93.0 158.9 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.339 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 64.5 mtt -88.69 -37.05 15.84 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.754 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -92.79 121.2 33.94 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.352 0.407 . . . . 0.0 110.922 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.19 124.19 31.99 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.043 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mp 49.82 97.65 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.253 1.021 . . . . 0.0 112.739 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.78 -38.85 0.12 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.011 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -93.72 -26.08 17.16 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.421 0.45 . . . . 0.0 111.972 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.44 -41.85 10.07 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.276 0.36 . . . . 0.0 111.681 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -88.86 155.96 49.89 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 123.288 0.368 . . . . 0.0 111.624 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -80.84 -54.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.732 2.288 . . . . 0.0 113.942 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.65 -59.48 0.19 Allowed Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.876 -0.958 . . . . 0.0 113.591 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.441 ' HA ' ' OE2' ' A' ' 126' ' ' GLU . 52.2 Cg_exo -54.65 -30.84 68.0 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.079 2.519 . . . . 0.0 114.04 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 8.1 m-20 -71.25 -29.72 65.44 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.538 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.701 ' HA ' HD12 ' A' ' 128' ' ' ILE . 6.4 mt -86.64 -19.06 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.441 ' OE2' ' HA ' ' A' ' 123' ' ' PRO . 37.5 mt-10 -65.24 -51.88 58.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.782 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 124' ' ' ASP . 1.9 ptp180 -57.9 -21.03 41.39 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.274 176.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 125' ' ' ILE . 83.2 mt -77.72 -50.11 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 122.577 0.351 . . . . 0.0 111.027 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 144' ' ' GLY . 4.6 m -61.98 -36.28 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 4.3 m -70.71 -58.18 3.91 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.502 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.9 m -52.7 -29.03 24.51 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.406 HD22 ' HB1' ' A' ' 140' ' ' ALA . 17.8 mt -76.19 -46.81 26.62 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.026 0.13 . . . . 0.0 111.15 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -87.43 16.49 5.36 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 123.517 0.511 . . . . 0.0 110.96 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 130' ' ' SER . 3.3 tmt_? -99.58 -34.97 10.01 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.694 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.549 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 75.1 m-70 -96.72 -32.9 11.93 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.561 0.538 . . . . 0.0 111.914 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.7 t70 74.72 81.08 0.11 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.227 1.011 . . . . 0.0 110.096 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.405 ' OE2' ' HB2' ' A' ' 135' ' ' HIS . 1.5 pm0 -137.11 128.18 27.7 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.088 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.68 159.47 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.396 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 96.25 -53.52 1.57 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 88' ' ' HIS . . . -104.48 -12.87 16.27 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.916 0.421 . . . . 0.0 111.7 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.46 -36.27 75.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.346 0.658 . . . . 0.0 112.436 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.508 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 9.9 m-20 -74.82 -34.99 62.43 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.5 tp -61.41 -58.81 6.7 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.319 0.387 . . . . 0.0 110.148 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.488 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -51.9 -46.7 54.99 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.934 178.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.77 -39.28 91.08 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.508 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -65.29 -49.45 69.47 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.992 0.183 . . . . 0.0 110.707 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 25.9 mt -59.3 -30.82 68.61 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.41 0.444 . . . . 0.0 111.64 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -83.25 -10.81 58.34 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 123.001 0.188 . . . . 0.0 111.381 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -97.15 0.13 47.89 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 123.162 0.288 . . . . 0.0 111.43 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.519 ' C ' HD12 ' A' ' 151' ' ' LEU . . . -65.68 112.89 3.89 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.519 HD12 ' C ' ' A' ' 150' ' ' ALA . 2.9 mp 72.61 -27.78 0.19 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.934 0.894 . . . . 0.0 110.873 -177.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 150' ' ' ALA . 8.7 m-20 -88.12 128.05 35.42 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 123.361 0.413 . . . . 0.0 111.255 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -100.1 -42.64 6.64 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.857 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.893 179.969 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.0 m . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 111.342 0.127 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -129.61 -7.62 4.61 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 123.384 0.427 . . . . 0.0 111.459 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.32 -62.28 1.05 Allowed Glycine 0 C--N 1.341 0.81 0 C-N-CA 121.47 -0.395 . . . . 0.0 113.004 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -98.94 -45.76 5.85 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.68 0.282 . . . . 0.0 111.209 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 159.73 -137.97 5.36 Favored Glycine 0 C--N 1.339 0.714 0 O-C-N 123.523 0.515 . . . . 0.0 112.255 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -98.03 79.37 2.61 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.318 0.58 . . . . 0.0 110.66 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.46 136.99 54.58 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.087 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -102.9 96.56 6.91 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 123.647 0.592 . . . . 0.0 110.607 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -135.34 70.4 67.98 Favored Pre-proline 0 CA--C 1.548 0.89 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.102 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.87 -47.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 123.044 2.496 . . . . 0.0 112.69 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 tt -143.57 -46.67 0.28 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.438 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 63.13 154.09 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.891 0.876 . . . . 0.0 111.988 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.54 83.35 7.26 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.253 0.549 . . . . 0.0 111.464 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -120.71 -35.14 3.43 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.528 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.486 ' HA ' ' HZ2' ' A' ' 90' ' ' LYS . 12.8 t80 -83.64 99.51 10.25 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.618 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.422 ' H ' ' HZ3' ' A' ' 90' ' ' LYS . 44.1 p -120.51 20.61 11.81 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.082 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HB2' ' NZ ' ' A' ' 90' ' ' LYS . 16.4 ttmt -91.01 105.77 18.05 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.323 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.4 tt -145.34 103.59 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.794 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -91.53 -23.2 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.644 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -78.94 17.96 0.68 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.4 t -85.77 137.34 32.87 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.955 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.6 -70.25 1.18 Allowed Glycine 0 C--N 1.34 0.792 0 O-C-N 123.531 0.52 . . . . 0.0 112.549 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -88.43 -42.75 0.47 Allowed Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.96 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.72 20.74 0.51 Allowed 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.415 2.077 . . . . 0.0 113.65 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.489 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 2.9 tp -78.48 -5.8 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 122.718 0.407 . . . . 0.0 111.038 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 83' ' ' SER . 37.9 tt0 -96.57 -49.73 5.01 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.817 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.7 p -54.26 -58.05 8.88 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.326 1.051 . . . . 0.0 112.595 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 t -60.16 -54.94 39.97 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.67 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.489 ' HB2' ' O ' ' A' ' 78' ' ' ILE . 3.4 m-85 -58.07 -16.73 14.02 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 8.4 t -86.36 -31.85 21.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.701 0.4 . . . . 0.0 111.255 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -46.08 165.18 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -90.37 113.88 25.87 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.212 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 90' ' ' LYS . . . 87.5 67.2 1.32 Allowed Glycine 0 C--N 1.34 0.787 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.635 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.495 HG22 ' OE1' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -91.96 -25.05 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 140' ' ' ALA . 15.6 t60 -113.78 -32.32 6.16 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 93' ' ' GLU . 11.4 pt-20 -99.06 43.68 1.05 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 123.488 0.493 . . . . 0.0 110.707 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 86' ' ' GLY . 25.7 pttt -98.5 -35.92 10.09 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.956 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.532 ' H ' HD12 ' A' ' 91' ' ' ILE . 1.6 mp -76.09 -11.06 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.273 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.549 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 3.6 tp -116.94 5.72 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 O-C-N 123.231 0.332 . . . . 0.0 111.302 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 14.1 tt0 -105.37 -41.47 5.51 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.996 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.87 -29.14 29.56 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.882 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -91.67 -5.49 53.7 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.206 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.549 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 6.2 t70 -74.87 142.88 44.06 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.859 0.464 . . . . 0.0 111.331 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.575 HD23 ' O ' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -122.84 162.88 21.31 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.047 -179.755 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -84.0 -36.39 23.2 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.08 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.575 ' O ' HD23 ' A' ' 97' ' ' LEU . 7.6 p -85.74 159.03 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 O-C-N 123.415 0.447 . . . . 0.0 110.84 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.7 m -85.22 -56.55 3.48 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.414 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm 55.33 178.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.77 0.828 . . . . 0.0 112.501 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.6 t -87.24 -8.11 57.17 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.78 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.516 ' O ' ' HD3' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -95.43 39.02 1.13 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.161 0.505 . . . . 0.0 111.272 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -86.02 173.36 9.96 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.671 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 66.97 135.02 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.295 0 C-N-CA 124.105 0.962 . . . . 0.0 112.056 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.21 163.54 38.38 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.622 2.215 . . . . 0.0 113.319 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 mt -121.55 -8.87 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.843 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -93.43 126.46 38.58 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.147 0.28 . . . . 0.0 111.082 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -135.29 152.9 51.94 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.715 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 63.03 148.85 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.943 0.897 . . . . 0.0 112.883 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.1 p -97.38 155.95 16.68 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.998 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.0 p -93.76 -41.15 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.388 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 85.9 mmm -136.74 108.86 7.21 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.878 0.37 . . . . 0.0 111.053 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.9 91.16 1.9 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.371 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.91 126.29 11.55 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.752 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.8 mt -112.74 -40.83 3.93 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.805 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -89.07 100.72 13.44 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.42 0.628 . . . . 0.0 111.279 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -179.77 -44.04 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.197 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.91 -17.91 12.8 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.357 0.41 . . . . 0.0 111.665 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 31.4 m-85 -94.15 135.22 24.75 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 119.323 -0.37 . . . . 0.0 111.184 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 5.4 Cg_exo -78.21 -36.32 1.04 Allowed 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.467 2.111 . . . . 0.0 113.1 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.64 -59.21 0.26 Allowed Glycine 0 CA--C 1.53 0.976 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.227 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.503 ' HA ' ' OE2' ' A' ' 126' ' ' GLU . 52.0 Cg_exo -56.49 -30.38 82.01 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.931 2.421 . . . . 0.0 114.096 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -65.89 -30.04 70.57 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.269 0.355 . . . . 0.0 111.844 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.546 ' HA ' HD12 ' A' ' 128' ' ' ILE . 10.9 mt -81.68 -31.19 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.503 ' OE2' ' HA ' ' A' ' 123' ' ' PRO . 42.7 mt-10 -56.26 -47.65 78.14 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.55 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -16.8 61.65 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 177.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 125' ' ' ILE . 76.0 mt -78.16 -51.06 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 144' ' ' GLY . 3.7 m -63.03 -35.32 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 4.9 m -73.2 -56.51 4.99 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.387 0.429 . . . . 0.0 111.37 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.8 m -56.13 -24.61 41.93 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.401 HD22 ' HB1' ' A' ' 140' ' ' ALA . 25.9 mt -79.97 -51.63 8.84 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.929 0.143 . . . . 0.0 111.017 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -85.06 16.16 3.65 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.453 0.47 . . . . 0.0 111.312 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.0 tmt_? -79.6 -42.78 24.21 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.27 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.438 ' CE1' HH11 ' A' ' 134' ' ' ARG . 91.2 m-70 -96.96 -11.88 24.07 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.135 0.272 . . . . 0.0 111.242 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.1 t70 67.83 55.85 0.58 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.129 0.972 . . . . 0.0 110.969 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.495 ' OE1' HG22 ' A' ' 87' ' ' ILE . 11.1 pt-20 -88.99 124.46 34.29 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.936 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.07 -8.17 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.825 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.99 -26.89 20.69 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.417 -0.42 . . . . 0.0 112.857 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.483 ' HB2' ' HB2' ' A' ' 88' ' ' HIS . . . -121.81 6.05 9.93 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 122.807 0.443 . . . . 0.0 111.613 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -34.63 78.61 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.541 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 2.8 t70 -78.81 -34.62 45.19 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.596 0.236 . . . . 0.0 110.899 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.7 tp -64.45 -68.97 0.31 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.846 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.524 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -48.81 -43.72 30.4 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 114.843 0.697 . . . . 0.0 114.843 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.5 96.69 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.541 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 14.4 mptt -60.86 -49.74 76.24 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.995 0.184 . . . . 0.0 110.896 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 35.8 mt -57.56 -30.45 65.25 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.405 0.441 . . . . 0.0 112.05 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -80.18 -35.98 35.62 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 120.565 0.221 . . . . 0.0 110.67 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -78.84 8.93 4.71 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.988 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.83 -4.65 53.09 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.61 0.364 . . . . 0.0 111.749 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.1 tt -93.91 -42.89 8.83 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.583 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -83.31 157.88 22.43 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 123.407 0.442 . . . . 0.0 111.022 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 72.41 -45.57 0.62 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.474 1.11 . . . . 0.0 112.3 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.904 180.0 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.424 ' O ' ' HD2' ' A' ' 82' ' ' TYR . 1.2 tp . . . . . 0 CA--C 1.552 1.031 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -116.7 -65.98 1.13 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.901 -0.136 . . . . 0.0 110.93 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 51.6 p -41.66 -50.21 4.17 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.748 1.219 . . . . 0.0 112.848 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.561 ' O ' HD13 ' A' ' 87' ' ' ILE . 8.5 t -62.86 -49.37 75.14 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 113.367 -1.742 . . . . 0.0 110.371 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.424 ' HD2' ' O ' ' A' ' 78' ' ' ILE . 64.3 m-85 -86.79 17.22 4.14 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.639 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.544 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 13.1 t -119.15 -17.47 8.92 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.405 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.54 164.91 22.59 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.768 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -88.68 117.84 27.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.026 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.23 68.13 1.21 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.284 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.561 HD13 ' O ' ' A' ' 81' ' ' SER . 2.4 tp -96.95 -29.05 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.635 ' HB3' ' O ' ' A' ' 139' ' ' GLY . 39.1 t60 . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.549 ' HA ' ' CD1' ' A' ' 120' ' ' TYR . 10.2 mt . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -130.28 -6.1 4.31 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -96.11 -43.42 7.76 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.81 -5.59 18.29 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.294 0.371 . . . . 0.0 111.892 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.549 ' CD1' ' HA ' ' A' ' 116' ' ' LEU . 36.0 m-85 -97.16 139.29 21.4 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.786 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.13 -58.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.523 2.149 . . . . 0.0 114.074 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.33 -60.73 0.08 OUTLIER Glycine 0 C--N 1.343 0.972 0 CA-C-O 118.919 -0.934 . . . . 0.0 113.596 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.27 -31.98 69.18 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.078 2.519 . . . . 0.0 114.017 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.94 -41.81 97.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.38 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.515 ' O ' HG22 ' A' ' 129' ' ' VAL . 7.1 mt -70.54 -40.11 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.574 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.98 -24.12 66.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.793 0.437 . . . . 0.0 111.941 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -77.76 -45.09 25.64 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.407 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.7 mt -63.06 -47.24 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 122.844 0.457 . . . . 0.0 111.197 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 125' ' ' ILE . 5.3 m -58.64 -51.56 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.791 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.1 m -58.35 -39.03 78.4 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 m -71.38 -26.17 62.67 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.9 mt -85.65 -37.6 19.29 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -83.81 6.38 21.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.598 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.488 HH11 ' CE1' ' A' ' 135' ' ' HIS . 4.5 tmt_? -86.9 -42.82 12.9 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.28 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.544 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 88.5 m-70 -91.64 -25.38 19.18 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.982 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.2 t70 70.54 76.12 0.2 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.115 0.966 . . . . 0.0 110.535 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -101.02 130.02 46.95 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.503 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.69 -14.91 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 123.437 0.461 . . . . 0.0 111.695 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.635 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -96.76 -7.57 57.64 Favored Glycine 0 C--N 1.336 0.575 0 O-C-N 123.344 0.403 . . . . 0.0 112.293 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -130.02 1.59 4.77 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.363 0.665 . . . . 0.0 111.607 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -62.59 -27.39 69.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.003 0.521 . . . . 0.0 111.398 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.517 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 1.5 p30 -76.21 -39.06 55.59 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.441 0.463 . . . . 0.0 110.887 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.0 tp -64.07 -59.97 3.81 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.885 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -58.41 -56.3 25.99 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.799 -0.637 . . . . 0.0 114.66 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.4 -41.84 76.98 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.517 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -65.98 -40.25 91.05 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.929 0.143 . . . . 0.0 111.357 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 22.0 mt -69.85 -27.9 65.23 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.336 0.398 . . . . 0.0 110.781 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -95.6 5.56 51.16 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 123.142 0.276 . . . . 0.0 110.937 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -85.38 -2.71 58.39 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.329 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.627 179.575 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.5 tp . . . . . 0 CA--C 1.551 1.012 0 CA-C-O 121.15 0.5 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 83' ' ' SER . 7.1 tp10 -119.8 -53.89 2.17 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.137 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.1 m -56.46 -56.78 16.89 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.419 0.688 . . . . 0.0 112.235 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.8 m -59.51 -55.81 29.86 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.289 0.368 . . . . 0.0 111.043 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.468 ' HB3' HG21 ' A' ' 131' ' ' THR . 2.1 m-85 -61.43 -11.88 12.29 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.492 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 8.3 t -87.94 -40.09 14.21 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.624 0.193 . . . . 0.0 111.324 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.71 152.62 30.56 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -82.88 131.56 35.19 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.081 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.78 28.05 5.79 Favored Glycine 0 C--N 1.336 0.536 0 O-C-N 123.731 0.644 . . . . 0.0 112.783 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.592 HD13 ' O ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -91.51 -19.54 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 122.735 0.414 . . . . 0.0 111.049 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.8 p80 . . . . . 0 CA--C 1.547 0.832 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.641 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 120' ' ' TYR . 3.0 mp . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -98.87 146.6 25.8 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.142 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt 70.77 -34.59 0.3 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.455 1.102 . . . . 0.0 112.889 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.5 -31.78 19.78 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.505 ' CE2' HD23 ' A' ' 116' ' ' LEU . 13.6 m-85 -88.82 158.14 48.01 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 119.241 -0.409 . . . . 0.0 111.095 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.67 -44.43 0.14 Allowed 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.412 2.074 . . . . 0.0 113.832 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.35 -59.58 0.42 Allowed Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.9 -0.944 . . . . 0.0 113.508 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.09 -18.03 41.48 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.905 2.403 . . . . 0.0 114.049 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -78.13 -40.03 39.38 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.299 0.374 . . . . 0.0 111.254 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.537 ' O ' HG22 ' A' ' 129' ' ' VAL . 6.1 mt -68.71 -33.14 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.626 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -69.43 -50.53 44.82 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.466 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -51.77 -44.52 63.39 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.617 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.579 ' O ' HD12 ' A' ' 132' ' ' LEU . 23.7 mt -63.61 -57.02 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 122.356 0.262 . . . . 0.0 111.546 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 125' ' ' ILE . 5.0 m -55.49 -45.07 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.8 t -64.38 -30.1 71.15 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.468 HG21 ' HB3' ' A' ' 82' ' ' TYR . 22.8 m -72.78 -34.91 67.25 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.994 0.184 . . . . 0.0 111.349 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.68 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 0.9 OUTLIER -75.02 -28.86 60.66 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.154 0.284 . . . . 0.0 111.336 178.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -90.01 18.93 5.28 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.373 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -109.97 -41.31 4.51 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.38 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.68 ' NE2' ' HA ' ' A' ' 132' ' ' LEU . 5.7 p80 -87.21 -41.98 13.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.94 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 70.95 81.06 0.16 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.254 1.022 . . . . 0.0 112.015 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.529 ' HG2' ' CE1' ' A' ' 135' ' ' HIS . 10.3 pt-20 -128.23 139.79 52.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.645 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.98 -13.5 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.709 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -79.76 -28.77 50.04 Favored Glycine 0 C--N 1.34 0.792 0 O-C-N 123.341 0.4 . . . . 0.0 113.849 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -123.11 1.95 9.22 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -58.79 -25.18 62.87 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.953 0.501 . . . . 0.0 112.22 179.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.577 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 7.6 m-20 -81.43 -32.99 32.42 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.784 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.8 tp -68.61 -56.84 6.9 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.532 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.413 ' H ' HD22 ' A' ' 132' ' ' LEU . . . -60.82 -48.28 87.04 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.851 -0.613 . . . . 0.0 114.153 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.7 -41.49 86.4 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.577 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 14.4 mptt -65.45 -34.57 78.61 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 30.8 mt -72.83 -30.89 64.4 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.205 0.316 . . . . 0.0 111.616 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.491 ' O ' ' HD2' ' A' ' 148' ' ' ARG . 1.8 tmm_? -87.67 -19.64 27.4 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 123.173 0.296 . . . . 0.0 111.189 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.49 22.65 3.33 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 123.382 0.426 . . . . 0.0 111.153 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.513 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.932 179.867 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.493 HD13 ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.8 0 CA-C-O 120.642 0.258 . . . . 0.0 110.379 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -75.13 -53.35 9.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.099 0.56 . . . . 0.0 111.974 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 83' ' ' SER . 37.3 m -49.57 -47.9 48.99 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.097 0.959 . . . . 0.0 112.815 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.9 p -54.65 -58.64 6.72 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.523 0.514 . . . . 0.0 111.943 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -74.45 -4.79 38.74 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.574 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 4.4 m -78.65 -37.01 43.01 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.85 0.46 . . . . 0.0 110.987 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.98 161.93 12.21 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.91 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -96.36 98.25 10.12 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.602 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.76 60.04 0.16 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.876 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.554 HG22 ' OE2' ' A' ' 137' ' ' GLU . 3.9 tp -86.44 -31.3 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 122.43 0.292 . . . . 0.0 111.181 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.8 t60 . . . . . 0 N--CA 1.466 0.369 0 O-C-N 123.387 0.43 . . . . 0.0 109.997 179.408 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.514 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 4.6 mt . . . . . 0 C--O 1.238 0.47 0 CA-C-O 120.748 0.309 . . . . 0.0 111.766 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 116' ' ' LEU . 36.0 mmtt -157.86 -48.64 0.06 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.89 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -94.22 -43.72 8.31 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -83.71 0.37 47.38 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 123.177 0.298 . . . . 0.0 111.688 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.407 ' CD1' HD23 ' A' ' 116' ' ' LEU . 58.7 m-85 -127.68 123.34 22.94 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.795 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -73.41 -49.61 0.21 Allowed 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.658 2.239 . . . . 0.0 113.871 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 172.81 -61.21 0.14 Allowed Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.94 -0.922 . . . . 0.0 113.556 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.96 -31.41 73.93 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.928 2.419 . . . . 0.0 113.926 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -70.5 -20.47 62.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.644 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.748 ' HA ' HD12 ' A' ' 128' ' ' ILE . 8.8 mt -95.1 -28.29 4.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.13 -36.49 84.19 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.745 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -77.73 -10.64 59.64 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.877 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.748 HD12 ' HA ' ' A' ' 125' ' ' ILE . 96.6 mt -84.14 -41.9 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.633 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.8 m -72.31 -38.29 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.132 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 21.2 t -71.77 -60.91 1.99 Allowed 'General case' 0 C--N 1.348 0.502 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.701 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.6 m -56.86 -25.11 55.81 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.615 ' HB2' ' O ' ' A' ' 128' ' ' ILE . 4.3 tt -74.77 -48.27 26.44 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.586 0.176 . . . . 0.0 111.191 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -96.29 13.18 28.43 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 120.873 0.368 . . . . 0.0 111.645 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 130' ' ' SER . 4.5 tmt_? -76.03 -42.17 48.65 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.574 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 21.2 m-70 -88.85 -111.6 0.07 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 176.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.428 ' H ' ' HB2' ' A' ' 135' ' ' HIS . 8.7 m-20 -123.17 -89.54 0.59 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.554 ' OE2' HG22 ' A' ' 87' ' ' ILE . 3.7 mm-40 55.48 89.87 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.487 1.115 . . . . 0.0 111.262 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.25 -15.64 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.021 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -94.02 -31.26 8.21 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.62 -16.92 29.47 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.106 0.562 . . . . 0.0 111.204 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 19.2 tptt -51.59 -28.83 15.24 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.445 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 1.3 p30 -78.34 -44.14 25.89 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.714 0.293 . . . . 0.0 110.495 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.4 tp -60.62 -66.55 0.51 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.964 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.54 -34.71 20.62 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.332 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.72 77.71 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 117.218 0.509 . . . . 0.0 112.104 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -66.78 -50.55 62.3 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.1 0.25 . . . . 0.0 110.685 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 26.9 mt -61.79 -28.43 69.45 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.225 0.328 . . . . 0.0 111.423 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -80.77 -38.15 29.07 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 123.369 0.418 . . . . 0.0 110.773 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.83 0.27 27.76 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.239 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.499 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.509 ' O ' HG21 ' A' ' 131' ' ' THR . 0.2 OUTLIER . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 121.443 0.64 . . . . 0.0 111.209 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 83' ' ' SER . 7.0 tp10 -120.87 -55.68 1.98 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.428 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 m -64.49 -58.94 5.0 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.6 m -53.21 -62.06 1.9 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.449 ' CD2' HG12 ' A' ' 87' ' ' ILE . 44.9 m-85 -51.64 -33.51 33.79 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 178.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 6.3 t -65.78 -33.73 76.54 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.22 174.58 0.13 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.261 0.624 . . . . 0.0 112.643 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -98.22 119.04 36.18 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.198 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.04 51.14 1.66 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.058 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.449 HG12 ' CD2' ' A' ' 82' ' ' TYR . 3.8 tp -85.54 -42.29 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 122.47 0.308 . . . . 0.0 111.189 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 140' ' ' ALA . 59.1 t60 . . . . . 0 CA--C 1.55 0.95 0 CA-C-O 121.235 0.54 . . . . 0.0 111.939 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.511 HD23 ' CZ ' ' A' ' 120' ' ' TYR . 9.2 mt . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 120.985 0.422 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -134.07 3.4 3.43 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.973 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.9 -48.96 13.63 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.44 10.48 6.74 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 123.394 0.434 . . . . 0.0 111.03 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.511 ' CZ ' HD23 ' A' ' 116' ' ' LEU . 63.5 m-85 -97.51 105.26 24.76 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.693 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.3 -35.38 14.11 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.653 2.236 . . . . 0.0 113.621 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 157.64 -56.85 0.37 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.868 -0.962 . . . . 0.0 113.122 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.16 -22.72 41.29 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.887 2.391 . . . . 0.0 114.028 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -74.31 -39.69 62.73 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.296 0.372 . . . . 0.0 111.293 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.696 ' HA ' HD12 ' A' ' 128' ' ' ILE . 5.0 mt -78.16 -30.91 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.371 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -62.38 -52.51 63.3 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.339 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.443 ' O ' ' OG1' ' A' ' 131' ' ' THR . 76.9 mtt180 -55.94 -27.72 53.65 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 177.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 125' ' ' ILE . 69.2 mt -70.9 -50.48 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 121.999 0.12 . . . . 0.0 111.022 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.4 m -60.37 -39.72 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 43.2 p -78.73 -18.19 54.67 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.509 HG21 ' O ' ' A' ' 78' ' ' ILE . 89.1 m -86.62 -28.67 23.1 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 122.883 0.114 . . . . 0.0 111.224 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 144' ' ' GLY . 1.7 mp -80.43 -46.27 16.25 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.087 0.242 . . . . 0.0 110.444 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.416 ' OE1' ' HG2' ' A' ' 148' ' ' ARG . 44.4 mt-10 -80.18 12.87 2.59 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.881 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 130' ' ' SER . 4.6 tmt_? -79.71 -46.18 17.57 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.218 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.593 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 3.9 p80 -110.22 -12.45 14.47 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 70.31 78.83 0.19 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.337 1.055 . . . . 0.0 111.935 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.593 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 0.2 OUTLIER -99.77 130.44 45.98 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.923 179.08 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.89 -7.62 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.025 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -93.08 -22.11 28.5 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.512 -0.375 . . . . 0.0 112.705 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.468 ' HB3' ' CG ' ' A' ' 137' ' ' GLU . . . -126.93 5.25 6.56 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.18 -33.83 59.05 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.039 0.536 . . . . 0.0 111.753 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.57 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 3.1 t70 -74.95 -34.95 62.12 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.47 0.481 . . . . 0.0 111.232 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.9 tp -69.05 -59.61 2.92 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.825 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.483 ' N ' HD22 ' A' ' 132' ' ' LEU . . . -55.43 -56.25 24.44 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.852 -0.613 . . . . 0.0 113.934 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . -54.94 -43.63 73.57 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.57 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 14.3 mptt -62.24 -41.13 98.15 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.922 0.139 . . . . 0.0 111.246 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.4 mt -59.47 -34.42 72.54 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.44 0.463 . . . . 0.0 111.622 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 145' ' ' ALA . 0.1 OUTLIER -94.17 7.3 45.77 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 120.656 0.265 . . . . 0.0 111.029 178.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -108.18 17.65 22.02 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.245 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.447 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.976 179.963 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.56 1.335 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -120.38 -77.99 0.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 35.2 m -41.63 -47.55 3.92 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.313 1.045 . . . . 0.0 112.715 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.4 t -61.54 -51.61 67.87 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.806 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -88.37 17.98 4.83 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.392 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m -119.73 -15.88 8.85 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.997 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.34 154.74 17.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.169 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.522 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -78.6 133.67 37.27 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.504 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 94.44 34.12 6.5 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.669 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.7 tp -89.31 -24.06 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 140' ' ' ALA . 29.2 p-80 . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.514 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 6.2 mt . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -91.64 141.23 28.93 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.213 0.321 . . . . 0.0 111.062 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.2 mptt 70.64 -35.68 0.33 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.348 1.059 . . . . 0.0 113.018 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.99 -18.09 20.51 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 122.252 0.221 . . . . 0.0 111.324 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.514 ' HB3' ' O ' ' A' ' 116' ' ' LEU . 19.3 t80 -133.57 50.55 5.48 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 123.335 0.397 . . . . 0.0 111.315 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 120' ' ' TYR . 3.5 Cg_exo -76.19 111.18 3.22 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.26 1.973 . . . . 0.0 112.287 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -172.91 -160.55 21.69 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.713 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.677 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 12.5 Cg_exo -70.29 -34.83 12.12 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 123.295 2.663 . . . . 0.0 112.803 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -56.09 -30.69 62.41 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.492 0.495 . . . . 0.0 111.62 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.476 ' O ' HG22 ' A' ' 129' ' ' VAL . 46.4 mm -67.12 -44.53 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.642 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -68.9 -18.71 64.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.237 0.615 . . . . 0.0 111.243 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.677 ' HG2' ' O ' ' A' ' 123' ' ' PRO . 24.2 mmm180 -79.99 -46.63 16.32 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.604 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.4 mt -61.23 -49.33 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.916 0.487 . . . . 0.0 110.744 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 125' ' ' ILE . 7.0 m -58.68 -52.11 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.699 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 57.9 m -59.48 -38.41 80.77 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.2 m -72.69 -24.12 60.97 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 19.3 mt -85.66 -30.91 22.85 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.075 0.235 . . . . 0.0 111.406 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -84.97 5.1 30.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.15 0.5 . . . . 0.0 111.167 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -98.04 -36.22 10.18 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.442 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -85.36 -33.41 22.03 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.436 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 67.18 69.84 0.38 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.225 1.01 . . . . 0.0 111.492 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 140' ' ' ALA . 36.1 mt-10 -95.82 136.68 35.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.49 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.2 m -75.23 -48.71 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -77.43 -2.12 78.53 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.176 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.768 ' HB2' ' HB3' ' A' ' 88' ' ' HIS . . . -122.53 -4.79 8.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.737 0.415 . . . . 0.0 111.386 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -62.28 -37.61 86.19 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 122.798 0.439 . . . . 0.0 111.013 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.511 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 8.1 m-20 -73.42 -38.16 65.65 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.482 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.3 tp -66.74 -55.91 12.91 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.75 0.42 . . . . 0.0 110.781 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.05 -41.65 85.65 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.483 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -61.51 -41.21 96.96 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.511 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -62.13 -38.05 87.49 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.141 0.275 . . . . 0.0 111.464 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.2 mt -66.41 -32.15 73.35 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.257 0.348 . . . . 0.0 110.328 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.41 12.47 31.19 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.423 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 5.4 t70 -106.47 43.32 1.16 Allowed 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.288 0.566 . . . . 0.0 110.375 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.503 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.661 179.826 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 tt . . . . . 0 CA--C 1.554 1.103 0 CA-C-O 120.732 0.301 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -120.18 -57.57 1.92 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.272 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.9 m -47.35 -46.84 25.98 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.191 0.996 . . . . 0.0 112.7 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.2 t -61.19 -53.04 61.91 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.887 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -79.62 5.28 13.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.926 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.523 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 23.3 t -91.32 -47.45 7.47 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.943 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.98 160.21 4.97 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -92.07 92.13 8.13 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.219 0.533 . . . . 0.0 110.921 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.5 48.31 0.05 OUTLIER Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.98 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.522 HG22 ' OE1' ' A' ' 137' ' ' GLU . 2.7 tp -91.84 -29.62 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 122.623 0.369 . . . . 0.0 111.929 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.445 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 32.4 t60 . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.4 mp . . . . . 0 C--O 1.236 0.367 0 CA-C-O 120.528 0.204 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 71.02 -3.48 2.02 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.376 1.07 . . . . 0.0 112.759 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -97.43 -45.1 6.57 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.396 0.278 . . . . 0.0 110.69 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.46 7.34 1.93 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.834 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -92.93 114.13 61.76 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.618 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.55 177.85 1.12 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.709 2.273 . . . . 0.0 112.863 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.68 -55.58 14.15 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.878 -0.957 . . . . 0.0 113.87 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.5 -15.17 39.51 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.732 2.288 . . . . 0.0 113.762 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.408 ' O ' HG13 ' A' ' 128' ' ' ILE . 3.2 t70 -80.05 -41.35 25.86 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.553 0.341 . . . . 0.0 111.021 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.0 mt -67.7 -39.11 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.472 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.8 -50.65 65.89 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.183 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -49.34 -40.67 36.27 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.828 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 124' ' ' ASP . 29.0 mt -66.64 -54.59 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.142 0.177 . . . . 0.0 111.436 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.2 m -60.23 -51.78 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 75.2 m -62.91 -25.49 68.35 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.2 m -83.28 -26.0 31.06 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 117.54 0.154 . . . . 0.0 111.297 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.5 mt -81.15 -38.55 26.99 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.592 0.234 . . . . 0.0 111.031 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -88.45 8.81 26.1 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.822 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.577 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.1 tmt_? -82.17 -40.63 21.51 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.987 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.523 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 87.6 m-70 -100.4 -9.4 22.25 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.457 0.473 . . . . 0.0 111.298 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 67.67 70.21 0.35 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.178 0.991 . . . . 0.0 111.326 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.522 ' OE1' HG22 ' A' ' 87' ' ' ILE . 43.5 mt-10 -90.7 129.13 36.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.437 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 138' ' ' VAL . 0.5 OUTLIER -78.16 -45.15 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -178.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -76.16 -18.53 79.29 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.579 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.62 -11.58 17.61 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 124.041 0.495 . . . . 0.0 111.033 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -51.78 -34.76 41.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.643 0.777 . . . . 0.0 112.461 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.533 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 8.0 m-20 -74.57 -36.62 63.06 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.434 0.459 . . . . 0.0 111.495 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.445 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 14.3 tp -67.39 -60.24 2.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.74 0.416 . . . . 0.0 110.884 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.49 -43.6 85.42 Favored Glycine 0 C--N 1.343 0.947 0 O-C-N 123.618 0.574 . . . . 0.0 113.928 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -60.64 -43.6 97.35 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.533 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -61.97 -40.19 94.73 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.3 mt -67.11 -30.75 70.85 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 123.264 0.352 . . . . 0.0 110.302 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -94.25 9.84 36.44 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.367 0.417 . . . . 0.0 110.703 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 3.7 t70 -114.27 16.49 17.93 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.694 0.283 . . . . 0.0 111.082 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.611 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.826 179.736 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 tp . . . . . 0 CA--C 1.554 1.096 0 CA-C-O 121.114 0.483 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 83' ' ' SER . 37.5 tt0 -120.03 -60.82 1.66 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.835 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.5 m -52.17 -56.42 14.7 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.589 0.755 . . . . 0.0 112.196 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.0 p -60.59 -53.72 54.02 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.958 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.501 ' HB3' HG21 ' A' ' 131' ' ' THR . 3.9 m-85 -69.21 -0.31 5.88 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.6 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 10.9 t -95.55 -43.48 7.93 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.51 161.96 26.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.271 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.637 ' HA ' ' OE1' ' A' ' 137' ' ' GLU . 19.3 mtpp -86.19 145.99 26.75 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.083 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.65 18.68 27.15 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.255 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -79.23 -19.36 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 122.528 0.331 . . . . 0.0 111.717 179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.538 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 75.2 t60 . . . . . 0 CA--C 1.546 0.79 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.169 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.305 0 CA-C-O 120.943 0.401 . . . . 0.0 111.637 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -147.33 -39.3 0.19 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.527 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.06 -8.09 46.89 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.632 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.2 -46.61 10.91 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.236 0.335 . . . . 0.0 111.08 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -98.28 161.36 25.61 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 123.495 0.497 . . . . 0.0 110.902 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.17 -31.01 24.06 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.467 2.112 . . . . 0.0 113.419 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 152.1 -52.66 0.48 Allowed Glycine 0 CA--C 1.531 1.077 0 CA-C-O 118.781 -1.01 . . . . 0.0 113.751 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.87 -17.52 18.92 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.986 2.457 . . . . 0.0 114.847 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -74.93 -42.1 58.36 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.313 0.245 . . . . 0.0 111.453 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.535 ' O ' HG22 ' A' ' 129' ' ' VAL . 4.6 mp -62.7 -32.69 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.794 0.438 . . . . 0.0 110.667 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -70.19 -50.53 39.2 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.68 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.62 -46.26 70.38 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.476 HG23 ' CE1' ' A' ' 82' ' ' TYR . 23.3 mt -61.17 -59.36 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 122.532 0.333 . . . . 0.0 111.488 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 125' ' ' ILE . 16.5 m -53.42 -41.94 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 123.49 0.494 . . . . 0.0 112.078 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 12.9 t -68.25 -26.48 65.7 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.501 HG21 ' HB3' ' A' ' 82' ' ' TYR . 20.5 m -72.06 -40.8 68.06 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.238 0.215 . . . . 0.0 110.933 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.526 HD22 ' N ' ' A' ' 144' ' ' GLY . 4.1 mp -77.1 -24.54 51.76 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.283 0.365 . . . . 0.0 111.508 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -91.13 12.1 21.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.272 0.558 . . . . 0.0 110.324 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.9 tmt_? -118.95 -36.64 3.38 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.128 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.6 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 52.2 m-70 -90.18 -32.17 16.73 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.912 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.9 t70 60.62 61.16 1.77 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.064 0.945 . . . . 0.0 111.674 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.637 ' OE1' ' HA ' ' A' ' 85' ' ' LYS . 37.1 mt-10 -84.99 130.22 34.66 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.641 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.474 ' O ' ' HD2' ' A' ' 141' ' ' LYS . 3.4 t -79.8 -22.42 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.404 0.44 . . . . 0.0 111.645 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -87.09 -19.05 56.66 Favored Glycine 0 C--N 1.342 0.884 0 C-N-CA 121.424 -0.417 . . . . 0.0 112.742 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.89 3.25 11.05 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.893 0.477 . . . . 0.0 111.374 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER -48.05 -42.33 28.25 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.783 0.833 . . . . 0.0 112.617 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 2.4 p-10 -68.21 -40.96 81.98 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.532 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.538 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 32.6 tp -56.18 -51.92 66.26 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.56 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.526 ' N ' HD22 ' A' ' 132' ' ' LEU . . . -60.92 -60.78 7.84 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.923 -0.581 . . . . 0.0 113.654 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -54.97 -42.11 72.01 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -63.54 -32.81 74.39 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.112 0.258 . . . . 0.0 111.518 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.0 mt -70.82 -30.93 67.5 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.295 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.413 ' O ' ' HD3' ' A' ' 148' ' ' ARG . 1.0 OUTLIER -98.93 4.47 47.37 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 123.153 0.283 . . . . 0.0 111.041 178.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 1.8 t70 -99.24 24.77 7.55 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.84 0.352 . . . . 0.0 111.2 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.453 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.022 179.885 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 tt . . . . . 0 CA--C 1.549 0.923 0 CA-C-O 120.644 0.259 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -103.96 -43.52 5.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.842 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 m -63.53 -63.06 1.28 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.4 t -45.24 -25.39 0.37 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -104.29 -10.9 17.5 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.8 t -91.91 -25.01 19.12 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.91 118.07 2.92 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.98 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.506 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 12.4 ptmt -60.64 105.61 0.46 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.86 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.23 75.58 1.3 Allowed Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.295 -0.866 . . . . 0.0 114.256 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.67 HG23 ' H ' ' A' ' 88' ' ' HIS . 8.1 tt -106.65 -103.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.67 ' H ' HG23 ' A' ' 87' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 120' ' ' TYR . 5.2 mt . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 120.745 0.307 . . . . 0.0 111.501 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -92.47 -11.69 34.01 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.815 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -96.54 -38.4 10.0 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.108 0.255 . . . . 0.0 111.674 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.8 t -94.4 -42.45 8.87 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 123.316 0.385 . . . . 0.0 111.638 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 116' ' ' LEU . 6.3 m-30 -97.86 119.39 62.43 Favored Pre-proline 0 CA--C 1.543 0.707 0 O-C-N 123.429 0.455 . . . . 0.0 110.67 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.87 -48.81 0.35 Allowed 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.638 2.225 . . . . 0.0 114.041 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -171.03 -63.92 0.04 OUTLIER Glycine 0 C--N 1.342 0.891 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.448 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.08 -30.45 78.87 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.061 2.507 . . . . 0.0 113.85 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.8 -21.58 66.04 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.347 0.404 . . . . 0.0 111.977 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.575 ' HA ' HD12 ' A' ' 128' ' ' ILE . 6.9 mt -89.41 -50.13 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -45.53 -41.18 9.46 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.649 0.78 . . . . 0.0 112.082 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -62.17 -42.76 99.57 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.967 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.575 HD12 ' HA ' ' A' ' 125' ' ' ILE . 14.8 mt -61.51 -61.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.962 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 144' ' ' GLY . 3.4 m -49.16 -31.27 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 18.3 t -76.76 -50.36 13.75 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.04 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.5 m -56.55 -33.89 66.55 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.748 HD23 ' HB1' ' A' ' 140' ' ' ALA . 4.5 mp -79.24 -48.99 13.2 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.645 0.202 . . . . 0.0 111.243 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -56.29 -20.41 18.58 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -79.58 -45.27 19.49 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.28 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.506 ' NE2' ' HA ' ' A' ' 85' ' ' LYS . 50.0 t-80 -64.97 -41.51 95.39 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 72.9 80.4 0.14 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.032 0.933 . . . . 0.0 111.162 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.866 ' HB2' ' HB3' ' A' ' 140' ' ' ALA . 20.5 mt-10 -125.09 153.59 42.71 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.157 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 5.3 t -83.9 -40.23 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 88' ' ' HIS . . . -86.9 -15.49 62.96 Favored Glycine 0 N--CA 1.47 0.931 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.402 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.866 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . . . -95.98 -17.47 20.98 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 113.832 -1.184 . . . . 0.0 109.771 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.838 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 3.2 tptm -70.04 -22.38 63.09 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 9.8 m-20 -81.17 -28.42 35.0 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.767 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.2 tp -76.51 -63.38 1.35 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.867 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.5 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -61.87 -26.59 67.32 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.541 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . -85.27 -39.81 17.31 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.581 0.691 . . . . 0.0 112.409 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -70.47 -31.85 69.15 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 121.331 -0.148 . . . . 0.0 111.009 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.7 mt -71.27 -45.12 63.88 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 123.126 0.266 . . . . 0.0 110.406 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -66.07 -21.67 66.38 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 178.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -95.56 -13.19 24.64 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 123.322 0.389 . . . . 0.0 111.378 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.193 179.307 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.434 HG23 ' CG ' ' A' ' 82' ' ' TYR . 4.5 mp . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 121.474 0.654 . . . . 0.0 110.958 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 83' ' ' SER . 4.9 mm-40 -120.81 -89.41 0.6 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.695 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.9 m -54.04 -43.36 70.13 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.89 0.876 . . . . 0.0 112.602 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.49 ' O ' HG13 ' A' ' 87' ' ' ILE . 24.1 p -68.46 -41.14 80.63 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.71 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.434 ' CG ' HG23 ' A' ' 78' ' ' ILE . 10.2 m-85 -94.33 13.05 24.83 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.247 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 26.3 t -110.02 -25.51 10.21 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.03 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.19 164.34 26.18 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.728 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -95.06 135.56 36.45 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.511 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 77.36 55.82 4.17 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.898 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.549 HD13 ' O ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -113.61 -13.25 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.596 ' HB3' ' O ' ' A' ' 139' ' ' GLY . 61.5 t60 . . . . . 0 CA--C 1.54 0.562 0 CA-C-N 117.859 0.299 . . . . 0.0 111.732 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.66 HD13 HD21 ' A' ' 147' ' ' LEU . 1.2 mp . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? 73.52 -0.27 3.42 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.203 1.001 . . . . 0.0 111.722 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.9 mmpt? -103.9 -33.47 8.84 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.018 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.28 -42.84 8.33 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.545 0.528 . . . . 0.0 111.27 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -85.55 159.27 55.94 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 119.336 -0.364 . . . . 0.0 111.425 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.83 -37.61 1.58 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.536 2.157 . . . . 0.0 113.389 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 160.94 -55.46 0.32 Allowed Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.776 -1.013 . . . . 0.0 113.646 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.58 -24.97 38.96 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.973 2.448 . . . . 0.0 114.364 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -65.63 -40.47 92.59 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.254 0.346 . . . . 0.0 111.327 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.581 ' O ' HG22 ' A' ' 129' ' ' VAL . 4.8 mp -69.25 -46.57 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.456 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -53.0 -39.03 62.81 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.145 0.578 . . . . 0.0 112.223 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -70.79 -48.44 54.25 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.378 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.2 mt -55.87 -48.86 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.088 0.555 . . . . 0.0 111.657 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 125' ' ' ILE . 4.9 m -61.66 -52.98 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.0 t -55.77 -51.59 66.88 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.3 m -60.13 -29.71 68.81 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.636 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 27.6 mt -79.25 -32.23 43.71 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -79.6 -4.95 53.87 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.307 0.243 . . . . 0.0 111.57 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -82.91 -47.14 12.12 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.887 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.636 ' NE2' ' HA ' ' A' ' 132' ' ' LEU . 9.2 p80 -85.03 -35.6 21.81 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.562 0.345 . . . . 0.0 111.584 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 t70 64.5 11.81 6.89 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.255 1.022 . . . . 0.0 113.622 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.537 ' HG2' ' CE1' ' A' ' 135' ' ' HIS . 12.7 pt-20 -47.09 153.29 0.46 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.98 -30.68 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -79.94 3.37 70.73 Favored Glycine 0 N--CA 1.466 0.645 0 O-C-N 123.374 0.421 . . . . 0.0 113.67 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -144.95 -3.49 0.77 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.388 0.675 . . . . 0.0 112.105 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.47 -42.24 70.43 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 123.822 0.849 . . . . 0.0 112.768 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 3.9 p-10 -65.98 -38.48 88.63 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.572 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.484 ' HB2' ' CE1' ' A' ' 88' ' ' HIS . 44.6 tp -61.65 -50.63 71.73 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.44 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -62.69 -62.65 5.33 Favored Glycine 0 C--N 1.343 0.958 0 N-CA-C 115.171 0.828 . . . . 0.0 115.171 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -58.85 -36.91 75.36 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 14.1 mptt -71.97 -33.23 68.01 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.494 0.134 . . . . 0.0 111.326 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.66 HD21 HD13 ' A' ' 116' ' ' LEU . 0.5 OUTLIER -72.92 -31.81 64.88 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 123.292 0.37 . . . . 0.0 110.845 177.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -79.75 -40.91 27.73 Favored 'General case' 0 C--N 1.348 0.523 0 O-C-N 123.415 0.447 . . . . 0.0 110.139 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -85.56 45.04 1.15 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.241 0.543 . . . . 0.0 111.446 179.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.528 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.941 179.922 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.518 ' HB ' ' CD1' ' A' ' 82' ' ' TYR . 1.6 pp . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -120.36 -59.11 1.8 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.338 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.9 m -62.33 -56.04 22.25 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.444 0.697 . . . . 0.0 112.86 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.8 m -56.51 -55.49 33.07 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.632 0.373 . . . . 0.0 111.937 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.518 ' CD1' ' HB ' ' A' ' 78' ' ' ILE . 36.2 m-85 -58.98 -27.99 65.91 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.9 t -70.82 -28.41 64.59 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.31 0.381 . . . . 0.0 110.608 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.77 171.45 11.59 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.561 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -100.02 78.59 2.11 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.224 0.535 . . . . 0.0 110.408 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 143.87 70.21 0.02 OUTLIER Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.411 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.5 tp -100.6 -29.66 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 122.44 0.296 . . . . 0.0 111.73 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.474 ' ND1' HD22 ' A' ' 143' ' ' LEU . 18.1 t60 . . . . . 0 C--O 1.235 0.335 0 O-C-N 123.154 0.284 . . . . 0.0 110.55 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.487 HD23 ' CE1' ' A' ' 120' ' ' TYR . 5.2 mt . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 121.112 0.482 . . . . 0.0 111.608 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -140.3 -40.24 0.43 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.644 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -94.93 -39.27 10.29 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.85 -6.39 59.1 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.254 0.346 . . . . 0.0 111.901 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.487 ' CE1' HD23 ' A' ' 116' ' ' LEU . 39.8 m-85 -123.75 134.32 25.23 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.683 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 2.9 Cg_exo -75.15 -45.45 0.27 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.586 2.191 . . . . 0.0 113.646 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 163.1 -61.85 0.26 Allowed Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.887 -0.951 . . . . 0.0 112.957 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.28 -30.01 78.69 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.898 2.399 . . . . 0.0 113.516 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.36 -25.66 67.68 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.508 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.697 ' HA ' HD12 ' A' ' 128' ' ' ILE . 13.4 mt -86.88 -36.52 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.725 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.25 -36.54 68.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.61 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -77.02 -11.04 59.75 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.189 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.697 HD12 ' HA ' ' A' ' 125' ' ' ILE . 80.9 mt -83.73 -47.66 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 144' ' ' GLY . 4.4 m -69.28 -34.68 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.628 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.5 t -66.58 -52.4 45.79 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.651 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.3 m -64.71 -27.51 68.96 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.547 ' HA ' ' CE1' ' A' ' 135' ' ' HIS . 30.1 mt -79.14 -39.79 32.62 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 129' ' ' VAL . 12.1 pt-20 -71.52 -6.82 43.44 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -79.17 -69.41 0.58 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.141 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.572 ' ND1' ' HG2' ' A' ' 137' ' ' GLU . 5.7 p80 -65.01 -35.5 81.38 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.4 t70 57.49 61.65 2.41 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.871 0.868 . . . . 0.0 111.641 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.572 ' HG2' ' ND1' ' A' ' 135' ' ' HIS . 11.1 pt-20 -107.14 139.02 42.23 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.409 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.3 153.09 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.848 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . 96.73 -17.94 58.38 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -138.78 -16.67 1.12 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.113 0.965 . . . . 0.0 111.055 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -68.92 -29.57 67.86 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 123.906 0.883 . . . . 0.0 111.235 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.571 ' O ' ' HG2' ' A' ' 146' ' ' LYS . 2.4 p-10 -72.13 -43.7 64.29 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.604 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.474 HD22 ' ND1' ' A' ' 88' ' ' HIS . 12.3 tp -58.11 -63.97 1.07 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.578 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.497 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -48.96 -43.67 31.36 Favored Glycine 0 C--N 1.345 1.043 0 O-C-N 123.959 0.787 . . . . 0.0 114.38 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.42 -45.32 84.73 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 142' ' ' ASP . 5.7 mmmt -63.18 -45.39 92.01 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.0 mt -58.17 -36.96 73.79 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.676 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -77.99 -39.29 42.77 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 120.647 0.261 . . . . 0.0 110.554 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.91 3.99 18.17 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.406 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.524 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.969 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.507 ' HB ' ' CD1' ' A' ' 82' ' ' TYR . 1.2 pp . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 121.44 0.638 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 83' ' ' SER . 7.3 tp10 -120.42 -53.42 2.12 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.434 -178.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.5 m -56.71 -60.82 2.99 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.245 0.618 . . . . 0.0 112.506 -177.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.7 t -59.14 -53.99 52.11 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.082 0.239 . . . . 0.0 110.436 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.507 ' CD1' ' HB ' ' A' ' 78' ' ' ILE . 18.8 m-85 -57.16 -15.13 4.97 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.625 ' HA ' ' CD2' ' A' ' 135' ' ' HIS . 23.0 t -86.06 -34.96 20.56 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 122.459 0.304 . . . . 0.0 110.394 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.01 159.75 33.68 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.72 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.53 150.07 22.6 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.286 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 98.65 14.49 37.37 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.41 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.1 tt -77.14 -27.14 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.566 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 70.8 t60 . . . . . 0 CA--C 1.544 0.736 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.469 ' O ' HD11 ' A' ' 125' ' ' ILE . 12.8 mt . . . . . 0 N--CA 1.468 0.461 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -112.35 97.16 6.43 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.371 0.605 . . . . 0.0 110.499 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.8 tptt -179.89 -55.85 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.899 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.6 -4.53 2.28 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.273 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.497 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -88.41 -29.94 0.37 Allowed Pre-proline 0 CA--C 1.549 0.936 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.759 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 120' ' ' TYR . 88.1 Cg_exo -49.65 112.18 0.64 Allowed 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 122.734 2.289 . . . . 0.0 113.516 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 126' ' ' GLU . . . 149.95 -135.82 5.44 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.768 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.416 ' HA ' ' CD ' ' A' ' 126' ' ' GLU . 51.0 Cg_exo -55.64 -32.37 83.19 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.164 2.576 . . . . 0.0 114.322 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.563 ' O ' HG13 ' A' ' 128' ' ' ILE . 8.4 m-20 -70.5 -49.64 46.25 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.596 ' HA ' HD12 ' A' ' 128' ' ' ILE . 5.3 mt -71.27 -39.11 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 122' ' ' GLY . 10.8 pt-20 -59.68 -47.63 84.87 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.037 0.211 . . . . 0.0 110.871 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -57.0 -35.34 69.09 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 125' ' ' ILE . 53.3 mt -61.49 -57.2 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 123.095 0.247 . . . . 0.0 110.81 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 8.0 m -57.44 -38.68 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 123.475 0.484 . . . . 0.0 111.746 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 12.1 t -70.48 -20.22 62.88 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.3 m -77.6 -44.84 27.05 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 128' ' ' ILE . 3.2 mp -72.14 -27.19 62.45 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.782 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -89.03 10.78 20.36 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.205 0.526 . . . . 0.0 110.551 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.2 tmt_? -115.93 -31.16 5.84 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.345 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.625 ' CD2' ' HA ' ' A' ' 83' ' ' SER . 42.9 m-70 -92.68 -32.71 14.64 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.812 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 63.67 64.43 0.79 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.028 0.931 . . . . 0.0 111.927 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -91.11 120.17 31.85 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.341 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.481 ' O ' ' HD3' ' A' ' 141' ' ' LYS . 3.5 t -78.49 -16.5 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.644 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -91.07 -22.19 33.47 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.022 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.88 4.25 14.8 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.327 0.651 . . . . 0.0 110.731 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 138' ' ' VAL . 42.6 pttt -50.92 -37.68 45.5 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.11 0.964 . . . . 0.0 112.948 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.53 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 3.4 t70 -73.91 -30.17 62.44 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.174 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.566 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 15.9 tp -67.7 -57.23 6.73 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.475 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.18 -49.67 62.48 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.87 -0.604 . . . . 0.0 114.035 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.73 87.9 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.53 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.2 mptm? -61.44 -40.2 93.61 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 30.1 mt -63.33 -32.86 74.39 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.417 0.448 . . . . 0.0 111.509 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -75.21 -39.32 60.17 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.14 0.275 . . . . 0.0 110.529 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -78.7 5.59 10.82 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.945 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.44 0 C-N-CA 122.628 0.371 . . . . 0.0 111.608 179.396 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.583 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 1.3 mp . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 83' ' ' SER . 5.0 pt-20 -85.78 -67.5 0.8 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.409 ' H ' ' HG3' ' A' ' 79' ' ' GLU . 18.3 m -64.5 -56.99 10.47 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.416 ' C ' HD13 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -48.52 -57.24 6.44 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.636 0.374 . . . . 0.0 111.231 179.616 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.583 ' HB2' ' O ' ' A' ' 78' ' ' ILE . 27.6 m-85 -69.15 -11.47 60.83 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.551 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 7.4 t -100.23 -1.91 35.23 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.62 147.12 24.21 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.796 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.537 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.9 OUTLIER -73.51 126.3 29.91 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.329 -0.396 . . . . 0.0 112.014 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.88 57.24 2.73 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.408 -0.814 . . . . 0.0 113.501 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.546 HG22 ' OE1' ' A' ' 137' ' ' GLU . 2.9 tp -79.27 -38.39 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 122.749 0.42 . . . . 0.0 111.348 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.837 ' HB3' ' HB2' ' A' ' 140' ' ' ALA . 21.6 p-80 . . . . . 0 CA--C 1.547 0.853 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mt . . . . . 0 N--CA 1.473 0.69 0 CA-C-O 120.981 0.419 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -147.69 -45.84 0.17 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.209 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -112.45 -36.22 5.32 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.401 ' C ' ' HD3' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -79.97 -33.48 39.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.555 0.342 . . . . 0.0 111.451 -179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -127.0 64.39 60.16 Favored Pre-proline 0 CA--C 1.549 0.904 0 O-C-N 123.523 0.514 . . . . 0.0 110.556 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.401 ' HD3' ' C ' ' A' ' 119' ' ' THR . 18.7 Cg_endo -95.06 133.94 0.62 Allowed 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.778 2.319 . . . . 0.0 114.648 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.473 ' H ' HD12 ' A' ' 125' ' ' ILE . . . 74.01 -110.99 3.28 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 119.087 -0.84 . . . . 0.0 114.923 177.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -46.72 -30.09 8.68 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.66 2.907 . . . . 0.0 114.911 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -72.23 -39.91 68.13 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.309 0.381 . . . . 0.0 111.355 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 129' ' ' VAL . 16.3 mt -76.59 -29.73 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.307 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.42 -56.41 16.44 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.629 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -55.86 -29.82 60.5 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.491 HG23 ' CZ ' ' A' ' 82' ' ' TYR . 50.6 mt -73.64 -45.03 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 120.563 0.221 . . . . 0.0 110.53 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 125' ' ' ILE . 12.6 m -77.79 -25.6 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.238 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.1 t -83.74 -19.05 35.83 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.781 0.676 . . . . 0.0 112.306 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.7 m -98.11 -27.3 14.26 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.072 0.232 . . . . 0.0 110.496 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.479 HD13 ' HA3' ' A' ' 144' ' ' GLY . 2.4 tt -80.41 -35.21 35.51 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.176 0.297 . . . . 0.0 110.884 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -72.65 -1.37 15.98 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -97.03 -76.19 0.52 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -46.34 -37.9 8.07 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.604 0.762 . . . . 0.0 112.676 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.8 t70 69.7 76.81 0.21 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.128 0.971 . . . . 0.0 111.203 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.546 ' OE1' HG22 ' A' ' 87' ' ' ILE . 10.4 mm-40 -83.94 123.44 29.97 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.063 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -78.7 -25.6 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.601 ' HA3' ' CE1' ' A' ' 88' ' ' HIS . . . -88.33 -27.83 24.2 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 178.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.837 ' HB2' ' HB3' ' A' ' 88' ' ' HIS . . . -100.49 -1.66 35.13 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.212 -0.494 . . . . 0.0 111.324 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -32.13 36.64 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.14 0.576 . . . . 0.0 112.533 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.569 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 19.8 m-20 -77.49 -40.21 43.77 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.258 0.349 . . . . 0.0 110.679 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.3 tp -65.59 -61.79 1.89 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.58 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.479 ' HA3' HD13 ' A' ' 132' ' ' LEU . . . -53.31 -47.35 62.16 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.724 -0.671 . . . . 0.0 114.511 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.13 -41.9 89.32 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.569 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -61.26 -41.09 96.32 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.021 0.2 . . . . 0.0 111.278 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.0 mt -62.36 -37.9 87.45 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.269 0.355 . . . . 0.0 111.345 177.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -88.44 3.16 51.03 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -120.12 -11.0 9.31 Favored 'General case' 0 C--N 1.345 0.373 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.365 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.163 179.387 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 tt . . . . . 0 CA--C 1.548 0.901 0 CA-C-O 120.466 0.174 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.19 -76.51 0.51 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.018 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.1 m -65.26 -60.75 2.65 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.683 0.393 . . . . 0.0 110.49 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.523 ' O ' HD13 ' A' ' 87' ' ' ILE . 25.6 p -44.45 -39.61 4.9 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.405 0.682 . . . . 0.0 112.687 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.573 ' CE1' HG23 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -89.46 -10.09 47.69 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.2 t -95.04 -6.99 40.93 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.555 0.217 . . . . 0.0 110.685 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.47 149.63 27.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.464 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -74.68 87.03 2.17 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.377 0.608 . . . . 0.0 111.072 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 133.57 63.19 0.07 OUTLIER Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.929 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.602 HG22 ' OE2' ' A' ' 137' ' ' GLU . 4.4 tp -105.79 -15.53 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.596 ' HB3' ' O ' ' A' ' 139' ' ' GLY . 49.2 t60 . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.482 ' HA ' ' CD1' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -172.72 -24.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.048 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -52.96 -34.55 56.28 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.06 0.457 . . . . 0.0 110.998 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.455 ' O ' HD13 ' A' ' 125' ' ' ILE . 6.6 t -129.6 46.5 2.63 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.664 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.574 ' CD1' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -57.34 -45.34 99.9 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.389 -178.349 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -78.79 37.86 0.68 Allowed 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.086 1.857 . . . . 0.0 112.116 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.5 -171.47 18.45 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 115.946 -0.57 . . . . 0.0 114.234 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.537 ' HA ' ' OE1' ' A' ' 126' ' ' GLU . 3.6 Cg_exo -75.24 -37.4 1.93 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.56 2.84 . . . . 0.0 113.33 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.409 ' OD2' HD12 ' A' ' 125' ' ' ILE . 6.9 p-10 -61.95 -19.74 63.07 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.574 HG12 ' CD1' ' A' ' 120' ' ' TYR . 1.1 mp -89.97 -51.81 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 123.372 0.42 . . . . 0.0 111.181 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.537 ' OE1' ' HA ' ' A' ' 123' ' ' PRO . 8.5 pt-20 -50.45 -27.78 7.12 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 177.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -72.04 -35.32 69.31 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.87 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.573 HG23 ' CE1' ' A' ' 82' ' ' TYR . 75.1 mt -58.86 -52.31 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.713 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.7 m -59.91 -54.55 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 123.114 0.259 . . . . 0.0 111.639 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.7 t -56.06 -52.55 63.87 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.2 m -67.88 -17.66 64.55 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.776 HD11 ' HB1' ' A' ' 140' ' ' ALA . 3.5 tt -88.33 -44.47 10.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 117.782 0.265 . . . . 0.0 111.09 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -79.01 -1.49 35.78 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -79.55 -50.0 11.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.191 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.484 ' HE1' ' OE2' ' A' ' 137' ' ' GLU . 5.8 p80 -89.13 -35.86 16.04 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.174 0.297 . . . . 0.0 111.772 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.412 ' OD2' ' HE3' ' A' ' 141' ' ' LYS . 5.5 m-20 74.84 87.72 0.09 Allowed 'General case' 0 C--N 1.357 0.91 0 C-N-CA 124.205 1.002 . . . . 0.0 112.159 177.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.602 ' OE2' HG22 ' A' ' 87' ' ' ILE . 6.6 pt-20 -114.96 151.7 33.66 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.709 178.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.2 m -76.44 -44.89 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -68.7 0.65 12.64 Favored Glycine 0 N--CA 1.471 1.012 0 N-CA-C 115.2 0.84 . . . . 0.0 115.2 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.776 ' HB1' HD11 ' A' ' 132' ' ' LEU . . . -136.74 -11.4 1.79 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.91 0.484 . . . . 0.0 112.036 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 6.4 tptm -53.65 -41.33 66.69 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.292 0.637 . . . . 0.0 112.084 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 2.1 p-10 -70.16 -42.46 72.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.574 ' O ' HD12 ' A' ' 147' ' ' LEU . 14.2 tp -63.81 -52.25 61.08 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.953 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.442 ' CA ' HD13 ' A' ' 132' ' ' LEU . . . -58.04 -38.6 89.89 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 123.697 0.623 . . . . 0.0 113.851 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.91 83.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.873 0.337 . . . . 0.0 111.867 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.477 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.3 mptm? -66.96 -33.82 76.41 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.211 0.319 . . . . 0.0 110.662 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.574 HD12 ' O ' ' A' ' 143' ' ' LEU . 0.6 OUTLIER -66.04 -41.11 91.3 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.548 0.53 . . . . 0.0 110.315 177.507 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -64.73 -38.41 90.88 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.85 1.03 48.85 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.091 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.513 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.129 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 tt . . . . . 0 CA--C 1.544 0.726 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 83' ' ' SER . 1.9 mt-10 -91.86 -28.84 17.06 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.059 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.8 m -69.08 -61.48 1.78 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.842 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.518 ' O ' HD13 ' A' ' 87' ' ' ILE . 40.6 m -86.9 58.41 5.06 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-O 123.389 1.566 . . . . 0.0 109.727 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.56 ' CD2' HG12 ' A' ' 87' ' ' ILE . 0.9 OUTLIER -158.66 -41.62 0.06 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 111.651 -2.522 . . . . 0.0 105.327 -179.426 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.406 ' HA ' ' CD2' ' A' ' 135' ' ' HIS . 8.3 t -70.55 -23.76 62.67 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.097 176.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.86 1.03 4.82 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt 59.34 152.79 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.959 0.903 . . . . 0.0 112.949 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.65 2.6 78.78 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.66 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.56 HG12 ' CD2' ' A' ' 82' ' ' TYR . 7.6 tp -64.05 -9.12 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.517 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 70.1 t60 . . . . . 0 CA--C 1.546 0.825 0 CA-C-O 121.599 0.714 . . . . 0.0 110.903 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 CA--C 1.542 0.635 0 CA-C-O 120.838 0.351 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -147.23 0.54 0.71 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.13 -54.01 4.01 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.09 8.44 2.49 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.873 0.368 . . . . 0.0 110.907 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -89.57 -30.68 0.36 Allowed Pre-proline 0 CA--C 1.55 0.953 0 CA-C-O 118.285 -0.864 . . . . 0.0 112.886 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' TYR . 78.0 Cg_exo -44.93 120.65 3.02 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.065 2.51 . . . . 0.0 114.046 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 165.27 -147.63 12.76 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.726 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -62.71 -22.78 74.25 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.971 2.448 . . . . 0.0 113.754 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.516 ' O ' HG13 ' A' ' 128' ' ' ILE . 9.4 m-20 -71.43 -49.49 41.17 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.594 0.358 . . . . 0.0 111.595 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.623 ' HA ' HD12 ' A' ' 128' ' ' ILE . 10.2 mt -73.26 -34.97 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 123.271 0.357 . . . . 0.0 110.875 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -55.92 -48.22 76.08 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.72 0.637 . . . . 0.0 111.004 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -66.09 -35.65 81.08 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.623 HD12 ' HA ' ' A' ' 125' ' ' ILE . 32.9 mt -61.27 -55.34 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 125' ' ' ILE . 5.5 m -65.12 -27.32 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.223 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.2 t -83.26 -13.89 54.31 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 26.9 m -92.09 -42.42 9.95 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 123.037 0.211 . . . . 0.0 110.913 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 144' ' ' GLY . 4.7 mp -77.74 -37.25 49.61 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -76.97 7.53 4.76 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.295 0.372 . . . . 0.0 111.673 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -108.06 -80.25 0.57 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.406 ' CD2' ' HA ' ' A' ' 83' ' ' SER . 8.2 m-70 -47.81 -37.45 13.71 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.816 0.847 . . . . 0.0 112.789 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 65.69 68.24 0.48 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.995 0.918 . . . . 0.0 111.769 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -88.72 129.77 35.47 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.437 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.505 ' O ' ' HD3' ' A' ' 141' ' ' LYS . 3.1 t -73.41 -16.4 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -86.51 -32.02 17.23 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.43 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.416 ' CB ' ' HB2' ' A' ' 88' ' ' HIS . . . -110.0 5.74 22.51 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.84 0.456 . . . . 0.0 111.149 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.505 ' HD3' ' O ' ' A' ' 138' ' ' VAL . 21.3 pttm -47.32 -37.65 11.35 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.965 0.906 . . . . 0.0 113.087 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 2.5 p-10 -75.29 -41.6 56.75 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.303 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.517 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 17.6 tp -56.83 -55.04 39.53 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.218 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.495 ' N ' HD22 ' A' ' 132' ' ' LEU . . . -59.87 -59.5 10.37 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 115.793 -0.639 . . . . 0.0 114.049 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.71 78.17 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 14.1 mptt -62.51 -36.01 81.19 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 123.027 0.204 . . . . 0.0 111.418 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.6 mt -66.68 -35.71 80.8 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.417 0.448 . . . . 0.0 111.954 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.0 ttp180 -93.14 -2.66 55.15 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -105.94 28.94 7.1 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.938 0.399 . . . . 0.0 110.848 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.47 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.266 -179.917 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.544 0.714 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 83' ' ' SER . 4.5 pt-20 -93.2 -57.77 2.52 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.6 m -67.29 -50.07 61.71 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.4 p -53.96 -54.64 36.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.782 0.433 . . . . 0.0 111.595 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.549 ' CZ ' HG23 ' A' ' 128' ' ' ILE . 46.9 m-85 -58.94 -65.02 0.73 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.542 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -38.71 -32.79 0.09 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.19 144.93 44.55 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.274 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.498 ' HA ' ' OE2' ' A' ' 137' ' ' GLU . 58.9 mttp -77.95 105.31 9.07 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 123.439 0.462 . . . . 0.0 111.845 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.15 50.18 0.35 Allowed Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.817 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.0 tp -70.02 -23.41 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 79.2 t60 . . . . . 0 CA--C 1.553 1.08 0 CA-C-O 120.978 0.418 . . . . 0.0 111.035 179.37 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.475 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 13.5 mt . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -114.84 2.54 14.38 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.38 -47.28 6.35 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.9 t -134.34 -1.98 2.83 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 116' ' ' LEU . 2.9 t80 -94.38 144.27 27.71 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 119.288 -0.387 . . . . 0.0 110.725 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.407 ' HD2' ' CD2' ' A' ' 120' ' ' TYR . 46.3 Cg_exo -57.1 162.76 8.81 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.621 2.214 . . . . 0.0 113.54 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -86.44 -51.39 3.5 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.605 -1.108 . . . . 0.0 113.511 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.604 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 52.2 Cg_exo -55.15 -24.42 41.0 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.833 2.356 . . . . 0.0 114.134 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.48 -43.93 65.66 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.514 0.326 . . . . 0.0 111.423 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.479 ' O ' HG22 ' A' ' 129' ' ' VAL . 9.8 mt -61.99 -26.75 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 122.823 0.449 . . . . 0.0 110.764 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -73.2 -47.96 39.19 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.185 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 123' ' ' PRO . 25.5 mmm180 -56.04 -48.01 76.8 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.492 178.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.549 HG23 ' CZ ' ' A' ' 82' ' ' TYR . 17.4 mt -56.62 -64.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.114 0.566 . . . . 0.0 111.498 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 125' ' ' ILE . 31.5 m -51.26 -38.22 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.203 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.0 t -73.03 -42.41 63.19 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.8 m -60.79 -29.8 69.66 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.217 0.207 . . . . 0.0 111.483 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.448 HD13 ' CA ' ' A' ' 144' ' ' GLY . 1.9 mt -83.9 -33.79 24.68 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.314 0.384 . . . . 0.0 110.281 178.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -83.2 7.54 15.88 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.933 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -113.75 -41.02 3.66 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.149 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -88.1 -44.11 11.18 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 63.5 67.7 0.63 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.985 0.914 . . . . 0.0 111.185 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.498 ' OE2' ' HA ' ' A' ' 85' ' ' LYS . 22.5 mt-10 -87.37 139.21 30.78 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.887 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 138' ' ' VAL . 0.2 OUTLIER -77.7 -41.15 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.28 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.63 -1.61 62.04 Favored Glycine 0 CA--C 1.526 0.726 0 O-C-N 123.412 0.445 . . . . 0.0 113.93 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -137.06 -2.54 2.06 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.065 0.546 . . . . 0.0 111.53 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.436 ' HD3' ' O ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -50.85 -40.5 56.29 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.817 0.847 . . . . 0.0 113.002 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 7.9 m-20 -72.51 -36.41 68.35 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.22 0.325 . . . . 0.0 110.922 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.8 tp -65.64 -52.48 51.44 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.993 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.448 ' CA ' HD13 ' A' ' 132' ' ' LEU . . . -60.99 -62.75 5.58 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.58 -0.736 . . . . 0.0 114.007 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.574 ' HA ' ' NE ' ' A' ' 148' ' ' ARG . . . -53.37 -37.1 62.1 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 5.7 mptp? -72.79 -24.46 60.93 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.469 HD22 ' O ' ' A' ' 147' ' ' LEU . 0.6 OUTLIER -78.71 -30.88 46.25 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.574 ' NE ' ' HA ' ' A' ' 145' ' ' ALA . 8.6 ptt85 -84.31 -3.77 58.45 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 117.807 0.276 . . . . 0.0 110.848 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -81.44 -1.4 45.65 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.778 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.377 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.579 179.552 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 121.397 0.618 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 83' ' ' SER . 2.9 mt-10 -120.43 -41.79 2.59 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.155 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.9 m -65.82 -60.5 2.82 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.169 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.7 t -56.81 -55.25 36.74 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 123.218 0.324 . . . . 0.0 110.705 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -50.9 -31.36 17.3 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 5.7 t -73.57 -34.52 65.16 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 122.604 0.362 . . . . 0.0 111.713 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.5 146.34 20.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.854 0.462 . . . . 0.0 111.979 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.406 ' HE2' ' NE2' ' A' ' 135' ' ' HIS . 57.6 mmtt -79.96 99.99 7.88 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.189 0.518 . . . . 0.0 111.876 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 126.52 47.9 0.19 Allowed Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.371 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.4 tp -88.8 -43.65 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 122.842 0.457 . . . . 0.0 111.187 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.531 ' CE1' HD13 ' A' ' 143' ' ' LEU . 47.4 t60 . . . . . 0 CA--C 1.552 1.021 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.031 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 mt . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 110.638 -0.134 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.6 tptp 73.4 -2.1 2.85 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.205 1.002 . . . . 0.0 111.952 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -99.84 -37.09 9.2 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.948 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.5 t -93.83 -41.72 9.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.45 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -96.66 159.3 32.02 Favored Pre-proline 0 CA--C 1.541 0.596 0 O-C-N 123.423 0.452 . . . . 0.0 111.115 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.58 -34.84 2.35 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.505 2.137 . . . . 0.0 113.289 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 157.6 -55.7 0.38 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-O 118.939 -0.923 . . . . 0.0 113.433 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.16 -19.72 28.31 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.971 2.447 . . . . 0.0 114.431 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 2.4 t70 -73.65 -35.07 65.22 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.181 0.301 . . . . 0.0 111.133 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.9 mp -72.71 -27.33 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.382 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.95 -53.33 18.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.728 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 124' ' ' ASP . 13.6 ptm180 -53.83 -36.54 62.64 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 178.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.576 ' O ' HD12 ' A' ' 132' ' ' LEU . 44.7 mt -65.38 -56.51 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 122.199 0.2 . . . . 0.0 111.211 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.634 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 2.8 m -54.09 -43.96 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 12.4 t -64.67 -31.99 73.46 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.3 m -69.94 -38.57 76.23 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.576 HD12 ' O ' ' A' ' 128' ' ' ILE . 1.3 mp -73.83 -35.79 64.87 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 129' ' ' VAL . 10.6 pt-20 -89.08 14.02 11.7 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 120.954 0.407 . . . . 0.0 111.62 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.575 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.6 tmm_? -105.95 -41.29 5.44 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.851 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.406 ' NE2' ' HE2' ' A' ' 85' ' ' LYS . 49.5 t60 -94.64 -32.14 13.53 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.976 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 67.73 73.33 0.31 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.049 0.94 . . . . 0.0 111.633 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.33 132.12 43.36 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.99 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.55 -39.05 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 O-C-N 123.417 0.448 . . . . 0.0 111.684 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -74.26 -9.52 81.04 Favored Glycine 0 C--N 1.341 0.819 0 O-C-N 123.316 0.385 . . . . 0.0 113.914 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.6 2.34 5.54 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.726 0.411 . . . . 0.0 111.995 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -34.62 74.12 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.949 0.499 . . . . 0.0 111.732 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.627 ' O ' ' HG2' ' A' ' 146' ' ' LYS . 8.2 m-20 -75.08 -38.78 61.16 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.984 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.531 HD13 ' CE1' ' A' ' 88' ' ' HIS . 14.2 tp -60.49 -56.83 16.71 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.994 0.518 . . . . 0.0 110.609 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -54.77 -45.3 79.66 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.683 0.614 . . . . 0.0 113.756 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -54.89 -48.68 72.71 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.627 ' HG2' ' O ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -59.19 -42.57 91.18 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.716 0.234 . . . . 0.0 110.394 178.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.8 -41.42 82.12 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.41 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 144' ' ' GLY . 14.2 ptm180 -88.1 -14.19 39.45 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -87.47 27.06 1.14 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 122.784 0.433 . . . . 0.0 112.063 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.507 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.53 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.504 HG23 ' CD2' ' A' ' 82' ' ' TYR . 3.9 mp . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 121.216 0.532 . . . . 0.0 110.158 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 83' ' ' SER . 4.1 mm-40 -121.56 -86.63 0.65 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.09 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.2 m -55.1 -55.65 28.72 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.199 1.0 . . . . 0.0 113.601 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.406 ' O ' HD13 ' A' ' 87' ' ' ILE . 16.9 t -46.66 -55.58 7.49 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.728 0.643 . . . . 0.0 111.772 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.504 ' CD2' HG23 ' A' ' 78' ' ' ILE . 88.1 m-85 -84.06 0.11 49.59 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.53 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 8.0 t -103.71 -2.64 26.17 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.696 0.284 . . . . 0.0 110.388 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.44 156.31 16.82 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.848 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.522 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -82.21 142.53 32.08 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.244 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.77 34.79 14.62 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.304 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.406 HD13 ' O ' ' A' ' 81' ' ' SER . 2.5 tp -84.38 -28.4 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 36.6 t60 . . . . . 0 CA--C 1.547 0.83 0 CA-C-O 120.629 0.252 . . . . 0.0 111.356 178.991 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.7 mt . . . . . 0 CA--C 1.537 0.475 0 CA-C-O 121.182 0.515 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -150.63 -30.13 0.2 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.096 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -83.76 -44.43 14.42 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.74 19.51 7.23 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.546 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -134.9 50.08 4.42 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.546 ' HD3' ' N ' ' A' ' 120' ' ' TYR . 9.4 Cg_endo -91.6 127.96 1.08 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.805 2.337 . . . . 0.0 113.369 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 135.96 -148.82 19.84 Favored Glycine 0 C--N 1.343 0.97 0 C-N-CA 120.485 -0.864 . . . . 0.0 114.575 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.633 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 49.1 Cg_exo -56.45 -32.55 89.56 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.634 2.889 . . . . 0.0 113.871 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -52.27 -37.86 56.67 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 123.457 0.473 . . . . 0.0 111.02 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.539 ' O ' HG22 ' A' ' 129' ' ' VAL . 15.8 mt -67.85 -43.61 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.412 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -61.9 -21.34 64.65 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.977 0.511 . . . . 0.0 112.134 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 123' ' ' PRO . 17.4 mmm180 -79.97 -46.67 16.26 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.825 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.7 mt -62.95 -44.52 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.046 0.538 . . . . 0.0 111.278 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 125' ' ' ILE . 7.1 m -63.29 -55.1 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.523 0.514 . . . . 0.0 112.094 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 56.4 m -54.94 -34.79 63.55 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.7 m -82.41 -22.36 35.4 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 123.263 0.352 . . . . 0.0 111.831 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.433 ' HG ' ' OE2' ' A' ' 137' ' ' GLU . 3.0 tt -82.6 -40.31 21.01 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.474 0.31 . . . . 0.0 110.919 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -89.28 12.38 16.23 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.014 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -79.69 -49.15 12.52 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -96.08 -9.06 31.77 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 70.71 80.92 0.16 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.133 0.973 . . . . 0.0 112.46 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 141' ' ' LYS . 2.9 pt-20 -107.02 130.7 54.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.331 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -81.77 -26.43 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -84.98 -2.47 88.37 Favored Glycine 0 C--N 1.343 0.944 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.391 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.11 -9.76 3.39 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.903 0.481 . . . . 0.0 111.75 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 7.8 tptp -50.89 -33.29 23.46 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.866 0.867 . . . . 0.0 112.975 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.547 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 10.0 m-20 -74.82 -36.13 62.43 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.369 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.4 tp -66.13 -59.63 3.58 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.113 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.511 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -58.94 -41.97 96.56 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-N 116.089 -0.505 . . . . 0.0 114.089 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.08 92.16 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.547 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.6 mptp? -68.66 -36.07 78.08 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.032 0.207 . . . . 0.0 111.511 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.1 mt -71.16 -34.21 70.75 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.236 0.335 . . . . 0.0 110.449 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -75.29 -39.47 59.63 Favored 'General case' 0 C--N 1.349 0.562 0 O-C-N 123.478 0.486 . . . . 0.0 110.882 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.55 42.27 0.35 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.134 0.492 . . . . 0.0 112.038 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.46 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.854 179.598 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.571 HG23 ' CG ' ' A' ' 82' ' ' TYR . 4.6 mp . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 121.297 0.57 . . . . 0.0 110.865 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.639 ' O ' ' HB2' ' A' ' 83' ' ' SER . 3.6 tp10 -120.96 -81.27 0.64 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.47 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.5 m -70.59 -59.32 2.9 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.1 m -88.66 69.38 8.77 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 123.551 1.643 . . . . 0.0 109.62 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.571 ' CG ' HG23 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -179.45 -34.29 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 111.304 -2.68 . . . . 0.0 108.038 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.639 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.7 t -75.67 -32.58 60.21 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.279 177.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -45.89 157.14 0.12 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.446 ' HA ' ' OE2' ' A' ' 137' ' ' GLU . 6.6 mptt -84.37 100.97 11.62 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.667 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.53 74.27 0.9 Allowed Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.533 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 tp -103.71 -35.0 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 122.462 0.305 . . . . 0.0 111.558 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.585 ' ND1' HD22 ' A' ' 143' ' ' LEU . 39.9 t60 . . . . . 0 N--CA 1.468 0.469 0 O-C-N 122.979 0.174 . . . . 0.0 111.172 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.2 mt . . . . . 0 C--O 1.239 0.517 0 CA-C-O 121.048 0.451 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -149.99 -46.4 0.13 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.897 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.3 tttm -116.88 -6.51 11.48 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.6 m -79.83 -41.15 26.97 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.459 0.304 . . . . 0.0 111.624 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -97.71 158.82 32.34 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 123.29 0.368 . . . . 0.0 111.345 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -78.22 -38.08 0.66 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.646 2.231 . . . . 0.0 113.352 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.72 -55.48 0.27 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.835 -0.981 . . . . 0.0 113.731 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.4 -34.52 71.57 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.163 2.576 . . . . 0.0 114.48 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.417 ' O ' HG13 ' A' ' 128' ' ' ILE . 6.1 m-20 -70.58 -42.96 70.35 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.678 ' HA ' HD12 ' A' ' 128' ' ' ILE . 3.6 mt -73.08 -16.14 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 123.301 0.376 . . . . 0.0 110.276 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.78 -53.83 10.49 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.468 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -56.27 -33.57 65.61 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 125' ' ' ILE . 29.3 mt -67.61 -57.95 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 122.358 0.263 . . . . 0.0 111.236 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 125' ' ' ILE . 4.1 m -56.55 -39.03 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 18.2 t -71.5 -54.83 9.26 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.166 0.291 . . . . 0.0 111.772 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.493 HG21 ' HB3' ' A' ' 82' ' ' TYR . 11.8 m -54.92 -25.03 26.46 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 128' ' ' ILE . 33.4 mt -85.66 -48.22 9.07 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.672 0.273 . . . . 0.0 110.386 178.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -83.28 18.04 1.89 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.244 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 130' ' ' SER . 1.1 tmt_? -87.54 -38.83 15.67 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.351 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.402 ' CE1' HH11 ' A' ' 134' ' ' ARG . 64.7 m-70 -105.22 -16.24 14.83 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.607 0.567 . . . . 0.0 110.971 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 68.93 72.5 0.27 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.178 0.991 . . . . 0.0 110.536 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.446 ' OE2' ' HA ' ' A' ' 85' ' ' LYS . 28.9 mt-10 -96.43 133.59 40.67 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.767 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 t -76.61 -12.58 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 123.557 0.536 . . . . 0.0 111.274 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -87.31 -27.52 27.6 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.023 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.77 1.65 12.17 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.69 0.396 . . . . 0.0 111.762 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 8.7 tptp -53.27 -41.73 65.83 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.549 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 8.2 m-20 -77.88 -32.99 52.23 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.042 0.214 . . . . 0.0 111.546 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.585 HD22 ' ND1' ' A' ' 88' ' ' HIS . 14.8 tp -69.7 -59.38 2.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.414 0.286 . . . . 0.0 110.391 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.49 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -56.53 -55.39 30.03 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-N 115.775 -0.648 . . . . 0.0 114.163 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -58.59 -44.96 90.0 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.549 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -61.34 -42.66 99.05 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.718 0.235 . . . . 0.0 111.035 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.0 mt -60.15 -34.97 74.28 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.445 0.465 . . . . 0.0 111.36 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -88.18 -7.36 56.99 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.716 0.293 . . . . 0.0 110.522 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 1.4 m-20 -114.45 13.45 17.66 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.973 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.376 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.799 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.569 ' HB ' ' CD1' ' A' ' 82' ' ' TYR . 1.9 pp . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 121.382 0.611 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -103.99 -52.33 2.97 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.846 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.7 m -58.9 -59.35 5.6 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.207 0.603 . . . . 0.0 111.945 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.8 p -57.32 -55.21 37.73 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.761 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.569 ' CD1' ' HB ' ' A' ' 78' ' ' ILE . 17.2 m-85 -54.49 -24.47 20.58 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 177.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.549 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 11.8 t -75.66 -32.65 60.26 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 122.176 0.191 . . . . 0.0 110.752 178.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.05 162.03 1.09 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.334 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -94.16 103.55 15.59 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.864 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.89 65.04 0.56 Allowed Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.95 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.6 tt -93.12 -44.97 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 140' ' ' ALA . 51.2 t60 . . . . . 0 CA--C 1.541 0.623 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.78 -38.85 0.12 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.011 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -93.72 -26.08 17.16 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.421 0.45 . . . . 0.0 111.972 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.44 -41.85 10.07 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.276 0.36 . . . . 0.0 111.681 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -88.86 155.96 49.89 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 123.288 0.368 . . . . 0.0 111.624 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -80.84 -54.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.732 2.288 . . . . 0.0 113.942 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.65 -59.48 0.19 Allowed Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.876 -0.958 . . . . 0.0 113.591 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.441 ' HA ' ' OE2' ' A' ' 126' ' ' GLU . 52.2 Cg_exo -54.65 -30.84 68.0 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.079 2.519 . . . . 0.0 114.04 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 8.1 m-20 -71.25 -29.72 65.44 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.538 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.701 ' HA ' HD12 ' A' ' 128' ' ' ILE . 6.4 mt -86.64 -19.06 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.441 ' OE2' ' HA ' ' A' ' 123' ' ' PRO . 37.5 mt-10 -65.24 -51.88 58.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.782 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 124' ' ' ASP . 1.9 ptp180 -57.9 -21.03 41.39 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.274 176.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 125' ' ' ILE . 83.2 mt -77.72 -50.11 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 122.577 0.351 . . . . 0.0 111.027 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 144' ' ' GLY . 4.6 m -61.98 -36.28 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 4.3 m -70.71 -58.18 3.91 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.502 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.9 m -52.7 -29.03 24.51 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.406 HD22 ' HB1' ' A' ' 140' ' ' ALA . 17.8 mt -76.19 -46.81 26.62 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.026 0.13 . . . . 0.0 111.15 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -87.43 16.49 5.36 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 123.517 0.511 . . . . 0.0 110.96 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 130' ' ' SER . 3.3 tmt_? -99.58 -34.97 10.01 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.694 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.549 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 75.1 m-70 -96.72 -32.9 11.93 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.561 0.538 . . . . 0.0 111.914 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.7 t70 74.72 81.08 0.11 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.227 1.011 . . . . 0.0 110.096 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.405 ' OE2' ' HB2' ' A' ' 135' ' ' HIS . 1.5 pm0 -137.11 128.18 27.7 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.088 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.68 159.47 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.396 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 96.25 -53.52 1.57 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 88' ' ' HIS . . . -104.48 -12.87 16.27 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.916 0.421 . . . . 0.0 111.7 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.46 -36.27 75.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.346 0.658 . . . . 0.0 112.436 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.508 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 9.9 m-20 -74.82 -34.99 62.43 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.5 tp -61.41 -58.81 6.7 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.319 0.387 . . . . 0.0 110.148 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.488 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -51.9 -46.7 54.99 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.934 178.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.77 -39.28 91.08 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.508 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -65.29 -49.45 69.47 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.992 0.183 . . . . 0.0 110.707 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 25.9 mt -59.3 -30.82 68.61 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.41 0.444 . . . . 0.0 111.64 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -83.25 -10.81 58.34 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 123.001 0.188 . . . . 0.0 111.381 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -97.15 0.13 47.89 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 123.162 0.288 . . . . 0.0 111.43 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.319 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.987 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.489 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 2.9 tp . . . . . 0 CA--C 1.55 0.98 0 CA-C-O 120.716 0.294 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 83' ' ' SER . 37.9 tt0 -96.57 -49.73 5.01 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.817 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.7 p -54.26 -58.05 8.88 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.326 1.051 . . . . 0.0 112.595 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 t -60.16 -54.94 39.97 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.67 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.489 ' HB2' ' O ' ' A' ' 78' ' ' ILE . 3.4 m-85 -58.07 -16.73 14.02 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 8.4 t -86.36 -31.85 21.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.701 0.4 . . . . 0.0 111.255 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -46.08 165.18 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -90.37 113.88 25.87 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.212 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.5 67.2 1.32 Allowed Glycine 0 C--N 1.34 0.787 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.635 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.495 HG22 ' OE1' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -91.96 -25.05 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 140' ' ' ALA . 15.6 t60 . . . . . 0 N--CA 1.467 0.412 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.8 mt . . . . . 0 N--CA 1.466 0.369 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -89.07 100.72 13.44 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.42 0.628 . . . . 0.0 111.279 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -179.77 -44.04 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.197 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.91 -17.91 12.8 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.357 0.41 . . . . 0.0 111.665 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 31.4 m-85 -94.15 135.22 24.75 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 119.323 -0.37 . . . . 0.0 111.184 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 5.4 Cg_exo -78.21 -36.32 1.04 Allowed 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.467 2.111 . . . . 0.0 113.1 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.64 -59.21 0.26 Allowed Glycine 0 CA--C 1.53 0.976 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.227 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.503 ' HA ' ' OE2' ' A' ' 126' ' ' GLU . 52.0 Cg_exo -56.49 -30.38 82.01 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.931 2.421 . . . . 0.0 114.096 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -65.89 -30.04 70.57 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.269 0.355 . . . . 0.0 111.844 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.546 ' HA ' HD12 ' A' ' 128' ' ' ILE . 10.9 mt -81.68 -31.19 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.503 ' OE2' ' HA ' ' A' ' 123' ' ' PRO . 42.7 mt-10 -56.26 -47.65 78.14 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.55 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -16.8 61.65 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 177.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 125' ' ' ILE . 76.0 mt -78.16 -51.06 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 144' ' ' GLY . 3.7 m -63.03 -35.32 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 4.9 m -73.2 -56.51 4.99 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.387 0.429 . . . . 0.0 111.37 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.8 m -56.13 -24.61 41.93 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.401 HD22 ' HB1' ' A' ' 140' ' ' ALA . 25.9 mt -79.97 -51.63 8.84 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.929 0.143 . . . . 0.0 111.017 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -85.06 16.16 3.65 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.453 0.47 . . . . 0.0 111.312 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.0 tmt_? -79.6 -42.78 24.21 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.27 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.438 ' CE1' HH11 ' A' ' 134' ' ' ARG . 91.2 m-70 -96.96 -11.88 24.07 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.135 0.272 . . . . 0.0 111.242 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.1 t70 67.83 55.85 0.58 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.129 0.972 . . . . 0.0 110.969 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.495 ' OE1' HG22 ' A' ' 87' ' ' ILE . 11.1 pt-20 -88.99 124.46 34.29 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.936 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.07 -8.17 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.825 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.99 -26.89 20.69 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.417 -0.42 . . . . 0.0 112.857 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.483 ' HB2' ' HB2' ' A' ' 88' ' ' HIS . . . -121.81 6.05 9.93 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 122.807 0.443 . . . . 0.0 111.613 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -34.63 78.61 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.541 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 2.8 t70 -78.81 -34.62 45.19 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.596 0.236 . . . . 0.0 110.899 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.7 tp -64.45 -68.97 0.31 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.846 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.524 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -48.81 -43.72 30.4 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 114.843 0.697 . . . . 0.0 114.843 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.5 96.69 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.541 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 14.4 mptt -60.86 -49.74 76.24 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.995 0.184 . . . . 0.0 110.896 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 35.8 mt -57.56 -30.45 65.25 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.405 0.441 . . . . 0.0 112.05 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -80.18 -35.98 35.62 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 120.565 0.221 . . . . 0.0 110.67 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -78.84 8.93 4.71 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.988 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.47 0 C-N-CA 122.61 0.364 . . . . 0.0 111.749 179.56 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.0 t . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.516 0.198 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -100.4 136.27 40.54 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.895 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.91 151.02 23.23 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.612 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 tt -101.35 140.71 35.26 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.646 0.263 . . . . 0.0 110.521 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.38 30.69 6.82 Favored Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.999 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -120.21 -18.8 7.93 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.343 0.257 . . . . 0.0 111.225 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.71 151.78 20.49 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.375 0.422 . . . . 0.0 111.523 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -95.71 159.76 14.83 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.159 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -86.82 159.43 51.99 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.149 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.27 140.79 45.41 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.5 2.134 . . . . 0.0 112.961 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.84 151.93 20.72 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.065 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -94.91 11.97 29.89 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.499 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.2 mmpt? 63.99 125.75 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.013 0.925 . . . . 0.0 111.947 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -105.19 -2.96 23.51 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.791 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -90.09 137.23 32.51 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.305 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.8 p -102.88 0.4 32.43 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.67 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -89.09 42.49 1.09 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.222 0.534 . . . . 0.0 111.245 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.0 mm -92.99 -21.85 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.809 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 tp -62.88 -24.82 36.86 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 C-N-CA 123.169 0.587 . . . . 0.0 111.747 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -109.55 29.04 7.94 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.753 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.6 t -87.44 -55.86 3.61 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.239 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.31 -72.68 0.46 Allowed Glycine 0 C--N 1.343 0.95 0 C-N-CA 120.997 -0.62 . . . . 0.0 113.631 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 46.1 mmtt -83.5 -48.02 0.76 Allowed Pre-proline 0 CA--C 1.547 0.857 0 CA-C-O 118.421 -0.799 . . . . 0.0 113.151 -178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.48 112.75 3.54 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.089 1.86 . . . . 0.0 112.467 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.424 ' O ' ' HD2' ' A' ' 82' ' ' TYR . 1.2 tp -143.71 5.15 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.536 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -116.7 -65.98 1.13 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.901 -0.136 . . . . 0.0 110.93 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 51.6 p -41.66 -50.21 4.17 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.748 1.219 . . . . 0.0 112.848 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.561 ' O ' HD13 ' A' ' 87' ' ' ILE . 8.5 t -62.86 -49.37 75.14 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 113.367 -1.742 . . . . 0.0 110.371 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.424 ' HD2' ' O ' ' A' ' 78' ' ' ILE . 64.3 m-85 -86.79 17.22 4.14 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.639 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.544 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 13.1 t -119.15 -17.47 8.92 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.405 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -80.54 164.91 22.59 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.768 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.2 ptpp? -88.68 117.84 27.93 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.026 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.23 68.13 1.21 Allowed Glycine 0 C--N 1.338 0.645 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.284 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.561 HD13 ' O ' ' A' ' 81' ' ' SER . 2.4 tp -96.95 -29.05 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.635 ' HB3' ' O ' ' A' ' 139' ' ' GLY . 39.1 t60 -112.98 -31.92 6.53 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.579 ' OE2' ' HA2' ' A' ' 139' ' ' GLY . 26.3 mt-10 -117.16 46.44 1.68 Allowed 'General case' 0 C--O 1.24 0.583 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 50.0 tttt -121.01 -20.35 6.88 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.778 -0.192 . . . . 0.0 110.513 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.503 HD12 ' H ' ' A' ' 91' ' ' ILE . 1.2 mp -79.57 -6.02 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 O-C-N 123.424 0.452 . . . . 0.0 111.454 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 3.4 mp -94.3 -22.36 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 123.071 0.232 . . . . 0.0 110.848 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -93.78 -33.14 13.7 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.239 0.337 . . . . 0.0 111.285 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.28 -29.86 66.16 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.241 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -117.56 -56.82 2.18 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 123.624 0.577 . . . . 0.0 109.82 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 14.3 t70 42.47 91.14 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.58 1.152 . . . . 0.0 112.472 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.3 tp -144.8 135.67 24.79 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.184 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 68.7 m80 63.65 158.73 0.08 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.876 0.87 . . . . 0.0 112.218 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 m -90.2 122.42 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.561 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.0 m 62.7 124.68 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.037 0.935 . . . . 0.0 112.026 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -102.69 116.28 32.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.262 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.1 t -134.77 129.51 34.73 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.461 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.428 ' HE2' ' O ' ' A' ' 103' ' ' LYS . 0.3 OUTLIER -131.02 -48.96 1.02 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.588 0.555 . . . . 0.0 111.037 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.491 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 3.3 t-20 -128.68 -9.94 5.02 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 123.26 0.35 . . . . 0.0 111.789 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.0 104.45 9.5 Favored Pre-proline 0 CA--C 1.542 0.658 0 O-C-N 123.06 0.225 . . . . 0.0 111.483 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 104' ' ' ASN . 66.1 Cg_endo -82.52 162.07 16.93 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 122.406 2.071 . . . . 0.0 113.088 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.2 mt -124.15 99.35 6.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.773 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -136.35 -51.51 0.7 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.88 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -138.95 -60.35 0.58 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.399 0.437 . . . . 0.0 110.747 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -148.53 142.26 25.6 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.282 0.364 . . . . 0.0 111.028 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.8 p -133.32 113.84 13.05 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.661 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 10.7 p -145.38 134.79 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.886 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 23.1 mmt -134.72 120.02 18.95 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.448 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -133.22 130.81 39.57 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.847 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -133.75 -0.93 3.11 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.348 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.549 ' HA ' ' CD1' ' A' ' 120' ' ' TYR . 10.2 mt -88.85 11.97 16.48 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.26 -0.427 . . . . 0.0 112.044 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -130.28 -6.1 4.31 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.7 mmpt? -96.11 -43.42 7.76 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.81 -5.59 18.29 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.294 0.371 . . . . 0.0 111.892 -179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.549 ' CD1' ' HA ' ' A' ' 116' ' ' LEU . 36.0 m-85 -97.16 139.29 21.4 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 119.18 -0.438 . . . . 0.0 110.786 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.13 -58.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.523 2.149 . . . . 0.0 114.074 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.33 -60.73 0.08 OUTLIER Glycine 0 C--N 1.343 0.972 0 CA-C-O 118.919 -0.934 . . . . 0.0 113.596 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.27 -31.98 69.18 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.078 2.519 . . . . 0.0 114.017 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.94 -41.81 97.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.38 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.515 ' O ' HG22 ' A' ' 129' ' ' VAL . 7.1 mt -70.54 -40.11 76.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.574 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -65.98 -24.12 66.72 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.793 0.437 . . . . 0.0 111.941 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 76.6 mtt180 -77.76 -45.09 25.64 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.407 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 7.7 mt -63.06 -47.24 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 122.844 0.457 . . . . 0.0 111.197 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 125' ' ' ILE . 5.3 m -58.64 -51.56 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.791 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 38.1 m -58.35 -39.03 78.4 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 m -71.38 -26.17 62.67 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 12.9 mt -85.65 -37.6 19.29 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -83.81 6.38 21.59 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.598 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.488 HH11 ' CE1' ' A' ' 135' ' ' HIS . 4.5 tmt_? -86.9 -42.82 12.9 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.28 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.544 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 88.5 m-70 -91.64 -25.38 19.18 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.982 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.2 t70 70.54 76.12 0.2 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.115 0.966 . . . . 0.0 110.535 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -101.02 130.02 46.95 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.503 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 t -79.69 -14.91 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 123.437 0.461 . . . . 0.0 111.695 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.635 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -96.76 -7.57 57.64 Favored Glycine 0 C--N 1.336 0.575 0 O-C-N 123.344 0.403 . . . . 0.0 112.293 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -130.02 1.59 4.77 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.363 0.665 . . . . 0.0 111.607 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -62.59 -27.39 69.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.003 0.521 . . . . 0.0 111.398 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.517 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 1.5 p30 -76.21 -39.06 55.59 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.441 0.463 . . . . 0.0 110.887 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.0 tp -64.07 -59.97 3.81 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.885 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.481 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -58.41 -56.3 25.99 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.799 -0.637 . . . . 0.0 114.66 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.4 -41.84 76.98 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.517 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -65.98 -40.25 91.05 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 122.929 0.143 . . . . 0.0 111.357 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 22.0 mt -69.85 -27.9 65.23 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.336 0.398 . . . . 0.0 110.781 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -95.6 5.56 51.16 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 123.142 0.276 . . . . 0.0 110.937 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -85.38 -2.71 58.39 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.17 -8.14 49.49 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.627 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.9 mp -103.83 -37.88 7.26 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.711 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -86.91 -43.41 12.43 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.318 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -106.47 130.21 54.3 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.3 0.375 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.125 -0.941 . . . . 0.0 110.505 -179.978 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.0 p . . . . . 0 N--CA 1.487 1.419 0 N-CA-C 111.252 0.093 . . . . 0.0 111.252 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -127.81 125.7 40.31 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 123.366 0.417 . . . . 0.0 110.838 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.63 -60.07 1.24 Allowed Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.598 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 63.11 122.87 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.956 0.903 . . . . 0.0 111.824 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.2 73.71 0.22 Allowed Glycine 0 C--N 1.337 0.622 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.559 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 61.97 136.34 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.051 0.941 . . . . 0.0 112.477 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.88 -11.44 26.73 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.954 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -132.08 129.44 39.97 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.806 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.45 ' H ' ' CD ' ' A' ' 63' ' ' PRO . 6.4 m-20 -117.11 -44.76 0.05 OUTLIER Pre-proline 0 CA--C 1.546 0.81 0 CA-C-O 118.549 -0.738 . . . . 0.0 112.224 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.45 ' CD ' ' H ' ' A' ' 62' ' ' ASP . 2.9 Cg_exo -76.8 -35.59 1.88 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.224 1.949 . . . . 0.0 113.029 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.6 mt -99.13 132.49 44.4 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.387 0.43 . . . . 0.0 110.974 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -126.48 23.16 6.92 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.085 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.4 mttp 63.81 122.59 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.995 0.918 . . . . 0.0 111.935 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -118.37 21.78 12.47 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.163 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.531 ' O ' ' HB2' ' A' ' 102' ' ' SER . 91.9 m-85 -82.67 -32.68 28.02 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.165 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.0 t -92.16 105.53 17.74 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 120.993 0.425 . . . . 0.0 111.085 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.9 ttmt -137.64 174.84 10.15 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.359 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.534 HD11 ' O ' ' A' ' 90' ' ' LYS . 0.5 OUTLIER -82.26 -30.96 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.158 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.6 tt -67.16 122.77 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 O-C-N 123.257 0.348 . . . . 0.0 110.3 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 1.7 t80 62.75 31.29 16.63 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.44 0.696 . . . . 0.0 111.006 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.1 t -79.58 -40.67 28.86 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.011 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.03 -37.04 0.46 Allowed Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.157 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -90.07 159.93 41.49 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-O 119.126 -0.464 . . . . 0.0 110.456 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.11 148.44 69.23 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.453 2.102 . . . . 0.0 113.394 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.5 tp -88.75 28.43 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.99 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 83' ' ' SER . 7.1 tp10 -119.8 -53.89 2.17 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.137 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 13.1 m -56.46 -56.78 16.89 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.419 0.688 . . . . 0.0 112.235 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.8 m -59.51 -55.81 29.86 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.289 0.368 . . . . 0.0 111.043 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.468 ' HB3' HG21 ' A' ' 131' ' ' THR . 2.1 m-85 -61.43 -11.88 12.29 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.492 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 8.3 t -87.94 -40.09 14.21 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.624 0.193 . . . . 0.0 111.324 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -61.71 152.62 30.56 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -82.88 131.56 35.19 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.081 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 104.78 28.05 5.79 Favored Glycine 0 C--N 1.336 0.536 0 O-C-N 123.731 0.644 . . . . 0.0 112.783 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.592 ' O ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -91.51 -19.54 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 C-N-CA 122.735 0.414 . . . . 0.0 111.049 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.483 ' CE1' ' HG3' ' A' ' 89' ' ' GLU . 2.8 p80 -56.49 -29.84 62.27 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.483 ' HG3' ' CE1' ' A' ' 88' ' ' HIS . 40.5 mt-10 -93.11 -24.82 18.14 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.301 0.375 . . . . 0.0 111.07 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.534 ' O ' HD11 ' A' ' 71' ' ' ILE . 91.8 mttt -62.0 -4.97 1.85 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.92 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.6 mm -83.12 -16.84 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 mt -90.06 0.33 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.297 179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -67.14 -18.56 65.34 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.219 0.608 . . . . 0.0 111.891 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -67.58 -18.18 64.9 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.303 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -94.02 -28.64 15.64 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.801 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.418 ' OD1' HD12 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -96.24 129.99 43.42 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.755 -179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.418 HD12 ' OD1' ' A' ' 96' ' ' ASP . 4.7 mp 64.1 147.71 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.981 0.912 . . . . 0.0 112.067 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -128.01 111.21 13.28 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.796 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.1 p -148.24 133.65 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.493 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.0 m 63.06 149.22 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.954 0.902 . . . . 0.0 112.444 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -109.44 126.72 53.78 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.56 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.531 ' HB2' ' O ' ' A' ' 68' ' ' PHE . 55.4 m -130.12 157.88 41.21 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.912 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -90.14 124.67 35.01 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.203 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.419 HD22 ' HA ' ' A' ' 68' ' ' PHE . 36.2 m-80 -131.31 165.06 24.24 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.926 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -85.87 122.52 72.86 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.713 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.473 ' HG2' ' OE1' ' A' ' 108' ' ' GLN . 60.6 Cg_endo -77.12 169.62 21.15 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.438 2.092 . . . . 0.0 113.033 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.4 tp -91.43 134.3 30.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.473 ' OE1' ' HG2' ' A' ' 106' ' ' PRO . 2.4 mp0 -126.29 -35.4 2.41 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.306 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -88.51 166.19 14.35 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.199 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.25 -37.52 57.53 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 122.753 0.421 . . . . 0.0 112.089 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.8 p -96.83 122.92 40.32 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.709 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.9 p -100.62 116.29 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.014 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.42 ' HB3' ' OE2' ' A' ' 114' ' ' GLU . 23.2 mmt -141.85 -46.38 0.36 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.831 179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.42 ' OE2' ' HB3' ' A' ' 113' ' ' MET . 4.6 mp0 -128.97 134.91 48.36 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.474 0.484 . . . . 0.0 110.644 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -128.75 -4.25 5.23 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 123.619 0.574 . . . . 0.0 111.889 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 120' ' ' TYR . 3.0 mp -89.77 7.27 37.8 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -98.87 146.6 25.8 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.142 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt 70.77 -34.59 0.3 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.455 1.102 . . . . 0.0 112.889 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.5 -31.78 19.78 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.505 ' CE2' HD23 ' A' ' 116' ' ' LEU . 13.6 m-85 -88.82 158.14 48.01 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 119.241 -0.409 . . . . 0.0 111.095 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.67 -44.43 0.14 Allowed 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 122.412 2.074 . . . . 0.0 113.832 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 151.35 -59.58 0.42 Allowed Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.9 -0.944 . . . . 0.0 113.508 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.09 -18.03 41.48 Favored 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.905 2.403 . . . . 0.0 114.049 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -78.13 -40.03 39.38 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.299 0.374 . . . . 0.0 111.254 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.537 ' O ' HG22 ' A' ' 129' ' ' VAL . 6.1 mt -68.71 -33.14 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.626 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -69.43 -50.53 44.82 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.466 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -51.77 -44.52 63.39 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.617 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.579 ' O ' HD12 ' A' ' 132' ' ' LEU . 23.7 mt -63.61 -57.02 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 122.356 0.262 . . . . 0.0 111.546 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.537 HG22 ' O ' ' A' ' 125' ' ' ILE . 5.0 m -55.49 -45.07 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.8 t -64.38 -30.1 71.15 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.468 HG21 ' HB3' ' A' ' 82' ' ' TYR . 22.8 m -72.78 -34.91 67.25 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 122.994 0.184 . . . . 0.0 111.349 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.68 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 0.9 OUTLIER -75.02 -28.86 60.66 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 123.154 0.284 . . . . 0.0 111.336 178.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -90.01 18.93 5.28 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.373 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -109.97 -41.31 4.51 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.38 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.68 ' NE2' ' HA ' ' A' ' 132' ' ' LEU . 5.7 p80 -87.21 -41.98 13.31 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.94 -179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 70.95 81.06 0.16 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.254 1.022 . . . . 0.0 112.015 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.529 ' HG2' ' CE1' ' A' ' 135' ' ' HIS . 10.3 pt-20 -128.23 139.79 52.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.645 178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.98 -13.5 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.709 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -79.76 -28.77 50.04 Favored Glycine 0 C--N 1.34 0.792 0 O-C-N 123.341 0.4 . . . . 0.0 113.849 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -123.11 1.95 9.22 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -58.79 -25.18 62.87 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.953 0.501 . . . . 0.0 112.22 179.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.577 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 7.6 m-20 -81.43 -32.99 32.42 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.784 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.8 tp -68.61 -56.84 6.9 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.532 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.413 ' H ' HD22 ' A' ' 132' ' ' LEU . . . -60.82 -48.28 87.04 Favored Glycine 0 C--N 1.342 0.881 0 CA-C-N 115.851 -0.613 . . . . 0.0 114.153 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.7 -41.49 86.4 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.577 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 14.4 mptt -65.45 -34.57 78.61 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 30.8 mt -72.83 -30.89 64.4 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.205 0.316 . . . . 0.0 111.616 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.491 ' HD2' ' O ' ' A' ' 148' ' ' ARG . 1.8 tmm_? -87.67 -19.64 27.4 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 123.173 0.296 . . . . 0.0 111.189 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -90.49 22.65 3.33 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 123.382 0.426 . . . . 0.0 111.153 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -81.51 -7.18 59.55 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.932 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.3 tt -97.55 -49.44 4.88 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.3 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -120.01 108.19 14.0 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 123.442 0.464 . . . . 0.0 110.482 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -137.63 -44.34 0.54 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.853 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.534 -0.746 . . . . 0.0 110.561 -179.863 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.5 p . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 111.376 0.139 . . . . 0.0 111.376 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -99.98 -44.16 6.12 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.962 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -167.21 -159.16 12.32 Favored Glycine 0 C--N 1.339 0.743 0 O-C-N 123.44 0.462 . . . . 0.0 112.64 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 10.8 mt 70.77 -51.62 0.67 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.382 1.073 . . . . 0.0 112.319 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.71 -136.59 13.17 Favored Glycine 0 C--N 1.338 0.67 0 C-N-CA 121.45 -0.405 . . . . 0.0 112.499 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.46 153.06 26.67 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.711 0.301 . . . . 0.0 111.042 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.62 21.31 7.45 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.656 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -89.02 156.65 18.73 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.264 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -90.56 143.53 29.29 Favored Pre-proline 0 CA--C 1.544 0.721 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.807 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -70.36 -38.4 6.53 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.464 2.109 . . . . 0.0 113.224 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 tt -130.16 123.66 30.81 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 123.301 0.376 . . . . 0.0 110.643 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -137.41 160.2 39.77 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.029 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.4 tttt 64.56 175.3 0.19 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.876 0.871 . . . . 0.0 111.891 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 68.05 94.05 0.07 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.166 0.987 . . . . 0.0 111.378 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -123.86 -168.6 1.81 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.451 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 46.1 p -106.9 156.52 18.61 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.341 0.256 . . . . 0.0 110.985 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.2 mtmt -87.48 116.01 25.29 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.022 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.612 HG12 ' H ' ' A' ' 74' ' ' SER . 2.9 tt -149.58 162.7 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.624 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.447 HG23 ' CD2' ' A' ' 73' ' ' PHE . 2.9 tp -112.47 -37.62 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.573 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.447 ' CD2' HG23 ' A' ' 72' ' ' ILE . 66.5 m-85 -90.95 -42.18 10.72 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.612 ' H ' HG12 ' A' ' 71' ' ' ILE . 30.7 t 54.66 26.79 7.84 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.866 0.866 . . . . 0.0 112.249 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.7 -72.93 0.48 Allowed Glycine 0 C--N 1.34 0.768 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.362 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.544 ' H ' ' CD ' ' A' ' 77' ' ' PRO . 20.8 tttm -139.29 -45.86 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.852 0 CA-C-O 118.801 -0.618 . . . . 0.0 112.058 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.544 ' CD ' ' H ' ' A' ' 76' ' ' LYS . 7.0 Cg_exo -75.07 157.05 42.69 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.406 2.071 . . . . 0.0 113.61 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.493 HD13 ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -122.56 -18.5 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.379 179.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -75.13 -53.35 9.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.099 0.56 . . . . 0.0 111.974 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 83' ' ' SER . 37.3 m -49.57 -47.9 48.99 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.097 0.959 . . . . 0.0 112.815 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.9 p -54.65 -58.64 6.72 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 123.523 0.514 . . . . 0.0 111.943 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -74.45 -4.79 38.74 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.574 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 4.4 m -78.65 -37.01 43.01 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 122.85 0.46 . . . . 0.0 110.987 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.98 161.93 12.21 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.91 178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.4 mtmm -96.36 98.25 10.12 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.602 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 90' ' ' LYS . . . 125.76 60.04 0.16 Allowed Glycine 0 C--N 1.337 0.62 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.876 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.554 HG22 ' OE2' ' A' ' 137' ' ' GLU . 3.9 tp -86.44 -31.3 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 122.43 0.292 . . . . 0.0 111.181 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -122.41 -38.46 2.67 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.387 0.43 . . . . 0.0 109.997 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.558 ' O ' ' HB2' ' A' ' 93' ' ' GLU . 7.3 tt0 -87.07 26.57 1.15 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.095 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 13.4 ttpp -76.45 -28.8 56.7 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.345 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.6 tp -78.62 0.35 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 O-C-N 123.354 0.409 . . . . 0.0 111.712 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.519 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 1.0 OUTLIER -132.88 -4.35 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.722 179.12 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 2.7 tp10 -89.23 -37.61 14.85 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -79.82 -0.78 36.03 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -119.69 -11.36 9.42 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.341 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 2.1 t70 -94.76 -26.14 16.38 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.33 0.394 . . . . 0.0 111.606 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.8 mt -90.21 137.39 32.39 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.35 0.406 . . . . 0.0 111.454 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -109.4 125.78 52.76 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.077 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.3 154.08 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.622 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.4 t -92.24 144.01 25.83 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.918 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.3 tttm 62.18 114.84 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.844 0.858 . . . . 0.0 111.43 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.7 m -131.17 150.91 51.94 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.094 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -115.87 157.99 23.64 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.802 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.5 2.38 50.82 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.001 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.414 ' N ' ' HD2' ' A' ' 106' ' ' PRO . . . -90.95 -49.57 0.34 Allowed Pre-proline 0 CA--C 1.547 0.831 0 CA-C-O 118.673 -0.68 . . . . 0.0 112.406 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 105' ' ' ALA . 33.6 Cg_endo -64.8 165.13 21.93 Favored 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.1 1.866 . . . . 0.0 113.32 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.0 mt 65.77 126.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 123.791 0.836 . . . . 0.0 110.988 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -129.45 147.15 51.24 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.77 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -100.35 113.84 26.88 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.563 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -139.92 130.05 25.07 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.024 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.0 p -131.79 113.08 13.08 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.909 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.8 t -131.18 148.79 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.093 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.02 133.28 45.75 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.139 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.438 ' OE2' ' HB ' ' A' ' 72' ' ' ILE . 9.1 pt-20 -130.75 150.45 51.92 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.563 0.539 . . . . 0.0 111.619 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -129.51 125.39 36.23 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.939 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.514 ' O ' ' HG2' ' A' ' 117' ' ' LYS . 4.6 mt -109.75 77.32 1.05 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.766 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 116' ' ' LEU . 36.0 mmtt -157.86 -48.64 0.06 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.89 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -94.22 -43.72 8.31 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -83.71 0.37 47.38 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 123.177 0.298 . . . . 0.0 111.688 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.407 ' CD1' HD23 ' A' ' 116' ' ' LEU . 58.7 m-85 -127.68 123.34 22.94 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.795 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -73.41 -49.61 0.21 Allowed 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.658 2.239 . . . . 0.0 113.871 -179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 172.81 -61.21 0.14 Allowed Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.94 -0.922 . . . . 0.0 113.556 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.96 -31.41 73.93 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.928 2.419 . . . . 0.0 113.926 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -70.5 -20.47 62.85 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.644 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.748 ' HA ' HD12 ' A' ' 128' ' ' ILE . 8.8 mt -95.1 -28.29 4.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.13 -36.49 84.19 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.745 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -77.73 -10.64 59.64 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.877 178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.748 HD12 ' HA ' ' A' ' 125' ' ' ILE . 96.6 mt -84.14 -41.9 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.633 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.8 m -72.31 -38.29 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.132 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 21.2 t -71.77 -60.91 1.99 Allowed 'General case' 0 C--N 1.348 0.502 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.701 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 10.6 m -56.86 -25.11 55.81 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.615 ' HB2' ' O ' ' A' ' 128' ' ' ILE . 4.3 tt -74.77 -48.27 26.44 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.586 0.176 . . . . 0.0 111.191 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -96.29 13.18 28.43 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 120.873 0.368 . . . . 0.0 111.645 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 130' ' ' SER . 4.5 tmt_? -76.03 -42.17 48.65 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.574 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 21.2 m-70 -88.85 -111.6 0.07 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 176.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.428 ' H ' ' HB2' ' A' ' 135' ' ' HIS . 8.7 m-20 -123.17 -89.54 0.59 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.554 ' OE2' HG22 ' A' ' 87' ' ' ILE . 3.7 mm-40 55.48 89.87 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.487 1.115 . . . . 0.0 111.262 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 t -85.25 -15.64 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.021 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -94.02 -31.26 8.21 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.62 -16.92 29.47 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.106 0.562 . . . . 0.0 111.204 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 19.2 tptt -51.59 -28.83 15.24 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.445 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 1.3 p30 -78.34 -44.14 25.89 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.714 0.293 . . . . 0.0 110.495 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 11.4 tp -60.62 -66.55 0.51 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.964 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -49.54 -34.71 20.62 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.332 177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.72 77.71 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 117.218 0.509 . . . . 0.0 112.104 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.445 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -66.78 -50.55 62.3 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.1 0.25 . . . . 0.0 110.685 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 26.9 mt -61.79 -28.43 69.45 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.225 0.328 . . . . 0.0 111.423 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -80.77 -38.15 29.07 Favored 'General case' 0 C--N 1.349 0.579 0 O-C-N 123.369 0.418 . . . . 0.0 110.773 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.83 0.27 27.76 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.239 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -82.93 -6.74 59.59 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.406 HD22 ' N ' ' A' ' 151' ' ' LEU . 1.3 mm? -102.67 -44.25 5.37 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.476 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -98.0 146.89 25.06 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.637 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -118.7 -43.27 2.69 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.304 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.469 -0.777 . . . . 0.0 111.121 179.98 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.6 p . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.475 0.179 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -127.82 122.25 32.19 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.871 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.37 -110.39 3.95 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.512 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 58' ' ' GLY . 2.5 pp -120.08 -40.12 2.75 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 122.341 0.256 . . . . 0.0 111.27 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.405 ' N ' HD12 ' A' ' 57' ' ' LEU . . . 152.57 -167.61 31.49 Favored Glycine 0 C--N 1.337 0.594 0 O-C-N 123.494 0.496 . . . . 0.0 112.764 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt 54.81 28.87 10.92 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.878 0.871 . . . . 0.0 112.795 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.62 -10.87 38.84 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.89 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -99.86 178.32 4.85 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.648 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -68.43 158.2 85.64 Favored Pre-proline 0 CA--C 1.544 0.729 0 CA-C-O 119.211 -0.424 . . . . 0.0 111.468 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -65.87 109.5 1.49 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.417 2.078 . . . . 0.0 113.268 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 tt -145.45 127.81 15.89 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.027 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -128.93 -43.17 1.36 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.451 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.2 tptt -113.51 138.41 50.17 Favored 'General case' 0 C--O 1.235 0.299 0 O-C-N 123.345 0.403 . . . . 0.0 110.764 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.539 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 88.4 m-85 -100.81 -12.61 18.91 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.437 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -100.19 130.5 46.33 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.744 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.58 ' OG ' ' HA ' ' A' ' 91' ' ' ILE . 18.3 t -97.03 31.31 2.44 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.218 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -84.48 126.91 33.7 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.431 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.0 mt -109.99 -35.05 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.568 -178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.3 mp -63.73 -30.11 49.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 O-C-N 122.976 0.172 . . . . 0.0 110.81 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -92.04 9.54 32.88 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.42 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 t -87.13 171.72 10.48 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.828 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.34 13.58 39.24 Favored Glycine 0 C--N 1.344 1.014 0 C-N-CA 121.532 -0.366 . . . . 0.0 113.513 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.1 ptpp? -138.54 157.91 71.36 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 119.297 -0.382 . . . . 0.0 110.734 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -74.23 164.86 33.25 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.519 2.146 . . . . 0.0 112.821 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.778 ' H ' HD13 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -87.65 63.52 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.443 0.64 . . . . 0.0 111.209 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 83' ' ' SER . 7.0 tp10 -120.87 -55.68 1.98 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.428 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.8 m -64.49 -58.94 5.0 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 73.6 m -53.21 -62.06 1.9 Allowed 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.449 ' CD2' HG12 ' A' ' 87' ' ' ILE . 44.9 m-85 -51.64 -33.51 33.79 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 178.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 6.3 t -65.78 -33.73 76.54 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -56.22 174.58 0.13 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.261 0.624 . . . . 0.0 112.643 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -98.22 119.04 36.18 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.198 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.04 51.14 1.66 Allowed Glycine 0 C--N 1.338 0.646 0 CA-C-N 115.857 -0.61 . . . . 0.0 113.058 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.449 HG12 ' CD2' ' A' ' 82' ' ' TYR . 3.8 tp -85.54 -42.29 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 122.47 0.308 . . . . 0.0 111.189 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 140' ' ' ALA . 59.1 t60 -81.19 43.76 0.73 Allowed 'General case' 0 CA--C 1.55 0.95 0 CA-C-O 121.235 0.54 . . . . 0.0 111.939 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -141.7 -74.64 0.31 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.163 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.5 tptp -64.97 2.98 0.62 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.58 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 3.1 tp -86.68 -38.92 12.85 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 122.64 0.376 . . . . 0.0 111.57 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 pt -105.05 15.38 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -93.72 -34.33 13.28 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.455 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.539 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -83.17 -29.27 28.73 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.504 0.502 . . . . 0.0 112.178 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.441 ' CE1' ' H ' ' A' ' 69' ' ' SER . 46.5 m80 -85.89 -7.09 58.93 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 123.371 0.419 . . . . 0.0 111.727 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -84.47 6.48 23.32 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.051 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.5 mp -98.38 -57.06 2.29 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.155 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.8 t-80 56.18 110.79 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.956 0.902 . . . . 0.0 111.931 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.91 -45.1 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.77 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.9 m -91.29 150.49 21.29 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.482 0.489 . . . . 0.0 111.25 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.423 ' H ' ' HG3' ' A' ' 101' ' ' LYS . 2.1 pptp? -93.53 -15.06 25.88 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.113 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 18.6 t -91.95 108.4 19.91 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.99 0.424 . . . . 0.0 110.965 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -139.66 158.85 43.42 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.911 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t30 64.68 163.6 0.14 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.858 0.863 . . . . 0.0 111.911 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -83.98 149.56 56.51 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.417 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.83 134.3 52.89 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.84 2.36 . . . . 0.0 113.435 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 pt -140.76 158.54 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.294 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -91.6 -3.05 56.84 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.73 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -93.33 152.69 18.99 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.007 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.56 134.42 35.86 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.361 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.1 m -130.34 148.68 52.19 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.009 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.53 HG13 ' SD ' ' A' ' 113' ' ' MET . 12.2 p -118.49 -42.45 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.85 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.53 ' SD ' HG13 ' A' ' 112' ' ' VAL . 4.4 mpp? -123.61 165.23 17.53 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.523 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -78.28 -96.62 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.636 -0.257 . . . . 0.0 111.259 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 2.3 t80 54.87 172.98 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.905 0.882 . . . . 0.0 112.546 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.511 HD23 ' CZ ' ' A' ' 120' ' ' TYR . 9.2 mt -94.07 34.39 1.25 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.214 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -134.07 3.4 3.43 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.973 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.9 -48.96 13.63 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -127.44 10.48 6.74 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 123.394 0.434 . . . . 0.0 111.03 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.511 ' CZ ' HD23 ' A' ' 116' ' ' LEU . 63.5 m-85 -97.51 105.26 24.76 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.693 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.3 -35.38 14.11 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.653 2.236 . . . . 0.0 113.621 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 157.64 -56.85 0.37 Allowed Glycine 0 CA--C 1.529 0.965 0 CA-C-O 118.868 -0.962 . . . . 0.0 113.122 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.16 -22.72 41.29 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.887 2.391 . . . . 0.0 114.028 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -74.31 -39.69 62.73 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.296 0.372 . . . . 0.0 111.293 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.696 ' HA ' HD12 ' A' ' 128' ' ' ILE . 5.0 mt -78.16 -30.91 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.371 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -62.38 -52.51 63.3 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.339 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.443 ' O ' ' OG1' ' A' ' 131' ' ' THR . 76.9 mtt180 -55.94 -27.72 53.65 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 177.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.696 HD12 ' HA ' ' A' ' 125' ' ' ILE . 69.2 mt -70.9 -50.48 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 121.999 0.12 . . . . 0.0 111.022 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 6.4 m -60.37 -39.72 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 43.2 p -78.73 -18.19 54.67 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.509 HG21 ' O ' ' A' ' 78' ' ' ILE . 89.1 m -86.62 -28.67 23.1 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 122.883 0.114 . . . . 0.0 111.224 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 144' ' ' GLY . 1.7 mp -80.43 -46.27 16.25 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 123.087 0.242 . . . . 0.0 110.444 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.416 ' OE1' ' HG2' ' A' ' 148' ' ' ARG . 44.4 mt-10 -80.18 12.87 2.59 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.881 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 130' ' ' SER . 4.6 tmt_? -79.71 -46.18 17.57 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.218 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.593 ' CE1' ' HB3' ' A' ' 137' ' ' GLU . 3.9 p80 -110.22 -12.45 14.47 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 70.31 78.83 0.19 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.337 1.055 . . . . 0.0 111.935 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.593 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 0.2 OUTLIER -99.77 130.44 45.98 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.923 179.08 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.9 t -78.89 -7.62 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.025 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -93.08 -22.11 28.5 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.512 -0.375 . . . . 0.0 112.705 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.468 ' HB3' ' CG ' ' A' ' 137' ' ' GLU . . . -126.93 5.25 6.56 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.18 -33.83 59.05 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.039 0.536 . . . . 0.0 111.753 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.57 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 3.1 t70 -74.95 -34.95 62.12 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.47 0.481 . . . . 0.0 111.232 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 20.9 tp -69.05 -59.61 2.92 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.825 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.483 ' N ' HD22 ' A' ' 132' ' ' LEU . . . -55.43 -56.25 24.44 Favored Glycine 0 C--N 1.345 1.03 0 CA-C-N 115.852 -0.613 . . . . 0.0 113.934 178.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.459 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . -54.94 -43.63 73.57 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.57 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 14.3 mptt -62.24 -41.13 98.15 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.922 0.139 . . . . 0.0 111.246 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.4 mt -59.47 -34.42 72.54 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.44 0.463 . . . . 0.0 111.622 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 145' ' ' ALA . 0.1 OUTLIER -94.17 7.3 45.77 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-O 120.656 0.265 . . . . 0.0 111.029 178.544 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -108.18 17.65 22.02 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.245 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.16 -5.76 59.24 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.976 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.2 tt -98.95 -46.22 5.69 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.722 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -91.9 135.27 34.06 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.365 0.416 . . . . 0.0 111.266 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -111.86 151.64 28.87 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.931 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 69.1 mm-40 . . . . . 0 N--CA 1.484 1.23 0 C-N-CA 123.945 0.898 . . . . 0.0 111.961 179.933 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.5 t . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.496 0.188 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -116.9 -42.46 2.95 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.155 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.82 106.84 0.96 Allowed Glycine 0 C--N 1.341 0.819 0 O-C-N 123.461 0.476 . . . . 0.0 112.545 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.0 tt -100.53 120.1 39.51 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 123.625 0.25 . . . . 0.0 110.431 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.14 -89.0 1.22 Allowed Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.494 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -120.08 130.89 54.87 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.401 0.28 . . . . 0.0 110.672 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -96.72 -12.44 23.75 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.007 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -132.41 122.77 25.5 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.369 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.06 106.48 13.73 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.823 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.62 -33.82 27.19 Favored 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.56 2.173 . . . . 0.0 113.161 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mt -100.71 130.03 46.69 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.475 0.485 . . . . 0.0 110.95 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.465 ' O ' ' HE1' ' A' ' 68' ' ' PHE . 3.2 t70 -119.2 -14.77 9.25 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.132 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -117.37 166.5 12.23 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.297 0.373 . . . . 0.0 110.693 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 65.96 93.31 0.07 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.07 0.948 . . . . 0.0 111.962 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.465 ' HE1' ' O ' ' A' ' 65' ' ' ASP . 86.0 m-85 -131.48 -41.21 1.08 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.866 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.8 p -113.39 178.57 4.23 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.71 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -71.6 156.96 38.8 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.553 0.341 . . . . 0.0 111.457 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.496 HG22 ' H ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -84.68 -172.2 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.656 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.496 ' H ' HG22 ' A' ' 71' ' ' ILE . 33.3 mm 76.15 -48.87 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 124.054 0.942 . . . . 0.0 110.708 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.74 29.66 7.83 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.096 0.474 . . . . 0.0 111.012 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.8 t -88.39 -39.56 14.2 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.44 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.4 37.07 0.02 OUTLIER Glycine 0 C--N 1.337 0.614 0 O-C-N 123.673 0.608 . . . . 0.0 112.335 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.584 ' N ' ' HD3' ' A' ' 77' ' ' PRO . 33.7 tttm 53.38 47.41 4.01 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 124.211 1.004 . . . . 0.0 112.786 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.584 ' HD3' ' N ' ' A' ' 76' ' ' LYS . 6.7 Cg_endo -87.75 -62.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.537 2.158 . . . . 0.0 112.249 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER 46.93 19.25 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 124.906 1.282 . . . . 0.0 114.144 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -120.38 -77.99 0.59 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 35.2 m -41.63 -47.55 3.92 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.313 1.045 . . . . 0.0 112.715 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 9.4 t -61.54 -51.61 67.87 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.806 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -88.37 17.98 4.83 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.392 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 3.5 m -119.73 -15.88 8.85 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.997 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.34 154.74 17.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.169 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.522 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -78.6 133.67 37.27 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.504 179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.533 ' O ' ' HB2' ' A' ' 90' ' ' LYS . . . 94.44 34.12 6.5 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.669 -179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.7 tp -89.31 -24.06 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.768 ' HB3' ' HB2' ' A' ' 140' ' ' ALA . 29.2 p-80 -47.78 -36.91 12.39 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.545 ' HG3' ' CD2' ' A' ' 88' ' ' HIS . 41.4 mt-10 -108.46 -30.14 8.43 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 123.322 0.389 . . . . 0.0 111.429 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 36.5 tttt -54.18 -10.87 0.4 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.2 mt -83.82 -35.77 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 122.252 0.221 . . . . 0.0 110.559 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.5 tp -92.64 -35.13 6.46 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.481 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -92.94 -80.26 0.38 Allowed 'General case' 0 CA--C 1.533 0.307 0 O-C-N 123.395 0.434 . . . . 0.0 110.653 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 90' ' ' LYS . . . 66.37 -35.7 0.24 Allowed 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -133.42 -41.92 0.87 Allowed 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.03 155.73 13.08 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.22 0.608 . . . . 0.0 112.205 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.8 mp -92.87 161.76 14.36 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.106 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -86.99 115.39 24.34 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.095 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.0 p -139.06 -38.57 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.959 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.1 m -112.81 112.49 24.02 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 123.443 0.464 . . . . 0.0 110.698 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -139.13 150.92 46.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.7 t -121.42 123.71 42.74 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.763 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -101.89 -42.74 6.03 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.836 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -111.94 131.02 55.64 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.797 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 108' ' ' GLN . . . -95.06 113.08 60.59 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.262 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -80.4 -39.69 0.24 Allowed 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 122.232 1.955 . . . . 0.0 113.535 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.5 pt -142.18 -8.0 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.413 ' O ' ' HB1' ' A' ' 105' ' ' ALA . 54.4 mt-30 -91.45 112.37 24.25 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.827 0.346 . . . . 0.0 111.276 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -137.68 119.61 15.35 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.232 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 58.97 115.36 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.029 0.931 . . . . 0.0 112.315 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.1 m -129.62 145.36 51.5 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.042 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.8 p -106.57 149.6 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.478 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.443 ' SD ' HD21 ' A' ' 147' ' ' LEU . 18.2 ptp -97.26 127.01 42.85 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.245 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -97.96 22.39 9.38 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.045 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -113.52 -44.34 3.22 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.087 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.514 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 6.2 mt -102.01 -42.03 6.24 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.37 0.419 . . . . 0.0 111.648 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 20.5 mtpp -91.64 141.23 28.93 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.213 0.321 . . . . 0.0 111.062 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.2 mptt 70.64 -35.68 0.33 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 124.348 1.059 . . . . 0.0 113.018 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.99 -18.09 20.51 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 122.252 0.221 . . . . 0.0 111.324 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.514 ' HB3' ' O ' ' A' ' 116' ' ' LEU . 19.3 t80 -133.57 50.55 5.48 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 123.335 0.397 . . . . 0.0 111.315 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 120' ' ' TYR . 3.5 Cg_exo -76.19 111.18 3.22 Favored 'Trans proline' 0 C--N 1.375 1.963 0 C-N-CA 122.26 1.973 . . . . 0.0 112.287 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -172.91 -160.55 21.69 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.713 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.677 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 12.5 Cg_exo -70.29 -34.83 12.12 Favored 'Trans proline' 0 C--N 1.37 1.687 0 C-N-CA 123.295 2.663 . . . . 0.0 112.803 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -56.09 -30.69 62.41 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 123.492 0.495 . . . . 0.0 111.62 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.476 ' O ' HG22 ' A' ' 129' ' ' VAL . 46.4 mm -67.12 -44.53 87.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.642 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -68.9 -18.71 64.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.237 0.615 . . . . 0.0 111.243 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.677 ' HG2' ' O ' ' A' ' 123' ' ' PRO . 24.2 mmm180 -79.99 -46.63 16.32 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.604 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 17.4 mt -61.23 -49.33 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.916 0.487 . . . . 0.0 110.744 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 125' ' ' ILE . 7.0 m -58.68 -52.11 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.699 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 57.9 m -59.48 -38.41 80.77 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 5.2 m -72.69 -24.12 60.97 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 19.3 mt -85.66 -30.91 22.85 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 123.075 0.235 . . . . 0.0 111.406 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -84.97 5.1 30.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.15 0.5 . . . . 0.0 111.167 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.1 tmm_? -98.04 -36.22 10.18 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.442 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -85.36 -33.41 22.03 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.436 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 67.18 69.84 0.38 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.225 1.01 . . . . 0.0 111.492 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 140' ' ' ALA . 36.1 mt-10 -95.82 136.68 35.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.49 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.2 m -75.23 -48.71 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -77.43 -2.12 78.53 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.176 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.768 ' HB2' ' HB3' ' A' ' 88' ' ' HIS . . . -122.53 -4.79 8.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.737 0.415 . . . . 0.0 111.386 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 2.2 tmtt? -62.28 -37.61 86.19 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 122.798 0.439 . . . . 0.0 111.013 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.511 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 8.1 m-20 -73.42 -38.16 65.65 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.482 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 15.3 tp -66.74 -55.91 12.91 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 122.75 0.42 . . . . 0.0 110.781 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -56.05 -41.65 85.65 Favored Glycine 0 C--N 1.344 1.007 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.483 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -61.51 -41.21 96.96 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.511 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -62.13 -38.05 87.49 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 123.141 0.275 . . . . 0.0 111.464 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.443 HD21 ' SD ' ' A' ' 113' ' ' MET . 18.2 mt -66.41 -32.15 73.35 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.257 0.348 . . . . 0.0 110.328 177.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.41 12.47 31.19 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.423 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 5.4 t70 -106.47 43.32 1.16 Allowed 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.288 0.566 . . . . 0.0 110.375 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.26 -6.08 55.85 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.661 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 mp -97.47 -43.4 7.28 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.213 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 3.0 t70 57.23 176.75 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.886 0.874 . . . . 0.0 112.346 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.89 128.68 34.66 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.268 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.807 -179.912 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.4 p . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 111.319 0.118 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 70.91 -50.63 0.68 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.414 1.086 . . . . 0.0 112.399 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 125.91 50.07 0.18 Allowed Glycine 0 C--N 1.339 0.72 0 C-N-CA 121.537 -0.363 . . . . 0.0 112.69 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.3 tp -120.02 -47.36 2.39 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.549 0.205 . . . . 0.0 110.747 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.08 52.01 1.82 Allowed Glycine 0 C--N 1.343 0.949 0 O-C-N 123.463 0.477 . . . . 0.0 112.689 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -103.99 136.02 44.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.618 0.247 . . . . 0.0 111.172 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.95 -3.52 10.17 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.802 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -91.13 141.09 29.19 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.061 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.34 -46.06 0.13 Allowed Pre-proline 0 CA--C 1.545 0.772 0 CA-C-O 118.719 -0.658 . . . . 0.0 111.949 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.51 145.87 30.23 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.333 2.022 . . . . 0.0 112.903 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.7 tp -99.53 150.23 22.43 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.525 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -104.33 93.57 4.88 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.199 0.523 . . . . 0.0 111.624 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.6 mttt 54.16 -89.14 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.151 0.981 . . . . 0.0 112.983 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 73.16 -46.05 0.63 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 125.017 1.327 . . . . 0.0 112.101 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 57.4 157.36 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.12 0.968 . . . . 0.0 112.821 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 52.9 m -110.91 95.1 5.34 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.81 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -139.71 102.63 4.48 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.556 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.468 HD12 ' OG ' ' A' ' 81' ' ' SER . 4.6 mt -125.13 -2.95 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.648 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.512 HG23 ' CD2' ' A' ' 73' ' ' PHE . 3.1 tp -73.04 -40.97 59.49 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.253 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.512 ' CD2' HG23 ' A' ' 72' ' ' ILE . 2.3 p90 -123.18 52.8 1.35 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.398 0.618 . . . . 0.0 110.939 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.7 t -93.33 -43.6 8.7 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.293 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.08 -63.04 0.21 Allowed Glycine 0 C--N 1.341 0.807 0 C-N-CA 121.161 -0.543 . . . . 0.0 113.092 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.506 ' H ' ' CD ' ' A' ' 77' ' ' PRO . 4.4 tptp -130.26 -46.38 0.03 OUTLIER Pre-proline 0 CA--C 1.547 0.84 0 CA-C-O 118.612 -0.709 . . . . 0.0 112.62 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.506 ' CD ' ' H ' ' A' ' 76' ' ' LYS . 35.6 Cg_exo -61.28 119.75 7.06 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.261 1.974 . . . . 0.0 113.764 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 tt -149.74 10.49 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.103 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.655 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -120.18 -57.57 1.92 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.272 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 45.9 m -47.35 -46.84 25.98 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.191 0.996 . . . . 0.0 112.7 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.468 ' OG ' HD12 ' A' ' 71' ' ' ILE . 43.2 t -61.19 -53.04 61.91 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.887 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.493 ' OH ' ' HB ' ' A' ' 72' ' ' ILE . 73.7 m-85 -79.62 5.28 13.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.926 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.523 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 23.3 t -91.32 -47.45 7.47 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.943 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -57.98 160.21 4.97 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -92.07 92.13 8.13 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.219 0.533 . . . . 0.0 110.921 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.5 48.31 0.05 OUTLIER Glycine 0 C--N 1.336 0.547 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.98 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.584 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 2.7 tp -91.84 -29.62 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 122.623 0.369 . . . . 0.0 111.929 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.445 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 32.4 t60 -85.68 -16.97 37.35 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.526 ' HG3' ' H ' ' A' ' 90' ' ' LYS . 5.1 pt-20 -106.0 -73.72 0.67 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.987 0.179 . . . . 0.0 111.065 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.526 ' H ' ' HG3' ' A' ' 89' ' ' GLU . 2.2 ttmm -48.82 -7.21 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.584 ' HB ' ' O ' ' A' ' 87' ' ' ILE . 3.6 tp -66.53 -21.41 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 122.536 0.334 . . . . 0.0 111.229 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 tp -107.93 20.2 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.422 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -81.54 -31.99 32.48 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.769 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.08 -22.81 42.2 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -113.85 -19.54 11.45 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 123.403 0.439 . . . . 0.0 111.043 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -96.52 160.06 14.6 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.329 0.393 . . . . 0.0 110.931 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 tt -129.63 126.02 37.44 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.613 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 64.11 135.43 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.029 0.931 . . . . 0.0 111.961 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.8 m -107.06 155.46 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.402 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.6 p -126.31 -55.91 1.43 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.142 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt 56.83 115.2 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.926 0.89 . . . . 0.0 112.523 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 54.1 p -133.0 -61.78 0.82 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.107 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.3 mtmm -145.78 27.16 1.22 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 122.635 0.374 . . . . 0.0 111.241 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.7 m120 64.73 133.97 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.935 0.894 . . . . 0.0 111.759 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.422 ' H ' ' HD2' ' A' ' 106' ' ' PRO . . . -92.55 -48.57 0.3 Allowed Pre-proline 0 CA--C 1.545 0.783 0 CA-C-O 118.679 -0.677 . . . . 0.0 112.766 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.422 ' HD2' ' H ' ' A' ' 105' ' ' ALA . 32.1 Cg_endo -64.2 133.73 39.27 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 122.053 1.836 . . . . 0.0 113.729 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.462 ' HB ' ' CE2' ' A' ' 109' ' ' TYR . 0.8 OUTLIER -125.08 158.55 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.673 179.554 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.463 ' HG2' ' NZ ' ' A' ' 146' ' ' LYS . 1.1 mp0 -97.3 124.19 41.35 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.649 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.462 ' CE2' ' HB ' ' A' ' 107' ' ' ILE . 74.9 m-85 -136.69 -54.43 0.72 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.133 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -142.84 172.42 12.73 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.409 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.0 p -81.68 -67.16 0.8 Allowed 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.174 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.8 t 59.96 151.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 123.982 0.913 . . . . 0.0 112.014 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 72.9 mtm 63.09 152.68 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.921 0.888 . . . . 0.0 112.443 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -129.24 124.24 33.99 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.862 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -130.75 -43.88 1.09 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.102 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.4 mp -98.47 166.6 11.28 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.184 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 97.4 mttt 71.02 -3.48 2.02 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.376 1.07 . . . . 0.0 112.759 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -97.43 -45.1 6.57 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.396 0.278 . . . . 0.0 110.69 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.46 7.34 1.93 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.834 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -92.93 114.13 61.76 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.618 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.55 177.85 1.12 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.709 2.273 . . . . 0.0 112.863 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -67.68 -55.58 14.15 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 118.878 -0.957 . . . . 0.0 113.87 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.5 -15.17 39.51 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.732 2.288 . . . . 0.0 113.762 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.408 ' O ' HG13 ' A' ' 128' ' ' ILE . 3.2 t70 -80.05 -41.35 25.86 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 122.553 0.341 . . . . 0.0 111.021 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 11.0 mt -67.7 -39.11 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.472 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.8 -50.65 65.89 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.183 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -49.34 -40.67 36.27 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.828 177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 124' ' ' ASP . 29.0 mt -66.64 -54.59 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.142 0.177 . . . . 0.0 111.436 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 4.2 m -60.23 -51.78 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 75.2 m -62.91 -25.49 68.35 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 88.2 m -83.28 -26.0 31.06 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 117.54 0.154 . . . . 0.0 111.297 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 10.5 mt -81.15 -38.55 26.99 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 120.592 0.234 . . . . 0.0 111.031 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -88.45 8.81 26.1 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.822 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.577 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.1 tmt_? -82.17 -40.63 21.51 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.987 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.523 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 87.6 m-70 -100.4 -9.4 22.25 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.457 0.473 . . . . 0.0 111.298 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 67.67 70.21 0.35 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.178 0.991 . . . . 0.0 111.326 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.522 ' OE1' HG22 ' A' ' 87' ' ' ILE . 43.5 mt-10 -90.7 129.13 36.83 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.437 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.4 HG22 ' H ' ' A' ' 138' ' ' VAL . 0.5 OUTLIER -78.16 -45.15 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -178.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -76.16 -18.53 79.29 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.579 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.62 -11.58 17.61 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 124.041 0.495 . . . . 0.0 111.033 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -51.78 -34.76 41.1 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.643 0.777 . . . . 0.0 112.461 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.533 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 8.0 m-20 -74.57 -36.62 63.06 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.434 0.459 . . . . 0.0 111.495 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.445 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 14.3 tp -67.39 -60.24 2.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.74 0.416 . . . . 0.0 110.884 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.49 -43.6 85.42 Favored Glycine 0 C--N 1.343 0.947 0 O-C-N 123.618 0.574 . . . . 0.0 113.928 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -60.64 -43.6 97.35 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.533 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -61.97 -40.19 94.73 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 28.3 mt -67.11 -30.75 70.85 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 123.264 0.352 . . . . 0.0 110.302 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -94.25 9.84 36.44 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 123.367 0.417 . . . . 0.0 110.703 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 3.7 t70 -114.27 16.49 17.93 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.694 0.283 . . . . 0.0 111.082 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.6 -8.29 57.63 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.826 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.466 ' HG ' ' H ' ' A' ' 152' ' ' ASP . 0.2 OUTLIER -101.08 -58.35 1.91 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.635 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.466 ' H ' ' HG ' ' A' ' 151' ' ' LEU . 4.2 t70 58.41 122.9 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.141 0.976 . . . . 0.0 112.347 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -97.79 148.9 22.91 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.142 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.137 -0.935 . . . . 0.0 110.87 179.938 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.8 t . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.539 0.209 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -116.51 -42.35 3.01 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.31 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.72 -45.69 1.13 Allowed Glycine 0 C--N 1.34 0.777 0 O-C-N 123.435 0.46 . . . . 0.0 112.687 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.438 HD23 ' H ' ' A' ' 57' ' ' LEU . 0.5 OUTLIER -95.63 158.53 15.41 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.404 0.282 . . . . 0.0 111.225 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.21 -95.83 1.07 Allowed Glycine 0 C--N 1.341 0.848 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.77 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -120.0 -48.5 2.34 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 123.579 0.223 . . . . 0.0 110.945 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.08 149.35 42.34 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 123.289 0.368 . . . . 0.0 111.492 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -127.07 119.36 26.38 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.796 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.582 ' H ' ' CD ' ' A' ' 63' ' ' PRO . 7.0 m-20 -132.54 -41.62 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 118.529 -0.748 . . . . 0.0 112.785 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.582 ' CD ' ' H ' ' A' ' 62' ' ' ASP . 19.6 Cg_exo -67.07 -34.75 27.66 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.13 1.887 . . . . 0.0 113.597 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.6 mp -108.53 121.11 44.29 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.23 0.331 . . . . 0.0 111.114 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.442 ' OD2' ' HG2' ' A' ' 66' ' ' LYS . 2.6 p-10 -137.01 -57.4 0.72 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.047 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.442 ' HG2' ' OD2' ' A' ' 65' ' ' ASP . 52.2 pttt -152.84 111.33 3.71 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.515 0.326 . . . . 0.0 111.235 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -120.38 -60.8 1.65 Allowed 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.076 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.453 ' HB2' ' OG ' ' A' ' 74' ' ' SER . 50.7 m-85 -146.32 -33.85 0.31 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.751 0.42 . . . . 0.0 111.218 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.508 ' N ' ' HB3' ' A' ' 74' ' ' SER . 57.3 m 62.28 22.21 13.03 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.095 0.958 . . . . 0.0 112.858 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -138.48 -20.12 1.06 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.508 ' H ' ' HB2' ' A' ' 74' ' ' SER . 0.7 OUTLIER -81.14 -174.4 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.021 0 C-N-CA 122.448 0.299 . . . . 0.0 111.561 -179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.465 HG23 ' CD2' ' A' ' 73' ' ' PHE . 1.6 tt -59.8 -41.69 86.46 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.465 ' CD2' HG23 ' A' ' 72' ' ' ILE . 66.0 m-85 -111.47 18.74 18.86 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-O 120.715 0.293 . . . . 0.0 111.773 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.508 ' HB3' ' N ' ' A' ' 69' ' ' SER . 0.4 OUTLIER -96.76 -43.03 7.7 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -165.03 -141.51 3.15 Favored Glycine 0 C--N 1.34 0.784 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.103 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -92.9 -44.49 0.33 Allowed Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 118.69 -0.672 . . . . 0.0 112.255 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.86 137.21 75.04 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 122.332 2.021 . . . . 0.0 113.432 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 tp -143.16 37.51 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.36 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 83' ' ' SER . 37.5 tt0 -120.03 -60.82 1.66 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.835 -178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.5 m -52.17 -56.42 14.7 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.589 0.755 . . . . 0.0 112.196 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 45.0 p -60.59 -53.72 54.02 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.958 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.501 ' HB3' HG21 ' A' ' 131' ' ' THR . 3.9 m-85 -69.21 -0.31 5.88 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 114.095 1.146 . . . . 0.0 114.095 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.6 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 10.9 t -95.55 -43.48 7.93 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -68.51 161.96 26.7 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.271 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.637 ' HA ' ' OE1' ' A' ' 137' ' ' GLU . 19.3 mtpp -86.19 145.99 26.75 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.083 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.65 18.68 27.15 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.255 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.576 ' O ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -79.23 -19.36 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 C-N-CA 122.528 0.331 . . . . 0.0 111.717 179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.538 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 75.2 t60 -82.83 -4.48 58.11 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.169 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -120.97 -46.39 2.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.525 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.541 ' O ' ' HD2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -68.81 -4.51 16.43 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 179.464 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.0 tt -80.55 -22.11 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 C-N-CA 122.561 0.344 . . . . 0.0 111.681 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.9 mm -95.96 1.62 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 O-C-N 123.352 0.407 . . . . 0.0 110.459 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -87.67 -34.67 18.36 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.465 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -77.63 -16.84 58.31 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -95.45 -10.98 28.34 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.437 0.461 . . . . 0.0 111.175 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -95.27 104.53 16.42 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.943 0.402 . . . . 0.0 110.545 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.4 tp -143.04 -30.36 0.52 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.073 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 65.8 m80 64.39 122.4 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.942 0.897 . . . . 0.0 111.817 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 t -123.1 148.35 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.9 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.5 p -112.39 122.95 49.17 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.966 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt 56.36 105.59 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.949 0.899 . . . . 0.0 112.278 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.4 p -138.55 -50.52 0.55 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.895 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -139.89 153.49 47.0 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.384 0.427 . . . . 0.0 111.03 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -124.42 -44.47 1.99 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.049 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.726 ' H ' ' HD2' ' A' ' 106' ' ' PRO . . . -126.58 -50.93 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.812 0 CA-C-O 118.432 -0.794 . . . . 0.0 112.609 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.726 ' HD2' ' H ' ' A' ' 105' ' ' ALA . 28.1 Cg_endo -62.87 134.96 49.25 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.074 1.849 . . . . 0.0 113.646 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.5 pt -142.58 150.96 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.949 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -124.77 -61.36 1.32 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.233 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -145.37 -46.34 0.22 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.288 0.367 . . . . 0.0 110.883 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 66.47 -68.0 0.14 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.365 1.066 . . . . 0.0 112.774 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.7 p -142.18 161.46 37.96 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.086 0.241 . . . . 0.0 111.349 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 8.2 p -91.59 152.88 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.648 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 71.9 mtm -98.74 116.51 31.13 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.455 0.472 . . . . 0.0 111.576 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 59.51 -75.37 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.567 1.147 . . . . 0.0 113.246 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -131.97 162.51 30.53 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.384 0.274 . . . . 0.0 111.551 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.612 HD22 ' H ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -88.38 123.35 32.86 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.637 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -147.33 -39.3 0.19 Allowed 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.527 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.06 -8.09 46.89 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.632 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.2 -46.61 10.91 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.236 0.335 . . . . 0.0 111.08 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -98.28 161.36 25.61 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 123.495 0.497 . . . . 0.0 110.902 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.17 -31.01 24.06 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 122.467 2.112 . . . . 0.0 113.419 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 152.1 -52.66 0.48 Allowed Glycine 0 CA--C 1.531 1.077 0 CA-C-O 118.781 -1.01 . . . . 0.0 113.751 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.87 -17.52 18.92 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.986 2.457 . . . . 0.0 114.847 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -74.93 -42.1 58.36 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.313 0.245 . . . . 0.0 111.453 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.535 ' O ' HG22 ' A' ' 129' ' ' VAL . 4.6 mp -62.7 -32.69 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 122.794 0.438 . . . . 0.0 110.667 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -70.19 -50.53 39.2 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.68 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -53.62 -46.26 70.38 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.476 HG23 ' CE1' ' A' ' 82' ' ' TYR . 23.3 mt -61.17 -59.36 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 122.532 0.333 . . . . 0.0 111.488 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 125' ' ' ILE . 16.5 m -53.42 -41.94 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 O-C-N 123.49 0.494 . . . . 0.0 112.078 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 12.9 t -68.25 -26.48 65.7 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.501 HG21 ' HB3' ' A' ' 82' ' ' TYR . 20.5 m -72.06 -40.8 68.06 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.238 0.215 . . . . 0.0 110.933 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.526 HD22 ' N ' ' A' ' 144' ' ' GLY . 4.1 mp -77.1 -24.54 51.76 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.283 0.365 . . . . 0.0 111.508 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -91.13 12.1 21.1 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.272 0.558 . . . . 0.0 110.324 178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.9 tmt_? -118.95 -36.64 3.38 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.128 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.6 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 52.2 m-70 -90.18 -32.17 16.73 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.912 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.9 t70 60.62 61.16 1.77 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.064 0.945 . . . . 0.0 111.674 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.637 ' OE1' ' HA ' ' A' ' 85' ' ' LYS . 37.1 mt-10 -84.99 130.22 34.66 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.641 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.474 ' O ' ' HD2' ' A' ' 141' ' ' LYS . 3.4 t -79.8 -22.42 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.404 0.44 . . . . 0.0 111.645 -179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -87.09 -19.05 56.66 Favored Glycine 0 C--N 1.342 0.884 0 C-N-CA 121.424 -0.417 . . . . 0.0 112.742 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.89 3.25 11.05 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.893 0.477 . . . . 0.0 111.374 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER -48.05 -42.33 28.25 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.783 0.833 . . . . 0.0 112.617 -179.639 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 2.4 p-10 -68.21 -40.96 81.98 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.532 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.538 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 32.6 tp -56.18 -51.92 66.26 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.56 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.526 ' N ' HD22 ' A' ' 132' ' ' LEU . . . -60.92 -60.78 7.84 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.923 -0.581 . . . . 0.0 113.654 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -54.97 -42.11 72.01 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -63.54 -32.81 74.39 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 123.112 0.258 . . . . 0.0 111.518 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.0 mt -70.82 -30.93 67.5 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.295 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.413 ' O ' ' HD3' ' A' ' 148' ' ' ARG . 1.0 OUTLIER -98.93 4.47 47.37 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 123.153 0.283 . . . . 0.0 111.041 178.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 1.8 t70 -99.24 24.77 7.55 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.84 0.352 . . . . 0.0 111.2 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -83.36 -4.81 58.82 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.022 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.7 tt -104.19 -48.92 3.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.763 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -120.08 153.18 36.49 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 123.297 0.373 . . . . 0.0 110.887 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.72 126.61 44.9 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.976 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 117.989 -1.005 . . . . 0.0 112.144 -179.868 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.451 0.167 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -111.32 -45.2 3.43 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.895 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.0 136.46 4.46 Favored Glycine 0 C--N 1.339 0.741 0 O-C-N 123.484 0.49 . . . . 0.0 112.668 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.7 mp -119.91 158.25 27.08 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 122.422 0.289 . . . . 0.0 110.962 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.6 -143.82 11.39 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.725 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -99.75 -49.16 4.46 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 123.563 0.213 . . . . 0.0 111.122 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.21 124.61 46.11 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.309 0.38 . . . . 0.0 111.203 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -133.0 102.07 5.47 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.338 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -141.84 159.39 59.74 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.636 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.69 129.02 19.02 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.445 2.097 . . . . 0.0 112.787 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.46 ' O ' HD23 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -97.39 7.15 47.08 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.121 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.6 t70 65.29 176.0 0.21 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.898 0.879 . . . . 0.0 111.294 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.43 ' HD3' ' H ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -70.76 118.57 13.71 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.823 0.344 . . . . 0.0 111.507 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -112.91 -43.81 3.37 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.366 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -99.06 121.54 41.12 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.429 0.456 . . . . 0.0 110.414 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 40.4 p -120.11 126.2 50.16 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.146 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -130.62 103.79 6.83 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.296 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.442 ' O ' ' N ' ' A' ' 73' ' ' PHE . 3.4 mt -129.66 -71.69 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.681 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.644 HG23 ' H ' ' A' ' 73' ' ' PHE . 4.4 tp 45.51 -74.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 124.969 1.308 . . . . 0.0 113.323 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.644 ' H ' HG23 ' A' ' 72' ' ' ILE . 11.9 t80 -135.4 90.26 2.6 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.233 0.539 . . . . 0.0 110.231 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 14.7 t -97.28 -39.78 9.07 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.964 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.96 -84.75 0.05 OUTLIER Glycine 0 C--N 1.34 0.769 0 O-C-N 123.475 0.484 . . . . 0.0 112.501 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.701 ' H ' ' CD ' ' A' ' 77' ' ' PRO . 14.0 ptmt -136.87 -30.81 0.02 OUTLIER Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.701 ' CD ' ' H ' ' A' ' 76' ' ' LYS . 12.4 Cg_exo -71.87 135.06 24.85 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.103 1.869 . . . . 0.0 113.583 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 tt -135.82 -0.08 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.461 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -103.96 -43.52 5.27 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.842 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 m -63.53 -63.06 1.28 Allowed 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.402 ' OG ' HD13 ' A' ' 71' ' ' ILE . 11.4 t -45.24 -25.39 0.37 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -104.29 -10.9 17.5 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.8 t -91.91 -25.01 19.12 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.91 118.07 2.92 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.98 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.506 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 12.4 ptmt -60.64 105.61 0.46 Allowed 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.86 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 93.23 75.58 1.3 Allowed Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.295 -0.866 . . . . 0.0 114.256 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.67 HG23 ' H ' ' A' ' 88' ' ' HIS . 8.1 tt -106.65 -103.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 177.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.67 ' H ' HG23 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -58.86 -2.94 0.27 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 178.285 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 138' ' ' VAL . 13.2 tt0 -69.08 -14.93 63.3 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.19 -21.04 24.79 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 88' ' ' HIS . 3.8 tp -89.48 26.71 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 CA-C-O 121.195 0.521 . . . . 0.0 110.843 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.553 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 3.3 tp -136.8 -10.61 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.331 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -120.48 -36.07 3.28 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.289 0.368 . . . . 0.0 111.085 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.37 -31.95 71.85 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 122.953 0.501 . . . . 0.0 111.916 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -120.9 -53.84 2.05 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.95 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 17.8 t70 43.18 77.86 0.06 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.515 1.126 . . . . 0.0 112.52 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.0 mt -148.56 138.16 22.05 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.465 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -98.55 -44.56 6.42 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 123.491 0.495 . . . . 0.0 110.668 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.5 m -143.67 109.21 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.7 t -130.21 152.52 49.55 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.011 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.4 tptt -98.84 157.17 16.48 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.478 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 61.9 m -87.95 121.76 30.75 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.124 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -132.51 -45.89 0.9 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.406 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -122.68 -45.02 2.19 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.029 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -128.32 137.21 30.38 Favored Pre-proline 0 CA--C 1.534 0.353 0 O-C-N 123.306 0.379 . . . . 0.0 111.251 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.4 161.48 44.18 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.649 2.232 . . . . 0.0 113.117 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.4 tp -117.31 -27.5 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.392 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -93.07 130.1 38.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.278 0.361 . . . . 0.0 111.03 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -130.46 -39.72 1.29 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.138 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 64.05 132.05 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.929 0.892 . . . . 0.0 112.343 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 56.1 m -113.14 152.87 29.11 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.007 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.9 m -95.51 -26.94 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.108 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 6.6 mmt -89.9 34.11 0.85 Allowed 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.147 0.498 . . . . 0.0 111.273 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -94.04 179.88 5.18 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.862 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 66.86 123.17 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.053 0.941 . . . . 0.0 111.863 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.495 ' O ' ' HB2' ' A' ' 120' ' ' TYR . 5.2 mt -107.59 16.5 23.68 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.501 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 54.8 tttt -92.47 -11.69 34.01 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.815 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.0 mmtt -96.54 -38.4 10.0 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.108 0.255 . . . . 0.0 111.674 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.8 t -94.4 -42.45 8.87 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 123.316 0.385 . . . . 0.0 111.638 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 116' ' ' LEU . 6.3 m-30 -97.86 119.39 62.43 Favored Pre-proline 0 CA--C 1.543 0.707 0 O-C-N 123.429 0.455 . . . . 0.0 110.67 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -71.87 -48.81 0.35 Allowed 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.638 2.225 . . . . 0.0 114.041 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -171.03 -63.92 0.04 OUTLIER Glycine 0 C--N 1.342 0.891 0 CA-C-O 119.067 -0.852 . . . . 0.0 113.448 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.08 -30.45 78.87 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 123.061 2.507 . . . . 0.0 113.85 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -66.8 -21.58 66.04 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.347 0.404 . . . . 0.0 111.977 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.575 ' HA ' HD12 ' A' ' 128' ' ' ILE . 6.9 mt -89.41 -50.13 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -45.53 -41.18 9.46 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.649 0.78 . . . . 0.0 112.082 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.2 mpt_? -62.17 -42.76 99.57 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.967 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.575 HD12 ' HA ' ' A' ' 125' ' ' ILE . 14.8 mt -61.51 -61.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.962 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 144' ' ' GLY . 3.4 m -49.16 -31.27 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 18.3 t -76.76 -50.36 13.75 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.04 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.5 m -56.55 -33.89 66.55 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.748 HD23 ' HB1' ' A' ' 140' ' ' ALA . 4.5 mp -79.24 -48.99 13.2 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 117.645 0.202 . . . . 0.0 111.243 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -56.29 -20.41 18.58 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -79.58 -45.27 19.49 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.28 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.506 ' NE2' ' HA ' ' A' ' 85' ' ' LYS . 50.0 t-80 -64.97 -41.51 95.39 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 72.9 80.4 0.14 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.032 0.933 . . . . 0.0 111.162 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.866 ' HB2' ' HB3' ' A' ' 140' ' ' ALA . 20.5 mt-10 -125.09 153.59 42.71 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.157 179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.456 ' H ' ' HG3' ' A' ' 89' ' ' GLU . 5.3 t -83.9 -40.23 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 88' ' ' HIS . . . -86.9 -15.49 62.96 Favored Glycine 0 N--CA 1.47 0.931 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.402 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.866 ' HB3' ' HB2' ' A' ' 137' ' ' GLU . . . -95.98 -17.47 20.98 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 113.832 -1.184 . . . . 0.0 109.771 178.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.838 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 3.2 tptm -70.04 -22.38 63.09 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 176.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 9.8 m-20 -81.17 -28.42 35.0 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.767 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.2 tp -76.51 -63.38 1.35 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.867 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.5 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -61.87 -26.59 67.32 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 114.935 0.734 . . . . 0.0 114.935 178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.541 ' O ' ' HG3' ' A' ' 148' ' ' ARG . . . -85.27 -39.81 17.31 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 117.581 0.691 . . . . 0.0 112.409 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -70.47 -31.85 69.15 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 121.331 -0.148 . . . . 0.0 111.009 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.7 mt -71.27 -45.12 63.88 Favored 'General case' 0 C--N 1.346 0.451 0 O-C-N 123.126 0.266 . . . . 0.0 110.406 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -66.07 -21.67 66.38 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 178.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -95.56 -13.19 24.64 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 123.322 0.389 . . . . 0.0 111.378 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -87.85 -8.31 56.03 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.193 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.1 tt -98.4 -41.76 7.66 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.525 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -90.25 124.23 34.7 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 123.353 0.408 . . . . 0.0 111.08 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 75.7 mtp180 -115.67 132.76 56.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.844 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 . . . . . 0 N--CA 1.484 1.268 0 C-N-CA 123.843 0.857 . . . . 0.0 112.076 -179.943 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.4 m . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.333 0.111 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -100.14 -43.03 6.46 Favored 'General case' 0 C--O 1.235 0.317 0 O-C-N 123.389 0.431 . . . . 0.0 110.919 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.29 -53.38 0.07 OUTLIER Glycine 0 C--N 1.341 0.806 0 O-C-N 123.373 0.421 . . . . 0.0 112.585 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.8 mp -99.71 141.0 33.09 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.642 0.26 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -117.72 179.32 17.21 Favored Glycine 0 C--N 1.337 0.602 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.739 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 56.23 25.55 9.37 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.789 0.836 . . . . 0.0 112.76 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -93.54 -12.63 29.14 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.93 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -133.84 127.41 32.54 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.64 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -127.15 96.97 32.85 Favored Pre-proline 0 CA--C 1.544 0.746 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.786 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.36 135.49 22.51 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.608 2.205 . . . . 0.0 112.71 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.479 HD21 ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -118.51 -3.08 10.93 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.62 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.8 t70 72.18 -48.71 0.68 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.562 1.145 . . . . 0.0 111.97 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -128.98 130.62 46.92 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.239 0.337 . . . . 0.0 111.051 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.479 ' CE2' HD21 ' A' ' 64' ' ' LEU . 86.2 m-85 -94.9 -12.86 26.1 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.713 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -92.91 28.65 2.02 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 120.93 0.395 . . . . 0.0 111.77 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.6 p -91.09 -43.4 9.93 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.575 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.593 ' HB3' HG22 ' A' ' 72' ' ' ILE . 1.8 mptp? 63.88 155.64 0.06 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.938 0.895 . . . . 0.0 112.317 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -92.91 -8.74 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.808 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.593 HG22 ' HB3' ' A' ' 70' ' ' LYS . 3.9 tp -72.53 -41.42 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.471 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.408 ' CD1' HG23 ' A' ' 72' ' ' ILE . 47.1 m-85 -89.71 15.57 9.42 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 123.375 0.422 . . . . 0.0 111.45 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.7 t -92.83 158.6 15.78 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.809 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.92 81.63 1.52 Allowed Glycine 0 C--N 1.34 0.759 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.771 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -128.19 157.31 74.67 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 119.319 -0.372 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.85 6.9 4.6 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.682 2.254 . . . . 0.0 113.564 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.434 HG23 ' CG ' ' A' ' 82' ' ' TYR . 4.5 mp 58.2 51.29 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.636 0.774 . . . . 0.0 110.958 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 83' ' ' SER . 4.9 mm-40 -120.81 -89.41 0.6 Allowed 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.695 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 94.9 m -54.04 -43.36 70.13 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.89 0.876 . . . . 0.0 112.602 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.49 ' O ' HG13 ' A' ' 87' ' ' ILE . 24.1 p -68.46 -41.14 80.63 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.71 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.434 ' CG ' HG23 ' A' ' 78' ' ' ILE . 10.2 m-85 -94.33 13.05 24.83 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.247 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 26.3 t -110.02 -25.51 10.21 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.03 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -76.19 164.34 26.18 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.728 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 21.6 mtmm -95.06 135.56 36.45 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.511 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.497 ' O ' ' HG3' ' A' ' 90' ' ' LYS . . . 77.36 55.82 4.17 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 116.148 -0.478 . . . . 0.0 112.898 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.549 ' O ' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -113.61 -13.25 11.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.596 ' HB3' ' O ' ' A' ' 139' ' ' GLY . 61.5 t60 -102.67 -65.77 0.97 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 117.859 0.299 . . . . 0.0 111.732 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -94.52 50.19 1.33 Allowed 'General case' 0 C--O 1.239 0.551 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 86' ' ' GLY . 18.6 mmtp -121.32 -20.96 6.5 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.13 178.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.422 ' O ' ' HD2' ' A' ' 95' ' ' HIS . 2.0 tt -71.9 -13.35 16.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.747 178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.0 tt -74.38 -23.94 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.658 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -73.23 -27.73 61.76 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.148 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -85.16 -29.71 24.54 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.849 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.433 ' NE2' ' HB3' ' A' ' 67' ' ' PHE . 46.7 m-70 -85.97 -9.58 56.62 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.855 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -91.13 123.2 34.4 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.697 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 pp -134.82 141.01 46.29 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.094 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 67.9 m80 63.55 145.6 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.069 0.948 . . . . 0.0 112.374 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 m -110.07 -18.04 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.99 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.7 m -89.42 -13.99 36.46 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 123.325 0.391 . . . . 0.0 111.88 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.51 ' HD3' ' N ' ' A' ' 102' ' ' SER . 0.8 OUTLIER -92.15 158.67 16.05 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.557 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.51 ' N ' ' HD3' ' A' ' 101' ' ' LYS . 52.2 m -73.54 145.81 45.26 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.594 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -96.85 124.94 40.96 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.132 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -134.14 122.05 22.31 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.644 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -129.71 142.82 46.64 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.185 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.92 134.5 23.69 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.547 2.165 . . . . 0.0 113.048 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.504 HD12 ' N ' ' A' ' 108' ' ' GLN . 1.5 pp -139.8 -35.84 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.859 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.504 ' N ' HD12 ' A' ' 107' ' ' ILE . 38.6 mt-30 -102.25 147.79 26.23 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.354 0.409 . . . . 0.0 110.973 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 61.78 115.84 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.935 0.894 . . . . 0.0 111.984 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 58.67 112.96 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.949 0.9 . . . . 0.0 112.525 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.6 m -135.48 136.54 41.36 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.919 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.9 m -141.48 15.3 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.826 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 89.2 mtp -91.16 -41.68 10.87 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.679 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -129.72 -13.23 4.23 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.407 0.442 . . . . 0.0 111.869 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -91.67 109.29 20.59 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.03 0.443 . . . . 0.0 111.454 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.66 HD13 HD21 ' A' ' 147' ' ' LEU . 1.2 mp -123.59 -156.72 0.72 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.422 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? 73.52 -0.27 3.42 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.203 1.001 . . . . 0.0 111.722 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.9 mmpt? -103.9 -33.47 8.84 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.018 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.28 -42.84 8.33 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.545 0.528 . . . . 0.0 111.27 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -85.55 159.27 55.94 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 119.336 -0.364 . . . . 0.0 111.425 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.83 -37.61 1.58 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.536 2.157 . . . . 0.0 113.389 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 160.94 -55.46 0.32 Allowed Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.776 -1.013 . . . . 0.0 113.646 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -54.58 -24.97 38.96 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.973 2.448 . . . . 0.0 114.364 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -65.63 -40.47 92.59 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 123.254 0.346 . . . . 0.0 111.327 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.581 ' O ' HG22 ' A' ' 129' ' ' VAL . 4.8 mp -69.25 -46.57 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.456 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -53.0 -39.03 62.81 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.145 0.578 . . . . 0.0 112.223 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -70.79 -48.44 54.25 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.378 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.2 mt -55.87 -48.86 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 123.088 0.555 . . . . 0.0 111.657 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.581 HG22 ' O ' ' A' ' 125' ' ' ILE . 4.9 m -61.66 -52.98 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 16.0 t -55.77 -51.59 66.88 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.3 m -60.13 -29.71 68.81 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.636 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 27.6 mt -79.25 -32.23 43.71 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -79.6 -4.95 53.87 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 122.307 0.243 . . . . 0.0 111.57 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? -82.91 -47.14 12.12 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.887 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.636 ' NE2' ' HA ' ' A' ' 132' ' ' LEU . 9.2 p80 -85.03 -35.6 21.81 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.562 0.345 . . . . 0.0 111.584 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 t70 64.5 11.81 6.89 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.255 1.022 . . . . 0.0 113.622 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.537 ' HG2' ' CE1' ' A' ' 135' ' ' HIS . 12.7 pt-20 -47.09 153.29 0.46 Allowed 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.98 -30.68 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -79.94 3.37 70.73 Favored Glycine 0 N--CA 1.466 0.645 0 O-C-N 123.374 0.421 . . . . 0.0 113.67 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -144.95 -3.49 0.77 Allowed 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.388 0.675 . . . . 0.0 112.105 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.47 -42.24 70.43 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 123.822 0.849 . . . . 0.0 112.768 179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 3.9 p-10 -65.98 -38.48 88.63 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.572 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.484 ' HB2' ' CE1' ' A' ' 88' ' ' HIS . 44.6 tp -61.65 -50.63 71.73 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.44 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -62.69 -62.65 5.33 Favored Glycine 0 C--N 1.343 0.958 0 N-CA-C 115.171 0.828 . . . . 0.0 115.171 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -58.85 -36.91 75.36 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 14.1 mptt -71.97 -33.23 68.01 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.494 0.134 . . . . 0.0 111.326 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.66 HD21 HD13 ' A' ' 116' ' ' LEU . 0.5 OUTLIER -72.92 -31.81 64.88 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 123.292 0.37 . . . . 0.0 110.845 177.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 ttp180 -79.75 -40.91 27.73 Favored 'General case' 0 C--N 1.348 0.523 0 O-C-N 123.415 0.447 . . . . 0.0 110.139 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -85.56 45.04 1.15 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.241 0.543 . . . . 0.0 111.446 179.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -87.25 -9.09 55.97 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.941 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 151' ' ' LEU . 1.3 mm? -119.9 -37.38 3.11 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.396 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -86.57 171.32 11.13 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.183 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 73.6 mtm180 -77.45 132.55 38.51 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.557 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.486 -0.769 . . . . 0.0 111.126 -179.976 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.3 p . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 111.307 0.114 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -99.09 -43.61 6.6 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.552 0.532 . . . . 0.0 111.152 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -103.09 112.12 4.16 Favored Glycine 0 C--N 1.34 0.769 0 O-C-N 123.464 0.477 . . . . 0.0 112.438 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.1 tt -99.77 -44.06 6.22 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 123.62 0.247 . . . . 0.0 111.044 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.36 -54.8 0.76 Allowed Glycine 0 C--N 1.34 0.803 0 C-N-CA 121.368 -0.444 . . . . 0.0 112.731 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.19 167.64 11.24 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.658 0.27 . . . . 0.0 111.318 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 64.89 124.67 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.048 0.939 . . . . 0.0 112.011 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -129.32 176.14 8.18 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.285 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -76.8 158.9 80.01 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 122.838 0.455 . . . . 0.0 111.412 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.21 -31.08 82.59 Favored 'Trans proline' 0 C--N 1.38 2.214 0 C-N-CA 122.687 2.258 . . . . 0.0 113.925 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.8 tp -98.1 121.87 40.55 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.416 0.448 . . . . 0.0 110.49 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -132.02 -25.05 2.07 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.851 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -91.5 117.2 29.49 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.248 0.342 . . . . 0.0 111.049 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -120.22 10.56 11.36 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.396 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -81.75 -92.46 0.06 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.333 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.458 ' OG ' ' HB3' ' A' ' 109' ' ' TYR . 74.2 m 54.73 121.95 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.181 0.993 . . . . 0.0 112.686 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -96.44 161.08 14.07 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.347 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.7 mt -86.14 6.24 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.97 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.5 tp -63.01 110.22 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.413 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 9.9 t80 55.88 71.71 0.54 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.981 0.913 . . . . 0.0 111.82 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 18.3 t -107.3 -42.05 4.94 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.914 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.69 -52.23 0.02 OUTLIER Glycine 0 C--N 1.341 0.811 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.357 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -98.24 161.85 23.98 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-O 119.185 -0.436 . . . . 0.0 110.648 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.528 ' O ' HG13 ' A' ' 78' ' ' ILE . 6.5 Cg_exo -74.47 59.67 4.82 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.562 2.174 . . . . 0.0 112.666 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 77' ' ' PRO . 1.6 pp 42.63 66.06 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 124.665 1.186 . . . . 0.0 113.126 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -120.36 -59.11 1.8 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.338 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.9 m -62.33 -56.04 22.25 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.444 0.697 . . . . 0.0 112.86 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 58.8 m -56.51 -55.49 33.07 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.632 0.373 . . . . 0.0 111.937 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.518 ' CD1' ' HB ' ' A' ' 78' ' ' ILE . 36.2 m-85 -58.98 -27.99 65.91 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.9 t -70.82 -28.41 64.59 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 123.31 0.381 . . . . 0.0 110.608 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -71.77 171.45 11.59 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.561 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.4 mtmm -100.02 78.59 2.11 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.224 0.535 . . . . 0.0 110.408 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 90' ' ' LYS . . . 143.87 70.21 0.02 OUTLIER Glycine 0 C--N 1.336 0.566 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.411 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 4.5 tp -100.6 -29.66 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 122.44 0.296 . . . . 0.0 111.73 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.474 ' ND1' HD22 ' A' ' 143' ' ' LEU . 18.1 t60 -111.53 -18.7 12.77 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.154 0.284 . . . . 0.0 110.55 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -116.64 48.31 1.31 Allowed 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.55 0.531 . . . . 0.0 110.694 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 54.8 tttt -121.1 -14.32 8.41 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.57 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.2 mt -74.35 -9.35 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 122.854 0.461 . . . . 0.0 111.225 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.0 mm -87.17 -15.57 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.346 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -82.42 -32.83 28.87 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.338 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -75.26 -26.47 58.84 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.222 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -90.68 -12.33 37.07 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 123.429 0.456 . . . . 0.0 111.303 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -97.19 106.46 18.79 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.939 0.4 . . . . 0.0 110.594 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.6 tp -141.54 152.03 43.75 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.476 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 -100.71 -106.88 0.23 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.838 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.6 m -150.8 15.09 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.8 p -89.79 -90.39 0.14 Allowed 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.2 tptm -154.65 155.87 35.46 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.603 0.361 . . . . 0.0 110.785 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.6 m -109.0 -77.18 0.6 Allowed 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.519 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.5 ttmt -164.74 -62.62 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.039 0.536 . . . . 0.0 110.087 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -149.88 161.16 42.83 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.995 0.518 . . . . 0.0 110.082 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.633 ' HB3' ' HD3' ' A' ' 106' ' ' PRO . . . -91.07 -56.78 0.25 Allowed Pre-proline 0 CA--C 1.547 0.835 0 CA-C-O 118.67 -0.681 . . . . 0.0 111.665 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.633 ' HD3' ' HB3' ' A' ' 105' ' ' ALA . 2.1 Cg_endo -84.18 102.54 0.92 Allowed 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.353 2.035 . . . . 0.0 112.553 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.2 pt -147.98 -49.86 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.664 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 50.54 149.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 125.171 1.388 . . . . 0.0 113.907 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.458 ' HB3' ' OG ' ' A' ' 69' ' ' SER . 78.2 m-85 -106.61 156.16 18.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.101 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -91.65 153.0 19.99 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.388 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 43.7 p -94.45 144.29 25.69 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.309 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.2 t -101.54 141.44 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.869 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 17.8 ptp -131.59 148.0 52.57 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.207 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 64.03 159.45 0.09 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.005 0.922 . . . . 0.0 112.369 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -89.09 -178.3 5.65 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.425 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.487 HD23 ' CE1' ' A' ' 120' ' ' TYR . 5.2 mt -80.14 50.8 1.28 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.972 0.509 . . . . 0.0 111.608 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.7 mtmt -140.3 -40.24 0.43 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.644 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -94.93 -39.27 10.29 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.85 -6.39 59.1 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.254 0.346 . . . . 0.0 111.901 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.487 ' CE1' HD23 ' A' ' 116' ' ' LEU . 39.8 m-85 -123.75 134.32 25.23 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-O 119.166 -0.445 . . . . 0.0 110.683 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 2.9 Cg_exo -75.15 -45.45 0.27 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.586 2.191 . . . . 0.0 113.646 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 163.1 -61.85 0.26 Allowed Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.887 -0.951 . . . . 0.0 112.957 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.28 -30.01 78.69 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.898 2.399 . . . . 0.0 113.516 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -65.36 -25.66 67.68 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.508 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.697 ' HA ' HD12 ' A' ' 128' ' ' ILE . 13.4 mt -86.88 -36.52 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.725 178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -56.25 -36.54 68.64 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.61 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -77.02 -11.04 59.75 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.189 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.697 HD12 ' HA ' ' A' ' 125' ' ' ILE . 80.9 mt -83.73 -47.66 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 144' ' ' GLY . 4.4 m -69.28 -34.68 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.628 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 17.5 t -66.58 -52.4 45.79 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.651 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.3 m -64.71 -27.51 68.96 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.547 ' HA ' ' CE1' ' A' ' 135' ' ' HIS . 30.1 mt -79.14 -39.79 32.62 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 129' ' ' VAL . 12.1 pt-20 -71.52 -6.82 43.44 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -79.17 -69.41 0.58 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.141 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.572 ' ND1' ' HG2' ' A' ' 137' ' ' GLU . 5.7 p80 -65.01 -35.5 81.38 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.068 0.396 . . . . 0.0 112.068 178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.4 t70 57.49 61.65 2.41 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.871 0.868 . . . . 0.0 111.641 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.572 ' HG2' ' ND1' ' A' ' 135' ' ' HIS . 11.1 pt-20 -107.14 139.02 42.23 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.409 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.3 153.09 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.848 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . 96.73 -17.94 58.38 Favored Glycine 0 C--N 1.339 0.718 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -138.78 -16.67 1.12 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.113 0.965 . . . . 0.0 111.055 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -68.92 -29.57 67.86 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 123.906 0.883 . . . . 0.0 111.235 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.571 ' O ' ' HG2' ' A' ' 146' ' ' LYS . 2.4 p-10 -72.13 -43.7 64.29 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.604 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.474 HD22 ' ND1' ' A' ' 88' ' ' HIS . 12.3 tp -58.11 -63.97 1.07 Allowed 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.578 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.497 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -48.96 -43.67 31.36 Favored Glycine 0 C--N 1.345 1.043 0 O-C-N 123.959 0.787 . . . . 0.0 114.38 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -57.42 -45.32 84.73 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 142' ' ' ASP . 5.7 mmmt -63.18 -45.39 92.01 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.0 mt -58.17 -36.96 73.79 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.676 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -77.99 -39.29 42.77 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 120.647 0.261 . . . . 0.0 110.554 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.91 3.99 18.17 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.406 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 151' ' ' LEU . . . -74.31 106.44 5.94 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.447 ' HB3' ' O ' ' A' ' 150' ' ' ALA . 8.5 tt 80.63 -25.72 0.17 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.958 0.903 . . . . 0.0 112.41 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -61.34 -74.8 0.08 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 -178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -150.66 106.97 3.47 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.8 0.333 . . . . 0.0 111.474 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.516 -0.754 . . . . 0.0 111.055 179.811 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.7 p . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.463 0.173 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 70.42 -53.77 0.64 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 124.444 1.098 . . . . 0.0 112.292 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.27 55.81 1.09 Allowed Glycine 0 C--N 1.341 0.838 0 C-N-CA 121.474 -0.393 . . . . 0.0 112.564 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.411 ' O ' HD12 ' A' ' 57' ' ' LEU . 2.4 pp -119.14 132.73 56.01 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 123.681 0.283 . . . . 0.0 111.174 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -145.15 120.22 1.34 Allowed Glycine 0 C--N 1.337 0.609 0 O-C-N 123.711 0.632 . . . . 0.0 112.534 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.8 mmtp -119.98 -14.82 8.87 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -92.57 134.89 34.56 Favored 'General case' 0 C--O 1.236 0.351 0 O-C-N 123.321 0.388 . . . . 0.0 111.34 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -127.61 163.68 23.68 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.681 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -86.8 142.83 34.73 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.732 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.89 141.83 66.57 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.489 2.126 . . . . 0.0 113.16 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.58 HD22 ' CZ ' ' A' ' 67' ' ' PHE . 0.9 OUTLIER -129.52 175.11 9.04 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.582 179.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.432 ' H ' ' HG ' ' A' ' 64' ' ' LEU . 7.3 m-20 -85.28 43.93 1.05 Allowed 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.21 0.529 . . . . 0.0 111.358 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 64.19 138.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.083 0.953 . . . . 0.0 112.248 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.58 ' CZ ' HD22 ' A' ' 64' ' ' LEU . 68.6 m-85 -94.77 -46.22 7.0 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.322 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -113.37 128.43 56.46 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.416 0.448 . . . . 0.0 111.48 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.5 p -120.07 26.95 8.94 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.736 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.63 ' NZ ' ' HB ' ' A' ' 72' ' ' ILE . 1.4 ttpm? -85.59 -175.88 5.83 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.35 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.472 HD12 ' OG ' ' A' ' 81' ' ' SER . 3.3 mt -79.89 -0.24 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 122.968 0.507 . . . . 0.0 111.426 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.63 ' HB ' ' NZ ' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -67.86 -31.91 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.096 179.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -106.01 -3.04 22.11 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.193 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 t -84.29 110.78 18.83 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 120.848 0.356 . . . . 0.0 110.981 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.82 -133.88 12.11 Favored Glycine 0 C--N 1.34 0.765 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.404 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.404 ' H ' ' CD ' ' A' ' 77' ' ' PRO . 4.3 mtpt -137.13 -52.15 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.782 0 CA-C-O 118.781 -0.628 . . . . 0.0 111.645 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.404 ' CD ' ' H ' ' A' ' 76' ' ' LYS . 1.7 Cg_endo -84.68 135.41 5.84 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.395 2.063 . . . . 0.0 113.261 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.507 ' HB ' ' CD1' ' A' ' 82' ' ' TYR . 1.2 pp -113.69 76.4 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 121.44 0.638 . . . . 0.0 110.254 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 83' ' ' SER . 7.3 tp10 -120.42 -53.42 2.12 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.434 -178.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.5 m -56.71 -60.82 2.99 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.245 0.618 . . . . 0.0 112.506 -177.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.472 ' OG ' HD12 ' A' ' 71' ' ' ILE . 45.7 t -59.14 -53.99 52.11 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.082 0.239 . . . . 0.0 110.436 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.507 ' CD1' ' HB ' ' A' ' 78' ' ' ILE . 18.8 m-85 -57.16 -15.13 4.97 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 177.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.625 ' HA ' ' CD2' ' A' ' 135' ' ' HIS . 23.0 t -86.06 -34.96 20.56 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 122.459 0.304 . . . . 0.0 110.394 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.01 159.75 33.68 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.72 179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.53 150.07 22.6 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.286 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 98.65 14.49 37.37 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.76 -0.655 . . . . 0.0 113.41 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.1 tt -77.14 -27.14 16.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 112.378 0.511 . . . . 0.0 112.378 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.566 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 70.8 t60 -77.58 -11.36 59.85 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -102.71 -43.99 5.43 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -65.93 -8.64 23.65 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.399 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.4 tp -79.47 -13.06 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 122.785 0.434 . . . . 0.0 110.94 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.1 mt -95.62 -1.02 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.405 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -59.41 -29.66 67.91 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.056 0.542 . . . . 0.0 112.229 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.562 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -76.94 -22.47 53.22 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.23 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -94.2 -19.08 21.07 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 123.473 0.483 . . . . 0.0 111.238 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.4 150.56 20.14 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.424 0.452 . . . . 0.0 110.864 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 65.47 9.26 5.65 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.856 0.863 . . . . 0.0 112.667 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -99.37 -40.94 7.65 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.2 t 63.82 98.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.628 0.771 . . . . 0.0 110.858 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.1 m -141.32 129.02 21.57 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.985 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -131.96 129.64 40.46 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.874 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.8 t -129.73 154.84 46.79 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.644 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.7 pttm 48.76 176.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 124.928 1.291 . . . . 0.0 113.56 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.463 ' O ' ' HD3' ' A' ' 106' ' ' PRO . 43.5 t30 -128.78 -45.83 1.29 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.197 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -110.44 88.86 7.99 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 123.315 0.384 . . . . 0.0 111.506 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 104' ' ' ASN . 8.2 Cg_exo -75.2 137.42 21.27 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 122.915 2.41 . . . . 0.0 112.702 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 11.7 mm -123.58 -56.73 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.068 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -139.88 152.6 46.57 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.333 0.396 . . . . 0.0 110.802 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -114.93 130.33 56.89 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.686 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.98 60.7 0.66 Allowed 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.428 0.632 . . . . 0.0 111.06 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.8 t 63.0 134.01 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 124.088 0.955 . . . . 0.0 112.184 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.1 p -113.67 -4.83 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.436 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 70.9 mtm -91.81 110.67 22.02 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.918 0.39 . . . . 0.0 111.076 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -143.64 15.21 1.78 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.002 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -87.23 -44.11 11.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.566 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.469 ' O ' HD11 ' A' ' 125' ' ' ILE . 12.8 mt -88.53 -10.0 50.41 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -112.35 97.16 6.43 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.371 0.605 . . . . 0.0 110.499 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 26.8 tptt -179.89 -55.85 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.899 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.6 -4.53 2.28 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.273 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.497 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -88.41 -29.94 0.37 Allowed Pre-proline 0 CA--C 1.549 0.936 0 CA-C-O 118.367 -0.825 . . . . 0.0 112.759 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 120' ' ' TYR . 88.1 Cg_exo -49.65 112.18 0.64 Allowed 'Trans proline' 0 C--N 1.39 2.751 0 C-N-CA 122.734 2.289 . . . . 0.0 113.516 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 126' ' ' GLU . . . 149.95 -135.82 5.44 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.768 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.416 ' HA ' ' CD ' ' A' ' 126' ' ' GLU . 51.0 Cg_exo -55.64 -32.37 83.19 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 123.164 2.576 . . . . 0.0 114.322 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.563 ' O ' HG13 ' A' ' 128' ' ' ILE . 8.4 m-20 -70.5 -49.64 46.25 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.596 ' HA ' HD12 ' A' ' 128' ' ' ILE . 5.3 mt -71.27 -39.11 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 122' ' ' GLY . 10.8 pt-20 -59.68 -47.63 84.87 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.037 0.211 . . . . 0.0 110.871 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -57.0 -35.34 69.09 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 125' ' ' ILE . 53.3 mt -61.49 -57.2 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 O-C-N 123.095 0.247 . . . . 0.0 110.81 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 8.0 m -57.44 -38.68 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 O-C-N 123.475 0.484 . . . . 0.0 111.746 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 12.1 t -70.48 -20.22 62.88 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.3 m -77.6 -44.84 27.05 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 128' ' ' ILE . 3.2 mp -72.14 -27.19 62.45 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.782 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -89.03 10.78 20.36 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.205 0.526 . . . . 0.0 110.551 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.2 tmt_? -115.93 -31.16 5.84 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.345 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.625 ' CD2' ' HA ' ' A' ' 83' ' ' SER . 42.9 m-70 -92.68 -32.71 14.64 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.812 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 63.67 64.43 0.79 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.028 0.931 . . . . 0.0 111.927 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -91.11 120.17 31.85 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.341 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.481 ' O ' ' HD3' ' A' ' 141' ' ' LYS . 3.5 t -78.49 -16.5 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.644 -178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -91.07 -22.19 33.47 Favored Glycine 0 C--N 1.342 0.89 0 C-N-CA 121.271 -0.49 . . . . 0.0 112.022 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.88 4.25 14.8 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.327 0.651 . . . . 0.0 110.731 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 138' ' ' VAL . 42.6 pttt -50.92 -37.68 45.5 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.11 0.964 . . . . 0.0 112.948 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.53 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 3.4 t70 -73.91 -30.17 62.44 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.174 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.566 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 15.9 tp -67.7 -57.23 6.73 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.475 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -55.18 -49.67 62.48 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-N 115.87 -0.604 . . . . 0.0 114.035 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -58.42 -42.73 87.9 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.53 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.2 mptm? -61.44 -40.2 93.61 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 30.1 mt -63.33 -32.86 74.39 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.417 0.448 . . . . 0.0 111.509 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -75.21 -39.32 60.17 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.14 0.275 . . . . 0.0 110.529 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -78.7 5.59 10.82 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.945 178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.2 -5.34 54.06 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.628 0.371 . . . . 0.0 111.608 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.4 tt -92.15 -47.97 6.96 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.453 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -96.67 124.7 40.74 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.426 0.454 . . . . 0.0 110.816 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -132.94 153.6 51.25 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.129 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.916 -179.94 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.0 t . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.476 0.179 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.3 t80 70.13 -55.67 0.6 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.517 1.127 . . . . 0.0 112.039 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.41 64.99 0.9 Allowed Glycine 0 C--N 1.34 0.782 0 C-N-CA 121.555 -0.355 . . . . 0.0 112.48 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 58' ' ' GLY . 2.7 tt -112.76 146.65 38.41 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 123.602 0.236 . . . . 0.0 110.607 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.414 ' N ' HD23 ' A' ' 57' ' ' LEU . . . 155.84 49.44 0.01 OUTLIER Glycine 0 C--N 1.337 0.601 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.622 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -120.05 46.95 1.84 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.21 0.529 . . . . 0.0 110.872 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -109.09 -7.93 15.25 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.696 -0.683 . . . . 0.0 111.876 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -129.59 -10.41 4.52 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.817 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -88.83 -45.77 0.44 Allowed Pre-proline 0 CA--C 1.547 0.834 0 CA-C-O 118.714 -0.66 . . . . 0.0 112.243 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.01 -12.98 28.72 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.365 2.044 . . . . 0.0 113.437 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.7 mp -97.18 126.34 42.29 Favored 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.294 0.371 . . . . 0.0 110.744 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -130.12 -59.68 1.04 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.361 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.469 ' O ' ' HD2' ' A' ' 66' ' ' LYS . 1.8 pptp? -147.7 123.08 10.32 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.696 0.284 . . . . 0.0 111.532 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -120.57 -45.49 2.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.969 179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 54.81 -88.86 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.164 0.986 . . . . 0.0 112.521 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.3 m -120.82 123.25 42.14 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.677 0.275 . . . . 0.0 111.63 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 74' ' ' SER . 57.6 mmtt -136.64 -56.73 0.74 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.238 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.434 ' CG2' ' O ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -148.88 94.59 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.659 0.743 . . . . 0.0 110.381 178.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.9 mp 53.14 70.73 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.577 -178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 57.4 21.56 7.0 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.132 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 7.3 t -117.15 174.61 6.02 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.278 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.46 -36.98 2.93 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 116.208 -0.451 . . . . 0.0 113.426 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.496 ' HB2' ' OG ' ' A' ' 81' ' ' SER . 1.8 mptp? -85.94 166.07 31.18 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.472 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.6 ' O ' ' HB2' ' A' ' 81' ' ' SER . 8.8 Cg_exo -73.14 -165.22 0.23 Allowed 'Trans proline' 0 C--N 1.383 2.372 0 C-N-CA 122.837 2.358 . . . . 0.0 112.836 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.583 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 1.3 mp -76.28 -14.45 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 83' ' ' SER . 5.0 pt-20 -85.78 -67.5 0.8 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.409 ' H ' ' HG3' ' A' ' 79' ' ' GLU . 18.3 m -64.5 -56.99 10.47 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.6 ' HB2' ' O ' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -48.52 -57.24 6.44 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.636 0.374 . . . . 0.0 111.231 179.616 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.583 ' HB2' ' O ' ' A' ' 78' ' ' ILE . 27.6 m-85 -69.15 -11.47 60.83 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.551 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 7.4 t -100.23 -1.91 35.23 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -96.62 147.12 24.21 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.796 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.537 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.9 OUTLIER -73.51 126.3 29.91 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 116.329 -0.396 . . . . 0.0 112.014 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.88 57.24 2.73 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.408 -0.814 . . . . 0.0 113.501 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.546 HG22 ' OE1' ' A' ' 137' ' ' GLU . 2.9 tp -79.27 -38.39 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 122.749 0.42 . . . . 0.0 111.348 179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.837 ' HB3' ' HB2' ' A' ' 140' ' ' ALA . 21.6 p-80 -66.22 -17.77 64.94 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -101.43 -54.91 2.65 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.11 0.256 . . . . 0.0 111.541 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -52.95 -7.49 0.08 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.487 HG23 ' O ' ' A' ' 87' ' ' ILE . 1.8 pt -73.04 -9.16 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.3 mm -117.18 13.81 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.29 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -89.67 -34.8 16.13 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.699 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.58 -20.1 60.07 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -98.93 -12.61 20.54 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 123.346 0.404 . . . . 0.0 111.227 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -97.65 141.82 30.21 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 123.321 0.388 . . . . 0.0 110.893 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 11.7 mt -131.95 144.0 50.51 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.666 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -130.5 152.8 49.49 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.396 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.9 m 43.36 99.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 124.76 1.224 . . . . 0.0 113.775 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.3 m -139.2 119.33 13.55 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.796 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -132.31 99.04 4.56 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.329 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.0 m -145.17 -19.31 0.49 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.606 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt 70.65 -10.19 0.74 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.291 1.036 . . . . 0.0 112.738 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -101.74 127.01 48.7 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -127.11 147.2 60.75 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.325 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.48 177.52 4.61 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.729 2.286 . . . . 0.0 112.966 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 107' ' ' ILE . 1.5 mp -88.84 42.94 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 CA-C-O 121.048 0.452 . . . . 0.0 110.411 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 43.93 105.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 125.032 1.333 . . . . 0.0 113.802 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -129.85 127.04 39.43 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.799 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -125.65 128.85 48.48 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.105 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.5 t -110.62 127.01 55.07 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.694 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.2 t -102.49 121.64 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.837 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 9.0 ttt -99.48 153.37 19.08 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.786 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -95.6 164.36 12.81 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.013 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -79.56 169.48 17.96 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.357 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mt -75.91 97.87 4.08 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.981 0.419 . . . . 0.0 111.107 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -147.69 -45.84 0.17 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.209 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -112.45 -36.22 5.32 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.401 ' C ' ' HD3' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -79.97 -33.48 39.47 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.555 0.342 . . . . 0.0 111.451 -179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -127.0 64.39 60.16 Favored Pre-proline 0 CA--C 1.549 0.904 0 O-C-N 123.523 0.514 . . . . 0.0 110.556 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.401 ' HD3' ' C ' ' A' ' 119' ' ' THR . 18.7 Cg_endo -95.06 133.94 0.62 Allowed 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.778 2.319 . . . . 0.0 114.648 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.473 ' H ' HD12 ' A' ' 125' ' ' ILE . . . 74.01 -110.99 3.28 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-O 119.087 -0.84 . . . . 0.0 114.923 177.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -46.72 -30.09 8.68 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.66 2.907 . . . . 0.0 114.911 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -72.23 -39.91 68.13 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.309 0.381 . . . . 0.0 111.355 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 129' ' ' VAL . 16.3 mt -76.59 -29.73 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.307 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.42 -56.41 16.44 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.629 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -55.86 -29.82 60.5 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.491 HG23 ' CZ ' ' A' ' 82' ' ' TYR . 50.6 mt -73.64 -45.03 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 120.563 0.221 . . . . 0.0 110.53 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 125' ' ' ILE . 12.6 m -77.79 -25.6 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.238 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.1 t -83.74 -19.05 35.83 Favored 'General case' 0 N--CA 1.473 0.675 0 O-C-N 123.781 0.676 . . . . 0.0 112.306 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.7 m -98.11 -27.3 14.26 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.072 0.232 . . . . 0.0 110.496 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.479 HD13 ' HA3' ' A' ' 144' ' ' GLY . 2.4 tt -80.41 -35.21 35.51 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.176 0.297 . . . . 0.0 110.884 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -72.65 -1.37 15.98 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -97.03 -76.19 0.52 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -46.34 -37.9 8.07 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.604 0.762 . . . . 0.0 112.676 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.8 t70 69.7 76.81 0.21 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.128 0.971 . . . . 0.0 111.203 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.546 ' OE1' HG22 ' A' ' 87' ' ' ILE . 10.4 mm-40 -83.94 123.44 29.97 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.063 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -78.7 -25.6 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.601 ' HA3' ' CE1' ' A' ' 88' ' ' HIS . . . -88.33 -27.83 24.2 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 178.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.837 ' HB2' ' HB3' ' A' ' 88' ' ' HIS . . . -100.49 -1.66 35.13 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.212 -0.494 . . . . 0.0 111.324 179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -32.13 36.64 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.14 0.576 . . . . 0.0 112.533 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.569 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 19.8 m-20 -77.49 -40.21 43.77 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 123.258 0.349 . . . . 0.0 110.679 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.3 tp -65.59 -61.79 1.89 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.58 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.479 ' HA3' HD13 ' A' ' 132' ' ' LEU . . . -53.31 -47.35 62.16 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.724 -0.671 . . . . 0.0 114.511 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.13 -41.9 89.32 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.569 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -61.26 -41.09 96.32 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.021 0.2 . . . . 0.0 111.278 178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 24.0 mt -62.36 -37.9 87.45 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.269 0.355 . . . . 0.0 111.345 177.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -88.44 3.16 51.03 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -120.12 -11.0 9.31 Favored 'General case' 0 C--N 1.345 0.373 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.1 -8.56 48.5 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.163 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.5 tt -108.38 -40.92 5.0 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.594 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.87 128.37 36.17 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.987 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -128.65 -42.79 1.43 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.145 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.102 -0.952 . . . . 0.0 111.123 -179.94 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 120.491 0.186 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 62.94 125.31 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.954 0.902 . . . . 0.0 112.056 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.79 138.43 5.19 Favored Glycine 0 C--N 1.337 0.604 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.44 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 12.5 mt -100.4 -43.34 6.27 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.617 0.245 . . . . 0.0 111.263 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.07 -41.08 1.98 Allowed Glycine 0 C--N 1.338 0.692 0 O-C-N 123.403 0.439 . . . . 0.0 112.931 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -93.52 146.9 23.45 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.406 0.282 . . . . 0.0 111.065 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -107.51 123.86 49.05 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.235 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -135.1 10.98 3.57 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.497 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.424 ' N ' ' CD ' ' A' ' 63' ' ' PRO . 2.7 p30 -85.07 -32.89 0.48 Allowed Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 62' ' ' ASP . 16.5 Cg_exo -69.36 -27.69 28.05 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.169 1.913 . . . . 0.0 113.347 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.4 mt -97.73 122.25 40.6 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 123.406 0.441 . . . . 0.0 110.741 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -137.28 -29.87 0.87 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.901 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -91.87 -6.81 50.88 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -103.53 -44.87 5.0 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.364 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 63.06 148.25 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.863 0.865 . . . . 0.0 112.368 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.4 m -101.78 -42.78 6.04 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.261 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -131.5 139.85 49.4 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.455 0.472 . . . . 0.0 110.935 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.0 mm -119.51 -26.85 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.565 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.402 HD13 HD11 ' A' ' 116' ' ' LEU . 3.7 tp -67.88 -19.75 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 122.975 0.51 . . . . 0.0 111.828 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -114.08 19.64 16.29 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.498 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.6 t -88.24 -39.72 14.22 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.008 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.22 -99.23 0.12 Allowed Glycine 0 C--N 1.338 0.683 0 O-C-N 123.7 0.625 . . . . 0.0 111.657 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.799 ' N ' ' HD3' ' A' ' 77' ' ' PRO . 32.2 mmtm -137.43 28.95 0.12 Allowed Pre-proline 0 CA--C 1.558 1.256 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.799 ' HD3' ' N ' ' A' ' 76' ' ' LYS . 5.1 Cg_endo -87.57 101.93 0.5 Allowed 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.241 1.961 . . . . 0.0 112.845 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 tt -145.73 7.01 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.102 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -97.19 -76.51 0.51 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.018 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.1 m -65.26 -60.75 2.65 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 122.683 0.393 . . . . 0.0 110.49 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.523 ' O ' HD13 ' A' ' 87' ' ' ILE . 25.6 p -44.45 -39.61 4.9 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.405 0.682 . . . . 0.0 112.687 177.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.573 ' CE1' HG23 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -89.46 -10.09 47.69 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 179.541 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.2 t -95.04 -6.99 40.93 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.555 0.217 . . . . 0.0 110.685 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.47 149.63 27.48 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.464 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -74.68 87.03 2.17 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.377 0.608 . . . . 0.0 111.072 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.579 ' O ' ' HD3' ' A' ' 90' ' ' LYS . . . 133.57 63.19 0.07 OUTLIER Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.929 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.602 HG22 ' OE2' ' A' ' 137' ' ' GLU . 4.4 tp -105.79 -15.53 8.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.596 ' HB3' ' O ' ' A' ' 139' ' ' GLY . 49.2 t60 -104.13 -74.81 0.63 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -96.02 52.41 1.3 Allowed 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.189 0.519 . . . . 0.0 112.06 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.579 ' HD3' ' O ' ' A' ' 86' ' ' GLY . 4.6 ttpp -121.13 -33.26 3.75 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.558 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.5 pt -78.21 -27.01 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.712 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.402 HG13 ' H ' ' A' ' 92' ' ' ILE . 2.2 pp -95.73 -1.79 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.667 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -80.85 -33.15 34.71 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 122.718 0.407 . . . . 0.0 111.336 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -80.19 -0.02 34.39 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.105 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.9 m-70 -120.37 -13.9 8.79 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.643 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -92.22 -43.78 9.13 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 123.268 0.355 . . . . 0.0 111.384 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.9 tp -100.26 -43.27 6.34 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.314 0.384 . . . . 0.0 111.077 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -100.28 144.95 28.69 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 123.376 0.422 . . . . 0.0 110.713 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 6.8 t 64.63 129.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.757 0.823 . . . . 0.0 111.237 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.7 m 63.34 149.8 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.034 0.934 . . . . 0.0 112.446 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -97.82 144.33 27.52 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.906 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 51.0 m -101.15 138.24 38.44 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 123.634 0.584 . . . . 0.0 111.021 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -111.31 -43.39 3.71 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.045 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -130.0 153.34 48.5 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.705 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.1 -47.81 0.32 Allowed Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 118.579 -0.724 . . . . 0.0 112.322 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -90.51 117.0 0.58 Allowed 'Trans proline' 0 C--N 1.377 2.051 0 C-N-CA 122.209 1.94 . . . . 0.0 113.153 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.409 HD13 ' N ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -146.67 111.7 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.0 179.139 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -138.34 -8.79 1.49 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.345 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -89.43 -4.37 58.02 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 122.509 0.324 . . . . 0.0 111.689 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.31 -47.7 6.49 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.603 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 37.8 p -137.09 136.08 38.03 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.141 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.6 p -137.95 122.49 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.567 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -138.7 161.29 37.54 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.685 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -90.69 140.62 29.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.977 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -117.51 -174.29 2.59 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.998 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.402 HD11 HD13 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -54.88 95.57 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.482 ' HA ' ' CD1' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -172.72 -24.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.048 179.045 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -52.96 -34.55 56.28 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.06 0.457 . . . . 0.0 110.998 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.455 ' O ' HD13 ' A' ' 125' ' ' ILE . 6.6 t -129.6 46.5 2.63 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.664 177.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.574 ' CD1' HG12 ' A' ' 125' ' ' ILE . 0.1 OUTLIER -57.34 -45.34 99.9 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.389 -178.349 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -78.79 37.86 0.68 Allowed 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.086 1.857 . . . . 0.0 112.116 178.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -112.5 -171.47 18.45 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 115.946 -0.57 . . . . 0.0 114.234 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.537 ' HA ' ' OE1' ' A' ' 126' ' ' GLU . 3.6 Cg_exo -75.24 -37.4 1.93 Allowed 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 123.56 2.84 . . . . 0.0 113.33 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.409 ' OD2' HD12 ' A' ' 125' ' ' ILE . 6.9 p-10 -61.95 -19.74 63.07 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.574 HG12 ' CD1' ' A' ' 120' ' ' TYR . 1.1 mp -89.97 -51.81 11.5 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 O-C-N 123.372 0.42 . . . . 0.0 111.181 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.537 ' OE1' ' HA ' ' A' ' 123' ' ' PRO . 8.5 pt-20 -50.45 -27.78 7.12 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 177.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -72.04 -35.32 69.31 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.87 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.573 HG23 ' CE1' ' A' ' 82' ' ' TYR . 75.1 mt -58.86 -52.31 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.713 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 15.7 m -59.91 -54.55 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 123.114 0.259 . . . . 0.0 111.639 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.7 t -56.06 -52.55 63.87 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.2 m -67.88 -17.66 64.55 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.776 HD11 ' HB1' ' A' ' 140' ' ' ALA . 3.5 tt -88.33 -44.47 10.78 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 117.782 0.265 . . . . 0.0 111.09 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -79.01 -1.49 35.78 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -79.55 -50.0 11.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.191 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.484 ' HE1' ' OE2' ' A' ' 137' ' ' GLU . 5.8 p80 -89.13 -35.86 16.04 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.174 0.297 . . . . 0.0 111.772 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.412 ' OD2' ' HE3' ' A' ' 141' ' ' LYS . 5.5 m-20 74.84 87.72 0.09 Allowed 'General case' 0 C--N 1.357 0.91 0 C-N-CA 124.205 1.002 . . . . 0.0 112.159 177.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.602 ' OE2' HG22 ' A' ' 87' ' ' ILE . 6.6 pt-20 -114.96 151.7 33.66 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.709 178.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.2 m -76.44 -44.89 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.596 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -68.7 0.65 12.64 Favored Glycine 0 N--CA 1.471 1.012 0 N-CA-C 115.2 0.84 . . . . 0.0 115.2 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.776 ' HB1' HD11 ' A' ' 132' ' ' LEU . . . -136.74 -11.4 1.79 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 122.91 0.484 . . . . 0.0 112.036 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 6.4 tptm -53.65 -41.33 66.69 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.292 0.637 . . . . 0.0 112.084 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 2.1 p-10 -70.16 -42.46 72.46 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.109 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.574 ' O ' HD12 ' A' ' 147' ' ' LEU . 14.2 tp -63.81 -52.25 61.08 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.953 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.442 ' CA ' HD13 ' A' ' 132' ' ' LEU . . . -58.04 -38.6 89.89 Favored Glycine 0 C--N 1.343 0.959 0 O-C-N 123.697 0.623 . . . . 0.0 113.851 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.91 83.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.873 0.337 . . . . 0.0 111.867 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.477 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.3 mptm? -66.96 -33.82 76.41 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.211 0.319 . . . . 0.0 110.662 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.574 HD12 ' O ' ' A' ' 143' ' ' LEU . 0.6 OUTLIER -66.04 -41.11 91.3 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.548 0.53 . . . . 0.0 110.315 177.507 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -64.73 -38.41 90.88 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.133 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.85 1.03 48.85 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.091 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.23 104.93 1.0 Allowed 'General case' 0 C--O 1.239 0.513 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 151' ' ' LEU . 3.1 tm? 80.59 -28.16 0.14 Allowed 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.099 0.959 . . . . 0.0 111.057 -177.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -94.78 134.11 37.75 Favored 'General case' 0 C--N 1.344 0.364 0 O-C-N 123.064 0.227 . . . . 0.0 111.076 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 28.0 mmt180 -129.45 -42.43 1.32 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.149 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.479 -0.772 . . . . 0.0 110.501 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.0 m . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 111.279 0.103 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -99.87 -46.58 5.33 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 123.404 0.44 . . . . 0.0 110.82 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.71 -118.8 6.03 Favored Glycine 0 C--N 1.342 0.911 0 O-C-N 123.428 0.455 . . . . 0.0 112.585 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.97 -43.07 2.57 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.385 0.274 . . . . 0.0 110.898 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 171.25 97.6 0.11 Allowed Glycine 0 C--N 1.34 0.788 0 O-C-N 123.502 0.501 . . . . 0.0 112.463 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.9 ttmt -99.89 156.74 16.97 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.784 0.326 . . . . 0.0 110.618 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 59.15 101.36 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.819 0.848 . . . . 0.0 112.057 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.568 ' O ' ' HD3' ' A' ' 63' ' ' PRO . 20.2 mm-40 -142.84 167.88 21.03 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.604 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -110.84 79.96 2.03 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.668 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.568 ' HD3' ' O ' ' A' ' 61' ' ' GLN . 1.7 Cg_endo -83.36 -168.0 0.52 Allowed 'Trans proline' 0 C--N 1.371 1.713 0 C-N-CA 123.088 2.525 . . . . 0.0 112.697 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.447 ' HG ' ' H ' ' A' ' 65' ' ' ASP . 5.1 tp -72.43 166.06 23.33 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 122.959 0.504 . . . . 0.0 110.834 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.447 ' H ' ' HG ' ' A' ' 64' ' ' LEU . 5.0 t70 -67.69 -51.44 49.61 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.563 0.345 . . . . 0.0 111.826 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -137.15 100.23 4.21 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 121.105 0.479 . . . . 0.0 110.845 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -120.42 -13.42 8.83 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.712 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -112.67 128.69 56.46 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.412 0.445 . . . . 0.0 110.391 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.6 t -95.15 135.52 36.62 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.592 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -93.49 -0.06 56.52 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.076 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -90.93 -33.29 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.48 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.571 HG23 ' CD1' ' A' ' 73' ' ' PHE . 5.0 tp -72.57 -24.84 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 O-C-N 123.134 0.271 . . . . 0.0 111.554 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.571 ' CD1' HG23 ' A' ' 72' ' ' ILE . 63.9 m-85 -105.59 17.49 23.74 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 123.401 0.438 . . . . 0.0 110.485 178.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.465 ' OG ' ' HD2' ' A' ' 77' ' ' PRO . 1.8 t -87.59 162.64 17.05 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.089 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.15 -63.92 1.76 Allowed Glycine 0 C--N 1.344 0.989 0 CA-C-N 116.239 -0.437 . . . . 0.0 113.483 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -90.73 -46.2 0.38 Allowed Pre-proline 0 CA--C 1.545 0.779 0 CA-C-O 118.551 -0.738 . . . . 0.0 112.545 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.465 ' HD2' ' OG ' ' A' ' 74' ' ' SER . 7.9 Cg_exo -73.06 94.69 0.82 Allowed 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.296 1.997 . . . . 0.0 113.015 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 tt -154.27 -35.8 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.084 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 83' ' ' SER . 1.9 mt-10 -91.86 -28.84 17.06 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.059 179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.8 m -69.08 -61.48 1.78 Allowed 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.842 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.518 ' O ' HD13 ' A' ' 87' ' ' ILE . 40.6 m -86.9 58.41 5.06 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-O 123.389 1.566 . . . . 0.0 109.727 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.56 ' CD2' HG12 ' A' ' 87' ' ' ILE . 0.9 OUTLIER -158.66 -41.62 0.06 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 111.651 -2.522 . . . . 0.0 105.327 -179.426 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.406 ' HA ' ' CD2' ' A' ' 135' ' ' HIS . 8.3 t -70.55 -23.76 62.67 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 113.547 -1.66 . . . . 0.0 110.097 176.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.86 1.03 4.82 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt 59.34 152.79 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.959 0.903 . . . . 0.0 112.949 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.65 2.6 78.78 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.66 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.56 HG12 ' CD2' ' A' ' 82' ' ' TYR . 7.6 tp -64.05 -9.12 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.304 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.517 ' ND1' ' HB2' ' A' ' 143' ' ' LEU . 70.1 t60 -90.49 51.78 2.08 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 121.599 0.714 . . . . 0.0 110.903 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.459 ' O ' HG22 ' A' ' 92' ' ' ILE . 10.2 mm-40 -145.82 -41.25 0.22 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.516 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -83.25 -2.9 56.75 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.004 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.1 tt -103.54 2.25 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.821 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.597 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 3.9 tp -114.2 -16.9 8.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.978 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -101.92 -42.33 6.17 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.041 0.213 . . . . 0.0 111.241 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -83.5 -29.35 28.03 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.271 0.357 . . . . 0.0 111.78 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -91.17 -4.79 55.8 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.063 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.597 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 12.2 t70 -67.75 129.95 41.48 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.07 0.548 . . . . 0.0 111.24 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.446 HD13 ' H ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -94.65 172.45 8.17 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.65 -179.162 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 65.23 116.49 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.178 0.991 . . . . 0.0 111.905 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 m -145.2 2.14 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 115.602 -0.727 . . . . 0.0 112.052 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.9 m -86.99 154.11 21.03 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.496 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -93.51 105.62 17.66 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.002 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.3 m -146.1 -43.39 0.2 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.996 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 33.1 mtmt -100.66 149.88 23.31 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.865 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -108.72 -13.58 14.76 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.763 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.99 147.02 33.97 Favored Pre-proline 0 CA--C 1.535 0.401 0 O-C-N 123.207 0.317 . . . . 0.0 111.504 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.59 165.83 31.6 Favored 'Trans proline' 0 C--N 1.372 1.771 0 C-N-CA 122.683 2.255 . . . . 0.0 113.258 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.1 mt -96.06 122.79 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.04 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -106.67 -43.66 4.66 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.132 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -123.16 155.16 37.6 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 123.421 0.451 . . . . 0.0 111.15 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -94.03 128.34 40.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.364 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.8 t -127.16 4.66 6.4 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.388 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.88 159.27 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.448 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 20.6 ttp -85.46 164.93 17.57 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.943 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -83.78 146.18 28.29 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.366 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -98.1 -27.66 14.1 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.31 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.2 mt -87.53 36.61 0.75 Allowed 'General case' 0 CA--C 1.542 0.635 0 O-C-N 123.283 0.364 . . . . 0.0 111.553 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 30.3 tttp -147.23 0.54 0.71 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.13 -54.01 4.01 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.483 0.179 . . . . 0.0 111.483 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -139.09 8.44 2.49 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.873 0.368 . . . . 0.0 110.907 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER -89.57 -30.68 0.36 Allowed Pre-proline 0 CA--C 1.55 0.953 0 CA-C-O 118.285 -0.864 . . . . 0.0 112.886 -179.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' TYR . 78.0 Cg_exo -44.93 120.65 3.02 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 123.065 2.51 . . . . 0.0 114.046 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 165.27 -147.63 12.76 Favored Glycine 0 CA--C 1.525 0.716 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.726 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -62.71 -22.78 74.25 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.971 2.448 . . . . 0.0 113.754 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.516 ' O ' HG13 ' A' ' 128' ' ' ILE . 9.4 m-20 -71.43 -49.49 41.17 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.594 0.358 . . . . 0.0 111.595 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.623 ' HA ' HD12 ' A' ' 128' ' ' ILE . 10.2 mt -73.26 -34.97 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 123.271 0.357 . . . . 0.0 110.875 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -55.92 -48.22 76.08 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.72 0.637 . . . . 0.0 111.004 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -66.09 -35.65 81.08 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.623 HD12 ' HA ' ' A' ' 125' ' ' ILE . 32.9 mt -61.27 -55.34 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 125' ' ' ILE . 5.5 m -65.12 -27.32 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.223 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.2 t -83.26 -13.89 54.31 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 26.9 m -92.09 -42.42 9.95 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 123.037 0.211 . . . . 0.0 110.913 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 144' ' ' GLY . 4.7 mp -77.74 -37.25 49.61 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -76.97 7.53 4.76 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 123.295 0.372 . . . . 0.0 111.673 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -108.06 -80.25 0.57 Allowed 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.406 ' CD2' ' HA ' ' A' ' 83' ' ' SER . 8.2 m-70 -47.81 -37.45 13.71 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.816 0.847 . . . . 0.0 112.789 178.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 65.69 68.24 0.48 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.995 0.918 . . . . 0.0 111.769 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -88.72 129.77 35.47 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.437 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.505 ' O ' ' HD3' ' A' ' 141' ' ' LYS . 3.1 t -73.41 -16.4 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -86.51 -32.02 17.23 Favored Glycine 0 C--N 1.34 0.756 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.43 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.416 ' CB ' ' HB2' ' A' ' 88' ' ' HIS . . . -110.0 5.74 22.51 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.84 0.456 . . . . 0.0 111.149 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.505 ' HD3' ' O ' ' A' ' 138' ' ' VAL . 21.3 pttm -47.32 -37.65 11.35 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.965 0.906 . . . . 0.0 113.087 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 2.5 p-10 -75.29 -41.6 56.75 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.303 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.517 ' HB2' ' ND1' ' A' ' 88' ' ' HIS . 17.6 tp -56.83 -55.04 39.53 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.218 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.495 ' N ' HD22 ' A' ' 132' ' ' LEU . . . -59.87 -59.5 10.37 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 115.793 -0.639 . . . . 0.0 114.049 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -56.34 -42.71 78.17 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 14.1 mptt -62.51 -36.01 81.19 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 123.027 0.204 . . . . 0.0 111.418 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.6 mt -66.68 -35.71 80.8 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.417 0.448 . . . . 0.0 111.954 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.0 ttp180 -93.14 -2.66 55.15 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -105.94 28.94 7.1 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.938 0.399 . . . . 0.0 110.848 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.87 -9.95 59.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.143 -0.48 . . . . 0.0 112.266 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.1 tt -102.19 -53.53 2.9 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.263 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 41.53 -78.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 125.168 1.387 . . . . 0.0 114.198 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -128.12 -36.74 1.93 Allowed 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 122.505 0.322 . . . . 0.0 111.136 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.493 179.931 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.414 ' O ' ' HE3' ' A' ' 59' ' ' LYS . 70.2 m . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.691 0.281 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -136.93 -41.58 0.59 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.524 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.52 -27.72 16.69 Favored Glycine 0 C--N 1.34 0.798 0 O-C-N 123.443 0.464 . . . . 0.0 113.424 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.475 HD23 ' H ' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -92.27 -42.91 9.58 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 122.31 0.244 . . . . 0.0 111.454 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.92 133.94 3.28 Favored Glycine 0 C--N 1.339 0.716 0 O-C-N 123.472 0.482 . . . . 0.0 112.694 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 54' ' ' SER . 8.1 ptpp? -104.29 123.9 48.2 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.677 0.281 . . . . 0.0 110.94 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . 63.54 156.59 0.07 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.896 0.878 . . . . 0.0 112.383 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -91.94 -54.05 4.01 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.681 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 50.45 95.86 0.04 OUTLIER Pre-proline 0 N--CA 1.484 1.267 0 C-N-CA 123.969 0.908 . . . . 0.0 112.622 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -74.1 121.6 7.02 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.521 2.147 . . . . 0.0 112.501 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 12.2 mt -138.79 125.51 20.84 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.75 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.447 ' OD1' ' HG3' ' A' ' 66' ' ' LYS . 2.3 p30 -138.06 -44.64 0.52 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.579 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.447 ' HG3' ' OD1' ' A' ' 65' ' ' ASP . 97.6 mttt -101.53 1.81 38.42 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 123.407 0.442 . . . . 0.0 111.877 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.403 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 46.4 m-85 -89.53 8.34 31.65 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.497 ' HB3' ' OG ' ' A' ' 74' ' ' SER . 97.2 m-85 -93.54 139.47 30.72 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.024 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.5 t -108.77 -94.58 0.4 Allowed 'General case' 0 CA--C 1.542 0.67 0 O-C-N 123.445 0.466 . . . . 0.0 111.588 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.578 ' O ' HG13 ' A' ' 71' ' ' ILE . 1.5 mptp? -136.33 90.23 2.55 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.389 0.614 . . . . 0.0 111.284 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.604 ' H ' ' HB3' ' A' ' 74' ' ' SER . 4.7 mt -148.46 172.73 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.221 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.472 ' N ' HG22 ' A' ' 71' ' ' ILE . 4.0 tp -46.56 -60.47 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.416 ' H ' HG23 ' A' ' 72' ' ' ILE . 6.2 t80 -95.25 25.2 4.46 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.468 0.651 . . . . 0.0 109.866 179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.604 ' HB3' ' H ' ' A' ' 71' ' ' ILE . 48.1 t -120.23 -50.74 2.23 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.623 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.6 -110.34 0.84 Allowed Glycine 0 C--N 1.342 0.906 0 O-C-N 123.39 0.432 . . . . 0.0 112.888 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.536 ' H ' ' CD ' ' A' ' 77' ' ' PRO . 20.7 mtmm -132.47 -44.01 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.536 ' CD ' ' H ' ' A' ' 76' ' ' LYS . 50.7 Cg_exo -56.37 134.16 62.57 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.417 2.078 . . . . 0.0 113.753 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.19 21.49 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.946 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 83' ' ' SER . 4.5 pt-20 -93.2 -57.77 2.52 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.6 m -67.29 -50.07 61.71 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.4 p -53.96 -54.64 36.09 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 122.782 0.433 . . . . 0.0 111.595 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.549 ' CZ ' HG23 ' A' ' 128' ' ' ILE . 46.9 m-85 -58.94 -65.02 0.73 Allowed 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.542 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 0.3 OUTLIER -38.71 -32.79 0.09 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 176.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -74.19 144.93 44.55 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.274 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.498 ' HA ' ' OE2' ' A' ' 137' ' ' GLU . 58.9 mttp -77.95 105.31 9.07 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 123.439 0.462 . . . . 0.0 111.845 -179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.15 50.18 0.35 Allowed Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.817 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 6.0 tp -70.02 -23.41 25.33 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -87.04 13.29 9.52 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 120.978 0.418 . . . . 0.0 111.035 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.527 ' O ' HG22 ' A' ' 92' ' ' ILE . 11.7 mm-40 -136.65 -43.96 0.6 Allowed 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.935 178.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.9 mmmt -47.86 -10.55 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.22 1.008 . . . . 0.0 113.422 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.409 HD12 HG21 ' A' ' 71' ' ' ILE . 3.3 tp -69.57 -16.57 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 C-N-CA 123.095 0.558 . . . . 0.0 110.963 178.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 89' ' ' GLU . 1.7 tt -90.1 -3.18 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.394 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -59.3 -31.41 69.1 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.075 0.55 . . . . 0.0 111.781 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -70.97 -15.12 62.56 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.206 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -92.36 -10.79 36.93 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.689 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -90.14 143.53 26.69 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.208 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.5 tp -92.23 128.4 38.07 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.346 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -132.69 -41.98 0.93 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.941 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.5 t -112.25 158.48 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 O-C-N 123.511 0.507 . . . . 0.0 109.826 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.5 t -86.08 -43.38 13.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.409 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -129.5 122.24 28.86 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 123.318 0.386 . . . . 0.0 110.725 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 54.6 m -133.7 -41.06 0.86 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.311 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.5 ttpp 62.96 121.51 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.924 0.89 . . . . 0.0 111.612 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -100.47 141.52 33.22 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.022 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.7 147.93 33.72 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.054 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -70.93 119.49 6.35 Favored 'Trans proline' 0 C--N 1.37 1.68 0 C-N-CA 122.469 2.113 . . . . 0.0 113.049 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 pt -145.49 -45.13 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.689 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 16.9 tp60 -96.67 126.31 41.74 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.436 0.46 . . . . 0.0 111.051 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -135.13 -2.39 2.55 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.444 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 63.68 123.33 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.01 0.924 . . . . 0.0 112.107 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.9 m -127.2 171.4 11.47 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.081 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.8 t -79.67 122.37 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.422 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 24.8 mmt 60.66 108.17 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.756 0.822 . . . . 0.0 111.755 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -132.3 126.47 33.42 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.771 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -132.87 158.87 41.45 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.628 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.475 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 13.5 mt -82.23 -1.18 48.4 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -114.84 2.54 14.38 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.38 -47.28 6.35 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.9 t -134.34 -1.98 2.83 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 116' ' ' LEU . 2.9 t80 -94.38 144.27 27.71 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 119.288 -0.387 . . . . 0.0 110.725 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.407 ' HD2' ' CD2' ' A' ' 120' ' ' TYR . 46.3 Cg_exo -57.1 162.76 8.81 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.621 2.214 . . . . 0.0 113.54 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -86.44 -51.39 3.5 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.605 -1.108 . . . . 0.0 113.511 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.604 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 52.2 Cg_exo -55.15 -24.42 41.0 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.833 2.356 . . . . 0.0 114.134 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.48 -43.93 65.66 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.514 0.326 . . . . 0.0 111.423 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.479 ' O ' HG22 ' A' ' 129' ' ' VAL . 9.8 mt -61.99 -26.75 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 122.823 0.449 . . . . 0.0 110.764 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -73.2 -47.96 39.19 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.185 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 123' ' ' PRO . 25.5 mmm180 -56.04 -48.01 76.8 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.492 178.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.549 HG23 ' CZ ' ' A' ' 82' ' ' TYR . 17.4 mt -56.62 -64.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.114 0.566 . . . . 0.0 111.498 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 125' ' ' ILE . 31.5 m -51.26 -38.22 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.203 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.0 t -73.03 -42.41 63.19 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.002 0.742 . . . . 0.0 113.002 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.8 m -60.79 -29.8 69.66 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.217 0.207 . . . . 0.0 111.483 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.448 HD13 ' CA ' ' A' ' 144' ' ' GLY . 1.9 mt -83.9 -33.79 24.68 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.314 0.384 . . . . 0.0 110.281 178.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -83.2 7.54 15.88 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.933 178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -113.75 -41.02 3.66 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.149 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -88.1 -44.11 11.18 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.179 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 63.5 67.7 0.63 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.985 0.914 . . . . 0.0 111.185 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.498 ' OE2' ' HA ' ' A' ' 85' ' ' LYS . 22.5 mt-10 -87.37 139.21 30.78 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.887 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 138' ' ' VAL . 0.2 OUTLIER -77.7 -41.15 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -179.28 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -74.63 -1.61 62.04 Favored Glycine 0 CA--C 1.526 0.726 0 O-C-N 123.412 0.445 . . . . 0.0 113.93 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -137.06 -2.54 2.06 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.065 0.546 . . . . 0.0 111.53 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.436 ' HD3' ' O ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -50.85 -40.5 56.29 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.817 0.847 . . . . 0.0 113.002 -179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 7.9 m-20 -72.51 -36.41 68.35 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.22 0.325 . . . . 0.0 110.922 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 14.8 tp -65.64 -52.48 51.44 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.993 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.448 ' CA ' HD13 ' A' ' 132' ' ' LEU . . . -60.99 -62.75 5.58 Favored Glycine 0 C--N 1.341 0.833 0 CA-C-N 115.58 -0.736 . . . . 0.0 114.007 -179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.574 ' HA ' ' NE ' ' A' ' 148' ' ' ARG . . . -53.37 -37.1 62.1 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 142' ' ' ASP . 5.7 mptp? -72.79 -24.46 60.93 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.469 HD22 ' O ' ' A' ' 147' ' ' LEU . 0.6 OUTLIER -78.71 -30.88 46.25 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.574 ' NE ' ' HA ' ' A' ' 145' ' ' ALA . 8.6 ptt85 -84.31 -3.77 58.45 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 117.807 0.276 . . . . 0.0 110.848 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -81.44 -1.4 45.65 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.778 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.5 -6.56 57.53 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.579 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 5.7 tt -106.59 -44.43 4.48 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.736 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -89.72 144.95 25.55 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 123.383 0.427 . . . . 0.0 111.038 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 29.6 ttp180 -127.45 150.05 49.82 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.645 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 118.031 -0.985 . . . . 0.0 111.931 -179.966 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 55.3 m . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.52 0.2 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -99.97 -44.07 6.16 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.39 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -145.4 122.05 1.63 Allowed Glycine 0 C--N 1.34 0.803 0 CA-C-N 116.274 -0.421 . . . . 0.0 112.443 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 pp -101.44 134.82 43.94 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.594 0.232 . . . . 0.0 111.127 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 147.86 -68.65 0.37 Allowed Glycine 0 C--N 1.337 0.618 0 O-C-N 123.652 0.595 . . . . 0.0 112.651 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -119.42 -31.47 4.61 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.359 0.264 . . . . 0.0 111.62 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -88.3 -10.75 48.52 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.94 120.3 22.31 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.535 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -135.17 95.9 14.6 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.024 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.18 125.74 9.98 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.606 2.204 . . . . 0.0 112.589 179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.493 ' O ' HD23 ' A' ' 64' ' ' LEU . 1.3 tt -134.96 -18.48 1.82 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.34 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -73.99 96.48 2.66 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.164 0.507 . . . . 0.0 111.24 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -143.24 -12.33 0.72 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.665 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -109.33 2.95 21.08 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 123.365 0.415 . . . . 0.0 112.078 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -87.62 139.51 30.47 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.221 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.0 p -114.39 -16.11 12.01 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.959 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.5 ' O ' HD13 ' A' ' 71' ' ' ILE . 4.4 ttmm -95.25 111.37 23.23 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 120.779 0.323 . . . . 0.0 110.888 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.5 HD13 ' O ' ' A' ' 70' ' ' LYS . 13.9 mm -129.7 -30.76 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.396 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.0 tp -63.47 -30.06 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 123.121 0.568 . . . . 0.0 111.724 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -106.08 25.59 10.77 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.411 0.444 . . . . 0.0 111.279 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.4 t -89.0 -44.08 10.65 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.26 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.54 -117.75 0.63 Allowed Glycine 0 C--N 1.34 0.751 0 O-C-N 123.521 0.513 . . . . 0.0 112.417 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.501 ' H ' ' CD ' ' A' ' 77' ' ' PRO . 19.3 tttm -130.95 -47.47 0.03 OUTLIER Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.598 -0.715 . . . . 0.0 111.818 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.591 ' HA ' ' NH2' ' A' ' 127' ' ' ARG . 3.4 Cg_exo -82.49 133.18 7.12 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.359 2.039 . . . . 0.0 113.375 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.5 73.07 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.397 0.618 . . . . 0.0 110.833 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 83' ' ' SER . 2.9 mt-10 -120.43 -41.79 2.59 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.155 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.9 m -65.82 -60.5 2.82 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.169 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.7 t -56.81 -55.25 36.74 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 123.218 0.324 . . . . 0.0 110.705 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -50.9 -31.36 17.3 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 177.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 5.7 t -73.57 -34.52 65.16 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 122.604 0.362 . . . . 0.0 111.713 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -55.5 146.34 20.48 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.854 0.462 . . . . 0.0 111.979 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.406 ' HE2' ' NE2' ' A' ' 135' ' ' HIS . 57.6 mmtt -79.96 99.99 7.88 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.189 0.518 . . . . 0.0 111.876 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.589 ' O ' HG12 ' A' ' 91' ' ' ILE . . . 126.52 47.9 0.19 Allowed Glycine 0 C--N 1.336 0.529 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.371 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 3.4 tp -88.8 -43.65 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 122.842 0.457 . . . . 0.0 111.187 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.531 ' CE1' HD13 ' A' ' 143' ' ' LEU . 47.4 t60 -84.97 26.85 0.81 Allowed 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.031 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 92' ' ' ILE . 3.3 tp10 -143.83 -81.02 0.18 Allowed 'General case' 0 CA--C 1.541 0.632 0 O-C-N 122.361 -0.212 . . . . 0.0 111.21 179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 8.9 mtmp? -70.87 -24.89 62.59 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 86' ' ' GLY . 13.3 mm -94.09 -0.77 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 120.603 0.24 . . . . 0.0 110.665 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.425 HG22 ' O ' ' A' ' 89' ' ' GLU . 1.6 tt -110.02 -36.01 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.854 179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.487 ' OE1' ' HB3' ' A' ' 96' ' ' ASP . 1.7 tp10 -120.26 -84.96 0.66 Allowed 'General case' 0 CA--C 1.537 0.475 0 O-C-N 123.147 0.279 . . . . 0.0 110.529 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 90' ' ' LYS . . . 66.75 -45.56 0.45 Allowed 'General case' 0 C--N 1.36 1.057 0 C-N-CA 124.703 1.201 . . . . 0.0 113.355 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -148.2 -7.26 0.41 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.487 ' HB3' ' OE1' ' A' ' 93' ' ' GLU . 2.4 t70 -64.08 118.15 8.1 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.966 0.412 . . . . 0.0 112.041 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.461 ' HG ' ' H ' ' A' ' 98' ' ' HIS . 3.4 tp -135.15 174.45 10.59 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.132 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.461 ' H ' ' HG ' ' A' ' 97' ' ' LEU . 4.5 t60 -74.85 121.02 21.19 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 122.476 0.31 . . . . 0.0 111.073 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.4 m -126.43 -174.86 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.267 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.0 p -73.62 -11.28 60.37 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -94.7 121.63 36.48 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.701 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.6 m -130.71 163.61 26.88 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.146 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.0 mptt 64.37 122.97 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.021 0.929 . . . . 0.0 111.932 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -132.97 -41.74 0.91 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.153 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -98.99 142.39 24.53 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 123.396 0.435 . . . . 0.0 111.26 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.68 11.3 1.97 Allowed 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 122.572 2.181 . . . . 0.0 114.019 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 pt -87.87 126.15 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.72 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -130.13 -43.03 1.2 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.161 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -109.27 148.19 31.39 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 123.55 0.531 . . . . 0.0 110.94 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.3 130.66 50.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.166 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.8 t -125.09 -42.02 2.04 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.953 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.1 m -97.75 -4.21 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 O-C-N 123.364 0.415 . . . . 0.0 111.951 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 25.0 mmt 65.4 12.43 8.11 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.985 0.914 . . . . 0.0 112.508 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -110.69 154.07 24.37 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.952 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -92.16 -40.43 11.02 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.973 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.9 mt -95.85 -159.47 0.72 Allowed 'General case' 0 CA--C 1.539 0.524 0 O-C-N 123.507 0.504 . . . . 0.0 110.638 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 12.6 tptp 73.4 -2.1 2.85 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.205 1.002 . . . . 0.0 111.952 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 53.5 mmtt -99.84 -37.09 9.2 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.948 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.5 t -93.83 -41.72 9.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.45 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -96.66 159.3 32.02 Favored Pre-proline 0 CA--C 1.541 0.596 0 O-C-N 123.423 0.452 . . . . 0.0 111.115 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.58 -34.84 2.35 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 122.505 2.137 . . . . 0.0 113.289 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 157.6 -55.7 0.38 Allowed Glycine 0 CA--C 1.53 0.974 0 CA-C-O 118.939 -0.923 . . . . 0.0 113.433 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.16 -19.72 28.31 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.971 2.447 . . . . 0.0 114.431 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 2.4 t70 -73.65 -35.07 65.22 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.181 0.301 . . . . 0.0 111.133 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.9 mp -72.71 -27.33 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.382 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.95 -53.33 18.33 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.728 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.591 ' NH2' ' HA ' ' A' ' 77' ' ' PRO . 13.6 ptm180 -53.83 -36.54 62.64 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 178.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.576 ' O ' HD12 ' A' ' 132' ' ' LEU . 44.7 mt -65.38 -56.51 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 122.199 0.2 . . . . 0.0 111.211 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.634 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 2.8 m -54.09 -43.96 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.575 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 12.4 t -64.67 -31.99 73.46 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.3 m -69.94 -38.57 76.23 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.576 HD12 ' O ' ' A' ' 128' ' ' ILE . 1.3 mp -73.83 -35.79 64.87 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 129' ' ' VAL . 10.6 pt-20 -89.08 14.02 11.7 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 120.954 0.407 . . . . 0.0 111.62 179.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.575 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.6 tmm_? -105.95 -41.29 5.44 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.851 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.406 ' NE2' ' HE2' ' A' ' 85' ' ' LYS . 49.5 t60 -94.64 -32.14 13.53 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.976 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 67.73 73.33 0.31 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.049 0.94 . . . . 0.0 111.633 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.33 132.12 43.36 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.99 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.55 -39.05 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 O-C-N 123.417 0.448 . . . . 0.0 111.684 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 88' ' ' HIS . . . -74.26 -9.52 81.04 Favored Glycine 0 C--N 1.341 0.819 0 O-C-N 123.316 0.385 . . . . 0.0 113.914 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.6 2.34 5.54 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.726 0.411 . . . . 0.0 111.995 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -34.62 74.12 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.949 0.499 . . . . 0.0 111.732 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.627 ' O ' ' HG2' ' A' ' 146' ' ' LYS . 8.2 m-20 -75.08 -38.78 61.16 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.984 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.531 HD13 ' CE1' ' A' ' 88' ' ' HIS . 14.2 tp -60.49 -56.83 16.71 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 122.994 0.518 . . . . 0.0 110.609 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.474 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -54.77 -45.3 79.66 Favored Glycine 0 C--N 1.345 1.044 0 O-C-N 123.683 0.614 . . . . 0.0 113.756 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -54.89 -48.68 72.71 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.627 ' HG2' ' O ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -59.19 -42.57 91.18 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.716 0.234 . . . . 0.0 110.394 178.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.8 -41.42 82.12 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.41 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 144' ' ' GLY . 14.2 ptm180 -88.1 -14.19 39.45 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -87.47 27.06 1.14 Allowed 'General case' 0 C--O 1.239 0.518 0 C-N-CA 122.784 0.433 . . . . 0.0 112.063 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.404 ' O ' ' HB3' ' A' ' 151' ' ' LEU . . . -70.74 102.46 2.32 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.508 HD23 ' O ' ' A' ' 152' ' ' ASP . 8.2 tt 80.5 -31.14 0.12 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.269 1.028 . . . . 0.0 110.931 -177.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.508 ' O ' HD23 ' A' ' 151' ' ' LEU . 6.5 t70 59.63 157.17 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.874 0.87 . . . . 0.0 112.59 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 10.1 tpp180 -99.48 127.85 45.56 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.514 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.839 -179.95 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.4 m . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 111.345 0.128 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -100.53 132.0 46.14 Favored 'General case' 0 C--O 1.234 0.25 0 O-C-N 123.405 0.441 . . . . 0.0 110.878 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 162.5 55.33 0.02 OUTLIER Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.509 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 tp -113.17 -42.96 3.43 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 123.641 0.259 . . . . 0.0 110.911 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -131.82 -55.73 0.09 OUTLIER Glycine 0 C--N 1.34 0.791 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.431 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.78 127.17 50.05 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 122.331 0.253 . . . . 0.0 111.134 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.52 -8.41 20.11 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.662 0.602 . . . . 0.0 111.87 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -108.62 -40.7 5.01 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.336 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 57.25 85.88 0.18 Allowed Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 123.722 0.809 . . . . 0.0 112.055 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.95 149.91 26.26 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 122.788 2.325 . . . . 0.0 112.86 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.8 mp -108.65 118.3 36.42 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.507 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -135.69 26.98 3.36 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.18 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -118.69 -18.01 9.09 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -120.86 69.82 0.89 Allowed 'General case' 0 C--O 1.239 0.545 0 CA-C-O 121.607 0.718 . . . . 0.0 110.223 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -66.46 152.54 44.94 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.045 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.9 p -102.89 -13.29 17.01 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.147 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -90.32 114.39 26.45 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.789 0.328 . . . . 0.0 110.98 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.652 ' O ' HG22 ' A' ' 72' ' ' ILE . 0.3 OUTLIER -116.1 -168.14 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.974 -179.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.652 HG22 ' O ' ' A' ' 71' ' ' ILE . 0.7 OUTLIER 74.8 -36.71 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 124.716 1.206 . . . . 0.0 111.651 -179.461 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.48 ' HD2' HG23 ' A' ' 72' ' ' ILE . 3.4 m-85 -139.65 36.88 2.01 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.026 0.531 . . . . 0.0 110.769 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.2 t -86.63 -47.6 9.04 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.457 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.87 -57.21 0.08 OUTLIER Glycine 0 C--N 1.339 0.716 0 O-C-N 123.357 0.411 . . . . 0.0 112.165 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.89 156.29 59.53 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.492 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.44 77.6 3.54 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.376 2.051 . . . . 0.0 112.746 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.504 HG23 ' CD2' ' A' ' 82' ' ' TYR . 3.9 mp 57.85 57.12 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 123.628 0.771 . . . . 0.0 110.158 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.53 ' O ' ' HB2' ' A' ' 83' ' ' SER . 4.1 mm-40 -121.56 -86.63 0.65 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.09 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.431 ' CG2' HE21 ' A' ' 108' ' ' GLN . 13.2 m -55.1 -55.65 28.72 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.199 1.0 . . . . 0.0 113.601 -176.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.406 ' O ' HD13 ' A' ' 87' ' ' ILE . 16.9 t -46.66 -55.58 7.49 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.728 0.643 . . . . 0.0 111.772 -179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.504 ' CD2' HG23 ' A' ' 78' ' ' ILE . 88.1 m-85 -84.06 0.11 49.59 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.53 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 8.0 t -103.71 -2.64 26.17 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.696 0.284 . . . . 0.0 110.388 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.44 156.31 16.82 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.848 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.522 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -82.21 142.53 32.08 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.244 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 90' ' ' LYS . . . 84.77 34.79 14.62 Favored Glycine 0 C--N 1.339 0.749 0 CA-C-N 115.955 -0.566 . . . . 0.0 113.304 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.406 HD13 ' O ' ' A' ' 81' ' ' SER . 2.5 tp -84.38 -28.4 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 36.6 t60 -96.97 12.74 31.33 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 120.629 0.252 . . . . 0.0 111.356 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -137.12 -78.81 0.39 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.881 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 86' ' ' GLY . 23.4 mmtp -42.82 -13.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.562 HG22 ' H ' ' A' ' 110' ' ' ALA . 2.0 pp -65.0 -33.4 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 91' ' ' ILE . 1.8 tt -111.07 10.38 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 CA-C-O 120.793 0.33 . . . . 0.0 111.214 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.57 -40.09 9.21 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.095 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.46 -25.88 52.27 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -89.56 -9.03 51.35 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 123.22 0.325 . . . . 0.0 111.849 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -103.32 -68.55 0.83 Allowed 'General case' 0 CA--C 1.537 0.469 0 O-C-N 123.078 0.236 . . . . 0.0 111.124 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 3.4 mp -146.5 167.82 22.74 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.571 0.348 . . . . 0.0 111.142 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -90.04 170.77 10.06 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.755 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.1 p -91.08 -55.25 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 13.1 t -146.18 -10.33 0.5 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt 64.09 97.87 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.837 0.855 . . . . 0.0 111.74 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 41.1 p -144.35 -36.65 0.33 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.093 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 34.1 tttm 64.02 92.57 0.07 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.05 0.94 . . . . 0.0 111.624 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -148.7 137.65 21.54 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.47 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 63.24 154.17 0.12 Allowed Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 123.785 0.834 . . . . 0.0 112.278 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.55 176.5 0.15 Allowed 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 123.042 2.495 . . . . 0.0 113.334 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.486 HG23 ' H ' ' A' ' 108' ' ' GLN . 3.1 tp -60.01 -63.07 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 C-N-CA 122.687 0.395 . . . . 0.0 111.824 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.486 ' H ' HG23 ' A' ' 107' ' ' ILE . 51.0 mt-30 65.36 -18.07 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.413 ' H ' ' C ' ' A' ' 107' ' ' ILE . 98.1 m-85 -98.64 154.15 18.16 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.655 0.264 . . . . 0.0 111.703 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.562 ' H ' HG22 ' A' ' 91' ' ' ILE . . . -94.57 166.97 11.77 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.845 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.7 t -96.07 -71.35 0.68 Allowed 'General case' 0 CA--C 1.536 0.435 0 O-C-N 123.095 0.247 . . . . 0.0 111.576 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 6.3 t -134.35 -55.4 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 8.5 ttt 64.39 158.74 0.09 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.934 0.894 . . . . 0.0 111.986 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -88.55 175.2 7.67 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.251 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -72.72 132.2 43.35 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.653 0.381 . . . . 0.0 111.275 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 6.7 mt -101.08 54.15 0.84 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.524 -178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -150.63 -30.13 0.2 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.096 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 30.1 tttp -83.76 -44.43 14.42 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -126.74 19.51 7.23 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.546 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 0.1 OUTLIER -134.9 50.08 4.42 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.546 ' HD3' ' N ' ' A' ' 120' ' ' TYR . 9.4 Cg_endo -91.6 127.96 1.08 Allowed 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.805 2.337 . . . . 0.0 113.369 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 135.96 -148.82 19.84 Favored Glycine 0 C--N 1.343 0.97 0 C-N-CA 120.485 -0.864 . . . . 0.0 114.575 178.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.633 ' O ' ' HG2' ' A' ' 127' ' ' ARG . 49.1 Cg_exo -56.45 -32.55 89.56 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.634 2.889 . . . . 0.0 113.871 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -52.27 -37.86 56.67 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 123.457 0.473 . . . . 0.0 111.02 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.539 ' O ' HG22 ' A' ' 129' ' ' VAL . 15.8 mt -67.85 -43.61 85.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.412 177.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -61.9 -21.34 64.65 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 122.977 0.511 . . . . 0.0 112.134 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.633 ' HG2' ' O ' ' A' ' 123' ' ' PRO . 17.4 mmm180 -79.97 -46.67 16.26 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.825 -179.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.7 mt -62.95 -44.52 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.046 0.538 . . . . 0.0 111.278 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 125' ' ' ILE . 7.1 m -63.29 -55.1 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.523 0.514 . . . . 0.0 112.094 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 56.4 m -54.94 -34.79 63.55 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 4.7 m -82.41 -22.36 35.4 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 123.263 0.352 . . . . 0.0 111.831 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.433 ' HG ' ' OE2' ' A' ' 137' ' ' GLU . 3.0 tt -82.6 -40.31 21.01 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 122.474 0.31 . . . . 0.0 110.919 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -89.28 12.38 16.23 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.014 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -79.69 -49.15 12.52 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -96.08 -9.06 31.77 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 70.71 80.92 0.16 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.133 0.973 . . . . 0.0 112.46 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 141' ' ' LYS . 2.9 pt-20 -107.02 130.7 54.61 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.331 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -81.77 -26.43 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -84.98 -2.47 88.37 Favored Glycine 0 C--N 1.343 0.944 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.391 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.11 -9.76 3.39 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 122.903 0.481 . . . . 0.0 111.75 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 7.8 tptp -50.89 -33.29 23.46 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.866 0.867 . . . . 0.0 112.975 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.547 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 10.0 m-20 -74.82 -36.13 62.43 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.369 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.4 tp -66.13 -59.63 3.58 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.113 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.511 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -58.94 -41.97 96.56 Favored Glycine 0 C--N 1.344 0.978 0 CA-C-N 116.089 -0.505 . . . . 0.0 114.089 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.08 92.16 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.547 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.6 mptp? -68.66 -36.07 78.08 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.032 0.207 . . . . 0.0 111.511 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 23.1 mt -71.16 -34.21 70.75 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 123.236 0.335 . . . . 0.0 110.449 177.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -75.29 -39.47 59.63 Favored 'General case' 0 C--N 1.349 0.562 0 O-C-N 123.478 0.486 . . . . 0.0 110.882 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.55 42.27 0.35 Allowed 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.134 0.492 . . . . 0.0 112.038 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -86.98 -7.65 57.96 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.854 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.2 mp -101.01 -45.88 5.26 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.489 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 4.5 t70 60.66 156.89 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.109 0.964 . . . . 0.0 112.42 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -94.72 149.9 20.77 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.059 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.89 179.997 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.6 p . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.551 0.215 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -127.74 144.71 51.07 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.487 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 128.31 56.7 0.11 Allowed Glycine 0 C--N 1.337 0.602 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.481 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.0 mt 63.13 126.48 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.923 0.889 . . . . 0.0 112.017 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 166.57 -89.98 0.1 OUTLIER Glycine 0 C--N 1.338 0.64 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.644 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.7 mmpp? -119.45 158.09 26.92 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.635 0.255 . . . . 0.0 111.077 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.43 ' HA ' ' CE1' ' A' ' 115' ' ' TYR . . . 63.52 121.57 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.958 0.903 . . . . 0.0 112.379 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 tm0? -138.93 119.21 13.64 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.461 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 59.57 112.19 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.299 0 C-N-CA 123.929 0.892 . . . . 0.0 112.406 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.59 165.36 20.77 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.683 2.255 . . . . 0.0 113.006 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.5 mp -93.61 156.38 16.75 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.578 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -93.23 -177.84 4.58 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.802 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -75.99 125.15 28.57 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.486 0.315 . . . . 0.0 111.542 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.533 ' CD1' ' HD2' ' A' ' 70' ' ' LYS . 0.8 OUTLIER -119.77 -35.82 3.44 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.74 -179.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 64.37 169.57 0.18 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.784 0.834 . . . . 0.0 111.937 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.1 t 72.28 -10.24 0.93 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.26 1.024 . . . . 0.0 112.694 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.533 ' HD2' ' CD1' ' A' ' 67' ' ' PHE . 64.7 mttm -95.4 136.4 35.81 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 122.366 0.266 . . . . 0.0 110.388 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.452 ' CG2' ' H ' ' A' ' 75' ' ' GLY . 6.4 mt -134.13 135.35 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.095 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.2 tp -121.21 -49.81 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.856 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -135.37 5.47 3.22 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 123.313 0.383 . . . . 0.0 111.864 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.6 t -79.18 -41.89 27.34 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.249 0.22 . . . . 0.0 111.415 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.452 ' H ' ' CG2' ' A' ' 71' ' ' ILE . . . -119.93 92.75 0.53 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 111.543 -0.623 . . . . 0.0 111.543 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.9 mptt 66.65 155.1 0.13 Allowed Pre-proline 0 N--CA 1.485 1.32 0 C-N-CA 124.059 0.944 . . . . 0.0 111.519 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.09 76.37 3.46 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.435 2.09 . . . . 0.0 112.758 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.571 HG23 ' CG ' ' A' ' 82' ' ' TYR . 4.6 mp 53.82 60.33 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 123.706 0.802 . . . . 0.0 110.865 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.639 ' O ' ' HB2' ' A' ' 83' ' ' SER . 3.6 tp10 -120.96 -81.27 0.64 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.47 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 16.5 m -70.59 -59.32 2.9 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.1 m -88.66 69.38 8.77 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 123.551 1.643 . . . . 0.0 109.62 -178.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.571 ' CG ' HG23 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -179.45 -34.29 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 111.304 -2.68 . . . . 0.0 108.038 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.639 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.7 t -75.67 -32.58 60.21 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.279 177.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -45.89 157.14 0.12 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.446 ' HA ' ' OE2' ' A' ' 137' ' ' GLU . 6.6 mptt -84.37 100.97 11.62 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.667 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.476 ' O ' ' HD2' ' A' ' 90' ' ' LYS . . . 106.53 74.27 0.9 Allowed Glycine 0 C--N 1.338 0.662 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.533 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.3 tp -103.71 -35.0 3.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 122.462 0.305 . . . . 0.0 111.558 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.585 ' ND1' HD22 ' A' ' 143' ' ' LEU . 39.9 t60 -97.88 -46.63 5.86 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 122.979 0.174 . . . . 0.0 111.172 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -96.86 51.29 1.13 Allowed 'General case' 0 CA--C 1.539 0.528 0 O-C-N 123.36 0.412 . . . . 0.0 110.888 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' A' ' 86' ' ' GLY . 62.8 tttt -120.89 -5.63 9.6 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.8 tt -53.42 -24.08 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 123.589 0.756 . . . . 0.0 112.731 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.5 tp -72.0 -25.13 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 O-C-N 123.307 0.379 . . . . 0.0 110.855 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -95.31 -29.37 14.51 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.734 179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -74.52 -23.64 58.86 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.585 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -91.04 -11.02 40.06 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 123.402 0.439 . . . . 0.0 111.452 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -97.81 126.36 43.13 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.33 0.394 . . . . 0.0 110.575 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.96 125.6 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.965 0.906 . . . . 0.0 111.847 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -118.14 120.75 38.67 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.1 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.1 m -144.23 153.4 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.274 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.4 t -104.98 129.25 53.45 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.741 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -130.52 -42.67 1.16 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.141 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.3 p -128.43 164.88 21.75 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.498 0.499 . . . . 0.0 111.053 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -84.17 157.69 21.58 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.337 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -87.76 -38.59 15.63 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.753 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 64.39 145.66 0.09 OUTLIER Pre-proline 0 N--CA 1.485 1.313 0 C-N-CA 124.007 0.923 . . . . 0.0 112.309 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.19 145.07 83.39 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 122.742 2.294 . . . . 0.0 113.311 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -98.9 158.64 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.048 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -85.6 128.28 34.72 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.951 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -98.75 112.11 24.29 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.231 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.14 -47.1 0.43 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.862 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 54.0 m -138.91 158.78 43.58 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.707 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.7 m -85.98 129.99 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.325 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 38.2 mmt -93.37 104.21 16.39 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.405 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -147.52 105.09 3.68 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.879 179.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.43 ' CE1' ' HA ' ' A' ' 60' ' ' ALA . 57.6 m-85 63.66 134.7 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.891 0.877 . . . . 0.0 111.815 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 7.2 mt -94.2 76.4 4.01 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.085 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -149.99 -46.4 0.13 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.897 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 29.3 tttm -116.88 -6.51 11.48 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.6 m -79.83 -41.15 26.97 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.459 0.304 . . . . 0.0 111.624 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -97.71 158.82 32.34 Favored Pre-proline 0 CA--C 1.54 0.566 0 O-C-N 123.29 0.368 . . . . 0.0 111.345 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -78.22 -38.08 0.66 Allowed 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.646 2.231 . . . . 0.0 113.352 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.72 -55.48 0.27 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-O 118.835 -0.981 . . . . 0.0 113.731 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -53.4 -34.52 71.57 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.163 2.576 . . . . 0.0 114.48 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.417 ' O ' HG13 ' A' ' 128' ' ' ILE . 6.1 m-20 -70.58 -42.96 70.35 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.678 ' HA ' HD12 ' A' ' 128' ' ' ILE . 3.6 mt -73.08 -16.14 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 O-C-N 123.301 0.376 . . . . 0.0 110.276 178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.78 -53.83 10.49 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.468 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -56.27 -33.57 65.61 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 125' ' ' ILE . 29.3 mt -67.61 -57.95 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 122.358 0.263 . . . . 0.0 111.236 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 125' ' ' ILE . 4.1 m -56.55 -39.03 59.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 18.2 t -71.5 -54.83 9.26 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 123.166 0.291 . . . . 0.0 111.772 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.493 HG21 ' HB3' ' A' ' 82' ' ' TYR . 11.8 m -54.92 -25.03 26.46 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 128' ' ' ILE . 33.4 mt -85.66 -48.22 9.07 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.672 0.273 . . . . 0.0 110.386 178.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -83.28 18.04 1.89 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.244 178.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 130' ' ' SER . 1.1 tmt_? -87.54 -38.83 15.67 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.351 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.402 ' CE1' HH11 ' A' ' 134' ' ' ARG . 64.7 m-70 -105.22 -16.24 14.83 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.607 0.567 . . . . 0.0 110.971 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 68.93 72.5 0.27 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.178 0.991 . . . . 0.0 110.536 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.446 ' OE2' ' HA ' ' A' ' 85' ' ' LYS . 28.9 mt-10 -96.43 133.59 40.67 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.767 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.4 t -76.61 -12.58 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 O-C-N 123.557 0.536 . . . . 0.0 111.274 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -87.31 -27.52 27.6 Favored Glycine 0 C--N 1.34 0.784 0 CA-C-N 116.058 -0.519 . . . . 0.0 113.023 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.77 1.65 12.17 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.69 0.396 . . . . 0.0 111.762 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 8.7 tptp -53.27 -41.73 65.83 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.549 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 8.2 m-20 -77.88 -32.99 52.23 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 123.042 0.214 . . . . 0.0 111.546 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.585 HD22 ' ND1' ' A' ' 88' ' ' HIS . 14.8 tp -69.7 -59.38 2.99 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.414 0.286 . . . . 0.0 110.391 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.49 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -56.53 -55.39 30.03 Favored Glycine 0 C--N 1.341 0.861 0 CA-C-N 115.775 -0.648 . . . . 0.0 114.163 179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 149' ' ' ASP . . . -58.59 -44.96 90.0 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.549 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 5.4 mptp? -61.34 -42.66 99.05 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 117.718 0.235 . . . . 0.0 111.035 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 29.0 mt -60.15 -34.97 74.28 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 123.445 0.465 . . . . 0.0 111.36 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -88.18 -7.36 56.99 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.716 0.293 . . . . 0.0 110.522 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 145' ' ' ALA . 1.4 m-20 -114.45 13.45 17.66 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.973 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 151' ' ' LEU . . . -72.51 109.29 6.08 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.429 HD13 ' O ' ' A' ' 151' ' ' LEU . 3.0 tm? 80.68 -26.63 0.15 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.98 0.912 . . . . 0.0 111.446 -178.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -68.16 -13.21 62.06 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.862 0.689 . . . . 0.0 112.862 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 66.1 mtp180 -94.15 -45.63 7.46 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.227 0.211 . . . . 0.0 111.332 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.121 -0.942 . . . . 0.0 110.852 179.92 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.504 0.192 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -118.22 -44.36 2.69 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.881 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -140.2 131.1 4.91 Favored Glycine 0 C--N 1.339 0.746 0 O-C-N 123.477 0.486 . . . . 0.0 112.471 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.8 mp -119.96 -42.27 2.61 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 123.659 0.27 . . . . 0.0 111.353 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.09 -179.87 21.22 Favored Glycine 0 C--N 1.341 0.836 0 C-N-CA 121.445 -0.407 . . . . 0.0 112.831 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 29.1 tttp -98.83 -1.95 39.03 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.481 0.312 . . . . 0.0 111.314 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -87.45 3.02 48.84 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.93 152.65 21.12 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.824 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -90.0 130.53 42.15 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.272 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.48 34.18 0.52 Allowed 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.595 2.197 . . . . 0.0 113.122 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.7 tp -89.86 126.33 35.67 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.057 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -119.33 -39.2 2.92 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.673 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.559 ' NZ ' ' HB3' ' A' ' 68' ' ' PHE . 4.9 ttpp -97.52 132.89 42.78 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.538 0.524 . . . . 0.0 110.42 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -92.26 -12.01 33.76 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.06 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.559 ' HB3' ' NZ ' ' A' ' 66' ' ' LYS . 16.9 t80 -88.48 119.16 28.66 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 123.219 0.324 . . . . 0.0 110.191 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.462 ' OG ' ' HA ' ' A' ' 91' ' ' ILE . 54.7 p -102.8 101.75 11.84 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.378 0.609 . . . . 0.0 112.122 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.84 98.6 1.79 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.734 178.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 mt -123.07 -24.11 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.711 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.446 HD13 ' OH ' ' A' ' 82' ' ' TYR . 4.4 tp -71.78 141.77 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 178.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 12.0 t80 67.96 20.18 9.23 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.722 0.809 . . . . 0.0 111.047 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 7.5 t -84.58 -43.22 14.68 Favored 'General case' 0 C--N 1.348 0.536 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.377 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.5 -107.31 0.26 Allowed Glycine 0 C--N 1.339 0.729 0 O-C-N 123.555 0.535 . . . . 0.0 112.483 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.559 ' H ' ' CD ' ' A' ' 77' ' ' PRO . 37.1 mtmt -135.24 -44.13 0.02 OUTLIER Pre-proline 0 CA--C 1.545 0.775 0 CA-C-O 118.583 -0.722 . . . . 0.0 112.531 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.559 ' CD ' ' H ' ' A' ' 76' ' ' LYS . 6.7 Cg_exo -74.9 134.32 17.84 Favored 'Trans proline' 0 C--N 1.38 2.195 0 C-N-CA 122.33 2.02 . . . . 0.0 113.292 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.569 ' HB ' ' CD1' ' A' ' 82' ' ' TYR . 1.9 pp -144.71 46.16 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.855 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -103.99 -52.33 2.97 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.846 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.7 m -58.9 -59.35 5.6 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.207 0.603 . . . . 0.0 111.945 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.8 p -57.32 -55.21 37.73 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.761 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.569 ' CD1' ' HB ' ' A' ' 78' ' ' ILE . 17.2 m-85 -54.49 -24.47 20.58 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 177.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.549 ' HA ' ' NE2' ' A' ' 135' ' ' HIS . 11.8 t -75.66 -32.65 60.26 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 122.176 0.191 . . . . 0.0 110.752 178.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -54.05 162.03 1.09 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.334 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 22.4 pttm -94.16 103.55 15.59 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.864 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 108.89 65.04 0.56 Allowed Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.95 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.6 tt -93.12 -44.97 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 140' ' ' ALA . 51.2 t60 -84.15 -13.7 52.19 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -178.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -95.5 -74.6 0.55 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -45.42 -15.35 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 114.074 1.139 . . . . 0.0 114.074 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.462 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 1.7 tt -74.18 -10.93 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 O-C-N 123.219 0.324 . . . . 0.0 111.359 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mp -127.13 -25.38 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 122.833 0.453 . . . . 0.0 110.213 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.9 -53.71 4.75 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.325 0.65 . . . . 0.0 110.66 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . 55.63 91.47 0.03 OUTLIER 'General case' 0 C--N 1.355 0.831 0 C-N-CA 124.014 0.926 . . . . 0.0 112.712 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 66.86 -6.89 0.51 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 124.244 1.017 . . . . 0.0 112.836 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -64.75 -53.51 46.0 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.059 0.544 . . . . 0.0 111.428 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.425 ' HG ' ' H ' ' A' ' 98' ' ' HIS . 1.1 tp 52.63 -167.43 0.05 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.879 0.872 . . . . 0.0 112.349 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.425 ' H ' ' HG ' ' A' ' 97' ' ' LEU . 63.7 m-70 -91.78 -6.58 51.56 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.7 m -82.21 -19.9 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 51.8 m -92.43 -24.37 18.87 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 123.342 0.401 . . . . 0.0 111.519 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt 64.66 137.18 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.101 0.96 . . . . 0.0 112.161 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 15.7 t -96.43 -29.41 13.94 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.398 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.7 tttp 72.2 -44.59 0.6 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.378 1.071 . . . . 0.0 112.277 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -92.41 119.78 32.27 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.745 0.307 . . . . 0.0 111.131 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.494 ' H ' ' HD2' ' A' ' 106' ' ' PRO . . . -96.55 -48.77 0.24 Allowed Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.339 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.494 ' HD2' ' H ' ' A' ' 105' ' ' ALA . 28.1 Cg_endo -63.04 139.75 74.96 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.166 1.911 . . . . 0.0 113.449 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.1 pp -139.21 161.94 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.156 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -88.74 -47.25 8.36 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.306 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -137.69 -52.72 0.64 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.893 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 63.8 -67.48 0.1 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.259 1.024 . . . . 0.0 112.532 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.0 t -138.61 154.09 48.66 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 122.697 0.399 . . . . 0.0 110.66 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.6 m -93.0 158.9 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.339 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 64.5 mtt -88.69 -37.05 15.84 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.754 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -92.79 121.2 33.94 Favored 'General case' 0 N--CA 1.467 0.418 0 O-C-N 123.352 0.407 . . . . 0.0 110.922 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -130.19 124.19 31.99 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.043 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mp 49.82 97.65 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.253 1.021 . . . . 0.0 112.739 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.78 -38.85 0.12 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.011 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.9 tttp -93.72 -26.08 17.16 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.421 0.45 . . . . 0.0 111.972 -179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.44 -41.85 10.07 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 123.276 0.36 . . . . 0.0 111.681 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -88.86 155.96 49.89 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 123.288 0.368 . . . . 0.0 111.624 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -80.84 -54.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.732 2.288 . . . . 0.0 113.942 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.65 -59.48 0.19 Allowed Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.876 -0.958 . . . . 0.0 113.591 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.441 ' HA ' ' OE2' ' A' ' 126' ' ' GLU . 52.2 Cg_exo -54.65 -30.84 68.0 Favored 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 123.079 2.519 . . . . 0.0 114.04 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 127' ' ' ARG . 8.1 m-20 -71.25 -29.72 65.44 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.538 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.701 ' HA ' HD12 ' A' ' 128' ' ' ILE . 6.4 mt -86.64 -19.06 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.441 ' OE2' ' HA ' ' A' ' 123' ' ' PRO . 37.5 mt-10 -65.24 -51.88 58.07 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.782 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 124' ' ' ASP . 1.9 ptp180 -57.9 -21.03 41.39 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.51 -0.768 . . . . 0.0 112.274 176.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.701 HD12 ' HA ' ' A' ' 125' ' ' ILE . 83.2 mt -77.72 -50.11 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 122.577 0.351 . . . . 0.0 111.027 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.488 HG12 ' O ' ' A' ' 144' ' ' GLY . 4.6 m -61.98 -36.28 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 4.3 m -70.71 -58.18 3.91 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.502 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 12.9 m -52.7 -29.03 24.51 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.406 HD22 ' HB1' ' A' ' 140' ' ' ALA . 17.8 mt -76.19 -46.81 26.62 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.026 0.13 . . . . 0.0 111.15 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -87.43 16.49 5.36 Favored 'General case' 0 CA--C 1.544 0.713 0 O-C-N 123.517 0.511 . . . . 0.0 110.96 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 130' ' ' SER . 3.3 tmt_? -99.58 -34.97 10.01 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.694 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.549 ' NE2' ' HA ' ' A' ' 83' ' ' SER . 75.1 m-70 -96.72 -32.9 11.93 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.561 0.538 . . . . 0.0 111.914 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.7 t70 74.72 81.08 0.11 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.227 1.011 . . . . 0.0 110.096 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.405 ' OE2' ' HB2' ' A' ' 135' ' ' HIS . 1.5 pm0 -137.11 128.18 27.7 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.088 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.68 159.47 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.396 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 96.25 -53.52 1.57 Allowed Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 88' ' ' HIS . . . -104.48 -12.87 16.27 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 123.916 0.421 . . . . 0.0 111.7 179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.46 -36.27 75.65 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.346 0.658 . . . . 0.0 112.436 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.508 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 9.9 m-20 -74.82 -34.99 62.43 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 17.5 tp -61.41 -58.81 6.7 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 123.319 0.387 . . . . 0.0 110.148 179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.488 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -51.9 -46.7 54.99 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.934 178.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.77 -39.28 91.08 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.508 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 3.1 mptm? -65.29 -49.45 69.47 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.992 0.183 . . . . 0.0 110.707 178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 25.9 mt -59.3 -30.82 68.61 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.41 0.444 . . . . 0.0 111.64 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -83.25 -10.81 58.34 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 123.001 0.188 . . . . 0.0 111.381 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -97.15 0.13 47.89 Favored 'General case' 0 C--O 1.238 0.458 0 O-C-N 123.162 0.288 . . . . 0.0 111.43 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.519 ' C ' HD12 ' A' ' 151' ' ' LEU . . . -65.68 112.89 3.89 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.519 HD12 ' C ' ' A' ' 150' ' ' ALA . 2.9 mp 72.61 -27.78 0.19 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.934 0.894 . . . . 0.0 110.873 -177.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.45 ' H ' ' C ' ' A' ' 150' ' ' ALA . 8.7 m-20 -88.12 128.05 35.42 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 123.361 0.413 . . . . 0.0 111.255 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -100.1 -42.64 6.64 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.857 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.893 179.969 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.0 m . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 111.342 0.127 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -129.61 -7.62 4.61 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 123.384 0.427 . . . . 0.0 111.459 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.32 -62.28 1.05 Allowed Glycine 0 C--N 1.341 0.81 0 C-N-CA 121.47 -0.395 . . . . 0.0 113.004 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -98.94 -45.76 5.85 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.68 0.282 . . . . 0.0 111.209 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 159.73 -137.97 5.36 Favored Glycine 0 C--N 1.339 0.714 0 O-C-N 123.523 0.515 . . . . 0.0 112.255 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -98.03 79.37 2.61 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.318 0.58 . . . . 0.0 110.66 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.46 136.99 54.58 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.087 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -102.9 96.56 6.91 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 123.647 0.592 . . . . 0.0 110.607 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -135.34 70.4 67.98 Favored Pre-proline 0 CA--C 1.548 0.89 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.102 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -80.87 -47.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 123.044 2.496 . . . . 0.0 112.69 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.0 tt -143.57 -46.67 0.28 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.438 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 63.13 154.09 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.891 0.876 . . . . 0.0 111.988 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.54 83.35 7.26 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.253 0.549 . . . . 0.0 111.464 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -120.71 -35.14 3.43 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.528 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.486 ' HA ' ' HZ2' ' A' ' 90' ' ' LYS . 12.8 t80 -83.64 99.51 10.25 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.618 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.422 ' H ' ' HZ3' ' A' ' 90' ' ' LYS . 44.1 p -120.51 20.61 11.81 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.082 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.519 ' HB2' ' NZ ' ' A' ' 90' ' ' LYS . 16.4 ttmt -91.01 105.77 18.05 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.323 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.4 tt -145.34 103.59 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.794 178.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -91.53 -23.2 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.644 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -78.94 17.96 0.68 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.4 t -85.77 137.34 32.87 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.955 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.6 -70.25 1.18 Allowed Glycine 0 C--N 1.34 0.792 0 O-C-N 123.531 0.52 . . . . 0.0 112.549 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -88.43 -42.75 0.47 Allowed Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 118.834 -0.603 . . . . 0.0 111.96 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.72 20.74 0.51 Allowed 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.415 2.077 . . . . 0.0 113.65 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.489 ' O ' ' HB2' ' A' ' 82' ' ' TYR . 2.9 tp -78.48 -5.8 8.4 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 122.718 0.407 . . . . 0.0 111.038 179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.444 ' O ' ' HB2' ' A' ' 83' ' ' SER . 37.9 tt0 -96.57 -49.73 5.01 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.817 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.7 p -54.26 -58.05 8.88 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.326 1.051 . . . . 0.0 112.595 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.7 t -60.16 -54.94 39.97 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.67 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.489 ' HB2' ' O ' ' A' ' 78' ' ' ILE . 3.4 m-85 -58.07 -16.73 14.02 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 177.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 8.4 t -86.36 -31.85 21.28 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.701 0.4 . . . . 0.0 111.255 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -46.08 165.18 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -90.37 113.88 25.87 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.212 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 90' ' ' LYS . . . 87.5 67.2 1.32 Allowed Glycine 0 C--N 1.34 0.787 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.635 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.495 HG22 ' OE1' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -91.96 -25.05 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 -179.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 140' ' ' ALA . 15.6 t60 -113.78 -32.32 6.16 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 93' ' ' GLU . 11.4 pt-20 -99.06 43.68 1.05 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 123.488 0.493 . . . . 0.0 110.707 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 86' ' ' GLY . 25.7 pttt -98.5 -35.92 10.09 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.956 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.532 ' H ' HD12 ' A' ' 91' ' ' ILE . 1.6 mp -76.09 -11.06 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.273 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.549 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 3.6 tp -116.94 5.72 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.018 0 O-C-N 123.231 0.332 . . . . 0.0 111.302 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 89' ' ' GLU . 14.1 tt0 -105.37 -41.47 5.51 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.996 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -82.87 -29.14 29.56 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.882 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -91.67 -5.49 53.7 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.206 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.549 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 6.2 t70 -74.87 142.88 44.06 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.859 0.464 . . . . 0.0 111.331 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.575 HD23 ' O ' ' A' ' 99' ' ' VAL . 0.0 OUTLIER -122.84 162.88 21.31 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.047 -179.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -84.0 -36.39 23.2 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.08 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.575 ' O ' HD23 ' A' ' 97' ' ' LEU . 7.6 p -85.74 159.03 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 O-C-N 123.415 0.447 . . . . 0.0 110.84 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.7 m -85.22 -56.55 3.48 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.414 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.2 mmmm 55.33 178.3 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.77 0.828 . . . . 0.0 112.501 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 14.6 t -87.24 -8.11 57.17 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.78 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.516 ' HD3' ' O ' ' A' ' 103' ' ' LYS . 0.0 OUTLIER -95.43 39.02 1.13 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.161 0.505 . . . . 0.0 111.272 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -86.02 173.36 9.96 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.671 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . 66.97 135.02 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.295 0 C-N-CA 124.105 0.962 . . . . 0.0 112.056 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.21 163.54 38.38 Favored 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 122.622 2.215 . . . . 0.0 113.319 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 mt -121.55 -8.87 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.843 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -93.43 126.46 38.58 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.147 0.28 . . . . 0.0 111.082 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -135.29 152.9 51.94 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.715 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 63.03 148.85 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.943 0.897 . . . . 0.0 112.883 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.1 p -97.38 155.95 16.68 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.998 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.0 p -93.76 -41.15 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.388 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 85.9 mmm -136.74 108.86 7.21 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 120.878 0.37 . . . . 0.0 111.053 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.9 91.16 1.9 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.371 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.91 126.29 11.55 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.752 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.8 mt -112.74 -40.83 3.93 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.805 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -89.07 100.72 13.44 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.42 0.628 . . . . 0.0 111.279 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -179.77 -44.04 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.197 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.91 -17.91 12.8 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.357 0.41 . . . . 0.0 111.665 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 31.4 m-85 -94.15 135.22 24.75 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-O 119.323 -0.37 . . . . 0.0 111.184 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 5.4 Cg_exo -78.21 -36.32 1.04 Allowed 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.467 2.111 . . . . 0.0 113.1 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 164.64 -59.21 0.26 Allowed Glycine 0 CA--C 1.53 0.976 0 CA-C-O 118.924 -0.931 . . . . 0.0 113.227 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.503 ' HA ' ' OE2' ' A' ' 126' ' ' GLU . 52.0 Cg_exo -56.49 -30.38 82.01 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 122.931 2.421 . . . . 0.0 114.096 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -65.89 -30.04 70.57 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 123.269 0.355 . . . . 0.0 111.844 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.546 ' HA ' HD12 ' A' ' 128' ' ' ILE . 10.9 mt -81.68 -31.19 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.503 ' OE2' ' HA ' ' A' ' 123' ' ' PRO . 42.7 mt-10 -56.26 -47.65 78.14 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.55 178.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.45 -16.8 61.65 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 177.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 125' ' ' ILE . 76.0 mt -78.16 -51.06 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 144' ' ' GLY . 3.7 m -63.03 -35.32 71.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 134' ' ' ARG . 4.9 m -73.2 -56.51 4.99 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.387 0.429 . . . . 0.0 111.37 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.8 m -56.13 -24.61 41.93 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.401 HD22 ' HB1' ' A' ' 140' ' ' ALA . 25.9 mt -79.97 -51.63 8.84 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 122.929 0.143 . . . . 0.0 111.017 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -85.06 16.16 3.65 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 123.453 0.47 . . . . 0.0 111.312 178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 130' ' ' SER . 2.0 tmt_? -79.6 -42.78 24.21 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.27 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.438 ' CE1' HH11 ' A' ' 134' ' ' ARG . 91.2 m-70 -96.96 -11.88 24.07 Favored 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.135 0.272 . . . . 0.0 111.242 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.1 t70 67.83 55.85 0.58 Allowed 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.129 0.972 . . . . 0.0 110.969 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.495 ' OE1' HG22 ' A' ' 87' ' ' ILE . 11.1 pt-20 -88.99 124.46 34.29 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.936 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.07 -8.17 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.825 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.99 -26.89 20.69 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.417 -0.42 . . . . 0.0 112.857 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.483 ' HB2' ' HB2' ' A' ' 88' ' ' HIS . . . -121.81 6.05 9.93 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 122.807 0.443 . . . . 0.0 111.613 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -34.63 78.61 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.541 ' O ' ' HD3' ' A' ' 146' ' ' LYS . 2.8 t70 -78.81 -34.62 45.19 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.596 0.236 . . . . 0.0 110.899 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 10.7 tp -64.45 -68.97 0.31 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.846 179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.524 ' O ' HG12 ' A' ' 129' ' ' VAL . . . -48.81 -43.72 30.4 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 114.843 0.697 . . . . 0.0 114.843 178.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.5 96.69 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.541 ' HD3' ' O ' ' A' ' 142' ' ' ASP . 14.4 mptt -60.86 -49.74 76.24 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.995 0.184 . . . . 0.0 110.896 178.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 35.8 mt -57.56 -30.45 65.25 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.405 0.441 . . . . 0.0 112.05 177.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -80.18 -35.98 35.62 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 120.565 0.221 . . . . 0.0 110.67 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -78.84 8.93 4.71 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.988 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -79.83 -4.65 53.09 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 122.61 0.364 . . . . 0.0 111.749 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 6.1 tt -93.91 -42.89 8.83 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.583 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -83.31 157.88 22.43 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 123.407 0.442 . . . . 0.0 111.022 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 72.41 -45.57 0.62 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.474 1.11 . . . . 0.0 112.3 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.904 180.0 . . . . . . . . 0 0 . 1 stop_ save_